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I - Curriculum Vitae 
 
1) Civil status  
 
Name:  Hatt Mathieu 
Birth date and place:  October the 5th, 1981 in Strasbourg, France 
Nationality:    French 
            Marital status:     Single 
 
2) Education (France) 
  2008: PhD from the University of Brest, with highest honors. 
« Automatic determination of functional volumes in emission imaging for oncology 
applications » -1st prize of IEEE France for best biomedical thesis in 2008. 
  2004: Master in computer sciences from the University of Strasbourg, with honors. 
Options: image processing, artificial intelligence, parallel computing, networks, 
algorithmic for graphics, bioinformatics. 
  2002: Licence in computer sciences from the University of Strasbourg. 
  1999: Scientific baccalauréat, specialization in physics and chemistry, with honors. 
 
 
3) Research formation 
  11/2011-present Stichting Maastricht Radiation Oncology (MAASTRO), Maastricht, 
the Netherlands. Director: Prof. P. Lambin. Supervisor : Prof. P. Lambin. 
  2005-2011 Laboratory of medical information processing (LaTIM INSERM U650), 
Brest. Director: Pr. C. Roux. Supervisor: DR D. Visvikis. 
  2004: 6 months trainee in the laboratory of sciences of image, computer sciences and 
remote sensing (LSITT UMR 7005), Strasbourg. 
Supervisors: Prof. C. Collet and F. Salzenstein. 
 
 
4) Additional formation 
  2006: 7th IEEE EMBS International Summer School on Biomedical Imaging, Berder 
Island, France.  2010: visiting fellow in MRC clinical center, Hammersmith Hospital, London, UK. 
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II - Professional experience 
 
2002-2003:  Trainee (two voluntary training periods of 2 months from July to August) as a 
computer scientist in training, in the astronomical observatory of Strasbourg 
(UMR 7550), stellar datacenter of Strasbourg (CDS). 
 In charge of JAVA developments for SIMBAD stellar catalogs 
interface under the supervision of M. Wenger. 
 
2003-2004:  Trainee in the laboratory of sciences of image, computer sciences and remote 
sensing (LSITT UMR 7005) for 1st and 2nd year 6 months projects of master in 
computer sciences.  
 Team « automation, vision and robotics » for the design of an expert 
system for robot control under the supervision of S. Besse.  
 Team « models, images and vision » for the development of fuzzy 
hidden Markov chains for astronomical images segmentation under the 
supervision of C. Collet and F. Salzenstein.  
 
2005-2008:  PhD student in the laboratory of medical information processing (LaTIM 
INSERM U650), team « Quantitative multi modality imaging for diagnosis and 
therapy » under the supervision of D. Visvikis and C. Roux 
 Development of methodologies dedicated to metabolically active tumor 
volume delineation in PET images for oncology applications. 
 
2009-2011:  Post-doc fellow in the laboratory of medical information processing (LaTIM 
INSERM U650), team « Quantitative multi modality imaging for diagnosis and 
therapy ». 
 Principal investigator on ANR project SIFR1 and in charge of 
supervising trainees and PhD students in the team. 
 
2011-2012: Research fellow in the imaging and radiotherapy research department, 
MAASTRO lab, Maastricht, the Netherlands. 
 In charge of collaborative research projects regarding the use of 
PET/CT imaging for the prediction of therapy response and prognosis 
in radiotherapy. Co-supervising two PhD students. 
                                                 
1
 Segmentation of functional images for radiotherapy, ANR TEC 2008, 500k€ (250k€ funded by ANR). 
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III - Educational activities 
 
1) Supervision and co-supervision of trainees and PhD students in the LaTIM 
 
PhD students (supervision) 
 2009-2011: Simon David (thesis viva 13/12/2011) 
Image analysis for therapy response studies in PET 
 2009-2011: Amandine Le Maître (thesis viva 1st semester of 2012) 
Realistic simulations, automatic segmentation and dosimetry in PET/CT imaging 
 2011-2013: Houda Hanzouli (started October 2011) 
Multi resolution image analysis for multi modal imaging 
PhD students (co-supervision) 
 2008-10: Adrien Le Pogam (thesis viva 04/2010) 
Partial volume effects correction in emission imaging 
 2010-12: Florent Tixier (thesis viva 2012) 
Characterization of tracer uptake heterogeneity in PET using textural features 
 
Trainees (supervision) 
 2011: M. Sayed (ISEN engineer, 3 months) (collaboration with INSERM U613, Brest) 
Automatic registration of fluorescence images of mice for gene transfer applications 
 2010: T. Merlin (ISEN engineer, 6 months) 
Development and validation of an automatic algorithm for estimation and comparison 
of PET delineations for oncology 
Trainees (co-supervision) 
 2011: Hela Rezgui (ENSI engineer, 9 months) 
Multivariate analysis for prognosis and response prediction in esophageal and head 
& neck cancers 
 2011: Houda Hanzouli (ENSI engineer, 6 months) 
PET images denoising using combined wavelet and curvelet transforms 
 
2) Teaching (University of Brest) 
 
Since 2010: DES of radiotherapy 
PET Physics and use of PET imaging in radiotherapy applications 
15h / year 
 
Since 2009: master 2 SIBM (Signal and Image in Biology and Medicine) 
PET/CT imaging, digital medical image processing, PET quantification 
9h / year 
Advanced image segmentation techniques and applications in medical imaging 
3h / year 
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IV - Publications and communications 
 
1)  Original articles in peer-reviewed journals 
 
1. A. Le Maitre, D. Visvikis, C. Cheze-Le Rest, O. Pradier, M. Hatt. Dose prescription adapted to 
functional tumor 18F-FDG heterogeneities: the influence of contrast and size of sub-volumes. Physics 
in Medicine and Biology 2012; in revision 
 
2. S. David, D. Visvikis, Q. Quellec, P. Fernandez, M. Allard, C. Roux, M. Hatt. Image change 
detection using paradoxical theory for patient follow-up quantitation and therapy assessment. IEEE 
Transactions on Medical Imaging 2012; in revision. 
 
3. F. Tixier, M. Hatt, C. Cheze Le Rest, A. Le Pogam, L. Corcos, D. Visvikis. Reproducibility of 
tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET 
imaging. Journal of Nuclear Medicine 2012; in press. 
 
4. M. Hatt, A. Le Pogam, D. Visvikis, O. Pradier, C. Cheze le Rest. Impact of partial volume effects 
correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal 
cancer. Journal of Nuclear Medicine 2012;53(1):12-20. 
 
5. M. Hatt, C. Cheze le Rest, A. van Baardwijk, P. Lambin, O. Pradier,  D. Visvikis. Impact of tumor 
size and tracer uptake heterogeneity in 18F-FDG PET and CT Non–Small Cell Lung Cancer tumor 
delineation. Journal of Nuclear Medicine 2011;52(11):1690-7. 
 
6. S. David, D. Visvikis, C. Roux, M. Hatt. Multi observation PET image analysis for patient follow-
up quantitation and therapy assessment. Physics in Medicine and Biology 2011;56(18):5771-88. 
[Featured free article as editor’s choice] 
 
7. A. Le Pogam, M. Hatt, P. Descourt, N. Boussion, C. Tsoumpas, FE. Turkheimer, C. Prunier-Aesch, 
J-L. Baulieu, D. Guilloteau, D. Visvikis. Evaluation of a 3D local multi-resolution algorithm for the 
correction of partial volume effects in positron emission tomography. Medical Physics 
2011;38(9):4920-4933. [Cover of the issue] 
 
8. M. Hatt, D. Visvikis, O. Pradier, C. Cheze-le Rest. Baseline 18F-FDG PET image derived 
parameters for therapy response prediction in œsophageal cancer. European Journal of Nuclear 
Medicine and Molecular Imaging 2011;38(9):1595-1606. 
 
9. M. Hatt, D. Visvikis, N. M. Albarghach, F. Tixier, O. Pradier, C. Cheze-le Rest. Prognostic value 
of 18F-FDG PET image-based parameters in œsophageal cancer and impact of tumor delineation 
methodology. European Journal of Nuclear Medicine and Molecular Imaging 2011;38(7):1191-1202. 
 
10. F. Tixier, C. Cheze Le Rest, M. Hatt, N. M. Albarghach, O. Pradier, J-P. Metges, L. Corcos, D. 
Visvikis. Intra-tumor heterogeneity characterized by textural features on baseline 18F-FDG PET 
images predicts response to concomitant radio-chemotherapy in esophageal cancer. Journal of Nuclear 
Medicine 2011;52(3):369-378. 
 
11. M. Hatt, C. Cheze le Rest, N. M. Albarghach, O. Pradier, D. Visvikis. Robustness and 
repeatability of image segmentation approaches dedicated to PET tumor uptake volume delineation. 
European Journal of Nuclear Medicine and Molecular Imaging 2011;38(4):663-672. 
 
12. M. Hatt, C. Cheze-Le Rest, E. O. Aboagye, L. M. Kenny, L. Rosso, F. E. Turkheimer, N. M. 
Albarghach, O. Pradier, D. Visvikis. Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine 
PET Tumor Volume Measurements. Journal of Nuclear Medicine 2010;51(9):1368-1376. 




13. M. Hatt, C. Cheze le Rest, P. Descourt, A. Dekker, D. De Ruysscher, M. Oellers, P. Lambin, O. 
Pradier,  D. Visvikis. Accurate automatic delineation of heterogeneous functional volumes in positron 
emission tomography for oncology applications. International Journal of Radiation Oncology Biology 
Physics  2010;77(1):301-308. 
 
14. A. Le Maitre, W.P. Segars, S. Marache, A. Reilhac, M. Hatt, S. Tomei, C. Lartizien, D. Visvikis. 
Incorporating patient specific variability in the simulation of realistic whole body 18F-FDG 
distributions for oncology applications. Proceedings of the IEEE Special Issue on Computational 
anthropomorphic anatomical models, 2009;97(12):2026-2038. 
 
15. M. Hatt, C. Cheze le Rest, A. Dekker, D. De Ruysscher, M. Oellers, P. Lambin, C. Roux,  D. 
Visvikis. Une nouvelle méthode de détermination automatique des volumes fonctionnels pour les 
applications de l'imagerie d'émission en oncologie. Ingénierie et Recherche BioMédicale (numéro 
spécial RITS 2009) 2009;34(4):144-149. 
 
16. M. Hatt, A. Turzo, C. Roux, D. Visvikis. A fuzzy locally adaptive Bayesian segmentation 
approach for volume determination in PET. IEEE Transactions on Medical Imaging 2009;28(6):881-
893. 
 
17. N. Boussion, C. Cheze Le Rest, M. Hatt, D. Visvikis. Incorporation of wavelet based denoising in 
iterative deconvolution for partial volume correction in whole body PET imaging. European Journal 
of Nuclear Medicine and Molecular Imaging 2008;36(7):1064-75. 
 
18. N. Boussion, M. Hatt, F. Lamare, C. Cheze Le Rest, D. Visvikis. Contrast enhancement in 
emission tomography by way of synergistic PET/CT image combination. Computer Methods and 
Programs in Biomedicine 2008;90(3):191-201. 
 
19. M. Hatt, F. Lamare, N. Boussion, A. Turzo, C. Collet, F. Salzenstein, C. Roux, K. Carson, P. 
Jarritt, C. Cheze-Le Rest, D. Visvikis. Fuzzy hidden Markov chains segmentation for volume 
determination and quantitation in PET. Physics in Medicine and Biology 2007;52(12):3467-3491. 
 
20. F. Salzenstein, C. Collet, S. Lecam, M. Hatt. Non-stationary fuzzy Markov chain. Pattern 
Recognition Letters 2007;28(16):2201-2208. 
 
21. N. Boussion, M. Hatt, F. Lamare, Y. Bizais, A. Turzo, C. Cheze-Le Rest, D. Visvikis. A multi 
resolution image based approach for correction of partial volume effects in emission tomography. 
Physics in Medicine and Biology 2006;51(7):1857-18766. 
 
 
2) Reviews in peer-reviewed journals 
 
M. Hatt, N. Boussion, C. Cheze-le Rest, D. Visvikis, O. Pradier. Metabolically active volumes 
automatic delineation methodologies in PET imaging: review and perspectives. Cancer/Radiothérapie 
2011; online in october. 
 
3) Letters to the editor of peer-reviewed journals 
 
M. Hatt, D. Visvikis, C. Cheze Le Rest. Regarding Autocontouring and Manual Contouring: Which Is 
the Better Method for Target Delineation Using 18F-FDG PET/CT in Non–Small Cell Lung Cancer? 
By K. Wu et al. Journal of Nuclear Medicine 2011;52(4):658. 
 
M. Hatt, D. Visvikis. Defining radiotherapy target volumes using 18F-Fluoro-Deoxy-Glucose Positron 
Emission Tomography: still a Pandora box?: in regard to Devic et al. International Journal of 
Radiation Oncology Biology Physics 2010; 78(5):1605. 




4) Book chapters 
 
M. Hatt, D. Visvikis, Chapitre 4 : Tomographie par émission de positons et tomographie d’émission 
monophotonique dynamiques, in 'Imagerie Dynamique Cardiaque : Systèmes et Techniques 
d'acquisition', P. Clarysse & F. Frouin publishing, 2011. 
 
5) Communications and invited talks in peer-reviewed international conferences 
 
See appendix for full list. 
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V - Scientific societies, grants, industrial and research partnerships, awards 
 
Scientific societies and professional committees 
 
 Member of the following scientific societies 
  IEEE (Institute of Electrical and Electronics Engineers)  AAPM (American Association of Physicists in Medicine)  SNM (Society of Nuclear Medicine)  SFGBM (French Society of BioMedical enGineering) 
 
 Member of AAPM Taskgroup n° 211 2 
Classification, Advantages and Limitations of the Auto-Segmentation Approaches for PET 
 
 Member of SNM computer & instrumentation council 
 
 Substitute member for France of COST European action TD-10-07 3 
Bimodal molecular imaging technologies coupling PET and MRI for in vivo visualization 
of pathologies and biological processes 
 
 Associate editorial board member of the American Journal of Nuclear Medicine and 
Molecular Imaging4 
 
 Referee for the following journals: 
  European Journal of Nuclear Medicine  IEEE Transactions on Medical Imaging  IEEE Transactions on Information Technology in BioMedicine  IEEE Transactions on Nuclear Science  Journal of Applied Clinical Medical Physics   Journal of Nuclear Medicine  Journal of Nuclear Medicine and Radiation Therapy  Medical Physics  Physics in Medicine and Biology 
 
Grants 
 French national research agency (ANR, 250 k€) 
 Ligue contre le cancer (30 k€) 
 Institut Telecom (55 k€) 


















 CHRU Brest 
 CHRU Bordeaux 
 CHRU Toulouse 
 
International 
 MAASTRO lab – Maastricht (The Netherlands) 
 Nijmegen (The Netherlands). 
 CHU Liège (Belgium) 
 MRC Clinical Sciences Centre Hammersmith (London, UK) 
 UCLH (University College London Hospital) (London, UK) 
 Royal Surrey County Hospital (Guilford, UK) 
 University of Wisconsin, Madison (USA) 
 University of Seattle, Washington (USA) 
 University of Maryland, Baltimore (USA) 
 MD Anderson, Houston, Texas (USA) 
 University of Washington (Seattle, USA) 
 Munich (Germany) 
 Freiburg (Germany) 
 
Industrial partnerships 
 Research agreements with Philips Healthcare and Siemens Healthcare regarding the 
exploitation of the PET segmentation FLAB algorithm 
 
Awards 
 « Best-in-physics » paper in AAPM annual meeting 20115. 
 « Young investigators award » of the New trends in molecular imaging and nuclear 
medicine conference, 2009. 
 « 1st prize research » for best biomedical PhD thesis in 2008, from IEEE-France. 
 Travel grant from NSS-MIC 2008 conference based on the « scientific excellence of the 
submitted contribution ». 
 
Other assignments in the laboratory 
 
 In charge of the internal review committee for the articles written within the group 
 
 Delegate for the post-doc fellows of the laboratory. 
 In charge of the organization and planning for the monthly meeting of the laboratory.
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Résumé en français (French summary) 
 
Avec une formation initiale en sciences de l’informatique et une spécialisation image, mes 
activités de recherche actuelles concernent le traitement et l’analyse de l’information et de 
l’image pour des applications en médecine, plus particulièrement l’oncologie et la 
radiothérapie. Plus spécifiquement, je m’intéresse à la segmentation et la classification 
automatique pour la définition des contours d’organes et de tumeurs, au filtrage du bruit et à 
la déconvolution pour l’amélioration qualitative et quantitative, et plus récemment, aux 
modèles multi observation pour la prise en compte des images multi modales, et la fusion 
d’informations pour l’aide à la décision dans la prise en charge des patients. Je poursuis ces 
thématiques spécifiquement dans le cadre de l’utilisation de l’imagerie TEP/TDM 
(Tomographie par Emission de Positons et scanner X) en oncologie et radiothérapie. 
Mes activités de recherche ont pris place dans le contexte de l’équipe « imagerie multi modale 
quantitative pour le diagnostic et la thérapie » du laboratoire INSERM U650 de traitement de 
l’information médicale (LaTIM). Ce contexte a garantit un travail d’équipe pluridisciplinaire, 
en collaboration notamment avec des radiothérapeutes, des médecins nucléaires, des 
physiciens, des ingénieurs, des mathématiciens et des informaticiens. 
En tant que doctorant, ma principale contribution a été le développement d’une méthode 
originale de segmentation d’image adaptée à la définition des volumes fonctionnels des 
tumeurs sur les images TEP. Lors de mon post-doctorat, j’ai poursuivi la validation de la 
précision, de la robustesse et de la reproductibilité de cette approche dans le cadre d’un projet 
ANR pour lequel j’ai reçu un financement de deux ans et demi. J’ai également étudié au cours 
de ces deux dernières années l’impact d’une telle méthode dans de nombreuses  applications, 
telles que la dosimétrie en planification de traitement en radiothérapie, et la prise en charge 
des patients en oncologie. 
Au cours de ces six dernières années, j’ai été de plus en plus impliqué dans des travaux de 
recherche connexes menés par d’autres doctorants et post-doctorants. Ces travaux incluent la 
fusion d’images TEP pour le suivi temporel quantitatif, les simulations réalistes et 
l’évaluation dosimétrique, la caractérisation de l’hétérogénéité intra tumorale des traceurs 
TEP par analyse de texture, et la réduction des effets de volume partiel et du bruit en imagerie 
d’émission. J’ai assumé la responsabilité de co-encadrant de plusieurs stagiaires et doctorants 
de l’équipe sous la direction du directeur de recherche D. Visvikis. Cette responsabilité inclus 
des réunions hebdomadaires et des discussions régulières avec les étudiants, l’aide à la mise 
en place des expériences et protocoles de validation, à l’analyse des résultats, la correction de 
rapports de stage, d’articles et de manuscrits de thèse, ainsi que réfléchir à des solutions aux 
problèmes tant théoriques que techniques. Je travaille actuellement en tant que chercheur 
associé au département de recherche en imagerie et radiothérapie de Maastricht (MAASTRO) 
aux Pays-bas. 
 Au cours des prochaines années, mon projet de recherche sera dédié au développement 
d’un contexte flexible et robuste permettant la modélisation et l’analyse semi-automatique 
d’ensemble d’images médicales multi modales, multi résolutions et multi temporelles, telles 
que TEP/TDM, TEMP/TDM, TEP/IRM, multi IRM ou TEP avec différents traceurs, ainsi que 
des acquisitions dynamiques. Ce développement permettra de déduire de nouveaux modèles 
prédictifs et des outils de décision adaptés à diverses applications cliniques tels que les 
cancers de l’œsophage, rectal, pulmonaire ou ORL, par la fusion de toute l’information 
disponible (imagerie, génétique, phénotypes et rapports cliniques). Ce projet se construira en 
partie sur les travaux préliminaires réalisés avec des doctorants venant de soutenir et en passe 
de terminer leur thèse, et sur les thèses de deux nouvelles doctorantes que j’encadrerai à partir 
d’octobre 2011 et courant 2012, recrutées sur des financements que j’ai contribué à obtenir en 
2010-2011. 
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VI - Overview of past and present research activities 
 
With an initial formation in theoretical computer sciences with a focus on image 
processing and analysis, my current research activities deal with image and information 
processing and analysis for applications in medicine, namely oncology and radiotherapy. 
More specifically, my research interests are image automatic segmentation and classification 
for organs and tumors delineation, image denoising and deconvolution for qualitative and 
quantitative improvement, and more recently, multi observation models for multi modal 
imaging and information fusion for computer-aided decision making in patients management. 
These developments are especially considered within the context of the use of Positron 
Emission Tomography and Computed Tomography (PET/CT) for oncology and radiotherapy 
applications. 
My research activities have been and are still carried out within the team “quantitative 
multi modal imaging for diagnosis and therapy”, in the LaTIM INSERM U1101. This 
framework ensures a multi disciplinary teamwork, in collaboration with radiation oncologists, 
nuclear medicine physicians, physicists, engineers, mathematicians and computer scientists.   
As a PhD student, my main contribution to the field has been the development of image 
segmentation algorithms dedicated to the automated delineation of metabolically active tumor 
volumes in PET images, with a specific focus on adapting the methodology to specific 
characteristics of the processed images. As a post-doctoral fellow, I have been further 
investigating the accuracy, robustness and reproducibility of this methodology within a 
project for which I had obtained funding from the French research agency (ANR) for two and 
a half years. I have also been investigating the impact of such methodology and its resulting 
tumor volumes measurements in various applications such as the dosimetry impact in 
radiotherapy treatment planning or patient management and therapy assessment in oncology. 
During the last six years I have also been more and more involved in research 
developments by several PhD students and post-doctoral fellows, such as PET images fusion 
for quantitative follow up, realistic simulations and dosimetry evaluation, methodologies for 
reduction of partial volume effects and noise in emission imaging, and textural features 
analysis for characterization of tracer uptake heterogeneity within tumors. Overall, I have 
been acting as co-supervisor of most of the trainees and PhD students of the team under the 
direction of Research Director D. Visvikis. This responsibility included weekly meetings and 
discussions with the students, help with designing experiments and analyzing the results, 
writing of thesis reports and research articles, as well as finding solutions to theoretical 
problems and technical issues. 
In the next few years, my research project will be focused on the development of a 
robust and flexible framework for the modeling and the automatic analysis of multi modality, 
multi resolution, multi observation and multi temporal images datasets, such as PET/CT, 
SPECT/CT, PET/MRI, multi MRI or PET tracers imaging, as well as dynamic acquisitions. 
This development will allow deriving new predictive models and decision tools by fusion of 
the available multi source information (imaging, genetics and other clinical data), validated in 
various models such as esophageal, rectal, lung, or head & neck cancers. Additional 
applications in neurology (for example Alzheimer’s disease) might also be explored. This 
project will be based on previous developments by PhD students that are almost finished with 
their thesis, and will focus on new PhD students beginning their work under my supervision 
in October 2011 and early 2012, whose recruitment was possible thanks to grants I 
contributed to obtain in 2010-2011. 
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1. Research during the PhD 
A. PhD methodological developments 
 
One of the main factors of error for semi-quantitative analysis in positron emission 
tomography (PET) imaging for diagnosis and patient follow up (1), as well as new flourishing 
applications like image guided radiotherapy (2), is the methodology used to define the 
volumes of interest in the functional images. This is explained by poor image quality in 
emission tomography resulting from noise  and partial volume effects (3) induced blurring, as 
well as the variability of acquisition protocols, scanner models and image reconstruction 
procedures (4). Manual delineation of the metabolically active tumor volumes (MATV) is 
extremely subjective and suffers from major inter and intra observer variability (5). In 
addition, it is especially tedious and time consuming; therefore it is never used in clinical 
practice. The majority of previously published approaches were based at the time (before 
2005) on deterministic binary thresholding (6) that are not robust to contrast variation and 
noise (7). In addition, these methodologies are unable to correctly handle heterogeneous 
uptake inside tumors (8). The objective of my thesis was to develop an automatic, robust, 
accurate and reproducible 3D image segmentation approach for the functional volumes 
determination of tumors of all sizes and shapes, and whose activity distribution may be 
strongly heterogeneous. The approach I have developed is based on a statistical image 
segmentation framework, combined with a fuzzy measure, which allows to take into account 
both noisy and blurry properties of emission images (9). A first development was carried out 
using fuzzy hidden Markov chains as a spatial model [1], which gave satisfying results except 
for small structures (either small lesions or small sub volumes within a lesion, as well as 
complex shapes and contours) [2]. A second development was carried out to solve these 
issues and was named FLAB for Fuzzy Locally Adaptive Bayesian [3]. It still exploited a 
stochastic iterative parameters estimation and a fuzzy measure as in the first method, however 
the hidden Markov chains model was replaced by a locally adaptive model of the voxel and 
its neighbors for the estimation and segmentation. This method was also improved in order to 
be able to consider up to three classes in the images, in order to account for heterogeneous 
activity (either in the background or within the tumor). FLAB was evaluated using a large 
array of datasets, comprising both simulated and real acquisitions of phantoms and tumors. 
The results obtained on phantom acquisitions allowed validating the accuracy of the 
segmentation with respect to the size of considered structures, down to 13-17 mm in diameter 
as well as its robustness with respect to noise, contrast variation, and acquisition parameters. 
The performance of the developed algorithm was shown to be superior to threshold-based 
methodologies and other clustering algorithms. The results demonstrated the ability of the 
developed approach to accurately delineate tumors with complex shapes and activity 
distributions, as illustrated in figure 1, in which the result of FLAB is compared to the results 
on an adaptive threshold approach used by two different clinicians on patient image with an 
esophageal lesion. This illustrates well the ability of FLAB to obtain a complete tumor 
volume in case of heterogeneous activity, contrary to the adaptive threshold approach. It also 
emphasizes the lack of repeatability of the adaptive threshold method due to heterogeneous 
background uptake in the mediastinum. 
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 The FLAB algorithm was also able to delineate multiples regions inside the tumor [4]. 
Some of the datasets used for the accuracy evaluation were generated using realistic Monte 
Carlo simulations that were improved in several ways in collaboration with another PhD 
student (A. Le Maitre), including patient-specific anatomical properties and complex non 
spherical shaped tumors exhibiting heterogeneous tracer uptake [5]. Both robustness and 
accuracy results demonstrated that the proposed methodology may be used in clinical context 
for diagnosis and patients follow up, as well as for radiotherapy treatment planning and "dose 
painting", facilitating optimized dosimetry and potentially reduced doses delivered to healthy 
tissues around the tumor and nearby organs. 
 
[1] F. Salzenstein, C. Collet, S. Lecam, M. Hatt, Non-stationary fuzzy Markov chain, PRL 2007 
[2] Hatt et al. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in 
PET, PMB 2007 
[3] Hatt et al. A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET, 
IEEE TMI 2009 
[4] Hatt et al. Accurate automatic delineation of heterogeneous functional volumes in positron emission 
tomography for oncology applications, IJROBP 2010 
[5] A. Le Maitre, W.P. Segars, S. Marache, A. Reilhac, M. Hatt, et al. Incorporating patient specific 
variability in the simulation of realistic whole body 18F-FDG distributions for oncology applications, 
Proceedings of the IEEE 2009 
 
This work was recognized by an award co-delivered by the French section of the IEEE and 
the French society of biomedical engineering (SFGBM) for the best research PhD thesis in 
biomedical imaging defended in 2008. A conference paper describing the latest developments 
and validation of the FLAB approach was recognized in 2008 by the IEEE-Medical Imaging 
Conference committee through a trainee grant based on the scientific excellence of the 
contribution. According to Google Scholar, the four methodological papers [1-4] add up to 
more than 100 citations, almost 50 of them for the FLAB paper [3]. 
 
 
 Fig.1 Coronal, sagital and axia views of a 18F-FDG PET image of a patient with esophageal cancer (large heterogeneous MATV). Delineation (blue contours) using 
FLAB (on the left) and adaptive threshold with two different observers (on the right and in the middle). Note the significant underestimation obtained with adaptive 
threshold (both users) due to the heterogeneity. 
B. Additional methodological developments 
 
There are numerous other pitfalls and sources of errors in PET imaging. Most importantly, 
the level of noise and its characteristics, as well as partial volume effects (PVE), lead to 
significant quantitative biases and qualitatively degraded images (4). Both aspects are also 
closely related to the problem of automatic delineation of PET images. Therefore, during my 
PhD I have been working closely with a post-doctoral fellow (N. Boussion) and a fellow PhD 
student in the team (A. Le Pogam), on denoising and deconvolution methodologies dedicated 
to emission imaging. I have contributed to several developments, including two PVE 
correction methods and a denoising approach. The first methodology was based on the use of 
anatomical high resolution details from the co-registered morphological images (such as CT 
or MRI) in order to correct for the spill in and spill out effects of partial volume effects in the 
associated functional dataset. This Mutual Multi resolution Analysis (MMA) method 
exploited spatial-frequency analysis, namely wavelet transforms, and extracted structural 
details from these decompositions in order to derive a model linking both image modalities 
[1-2]. Another approach was also developed in order to correct for PVE in emission images 
without requiring associated high resolution anatomical datasets, or in cases (and there are 
many) for which no spatial correlation between the morphological and functional datasets can 
be exploited. This second approach was based on iterative deconvolution (10-11), which is a 
well known method for improving spatial resolution of images. However, such algorithms are 
associated with increased noise levels in the deconvolved images, which is not compatible 
with their subsequent clinical use. Therefore, we designed a denoising methodology dedicated 
to emission imaging, based on the filtering of wavelet coefficients using a Bayesian based 
method to discriminate between noise and information in the wavelet domain (12). This 
methodology was then included in the iterative deconvolution process in order to control the 
noise propagation additively introduced by each iteration of the deconvolution. This allowed 
significantly reducing the blur in emission imaging without significant addition of noise. The 
validation of the method demonstrated its ability to restore accurate quantitative 
measurements in the images, while providing full whole-body corrected images [3]. Note that 
the developed denoising method was also considered as a standalone denoising approach for 
emission imaging (see part 2.3) 
 
[1] N. Boussion, M. Hatt, et al. A multiresolution image based approach for correction of partial volume 
effects in emission tomography, PMB 2006 
[2] N. Boussion, M. Hatt, et al. Contrast enhancement in emission tomography by way of synergistic 
PET/CT image combination, CMBP 2008 
[3] N. Boussion, C. Cheze Le Rest, M. Hatt, et al. Incorporation of wavelet based denoising in iterative 
deconvolution for partial volume correction in whole body PET imaging, EJNM 2008 
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2. Post-doctoral work  
  
During the last few months of my PhD, I applied for a research grant to the French 
National Research Agency (ANR Emergence TEC 2008 call to projects) and received a 250k€ 
grant for two and a half year for a project named SIFR (segmentation of functional images for 
radiotherapy, complete cost 500k€). 
The goals of this project were to i) further validate the automatic delineation algorithm 
proposed during my PhD and ii) investigate its impact and value in the clinical setting through 
various studies.  
The following describes my main research activities within this SIFR project, which included 
supervision of trainees and PhD students, as well as other contributions to additional 
methodological developments carried out in the team by various students under my co-
supervision. 
 
A. Robustness, repeatability and reproducibility of MATV measurements in PET 
imaging 
 
Automatic delineation approaches for MATV measurements in PET images may be of 
interest for applications such as target volume definition in radiotherapy for scenarios of dose 
redistribution, boosting or painting (13), and oncology applications such as diagnosis, 
prognosis and prediction or assessment of response to therapy (early or late during treatment) 
(1, 14). Their use however faces several pitfalls.  
 
First, there is a clear lack of standardization of acquisition and reconstruction protocols across 
clinical centers (4, 15). Each one has its own scanner model and associated vendor-specific 
iterative reconstruction algorithm (and associated pre or post filtering options and voxel sizes 
for the reconstruction grid), with a specific set of chosen and often optimized parameters for 
their specific acquisition protocols (injected dose, time between injection and acquisition, 
acquisition duration, etc). Such differences lead to images that have vastly different properties 
of noise levels, signal-to-noise ratios, textures, and spatial resolution. The robustness of the 
method used to delineate MATVs on images from different centers is therefore crucial, 
especially when considering multi-centric clinical studies. One objective was therefore to 
investigate the robustness of existing methods.  
Second, the reproducibility of PET scans is known to be limited, even with highly 
standardized acquisition and reconstruction protocols. The reproducibility of maximum 
activity measured in tumors had been previously assessed by various authors using double 
baseline PET scans (carried out at a few days interval with a procedure as identical as 
possible), and reported upper and lower reproducibility limits of about ±15 to 30% (16-17). 
These results constituted the basis for the definition of confidence intervals regarding the 
required maximum activity variation between pre and post treatment PET scans to 
characterize patient responding, stable or progressive disease in solid tumors (1). If the 
MATVs and their associated measurements (mean SUV for example) are to be used within 
the same context, it is mandatory to evaluate their reproducibility on double baseline scans, 
which was a second objective. 
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Third, the repeatability is an important characteristic of any automated approach, since one of 
the major advantages of using automatic algorithms is the low inter and intra user variability, 
with respect to manual delineation, in addition to the gain in time. The evaluation of the 
repeatability was therefore a third objective. 
 
a) Robustness 
We designed the following study for assessing the robustness of the FLAB methodology with 
respect to other existing approaches (fixed and adaptive threshold). We considered a single 
physical phantom containing spheres of various diameters that can be filled with activity, as 
well as the background, in order to create a contrast between the sphere (simulating a simple 
tumor) and the background (simulating an homogeneous physiological background). Clearly, 
such homogeneous spheres on homogeneous background are insufficient to properly validate 
the accuracy of a delineation algorithm since tumors are often non spherical and exhibit 
heterogeneous tracer uptake. However, this is a proper tool to investigate robustness of the 
delineation with respect to varying acquisition conditions. The originality of this study was to 
consider acquisitions carried out on four state-of-the-art PET/CT scanners by all three vendors 
(Siemens, GE, Philips), including a time-of-flight model (Philips), and their associated 
reconstruction algorithms (OSEM, RAMLA and MLEM) and post-filtering options. In 
addition, a protocol was designed such as for each scanner model, different acquisition 
parameters would be available: two contrasts between the spheres and the background 
(around 4-5 to 1, and 8-10 to 1), three acquisition durations (1, 2 and 5 minutes) to investigate 
the noise, and two voxel sizes used in the reconstruction (2 or 4-5 mm in each dimension). 
This allowed for a wide range of image qualities, texture and properties to investigate the 
robustness. FLAB demonstrated significantly higher robustness (lower variability of the 
results) to varying acquisition and reconstruction parameters or across scanner models than 
the other methods [1]. 
 
b) Reproducibility 
We designed the following study to investigate reproducibility of tumor volume 
measurements in PET images: two clinical datasets were considered, including esophageal 
lesions with 18F-FDG, and breast cancer with 18F-FLT, both with double baseline PET scans. 
At this occasion, I stayed as a visiting fellow in the MRC clinical center of the Hammersmith 
Hospital, in London, for the specific investigation of the reproducibility of tumor volumes 
measurements in breast cancer imaged with 18F-FLT. We demonstrated that using FLAB, 
tumor volumes could be automatically delineated on both FDG and FLT (despite the 
increased noise and lower contrast in FLT images) with reproducibility similar to the 
extraction of maximum activity with upper and lower limits of about 30%. On the contrary, 
using threshold-based methods, upper and lower limits were significantly higher (40-90%, 
consistent with another study (18)) and therefore less compatible for response monitoring 
purposes, especially early during treatment [2]. 
 
c) Repeatability 
Repeatability was investigated for FLAB and other methods in both the previous studies 
considering different simulated and real clinical datasets, demonstrating much higher 
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repeatability with the automated methods (less than a few % variability) than manual 
delineation (15-30% inter and intra observer variability) [1-2]. 
 
[1] M. Hatt, et al. Robustness and repeatability of image segmentation approaches dedicated to PET 
tumor uptake volume delineation, EJNM 2011. 
[2] M. Hatt, et al. Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume 
Measurements, JNM 2010. 
 
This work was recognized by a “young investigator award” delivered by the conference “New 
trends in molecular imaging and nuclear medicine” in 2009. Despite being relatively recent 
papers, these two papers add up to 24 citations according to Google Scholar. 
 
B. Clinical value and impact of automatic MATV delineation in oncology and 
radiotherapy 
 
Automatic delineation approaches for MATV measurements in PET images may be useful for 
several applications, for instance patient management and therapy monitoring in oncology, as 
well as tumor targeting in radiotherapy planning, dose redistribution and boosting. 
 
a) Prognosis and response to therapy prediction 
18F-FDG PET has been identified as a powerful tool for diagnosis and prognosis in several 
cancer models, such as lung, esophageal, rectal and head and neck (19). In addition, the use of 
PET has been suggested to assess treatment response after the end of treatment or earlier 
during treatment (1). Finally, it has been suggested that it may be possible to predict response 
based on the baseline scan before treatment, which could improve patients’ management. 
Potential non responders could indeed be identified before treatment, thus avoiding 
unnecessary toxicities. However, most of the studies have investigated the prognostic or 
predictive value of PET images by extracting maximum activity (SUVmax) only. In order to 
investigate the potential clinical value of accurate tumor volume delineation and the 
extraction of associated parameters from baseline 18F-FDG PET scans, we carried out a 
retrospective study on 50 patients treated for locally advanced esophageal cancer with 
concomitant radiochemotherapy. The results demonstrated that whereas standard clinical 
parameters and usual SUV measurements were neither prognostic nor predictive factors, 
measurements derived from metabolic volume were highly correlated with overall survival [1] 
or response to therapy [2], larger and more active volumes being associated with poor 
outcome and worse response. This is illustrated in figure 2. Receiver operating characteristic 
(ROC) curves are provided for the identification of complete responders or non responders, 
using various image-derived indices. MATV derived indices have significantly higher area 
under the curve (AUC) than SUV measurements. 
In both these studies we also demonstrated that more accurate prediction could be achieved 
with more accurate methods. I also took part in the investigation of additional PET derived 
indices by co-supervising a PhD student (F. Tixier) working on the spatial patterns 
characterization of the tracer uptake heterogeneity within the tumor in PET images. Tumor 
heterogeneity has been identified as a potential factor of failed treatment and its 
characterization is therefore of potentially high clinical value (20). After accurate tumor 
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volume delineation, several parameters derived from textural features analysis of the voxels 
within the tumor could provide characterization and quantification of local and regional 
heterogeneity patterns. Several of these parameters were significantly correlated with 
response, higher heterogeneity being associated with poorer or lack of response [3]. 
Therefore, we demonstrated that it may be possible to improve patient management by 
identifying potential non responders before even initiating treatment by exploiting more fully 
the information contained in the baseline PET images. However, such a more complete 
analysis requires validated and robust semi-automated tools (21). Similarly to MATV 
measurements, evaluation of the specific reproducibility of these new indices is crucial to 
identify which parameters could be used for heterogeneity characterization during treatment 
for response monitoring. Such a study has been conducted and allowed identifying several 
local and regional heterogeneity parameters with sufficient reproducibility, but also excluding 
some of them that were characterized by very high variability across double baseline scans 
[4]. 
 
[1] M. Hatt, et al. Prognostic value of 18F-FDG PET image-based parameters in œsophageal cancer and 
impact of tumor delineation methodology, EJNM 2011 
[2] M. Hatt, et al. Baseline 18F-FDG PET image derived parameters for therapy response prediction in 
œsophageal cancer, EJNM 2011 
[3] F. Tixier, C. Cheze Le Rest, M. Hatt, et al. Intra-tumor heterogeneity characterized by textural 
features on baseline 18F-FDG PET images predicts response to concomitant radio-chemotherapy in 
esophageal cancer, JNM 2011. 
[4] F. Tixier, M. Hatt, et al. Reproducibility of tumor uptake heterogeneity characterization through 
textural feature analysis in 18F-FDG PET imaging, JNM 2012; in press. 
 
 
 Fig.2: identification of complete responders (left) and non responders (right) in locally advanced esophageal cancer using SUV (max, peak or mean), or tumor 
volume (TV) and associated total lesion glycolysis (TLG, volume multiplied by mean SUV) extracted from baseline 18F-FDG PET scans. 
b) Tumor targeting and dosimetry in radiotherapy 
The use of CT images is considered the gold standard for the definition of tumor target 
volumes in radiotherapy planning (22). There is however a growing interest in including PET-
based target delineation in order to reduce inter and intra observer delineation variability 
especially in cases where the tumor morphological contours are not clearly distinguishable 
(23). Also, the use of PET in radiotherapy is being considered to derive modified treatment 
plans using boosting or redistribution of the dose to specific parts of the tumor identified as 
being more metabolically active (using FDG), proliferative (using FLT) or hypoxic (using 
CU-ATSM, HX4 or FMISO), in order to reach higher tumor control probability (TCP) (13). 
However, this potentially requires accurate delineation of tumor volumes and sub-volumes in 
PET images. We therefore conducted different studies to demonstrate the dosimetry impact of 
such accurate delineation on standard IMRT (intensity-modulated radiotherapy) plans as well 
as the interest of dose redistribution or boosting, based on PET images with different tracers. 
Most of this work was conducted under my supervision by a PhD student (A. Le maitre), 
building on our previous work regarding advanced Monte Carlo simulations (24). We used 
such simulated datasets to compare delineation results by several approaches (FLAB and 
threshold-based methods) in terms of volume errors, sensitivity and positive predictive value. 
In addition, we investigated target coverage, dose homogeneity and D95 (target volume 
receiving 95% of prescribed dose), with a specific focus on cases with heterogeneous tracer 
distribution [1]. In addition, we carried out a study on simulated and clinical datasets 
regarding the impact of contrast and size of tumor functional sub-volumes on the dose 
redistribution and dose boosting scenarios, demonstrating the TCP improvement using 
boosting if contrast between the sub-volumes within the tumor is sufficient [2]. Finally, in 
collaboration with the MAASTRO clinic in the Netherlands, I also recently investigated the 
impact of tumor size and tracer uptake heterogeneity on the gross target volume delineation of 
non-small cell lung cancer validated by histopathology data on surgical specimens. The 
results highlighted a significant correlation between morphological volume and FDG uptake 
level of heterogeneity, and confirmed the need for advanced segmentation algorithms to 
obtain accurate PET heterogeneous delineation of the target volume [3]. 
 
[1] A. Le Maître, D. Visvikis, C. Cheze-le Rest, O. Pradier, M. Hatt, Impact of the accuracy of automatic 
tumor functional volume delineation on radiotherapy treatment planning, Med Phys 2012, submitted. 
[2] A. Le Maître, D. Visvikis, C. Cheze-le Rest, O. Pradier, M. Hatt, Dose prescription adapted to 
functional tumor radiotracer heterogeneities: the influence of contrast, PMB 2012, in revision. 
[3] M. Hatt, et al, Impact of tumor size and tracer uptake heterogeneity in 18F-FDG PET and CT Non–









 C. Image fusion and paradoxical theory for therapy follow-up using sequential PET/CT 
images and multi-tracer PET images analysis 




It has been proposed to consider the analysis of sequential PET/CT scans carried out 
before, during and after treatment in order to monitor response to therapy. However until now, 
most of the studies have only considered the evolution of simple measurements like SUVmax 
(25). In addition, the use of multiple radiotracers to image different physiological processes 
(glucose consumption, cellular proliferation, hypoxia...) leads to as many images as tracers for 
a single patient (26). In both applications, the independent visual or semi-automatic analysis 
of each image might be insufficient as the correlation between images would not be fully 
exploited. In the work of a PhD student (S. David) under my supervision, we developed 
methods to automatically analyze and process multiple co-registered images, either sequential 
PET images for therapy follow-up, or the combination of different tracers, for instance to 
devise a biological target tumor volume in radiotherapy. The methods developed are based on 
multi observation fusion and classification within a Bayesian framework (27), in order to take 
into account all available information simultaneously. The approach demonstrated improved 
results with respect to independent segmentations on simulated data as well as clinical pre and 
post treatment PET images [1]. Another approach was also recently developed, based on 
paradoxical theory (Denzert-Smarandache fusion) (28) for the fusion of locally estimated 
parameters of interest [2]. Although these methods require rigid registration of multiple PET 
images and are therefore dependent on issues such as respiratory motion or anatomical 
changes during time, they could provide visual and quantitative estimation of tumor evolution 
during treatment as well as multi tracer analysis for radiotherapy target volume definition, as 
illustrated in figure 3 next page. 
 
[1] S. David, D. Visvikis, C. Roux, M. Hatt, Multi observation PET image analysis for patient follow-up 
quantitation and therapy assessment, PMB 2011 [selected as editor’s choice] 
[2] S. David, D. Visvikis, G. Quellec, P. Fernandez, M. Allard, C. Roux, M. Hatt, Image change detection 
using paradoxical theory for patient follow-up quantitation and therapy assessment, IEEE TMI 201, in 
revision. 






Fig.3: pre et post treatment PET images of a necrotic rectal cancer tumor, with corresponding fusion 
showing responding (dark blue) or stable (green) voxels, as well as different sub-volume heterogeneities 
disappearing (light blue) or appearing (red). 






D. PET image denoising and partial volume effects correction 
 
I have been involved in the improvement of PET image wavelet-based denoising process by 
co-supervising the work of a PhD student (A. Le Pogam) as well as a master 2 trainee (H. 
Hanzouli). The major disadvantage of wavelets is the lack of direction information in the 
spatial-frequency transform, and therefore contours are not well preserved in the filtered 
image. On the contrary, curvelets explicitly model contours and better preserve them, whereas 
they are not as appropriate as wavelets to describe small point discontinuities (29). A method 
was then devised to combine wavelets and curvelets to reach the best compromise between 
denoising and preservation of the important information such as contours [1]. It should be 
emphasized that this method was also incorporated in the previously described deconvolution 
technique to improve the required denoising step. Using this improved deconvolution method, 
I recently demonstrated the lack of impact of PVE correction on prognostic or predictive 
clinical value of parameters derived from baseline PET scans in locally advanced esophageal 
cancer [2], although the impact of PVE correction on lesion detectability tasks or serial PET 
scans analysis remains to be evaluated. 
I also contributed to another development of A. Le Pogam regarding the improvement of the 
partial volume effects correction method (MMA) developed in collaboration with N. 
Boussion and described previously (30). The first MMA method had two issues, first it was a 
global approach, meaning that the model linking functional and anatomical datasets was 
defined by one global parameter. The model was in addition applied to the entire image, 
independently of the correlation between datasets, which could introduce artefacts (such as 
bones from CT) in the corrected PET images. Second, it was a 2D method only. The method 
was therefore improved by designing a local and 3D model, and we demonstrated similar or 
significantly improved quantitative correction and qualitative visual aspects of the corrected 
images, with no artefacts in case of lack of correlation between the datasets [3]. This paper 
made the cover of the september issue of Medical Physics (see illustration in figure 4). 
 
[1] A. Le Pogam, H. Hanzouli, M. Hatt, et al, A combined 3-D wavelet and curvelet approach for edge 
preserving denoising in emission tomography, IEEE TMI 2012, submitted. 
[2] M. Hatt, et al, Impact of partial volume effects correction on the predictive and prognostic value of 
baseline 18F-FDG PET images in esophageal cancer, JNM 2012, in press 
[3] A. Le Pogam, M. Hatt, et al, Evaluation of a 3D local multi-resolution algorithm for the correction of 
partial volume effects in positron emission tomography, Med Phys 2011 [cover of the September issue] 
 Fig.4: PVE correction obtained with the original 2D MMA (3) versus the improved 3D local MMA (4) from the uncorrected PET (2) using details in the associated 
MRI (1). Notice the lack of artefacts in (4) with respect to the skull (red arrow) and the gadolinium injection (white cercle) that are introduced in the corrected 
image by the global approach (3). 
 VII -  Future research project 
Nowadays, the current trend in medical imaging is providing more and more images to 
characterize pathologies. Several imaging modalities have been used for decades (US, MRI, 
CT, PET), and new modalities are developed (optical imaging for instance). Existing 
modalities have also been expanded with new modes of acquisitions, providing 
complementary information, such as for instance different radiotracers in PET imaging 
beyond glucose metabolism, or various sequences with MRI. This trend has also been further 
emphasized since PET/CT multi modal devices have been introduced in the clinical setting for 
a decade now, and today with emerging PET/MRI systems, either sequential or simultaneous 
(31). The fourth dimension is also being more and more available, with significant advances 
in both hardware and software, allowing dynamic acquisitions to provide information on 
organs and tumors motion in both anatomical and functional modalities (32). It should also be 
emphasized that the dynamic nature of the acquisition can in addition be considered regarding 
the kinetics of tracers or contrast agents injected to the patients (33). In the near future, it may 
become more and more routine practice to carry out 5D acquisitions taking into account both 
temporal properties (physiological and morphological motion in addition to tracer kinetics). 
Thanks to less and less invasive procedures, another current trend in medical imaging consists 
of multiple acquisitions during the course of treatment, which may allow adaptive and 
potentially improved therapy in a variety of cancers (34-40). 
Clinicians now have access to a large array of imaging modalities and devices 
providing complementary information and various views of the human body, on both 
morphological and physiological levels. In addition, these image datasets are almost 
systematically in three dimensions and full of details, therefore rather complex and time-
consuming to fully analyze. The limitation of visual and manual analysis of one single 3D 
image dataset has already been underlined in numerous studies for specific tasks, such as for 
instance manual delineation of organs or tumors or detectability tasks. This led to restricting 
the majority of their clinical use to diagnosis or staging purposes in oncology, or sub-optimal 
treatment planning in radiotherapy. Such difficulties are exponentially increasing with the 
availability of additional 3D datasets of different imaging modalities, and/or additional 
dimensions to consider (motion, kinetics, and comparison of datasets during the course of 
treatment). A comprehensive, robust, reproducible and fast analysis of such large image 
datasets for a single patient or a patients’ cohort would be impossible without semi-automated 
dedicated tools. The first contributions to the field in my research project will therefore be 
new and innovate approaches for the semi-automated processing and analysis of multi modal, 
multi resolution, multi dimensional images datasets.  
Although primordial in today medicine, especially in oncology and radiotherapy, 
imaging is not the only source of information physicians base their decisions on. Similarly to 
the current increase of image-based data, another trend in medicine is the increase of the 
amount of data beyond imaging. Additional clinical information and data such as genetics or 
tumor biology are available and need to be taken into account. This means that this 
information may not only be correlated with imaging, but also combined with imaging for 
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increased predictive and prognostic power. A more personalized, preventive and predictive 
medicine for the future may benefit from decision aid systems combining the available data, 
both clinical and image-based (41-44). Additional contributions to the oncology and 
radiotherapy fields in my project will therefore be the development of a multi source fusion 
information framework to combine imaging and other clinical data into predictive and 
prognostic models for clinically reliable decision tools. This will require large datasets and the 
use of combined databases, which depends on local, regional, national and international 
research collaborations. 
 
1. Multi observation framework for multi modal medical imaging 
This part of my research project will be dedicated to the design and development of a 
robust and flexible mathematical and computational framework allowing to process or 
analyze complex, multi dimensional, multi resolution, multi modal co-registered images 
datasets. The goal is to design a framework that is flexible and robust enough to be able to 
carry out and implement the following fully or semi-automated complex image processing 
procedures on various image datasets such as for instance multi tracer PET images, PET/MRI 
or PET/CT datasets, including multiple scans during treatment and/or dynamic acquisitions: 
filtering and resolution recovery, segmentation and delineation, classification and pattern 
recognition. 
I intend to develop such a framework by building on existing statistical hierarchical 
models such as Markov trees. I will focus on two major developments: 
1. The multi observation framework 
Markov trees can be used in order to include several images (or observations) within 
the same structure, instead of analyzing or processing each image separately (27). This 
requires prior co-registration, which could be obtained with high accuracy especially since 
multiple modalities are now often acquired almost (PET/CT) or completely simultaneously 
(integrated PET/MRI). Images with different resolutions can be included in the hierarchical 
model on appropriate scales, whereas images with similar resolution can also be included on 
the same scale, but with multi observation vectors associated to each node of the tree. Note 
that additional data could be taken into account in such a framework: wavelet decompositions 
of the images, annotations from physicians, various textural features images associated to 
each dataset, etc. 
2. The modeling of correlations 
One advantage of using such Markov tree models is that it should be possible to 
include in the model various correlations existing within or between the different images (see 
figure 5). Within each image, spatial correlations would be modeled by the intrinsic structure 
of the tree, and additional spatial correlation might be added. Similarly, correlations between 
images of different resolutions could be exploited by associating data of different resolution to 
different scales of the hierarchical model. Correlation between different modalities or 
different images at the same level of resolution could be estimated and used. This would be 
achieved thanks to the multi observation modeling, with a vector of several values 
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corresponding to the different images being associated with each node of the tree. The 
different types of noise and partial volume effects could be efficiently handled both within 
each image and in relationship with the other images included in the framework. This would 
be achieved via appropriate non stationary and correlated noise models (45). Such a 
framework would also be robust versus potential misregistration errors between datasets and 





Father-son (inter-scale) correlations (quad tree)
Inter-observation correlations (non stationary, correlated noise + missing data)
Additional spatial intra-scale correlations (Markov field or chain)
Additional spatial inter-scale correlations
 
Fig.5: illustration of the multi observation, multi scale framework 
The figure 5 on the previous page illustrates the potential of such structures for the 
proposed flexible framework. Note that this figure illustrates a Markov tree (a 3D structure) 
applied to 2D images with 16 (4x4) leaves and three scales (the root, a scale at 4 voxels and 
the last scale with 16), but it could in practice be extended to 3D datasets and obviously with a 
number of leaves adapted to the number of voxels in the attached images. 
Grey circles represent the nodes of the tree (prior model) whereas white ones represent 
attached data (observed values in the images or other data such as wavelet decompositions, 
textural features, and so forth). As pointed out by the green arrow, this attached data may be 
multi observation, with various images or associated data included (see blue arrows linking 
elements of the observation vector to various images).  
Large double arrows represent the various correlations that could be modeled and used 
for various applications. Blue ones denote correlations within the observations vector and 
could be implemented as various noise models. Basic modeling assumes independent 
observation and Gaussian noise, although more complex models could be used, such as non 
stationary, correlated, non Gaussian noise. It may also allow for missing data to be handled, 
since observation vectors may not contain the same data in each scale of the tree. Purple ones 
denote father-son statistical correlations linking elements of different scales in the quadtree 
that can add better handling of missing data and may relate information of images with 
different resolution (in the example above, a PET image is related to its associated CT and 
MRI datasets who have about four times more voxels). Yellow and red ones indicate 
additional spatial intra and inter scale correlations respectively that could be added in such a 
model to increase the robustness (as well as the complexity) of the model. As previously 
explained, data/images of different spatial resolutions may be associated with appropriate 
scales in the tree structure.  
In this example, the leaves (the elements at the base of the quadtree) are associated 
with a vector of observation consisting of an MRI and a CT image (of approximately the same 
resolution). In the scale level above, a PET image (with about four times less voxels) is 
associated. WD denotes wavelet transforms. As these spatial-frequency transforms generates 
multi scale (from finer to coarser details as we go “up” in the tree structure) information, such 
additional data could also be attached as observations in the vector attached to the tree, or 
used as an guiding process, for instance within the context of couple or triplet Markov models 
that generalize standard Markov models allowing for more realistic modeling of real data 
(46). 
 Such models would also require dedicated developments of the associated parameters 
estimation procedures so the framework is automated enough to be used for applications such 
as image processing or analysis of large multi modal image datasets. The more complex and 
flexible the framework, the more parameters will need to be estimated in case of application 
to real data with unknown parameters. Robust algorithms such as Stochastic Expectation 
Maximization (SEM) or Iterative Conditional Estimation (ICE) will be adapted to the 
developed models (47). 
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As first applications of these developments, specific approaches will be investigated. 
They will be dedicated to multimodal PET/MRI and PET/CT, as well as dynamic imaging or 
sequential multimodal images during treatment. They will include automatic tumor 
localization/detection, improved denoising and partial volume effects correction, tumors and 
organs semi-automatic delineation, and static and dynamic parameters extraction to 
characterize pathologies. These approaches will be implemented within such a framework and 
are expected to benefit from its modeling versatility.  
 
2. Multi source information fusion for predictive models and computer-
aided decision in oncology 
This part of my research project will be dedicated to the design and development of 
decision aid systems based on the exploitation of patients databases in various cancer models 
(for example esophageal, lung, or rectal) with known outcome (pathological response, 
disease-free and overall survival, etc.) in combination with clinical data and image-based 
parameters extracted thanks to the framework described above. 
1. Multi modal image derived parameters obtained through developments carried out 
in the first part 
As a first application of the multi observation framework described in part 1, I will 
implement automated multi modal characterization of tumors in oncology. Parameters such as 
anatomico-functional tumor volumes and associated measurements in various image 
modalities (SUVs of various PET tracers, heterogeneity of the tracer uptake or of the tissues 
in CT or MRI, diffusion, perfusion, dynamic information, etc.) could be extracted from large 
multi modal dataset in order to characterize fully the pathology in head and neck, esophageal, 
lung or rectal cancers. In addition, the temporal evolution of this full tumor characterization 
during treatment will also be of interest. 
2. Clinical data including genetics and tumor biology 
Fusion information (Denzert-Smarandache theory) (28) and classification approaches 
such as decision trees or support vector machines (49) will be investigated and compared on 
multi source data in order to derive predictive and prognostic models regarding each 
pathology for which patients databases are available. The goal will be to reach pertinent 
fusion of image-derived parameters and other additional semantic information such as clinical 
data (age, gender, stage…), tumor biology and genetics (from biopsies or histopathological 
examination, phenotypes, genotypes, etc.) as illustrated in figure 6. Such model learning 
requires large databases to avoid over fitting of the data, and multiple research collaborations 
will be needed with national and international clinical centers. I will exploit existing 
collaborations with research clinical teams in the Netherlands (Maastricht, Nijmegen), the 
United Kingdom (London, Surrey), the United States (MD Anderson), Germany (Freiburg, 
Munich) and France (Rennes, Nantes, Toulouse, Bordeaux, Brest) to help building such 
databases. Developed predictive and prognostic models will then be validated on prospective 
studies. 
 Fig.6 : fusion of various data to build predictive models 
 VIII - Conclusion 
 
I now have a significant experience in modeling for PET and PET/CT imaging applications in 
oncology and radiotherapy, with a special focus on semi-automated delineation and image 
processing algorithms. I have also significantly contributed to developments in partial volume 
effects correction, denoising, image fusion, radiotracer heterogeneity characterization and 
realistic Monte Carlo simulations and dosimetry studies in radiotherapy. I have further 
investigated the impact of such methodological developments in the clinical setting and 
associated applications. Most of these developments have involved co-supervision of several 
PhD students (in addition to several master students), two of them being supervised mostly by 
me and have now finished their PhD. My project for the next years involves the full 
supervision of two additional PhD students and co-supervision of at least two others. 
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Abstract
Accurate volume of interest (VOI) estimation in PET is crucial in different
oncology applications such as response to therapy evaluation and radiotherapy
treatment planning. The objective of our study was to evaluate the performance
of the proposed algorithm for automatic lesion volume delineation; namely the
fuzzy hidden Markov chains (FHMC), with that of current state of the art in
clinical practice threshold based techniques. As the classical hidden Markov
chain (HMC) algorithm, FHMC takes into account noise, voxel intensity and
spatial correlation, in order to classify a voxel as background or functional
VOI. However the novelty of the fuzzy model consists of the inclusion of
an estimation of imprecision, which should subsequently lead to a better
modelling of the ‘fuzzy’ nature of the object of interest boundaries in emission
tomography data. The performance of the algorithms has been assessed on
both simulated and acquired datasets of the IEC phantom, covering a large
range of spherical lesion sizes (from 10 to 37 mm), contrast ratios (4:1 and 8:1)
and image noise levels. Both lesion activity recovery and VOI determination
tasks were assessed in reconstructed images using two different voxel sizes
(8 mm3 and 64 mm3). In order to account for both the functional volume
location and its size, the concept of % classification errors was introduced in the
evaluation of volume segmentation using the simulated datasets. Results reveal
that FHMC performs substantially better than the threshold based methodology
for functional volume determination or activity concentration recovery
considering a contrast ratio of 4:1 and lesion sizes of <28 mm. Furthermore
differences between classification and volume estimation errors evaluated were
smaller for the segmented volumes provided by the FHMC algorithm. Finally,
the performance of the automatic algorithms was less susceptible to image
0031-9155/07/123467+25$30.00 © 2007 IOP Publishing Ltd Printed in the UK 3467
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noise levels in comparison to the threshold based techniques. The analysis of
both simulated and acquired datasets led to similar results and conclusions
as far as the performance of segmentation algorithms under evaluation is
concerned.
1. Introduction
Positron emission tomography (PET) has been long established as a powerful tool in oncology,
particularly in the area of diagnosis. However, alternative applications such as the use of PET in
radiotherapy planning (Jarritt et al 2006) and response to therapy studies (Krak et al 2005) are
rapidly gaining ground. Whereas accurate activity concentration recovery is crucial for correct
diagnosis and monitoring response to therapy, applications such as the use of PET in intensity-
modulated radiation therapy (IMRT) treatment planning render equally vital the accurate
shape and volume determination of lesions. Different volume-of-interest (VOI) determination
methodologies have been proposed that can be classified as manual or automatic. On the
one hand, manual segmentation methods to delineate boundaries are laborious and highly
subjective (Krak et al 2005). On the other hand, automatic segmentation of objects of interest
in PET (Reutter et al 1997, Zhu and Jiang 2003, Kim et al 2002, Riddell et al 1999) is not a
trivial task because of low spatial resolution and resulting partial volume effects (PVE), low
contrast ratios, as well as noise resulting from the statistical nature of radioactive decay or the
choice of the reconstruction process.
The most widely used method to semi-automatically determine VOIs in PET is
thresholding, either adaptive, using a priori computed tomography (CT) knowledge (Erdi et al
1997), or fixed threshold (Krak et al 2005) using values derived from phantom studies (from
30 to 75% of maximum local activity concentration value) (Jarritt et al 2006, Krak et al 2005,
Erdi et al 1997). Such thresholding techniques, however, lead to variable VOI determination as
shown in recent clinical studies (Nestle et al 2005). On the other hand, numerous works have
addressed automatic lesion detection from PET datasets, including different methodologies
such as edge detection (Reutter et al 1997), fuzzy C-means (Zhu and Jiang 2003), clustering
(Kim et al 2002) or watersheds (Riddell et al 1999). The performance of these algorithms
is sensitive to variations of noise intensity and/or lesion contrast. In addition, past work
has in its majority considered the ability of such automatic methodologies for the detection
of lesions but not the accuracy with which the methods are capable for VOI and/or activity
concentration determination. Furthermore, all of the afore-mentioned algorithms often involve
user-dependent initializations, pre- and post-processing, or additional information like CT or
expert knowledge; rendering their employment more complicated and the outcome dependent
on choices made by the user in relation to the pre- and/or post-processing steps necessary.
For example in the case of the watershed algorithm a filtering pass as a pre-processing step to
smooth the image, and a post-processing step to fuse the different regions resulting from the
algorithm are necessary.
Hidden Markov models are automatic segmentation algorithms allowing noise modelling
and have proven to be less sensitive to variation of the values in the regions of the images
than other segmentation approaches thanks to their statistical modelling. They have only been
previously used in PET in the form of hidden Markov fields (HMF) (Chen et al 2001). Hidden
Markov chains (HMC) (Benmiloud and Pieczynski 1995) is a faster model and can offer
competitive results (Salzenstein and Pieczynski 1998). Furthermore, HMC leads to shorter
computational times, as quantities of interest can be computed directly on the chain, whereas
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the HMF algorithm needs iterative Monte Carlo like estimation procedures (Salzenstein and
Pieczynski 1998) that are time consuming. These algorithms offer an unsupervised estimation
of the parameters needed for the image segmentation and limit the user’s input to the number
of classes to be searched for in the image. Reconstructed images require no further pre- or
post-processing treatment (such as for example filtering) prior to the segmentation process.
Instead, image noise is considered as additional information (a parameter in the classification
decision process) to be taken into account, not to be suppressed or avoided.
The objectives of our study were to (a) develop a new fuzzy HMC (FHMC) model in an
attempt to account for the limited spatial resolution in PET and (b) compare the performance
of FHMC with those of the thresholding methodologies currently used in clinical practice.
Different imaging conditions in terms of statistical quality, as well as lesion size and source-
to-background (S/B) ratio were considered in this study. The analysis was carried out on both
simulated and acquired images reconstructed using iterative algorithms which form today’s
state of the art in whole body PET imaging in routine clinical oncology practice (Visvikis et al
2001, 2004).
2. Materials and methods
2.1. Hard and fuzzy hidden Markov chain models
The HMC model is an unsupervised methodology that takes place in the Bayesian framework.
Although we place ourselves in the application of image segmentation this methodology can
be used in other applications such as, for example, speech recognition (Dai 1994). Let T
be a finite set corresponding to the voxels of an image. We consider two random processes
Y = (yt )t∈T and X = (xt )t∈T . Y represents the observed image, and X represents the ‘hidden’
segmentation map. X takes its values in = {1, . . . , K}with K being the number of classes c,
and Y takes its values inR. We assume that a Markov process can model the prior distribution
of X. The segmentation problem consists in estimating the hidden X from the available noisy
observation Y. The relationship between X and Ycan be modelled by the joint distribution






P(Y|X) is the likelihood of the observation Y conditionally with respect to the hidden ground-
truth X, and P(X) is the prior knowledge concerning X. The Bayes rule allows us to know the
posterior distribution of X with respect to the observation Y. In the Markov chain framework we
have to assume the random variables Y = (yt )t∈T are conditionally independent with respect
to X and that the distribution of each yt conditional on X is equal to its distribution conditional
on xt . Many applications of hidden Markov models with unsupervised estimation have been
successful considering different types of images (radar, sonar, magnetic resonance images
(MRI), CT, satellite or astronomical) (Pieczynski 2003, Salzenstein et al 2004, Delignon et al
1997), but this kind of approach was almost never applied to PET data.
2.1.1. Markov chain definition. X is a Markov chain if:
P(xt |x1, . . . , xt−1) = P(xt |xt−1) for 1 < t  T . (2)
The distribution of X is then defined by the distribution of x1, called initial probabilities init(c)
for each class c (P (x1 = c)) and the transition matrix trans(c, d) (of dimension K × K)
containing the probabilities of transitions from the class c to the class d; P(xt+1 = d|xt = c).
As X and Y are one-dimensional elements in the HMC context, a spatial transformation
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Figure 1. The 3D Hilbert–Peano space filling curve for a 4 × 4 × 4 voxels VOI.
is necessary to process three-dimensional VOIs. For the best preservation of the spatial
correlation between voxels we use the Hilbert–Peano space-filling curve. This fractal path
can be extended to explore 3D VOIs (Kamata et al 1999). A visual illustration of the Hilbert–
Peano path for a 4 × 4 × 4 voxels 3D VOI is given in figure 1. Once the chain has been
segmented, the inverse path is used to reconstruct the 3D segmentation map.
2.1.2. Adding a fuzzy measure to the model. The general idea behind the implementation
of a fuzzy model within the Bayesian framework was previously introduced by Salzenstein
(Salzenstein and Pieczynski 1997). Its implementation in association with HMC developed
as a part of this work is based on the incorporation of a finite number of fuzzy levels Fi in
combination with two homogeneous (or ‘hard’) classes, in comparison to HMC where only
a finite number of hard classes are considered. This model allows the coexistence of voxels
belonging to one of two hard classes and voxels belonging to a ‘fuzzy level’ depending on
its membership to the two hard classes. Therefore, FHMC adds an estimation of imprecision
of the hidden data (X, see section 2.1) in contrast to HMC which only models uncertainty
of the observed data (Y, see section 2.1). The statistical part of the algorithm models the
uncertainty of the classification, with the assumption being that the voxel is clearly identified
but the observed data is noisy. On the other hand, the fuzzy part models the imprecision of the
voxel’s membership, with the assumption being that the voxel may contain both classes. One
way to achieve this extension is to simultaneously use Dirac and Lesbegue measures at the
class level. Hence we consider that X in the fuzzy model takes its values in [0, 1] instead of
 = {1, . . . , K}. Let δ0 and δ1 be the Dirac measures at 0 and 1, and ζ the Lesbegue measure
on ]0, 1[. We define the new measure ν = δ0 + δ1 + ζ on [0, 1]. Note that, for example, using
two hard classes and two fuzzy levels in the FHMC model is not equivalent to using four hard
classes in the HMC model where ν = δ1 + δ2 + · · ·+ δK . This has been previously stated using
Markov fields based segmentation (Salzenstein and Pieczynski 1997).
The distribution of X can then be defined using a conjoint density g for (xt , xt+1) on
[0, 1] × [0, 1]:
let (a, b) ∈ [0, 1] × [0, 1]
g(a = 0, b = 0) = α1 and g(a = 1, b = 1) = α2
g(a = 0, b = 1) = γ1 and g(a = 1, b = 0) = γ2






g(a, b) d(ν ⊗ ν)(a, b) = 1 and α1 + α2 + γ1 + γ2 + βλ = 1 (4)
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where d(ν ⊗ ν)(a, b) is the notation for integration with respect to the (a, b) variables, each
one being with respect to the measure ν on the interval [0, 1]. λ is a constant depending on
the form of the parameterized functionfg:
fg(a, b) = 1 − |a − b|. (5)
We now define the initial and transition probabilities (init(c) and trans(c, d)) using the conjoint
density g and an utility density h on [0, 1] defined by: h(a) = ∫ 10 g(a, b) dν(b):
init(c) using densities g and h:
P (x1 ∈ {0, 1}) =
∫ 1
0
g(x1, b) dν(b) = h(x1)
















trans(c, d) using the conditional densityf deduced from (1) : f (xt+1|xt ) = g(xt+1,xt )h(xt )





g(εj , εi) d(ν ⊗ ν)(εj , εi)∫
Fi
h(εi) dν(εi)
P (xt+1 ∈ Fj |xt ∈ {0, 1}) =
∫
Fj
g(εj , xt ) dν(εj )
h(xt )










where N − 1 is the number of fuzzy levels and εi = iN is the value associated with a fuzzy
level Fi .
The fuzzy model is a generalization of the hard model. The use of the Dirac measures
allows one to retrieve the standard two-class hard model when the fuzzy component is null. As
the theoretical framework described above has not been developed for a specific kind of image,
but as a general segmentation algorithm, the a priori and the noise (also called observation)
models are not directly derived from PET image characteristics. However this segmentation
approach may be appropriate in segmenting PET images since they are both noisy and of low
resolution. The ‘noise’ aspect when considering hidden Markov models in general is the way
the values of each class to be found in the image are distributed around a mean value. The
noise model used, whose respective mean and variance are to be determined by the estimation
steps, can therefore be adapted to image specific characteristics. On the other hand, the
fuzzy measure allows a more realistic modelling of the objects’ border transitions between
foreground and background, allowing in such a way to indirectly account for the effects
of blurring (partial volume effects) associated with low resolution images, such as those
in PET.
2.1.3. Segmentation and parameters estimation. In order to perform segmentation on the
chain level, we need to use a criterion to classify each element as background or functional
VOI. For this purpose we use the marginal posterior mode (MPM) (Marroquin et al 1987).
This approach aims to minimize the expectation E{L(xt ,⌢x t )|Y } where L is a loss (or cost)
function:
L(xt , xˆt ) = |xt − xˆt | (8)
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with xt the real class and xˆt = sˆ(yt ) the one affected by the segmentation process sˆ. This
criterion is adequate for the segmentation problem as it penalizes a configuration with respect to
the number of misclassified elements. In order to compute a solution, the MPM segmentation
needs the parameters defining the a priori model (initial and transition probabilities of the
chain) as well as the noisy observation data model (mean and variance of each class). The
assumption that the noise for each class of the observed data can fit a Gaussian distribution
was made as a first step. The mean and variance of each fuzzy level Fi is derived from the
ones estimated in the two hard classes as follows:
µFi = µ0(1 − εi) + εiµ1 σ 2Fi = σ 20 (1 − εi)2 + ε2i σ 21 . (9)
Both a priori and noise models parameters are unknown in the real case and therefore
they must be estimated. In order to achieve such estimation, we use the stochastic iterative
procedure called stochastic expectation maximization (SEM) (Celeux and Diebolt 1986), a
stochastic version of the EM algorithm (Dempster et al 1977). This is achieved in a similar
fashion to that used in the classical HMC context by simulating posterior realizations of X (see
the appendix for detailed posterior realization of X and the SEM procedure) and computing
empirical values of the parameters of interest using the simulated chain. The stochastic nature
of this procedure makes it less sensitive to the initial guess of the parameters using the K-
means (McQueen 1967) than deterministic procedures such as the EM algorithm. Both the
MPM segmentation and SEM parameters estimation use a practical recursive computation of
the values of interest called forward–backward procedure that is performed directly on the
chain (Benmiloud and Pieczynski 1995). The implementation of the FHMC segmentation
algorithm in a step-by-step fashion can be found in the appendix. Note that the overall
algorithm is entirely unsupervised (except for the number of classes and fuzzy levels to use)
and it is able to adjust to a large spectrum of image structures, noise or contrast. For example,
no a priori is made on the shape of the objects to extract or the source-to-background ratio in
the image.
2.2. Thresholding
Various thresholding methodologies have been proposed in the past for both functional volume
segmentation and/or activity concentration recovery (Krak et al 2005, Erdi et al 1997, Nestle
et al 2005). Thresholding using 42% and 50% of the maximum value in the lesion was chosen
for VOI determination and quantitation purposes respectively, based on previous publications
(Krak et al 2005, Erdi et al 1997). The methodology was implemented through region
growing using the voxel of maximum intensity in the object of interest as a seed. Using a
3D neighbourhood (26 neighbours) the region is iteratively increased by adding neighbouring
voxels if their intensity is superior or equal to the selected threshold value. The results derived
using these methods will be denoted from here onwards as T42 and T50 for the thresholds of
42% and 50% respectively.
2.3. Validation studies
2.3.1. Simulated and acquired datasets. Simulated datasets using the IEC image quality
phantom (IEC 1998), containing six different spherical lesions of 10, 13, 17, 22, 28 and
37 mm in diameter (figure 2) were generated using Geant4 Application for Tomographic
Emission (GATE) and a validated model of the Philips Allegro PET scanner (Lamare
et al 2006). Images, considering only the detected true coincidences, were subsequently
reconstructed using the OPL-EM iterative algorithm (Reader et al 2002) with seven iterations
(Lamare et al 2006). Two different voxel sizes were considered in the reconstructed images;
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(a)
(b) (c)
Figure 2. (a) A graphical representation of the IEC phantom, and the central slice of the digital
IEC phantom used in the generation of the simulated datasets (b) with 2 × 2 × 2 mm3 and (c) 4 ×
4 × 4 mm3.
namely 2 × 2 × 2 mm3 and 4 × 4 × 4 mm3. The 8 mm3 voxel size configuration leads to
better sampled objects of interest but with higher noise due to the number of counts being
divided by eight in each voxel in comparison to the 64 mm3 voxel sizes. A uniform activity
was simulated throughout the phantom cylinder and the lesions. Different parameters were
however considered to cover a large spectrum of configurations allowing assessment of the
influence of different parameters susceptible to affect the functional VOI determination or
quantitation accuracy. The statistical quality of the images was varied by considering 20, 40
and 60 million true coincidences. Two different signal-to-background (S/B) ratios were also
considered, 4:1 and 8:1 (with around 6 kBq cm−3 in the background, and 24 or 48 kBq cm−3
in the spheres respectively). Visual illustration of the reconstructed images corresponding to
different simulated configurations is given in figures 3(a)–(d).
In addition to the simulated datasets, acquisitions of the IEC phantom were carried out
in the list-mode format using a Philips GEMINI PET/CT scanner. The only difference with
the simulated datasets was the exclusion of the 28 mm diameter sphere in the study because
in the phantom used it was replaced by a plastic sphere of unknown diameter. The same S/B
ratios of 4:1 and 8:1 used in the simulations were also employed in this part of the study, by
introducing 7.4 kBq cm−3 in the background and 29.6 or 59.2 kBq cm−3 respectively in the
spheres. Different count statistical qualities were obtained by reconstructing 1 min, 2 min
or 5 min list-mode time frames using the 3D RAMLA algorithm, with specific parameters
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(a) (b)
(c)    (d)
Figure 3. Different images used in the segmentation study; (a)–(d) simulated: (a) ratio 4:1,
20 million coincidences, 64 mm3, (b) ratio 8:1, 40 million, 64 mm3, (c) ratio 4:1, 20 million
coincidences, 8 mm3, (d) ratio 8:1, 40 million, 8 mm3; (e)–(h) acquired: (e) ratio 4:1, 2 min
acquisition time, 64 mm3, (f) ratio 8:1, 5 min, 64 mm3, (g) ratio 4:1, 5 min, 8 mm3, (h) ratio 8:1,
5 min, 8 mm3.
previously optimized (Visvikis et al 2004). The same voxel sizes as for the simulated datasets
(8 mm3 and 64 mm3) were used in the reconstruction of each of the different statistical quality
datasets considered. Visual illustration of the acquired images is given in figures 3(e)–(h).
Each sphere in both simulated and acquired images was isolated in a box of the same size
(16× 16× 10 for the 4 mm case, and 32× 32× 20 for the 2 mm case) prior to the segmentation
process.
2.3.2. Computed volume versus classification error measurement. The majority of
previous works dealing with VOI determination in PET measure the performance of a given
methodology by computing the VOI obtained on the segmentation map and comparing it with
the true known volume of the object of interest. This type of approach has the potential to lead
to biased performance measurements since a segmentation result may contain two different
types of errors. On the one hand, one may have voxels of the background that are classified
as belonging to the object of interest, denoted from here on as positive classification errors
(PCE), while on the other hand, one may end up with voxels of the object that are classified
as belonging to the background, denoted from here on as negative classification errors (NCE).
These classification errors essentially occur on the boundaries of the objects of interest because
of ‘spill in’ (increasing probabilities of a NCE) and ‘spill out’ (increasing probabilities of a




PCE). If the segmentation results in PCEs and NCEs of equal amounts, the computed VOI
would be very close to the true known volume whereas the shape and position of the object
would be incorrect. The shape and position information is as important as the total volume
of the object in order to accurately derive a radiotherapy treatment planning or the activity
concentration of interest in a response to therapy study based on the derived functional volume.
For example, let us assume that the segmentation process results in 20% NCEs and 15% PCEs.
This leads to a classification error of 35% whereas the error in the overall computed volume
is only −5%. Hence, the use of classification error is a more pertinent measurement of the
accuracy with which a given algorithm performs the task of functional volume delineation
since it takes into account not only the segmented volume in comparison to the actual volume
of interest but also its position and shape.
In the simulation study the total number of PCEs and NCEs is considered with respect to
the number of voxels defining the sphere (VoS) in the digital phantom (the ground truth) in
order to obtain a percentage classification error (CE):
CE = (PCE + NCE)
VoS
× 100. (10)
The size of classification errors can be bigger than 100% in the case where a large number of
background voxels in the selected area of interest are misclassified as belonging to the sphere.
In practical terms, maximum classification errors calculated during this work where limited
to 200%, since any such values represent complete failure of the segmentation process. In
addition, the interest of classification errors is when they occur at the borders of the objects
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and not in other regions of the background. One should also keep in mind that a combined
representation of PCE and NCE into CE leads to a loss of information as far as the direction of
the bias is concerned. It does, however, still represent more pertinent information than overall
volume estimation errors, which reflect neither accurate magnitude nor direction of the bias
for a segmented volume.
On the other hand in the case of the images reconstructed from the acquired datasets
only overall computed volumes were considered in order to avoid any biases as a result of
misalignment and rescaling inaccuracies, as well as reconstruction artefacts in the higher and
lower slices of the associated CT datasets. As the goal is not to detect the lesion in the whole
image but to estimate its volume, shape and position with the best accuracy possible, we
assume that the lesion has been previously identified by the clinician and automatically or
manually placed in a 3D ‘box’ well encompassing the object. Subsequently, the images of
the selected area were segmented in two classes ( functional VOI and background) using each
of the three methods under evaluation (thresholding, FHMC and HMC). In the FHMC case,
different numbers of fuzzy levels were considered in the segmentation process (namely two
and three). Following the segmentation by FHMC, volumes of interest can be defined using
the hard classes and any number of the fuzzy levels considered.
2.3.3. Quantitation accuracy. In terms of quantitation the objective of our study was to
determine the accuracy of the average activity concentration recovered from a volume derived
using a given segmentation algorithm. The ‘ground truth’ for comparison purposes was
established using the exact size, shape and location of each lesion (using the known digital
phantom employed in the generation of the simulated datasets).
As a result, these recovered activity concentration values represented an under-estimation
of the true activity due to PVE. A comparison on a lesion-by-lesion basis was subsequently
carried out with the measured activity concentration from the segmented volumes obtained by
the three algorithms considered. T50 should lead to some improvements in the lesion activity
recovery with respect to T42 as a result of including less voxels in the volume used to compute
the activity and therefore less voxels associated with PVE. Similarly FHMC 0/2 (see section 3,
results, for the definition of FHMC x/y) should lead to concentration recovery improvements
with respect to FHMC 1/2, since voxels belonging to the fuzzy levels are found at the edges
of the lesions and their intensity is most significantly reduced by PVE. Therefore the inclusion
of these voxels should only result in even stronger under-evaluation of the true lesion activity
concentrations.
3. Results
Different segmentation maps obtained using each of the methods under evaluation are
presented in figure 4 for a slice centred on the 28 mm sphere of the simulated images to
visually illustrate the variations of the segmentation maps obtained. Figure 5(a) shows the
impact of the number of fuzzy levels included in the FHMC segmentation. The various
FHMC maps are denoted as FHMC x/y with x being the number of fuzzy levels included in
the segmentation map, and y being the total number of fuzzy levels used in the segmentation
process. The error bars in these figures represent different results obtained for each of the three
different levels of statistical quality considered (the top of the error bar is the result concerning
the worst statistical quality, the medium one concerns the medium quality and the lowest one
corresponds to the best quality considered). As figure 5(a) shows, for the range of simulated
spheres considered, no improvement was obtained in the % classification errors by having more
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Figure 4. Examples of segmentation maps for the 28 mm sphere (one slice): (a) PET ROI,
(b) digital ‘ground truth’, (c) HMC map, (d) T42 map, (e) FHMC with two fuzzy levels (light and
dark grey voxels) segmentation map, (f) map used for VOI (hard class + first fuzzy level, FHMC
1/2), (g) map for quantitation (only hard class voxels, FHMC 0/2), (h) T50 map. Note that in this
particular case, FHMC 1/2 for VOI and T50 result in the same map but this is of course not always
the case (especially having considered the complete 3D volume).
than two fuzzy levels in the FHMC segmentation process and keeping in the overall segmented
volume more than the voxels identified in the first fuzzy level. It should be emphasized at
this point that this conclusion was reached considering the results of the whole of the range of
simulated sphere diameters and keeping in mind that our objective is determining a single best
configuration of the algorithm parameters across a wide range of imaging conditions and not
different parameters for individual lesion sizes, image statistics or contrast ratios. In addition,
it is clearly shown in figure 5 that HMC leads to worse segmentation results in comparison
to FHMC for all different configurations considered. Therefore for all subsequent volume
determination analyses, the results associated with the FHMC 1/2 versus T42 are presented.
As shown in figure 5(b), no benefits are observed through the inclusion in the segmentation
map of any voxels belonging to the fuzzy domain. This confirms what was anticipated in
section 2.3.3. Therefore from here onwards all the quantitation results presented for FHMC
have been calculated using only the hard class voxels resulting from the segmentation process
(FHMC 0/2).
The % classification errors for reconstructed images of the simulated datasets as a function
of lesion size and contrast are presented in figure 6(a) for 64 mm3 and (b) for 8 mm3,
for the FHMC and the threshold based method (T42). A breakdown, in terms of PCEs
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Figure 5. (a) Classification errors for the lesion VOI determination and (b) lesion activity recovery
errors in the simulated images for the FHMC versus HMC segmentation. Different numbers of
fuzzy levels (two or three) were used in the segmentation process and different numbers of these
were subsequently selected to (a) form the segmented volumes or (b) determine lesion average
activity concentrations for the different imaging conditions considered.
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Figure 6. Classification errors in lesion VOI determination from the simulated images: (a) 64 mm3
voxels and (b) 8 mm3 voxels for the FHMC 1/2 versus T42 segmentation under variable imaging
conditions.
and NCEs, of the % classification errors in figure 6(a) is given in figures 7(a)–(c) for the
FHMC, HMC and T42 segmentation methods respectively. Finally, in order to facilitate
a comparison of the segmentation results between the simulated and the acquired datasets,
the % computed volume error is given in figures 8(a)–(b) for the same configurations as in
figures 6(a)–(b).
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Figure 7. Repartition of PCEs and NCEs from the (a) FHMC 1/2, (b) HMC and (c) T42
segmentation results for the different simulated imaging configurations considered.
Considering the simulated datasets, the introduction of FHMC led to superior results in
comparison to the current ‘gold standard’ in functional volume delineation of T42. FHMC
segmentations led to<25% classification errors in computed volumes for lesion sizes>13 mm
irrespective of contrast ratio, level of noise or lesion size. Errors of more than 200% for FHMC
were only observed for the 10 mm sphere. Results for the T42 were more dependent on the
lesion size, relative to FHMC results, varying from 10% to more than 200% (even for spheres
up to 22 mm in diameter for a contrast of 4:1 and 64 mm3 voxel size). However, the use of
T42 was found to work well for lesion sizes of >17 mm and a lesion-to-background ratio of
8:1 with % classification errors of 20–30%. On the other hand, for a lesion-to-background
ratio of 4:1, the T42 threshold led to over 100% overestimation in the functional volume
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for lesions <28 mm in diameter. As the errors bars in the different figures reveal, there
was a larger dependence on the statistical quality of the reconstructed images observed with
T42 in comparison to FHMC for the majority of the lesion sizes and contrast configurations
considered. In particular this was true for all of the lesions for a contrast ratio of 4:1 and
for lesions <22 mm for a contrast ratio of 8:1. For example, for the 17 mm sphere and
a contrast ratio of 8:1, T42 resulted in classification errors of 20 to 35% whereas FHMC
classification errors from 15 to 17% were observed (figure 6). On the other hand in the case
of the 28 mm sphere and a contrast ratio of 4:1, T42 errors were ranging from 85 to 110%
whereas FHMC resulted in errors of 17–18%. The reduction in the reconstruction voxel
size (from 64 mm3 to 8 mm3) led to small differences in the functional volumes determined
using the FHMC segmentation algorithm, and although it led to improvements in the T42
based segmented volumes, the % classification errors remained at 80–200%. The trend
observed with the standard voxel sizes on the variation of the segmentation results as a
function of statistical quality was similar for the reduced voxel size images. For example in
the case of the 22 m sphere and a contrast ratio of 4:1 errors of 77–100% and 26–27% were
observed for T42 and FHMC respectively. In general, the largest errors were observed for
the smaller lesions of 10 and 13 mm, where none of the segmentation algorithms considered
performed well under any of the configurations tested, with errors largely>200%. As shown in
figure 7(a) FHMC classification errors are essentially NCEs for the two biggest spheres and
PCEs for the small ones. In contrast, as shown in figures 7(b)–(c), T42 and HMC methods
result essentially in PCEs, apart from T42 in association with lesions >28 mm in diameter
and a lesion-to-background ratio of 8:1.
In terms of overall volume estimation errors on simulated datasets (see figures 8(a), (b))
FHMC results in errors of up to 10% and between 10% and 20% for a contrast ratio of 8:1 and
4:1 respectively, for lesions >13 mm. T42 led to volume determination errors of <10% for
lesions>17 mm in diameter and a lesion-to-background ratio of 8:1, while errors of over 100%
were observed for lesions <28 mm with a lesion-to-background ratio of 4:1. However, while
the lowest overall volume error of T42 was around 10%, the corresponding classification error
was >20%. In the case of an 8 mm3 reconstructed voxel size (figure 8(b)) small improvements
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Figure 8. Lesion VOI estimation errors from the simulated images: (a) 64 mm3 voxels and
(b) 8 mm3 voxels for the FHMC 1/2 versus T42 segmentation under variable imaging conditions.
were seen using the T42 for lesions 13 mm and >22 mm for a lesion-to-background ratio
of 8:1 and 4:1 respectively. Finally, no noticeable differences were seen in the FHMC based
segmentation results, apart from an improvement to <15% in the volume estimation error for
the 13 mm lesion with a contrast size of 8:1.
Figures 9(a), (b) show the results in terms of % error in the recovered activity as a function
of lesion size and contrast ratio considering the segmented volumes using 64 mm3 and 8 mm3
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Figure 9. Lesion average activity concentration estimation errors from the simulated images:
(a) 64 mm3 voxels and (b) 8 mm3 voxels for FHMC 0/2 versus T50 segmentation under variable
imaging conditions.
reconstructed voxel sizes. As can be seen from this figure, FHMC and T50 led to the best
results in comparison to the ‘ground truth’ throughout the different lesion sizes and contrasts
evaluated, although T50 introduces larger errors in comparison to the ‘ground truth’ for lesion
sizes of <22 mm and a contrast of 4:1. The use of the 8 mm3 voxels does not alter the
conclusions as far as the relationship between the results for the two methods evaluated is
concerned, although in absolute terms all algorithms perform worse in comparison to the
results obtained for 64 mm3 voxels.
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Figure 10. Lesion VOI estimation errors from the acquired images: (a) 64 mm3 voxels and
(b) 8 mm3 voxels for the FHMC 1/2 versus T42 segmentation under variable imaging conditions.
Considering the acquired datasets, figures 10(a) and (b) contain the results for the % overall
lesion volume estimation for the 64 mm3 and 8 mm3 voxels, while figures 11(a) and (b) show
the corresponding results for the activity quantitation errors. In terms of the volume estimation
the general trends were similar to those observed for the simulated datasets, with the FHMC
performing better than the T42 throughout the range of lesion sizes and contrasts evaluated.
In absolute terms, the FHMC results were better particularly in the case of 8 mm3 voxels
where errors of <20% and 10% were seen for lesions >10 mm and >22 mm respectively.
T42 errors were similar to FHMC for the 8:1 ratio and spheres >13 mm but ranged from 20
to >100% for the 4:1 ratio configuration. A larger dependence on the statistical quality of
the reconstructed images can be observed with the acquired datasets, demonstrating the more
robust performance of the FHMC algorithm in comparison to the T42 methodology which
was seen to be more affected by the images’ statistical quality. Using again the example of the
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Figure 11. Lesion average activity concentration estimation errors from the acquired images:
(a) 64 mm3 voxels and (b) 8 mm3 voxels for the FHMC 0/2 versus T50 segmentation under
variable imaging conditions.
22 mm sphere (figure 10(a)), T42 errors were from 30 to 95% while FHMC errors were less
than 5%. Although the variation of the FHMC results was higher for smaller spheres (10 and
13 mm), it was still smaller than in the case of the T42 results. For example, FHMC applied to
the 13 mm sphere with a 4:1 contrast ratio (figure 10(b)) resulted in errors between 5 and
30% whereas T42 errors ranged from 50 to 150%. Similar results between the FHMC and
the T50 algorithms were globally seen in terms of the % accuracy of the recovered activity
concentration, confirming the trends observed with the simulated datasets. Finally, similarly
with the volume estimation, better results were seen with the 8 mm3 reconstructed voxel’s size
for both the T50 and the FHMC leading to activity concentration estimation errors of between
+10% and −10% for lesions >17 mm in diameter.
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4. Discussion
Although PET imaging applications are currently, in their majority, diagnostic and largely
based on visual interpretation, there is increasing interest in applications such as the use of
PET for radiotherapy treatment planning, as well as response to therapy and outcome prediction
studies where accurate functional volume and concentration of activity estimation respectively
are indispensable. Current state-of-the-art methodologies for functional volume determination
involve the use of adaptive thresholding based on anatomical information or phantom studies.
The performance of these techniques is greatly dependent on lesion contrast and image noise
characteristics and as this work has demonstrated can lead to variable performance. On
the other hand, already proposed automatic segmentation methodologies have been mostly
evaluated for use in lesion detection rather than lesion volume determination. In addition, their
performance is highly dependent, similarly to the thresholding algorithms, on image contrast
and noise characteristics.
Hidden Markov chains is an automatic segmentation algorithm that allows noise modelling
in the images but has also previously been evaluated for lesion detection rather than functional
volume estimation. In the presented work a new algorithm (Fuzzy HMC) has been introduced
and evaluated allowing the incorporation within hidden Markov chains of a finite number
of fuzzy levels in combination with the ‘hard’ classes considered in HMC, adding this way
an estimation of imprecision that can account for the effects of limited spatial resolution in
emission tomography images. During the evaluation of the FHMC, the inclusion of more than
two fuzzy levels was found to not substantially alter the segmentation results, while only the
inclusion of the voxels belonging to the first fuzzy level led to the most accurate results in
terms of functional volume calculations throughout the range of configurations considered.
Although it would be possible to consider the use of HMC with four hard classes and an
additional rule to cluster the resulting segmentation map, the fuzzy nature of the borders leads
to computation issues in transition probabilities that HMC is not able to deal with. Note that
the significant addition of the fuzzy measure and mathematical changes in the model allows
FHMC to take into account such a configuration, mainly due to the fact that one given voxel
can contain both classes.
Finally, in this paper we have introduced the concept of classification errors rather
than volume estimation errors in the evaluation of segmentation algorithms for volume
determination tasks. An evaluation based on classification errors is more robust since it
does not simply consider the segmented volume but also its location with respect to the
‘ground truth’ known in simulated datasets. Therefore, while the absolute segmented volume
may be correct its location may be wrong, a fact that is as significant as the correct estimation
of the overall functional volume particularly for applications such as the use of PET volumes
in radiotherapy treatment planning.
In comparison to the recommended T42 for the accurate functional volume determination
in PET (Krak et al 2005), the FHMC algorithm gave clearly superior results for lesions
<28 mm, in particular considering a lesion contrast of 4:1, where the T42 methodology
completely failed to recover the functional volume. In addition, FHMC was more robust
considering the different image statistical quality levels evaluated, while the results of T42
were greatly influenced by the level of noise present in the images. Differences between
classification and volume estimation errors across the different configurations evaluated were
smaller for the segmented volumes provided by the FHMC algorithm. In addition, the
classification error results allow us to establish that the accuracy obtained on the estimated
volumes using the FHMC algorithm is not by chance due to a similar level of negative and
positive classification errors. A smaller reconstructed voxel size at the same statistical quality
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level led to worse overall segmentation results, without altering the conclusions as far as the
relative performance of the different algorithms evaluated is concerned.
The performance of the segmentation algorithms under evaluation in the reconstructed
images of the acquired datasets was similar to that obtained with the simulated datasets in
terms of volume estimation errors. The only difference observed in comparison with the
simulated dataset results was an improvement in the overall segmentation results for 8 mm3
reconstructed images in comparison to the 64 mm3, which can be attributed to an associated
adjustment of the optimized reconstruction parameters as a function of the voxel size in the
3D RAMLA algorithm used to reconstruct the acquired datasets.
As far as concentration recovery results are concerned, the performance of the different
segmentation algorithms was compared in the simulated datasets to the recovered activity
concentration considering the exact size and location of the simulated lesions. These results
were influenced by the effects of partial volume leading to increasing underestimation of the
activity concentration with decreasing lesion size. Segmentation algorithms concentrate on
accurate edge modelling in the object of interest and do not as such account for changes in the
values of the voxels as a result of PVE. FHMC and the current ‘state-of-the-art’ threshold of
50% of the maximum lesion value (Krak et al 2005) led to similar results independently of the
configurations evaluated, with absolute differences of 10–15% (due to an extra underestimation
for the T50 results). Similar trends to those observed with the simulated datasets were obtained
from the segmentation of the acquired images.
The presented results demonstrate the interest of FHMC over thresholding algorithms as
the flexibility of the fuzzy levels choice may allow the use of the same segmentation map for
different tasks, across a large range of lesion contrasts and sizes. FHMC through the addition
of the fuzzy levels associated with each hard class is able to more accurately model the object
of interest edges in reconstructed PET images. In addition, FHMC is clearly less susceptible
to alterations in statistical image quality and lesion contrasts than other methodologies. This
was observed on both images of simulated and acquired datasets. Having said that, none
of the evaluated algorithms was successful in accurate volume estimation for lesion sizes of
<17 mm, considering typical PET image statistical qualities and reconstructed voxels of either
8 mm3 or 64 mm3. The main reason behind the failure of FHMC concerning the segmentation
of such small lesions is the small number of voxels associated with the object of interest in
combination with image noise levels, and the Hilbert–Peano path used to transform the image
into a chain. The spatial correlation of such small objects may be lost once the image is
transformed into a chain. A local model may be able to overcome such an issue (Hatt et al
2007).
The results for FHMC may be further improved. Firstly, the direct estimation of the
noise in the reconstructed images may lead to better results in comparison to the assumed
Gaussian model used in this work to fit the distribution for each of the classes. Secondly, other
a priori models may be used for Markovian modelling, like couple (Pieczynski and Derode
2004) or triplet (Lanchantin and Pieczynski 2004) Markov chains or fields. These may be of
interest considering a better modelling of the transitions between boundary classes, as well
as the non-stationary nature of the hidden a priori model. In addition, the fuzzy model may
be extended to more than two hard classes to better model inhomogeneous or non-spherical
objects of interest.
5. Conclusion
A modified version of the hard Markov chains segmentation algorithm has been developed by
introducing a fuzzy measure (FHMC). Our results with both simulated and acquired datasets
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have shown that FHMC is more effective than the reference thresholding methodologies
for both VOI determination and quantification in PET imaging. As part of the evaluation
process, we have also introduced and assessed the interest of classification errors as a
robust measurement of the performance of segmentation algorithms for VOI determination in
contrast to a simple volume estimation which may introduce biases in terms of the segmented
lesion location. Future developments will concentrate on the use of more than two ‘hard’
classes in FHMC, which may more accurately account for the presence of inhomogeneous or
non-spherical functional volumes, as well as an investigation into more adequate noise and
a priori models.
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Appendix. The FHMC algorithm step by step









is used. For example with two fuzzy levels (or intervals) F1, F2,
we have N = 3 and there are N − 1 = 2 fuzzy levels with εi = iN : ε1 = 13 and ε2 = 23 . Note
that the symbol .˜ . . . denotes a density instead of a probability.
(1) Transformation of the 2D or 3D image into a 1D chain using the Hilbert–Peano path
(Kamata et al 1999) (save the path to be used in step 5 of the procedure).
From this point on, every step is performed on the image transformed into a chain.
(2) Parameters initialization
A priori model parameters:
α1 = α2 = 0.25
γ1 = γ2 = 0
}
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Initial and transition probabilities initializations can then be computed as follows:


































C = 1 if d ∈ {0, 1}
C = 1
N
if d ∈ ]0, 1]
Noise model parameters:
({µ0, µ1} , {σ0, σ1}) = K means(Y, 2) with Y the image and 2 for the two hard classes to
look for. Then we determine parameters of each fuzzy level with (9).
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(3) SEM procedure for parameters estimation
At each iteration q until no significant modification of the estimated parameters
(convergence):
(a) f˜ wd and b˜wd densities computation for each class c, c ∈ {0, 1, εi} , i = 1, . . . , N − 1
is performed recursively as follows:
for t = 1 : f˜ wd1(c) = h(c)Gc(y1)
for t > 1 : f˜ wd t (c) = Gc(yt )
(






f˜ wd t−1(εi)t˜rans (c, εi)
)
for t = T : b˜wd T (c) = 1






Gεi (yt+1)t˜rans (εi, c)b˜wd t+1(εi).




(− (y−µc)22σ 2c ).
(b) Stochastic re-estimation of parameters:
To obtain one a posteriori realization of X, simulate a fuzzy Markov chain using the following:
Posterior distributions of X are defined by:
i˜nit(c) = ˜fwdbwd1(c) and t˜rans (c, d)t+1 =
f (d|c)Gd(yt+1)b˜wd t+1(d)∫ 1
0 f (d|c)Gd(yt+1)b˜wd t+1(d)dv(d)
init(c) =
{
i˜nit(c) if c ∈ {0, 1}
1
N
i˜nit (c) if c ∈ ]0, 1] and trans(c, d)
t =
{
t˜rans (c, d)t if d ∈ {0, 1}
1
N
t˜rans (c, d) if d ∈ ]0, 1] .
It has to be noted that trans(c, d)t depends on t since a different transition matrix is computed
for each element of the posterior realization, as we are dealing with a non-stationary Markov
chain.
The estimated values of the parameters at the iteration q are computed on the simulated
a posteriori chain {xt |t = 1, . . . , T } as follows:
init(c)[q] = δ(x[q]1 , c).








































for c = 0 and c = 1. For fuzzy levels (c = εi) noise parameters, use equation (9)
with δ(m, n) =
{
1 if m = n
0 if m = n.
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(4) MPM segmentation of the chain using estimated parameters
For each xt , determine the class (hard class or fuzzy level) minimizing the error
classification probability by minimizing the following expression:
˜fwdbwd t (0)L(0, sˆ(yt )) + ˜fwdbwd t (1)L(1, sˆ(yt )) +
∫ 1
0
˜fwdbwd t (εi)L(εi, sˆ(yt )) dεi
for every ŝ(yt ), and where ˜fwdbwd denotes the product of the forward and backward densities.
The cost function L is given by (8).
(5) Reverse transformation of the 1D segmented chain into the 2D or 3D segmentation
map using the path saved at step 1.
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Abstract—Accurate volume estimation in positron emission to-
mography (PET) is crucial for different oncology applications. The
objective of our study was to develop a new fuzzy locally adaptive
Bayesian (FLAB) segmentation for automatic lesion volume delin-
eation. FLAB was compared with a threshold approach as well as
the previously proposed fuzzy hidden Markov chains (FHMC) and
the fuzzy C-Means (FCM) algorithms. The performance of the
algorithms was assessed on acquired datasets of the IEC phantom,
covering a range of spherical lesion sizes (10–37 mm), contrast
ratios (4:1 and 8:1), noise levels (1, 2, and 5 min acquisitions),
and voxel sizes (8 and 64 mm ). In addition, the performance
of the FLAB model was assessed on realistic nonuniform and
nonspherical volumes simulated from patient lesions. Results
show that FLAB performs better than the other methodologies,
particularly for smaller objects. The volume error was 5%–15%
for the different sphere sizes (down to 13 mm), contrast and image
qualities considered, with a high reproducibility (variation 4%).
By comparison, the thresholding results were greatly dependent
on image contrast and noise, whereas FCM results were less de-
pendent on noise but consistently failed to segment lesions 2 cm.
In addition, FLAB performed consistently better for lesions
2 cm in comparison to the FHMC algorithm. Finally the FLAB
model provided errors less than 10% for nonspherical lesions
with inhomogeneous activity distributions. Future developments
will concentrate on an extension of FLAB in order to allow the
segmentation of separate activity distribution regions within the
same functional volume as well as a robustness study with respect
to different scanners and reconstruction algorithms.
Index Terms—Oncology, positron emission tomography (PET),
segmentation, volume determination.
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I. INTRODUCTION
P OSITRON emission tomography (PET) is now a widelyused tool in the field of oncology, especially in applica-
tions such as diagnosis, and more recently radiotherapy plan-
ning [1] or response to therapy and patient follow-up studies
[2]. On the one hand, accurate activity concentration recovery is
crucial for correct diagnosis and monitoring response to therapy.
On the other hand, applications such as intensity-modulated ra-
diation therapy (IMRT) treatment planning using PET also re-
quire accurate shape and volume determination of the lesions of
interest, in order to reduce collateral damage to healthy tissues
and to ensure maximum dose delivered to the active disease.
Various methodologies used for the determination of volume of
interest (VOI) have been proposed. On the one hand, segmenta-
tion methods requiring a manual delineation of the boundaries
of the object of interest have been established as laborious and
highly subjective [2]. Alternatively, the performance of already
available automatic algorithms is hampered by the low resolu-
tion and associated partial volume effects (PVE), as well as low
contrast and signal to noise ratios generally characterizing PET
images.
Most of the previously proposed work dealing with VOIs de-
termination in PET use thresholding, either adaptive, based on
a priori computed tomography (CT) knowledge [3], or a fixed
threshold using values derived from phantom studies (from
30%–75% of maximum local activity concentration value)
[1]–[3]. Thresholding is however known to be significantly
susceptible to noise and contrast variations, leading to variable
VOIs determination as shown in recent clinical studies [4]. As
far as automatic detection of lesions from PET datasets is con-
cerned, different methodologies have been previously proposed
including edge detection [5], watersheds [6], fuzzy C-Means
[7], or clustering [8]. The performance of these algorithms is
also sensitive to variations in lesion-to-background contrast
and/or noise levels. In addition, past work has in its majority
considered the ability of such automatic methodologies for the
detection of lesions (sensitivity), and not for their performance
in terms of accuracy in the specific VOI determination task.
Finally, all of the aforementioned algorithms have additional
drawbacks associated with necessary preprocessing or post-
processing steps. For example in the case of the watershed
algorithm, a preprocessing step using a filtering pass is required
to smooth the image, and a postprocessing step is necessary to
fuse the regions resulting from the over-segmentation of the
algorithm. Such a need for user-dependent initializations, pre-
processing and postprocessing steps, or additional information
0278-0062/$25.00 © 2009 IEEE
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like CT or expert knowledge render the use of these algorithms
more complicated and the outcome dependent on choices made
by the user in relation to these necessary steps.
Bayesian-based image segmentation methods are automatic
algorithms allowing noise modelling and have shown to be
less sensitive to noise than other segmentation approaches due
to their statistical modelling [9]. They offer an unsupervised
estimation of the parameters needed for the image segmentation
and limit the user’s input to the number of classes to be searched
for in the image. Reconstructed images require no further pre-
processing or postprocessing treatment (such as for example
filtering) prior to the segmentation process. Instead, image
noise is considered as additional information (a parameter in
the classification decision process) to be taken into account
rather than to be filtered or ignored. They have only been
previously used in PET imaging in the form of hidden Markov
fields (HMFs) [10] and more recently we have investigated
the performance of hidden Markov chains (HMCs) for volume
determination, a faster model that was in addition extended to
include fuzzy modelling, fuzzy HMC (FHMC) [11]. Although
FHMC was shown to provide overall superior results relative
to the threshold reference methodology, independent of lesion
contrast and image signal-to-noise ratio, it is unable to correctly
segment objects 2 cm in diameter. This is mainly due to the
3-D Hilbert-Peano path [12] used to transform the 3-D volume
into an 1-D chain, since voxels defining small objects may
find themselves far away from each other on the chain, thus
being misidentified by the algorithm as noise and becoming not
significant enough to form a class apart from the background.
Consequently, the main objectives of this study were to im-
prove the segmentation of small objects by 1) developing a fuzzy
local adaptive Bayesian (FLAB) model and 2) comparing the
performance of this new algorithm with that of the thresholding
methodologies currently used in clinical practice as well as the
fuzzy C-Means (FCM) and the previously proposed FHMC al-
gorithms. In addition, as a secondary objective we have also in-
vestigated the use of the Pearson’s system [13] in order to poten-
tially improve the noise modelling used in the algorithm, instead
of simply assuming a Gaussian distribution.
Different imaging conditions were considered in this study in
terms of statistical quality, as well as lesion size and source-to-
background (S/B) ratio. The images were reconstructed using an
iterative algorithm, since this type of reconstruction algorithms
form today’s state of the art in whole body PET imaging in rou-
tine clinical oncology practice [14]. In addition, the new FLAB
algorithm was evaluated using simulated images of non homo-
geneous and non spherical tumors derived from tumors of pa-
tients undergoing radiotherapy.
II. MATERIAL AND METHODS
A. FLAB Model
The FLAB model is an unsupervised statistical methodology
that takes place in the Bayesian framework. Let be a finite set
corresponding to the voxels of a 3-D PET image. We consider
two random processes and . Y rep-
resents the observed image and takes its values in whereas X
represents the “hidden” segmentation map and takes its values
in the set , with C being the number of classes. The
segmentation problem consists of estimating the hidden X from
the available noisy observation Y. The relationship between X
and Y can be modeled by the joint distribution , which
can be obtained using the Bayes formula
(1)
is the likelihood of the observation Y conditionally
with respect to the hidden ground-truth X, and is the prior
knowledge concerning X. The Bayes rule allows the determina-
tion of the posterior distribution of X with respect to the obser-
vation . Contrary to the FHMC model [11], we do
not assume here that a Markov process can model the prior dis-
tribution of X, thus simplifying its expression.
The Fuzzy Measure: The general idea behind the implemen-
tation of a fuzzy model within the Bayesian framework was pre-
viously introduced in [15] and [16] and was used for a local
Bayesian segmentation scheme in [15]. Its implementation is
based on the incorporation of a finite number of fuzzy levels
in combination with two homogeneous (or “hard”) classes,
in comparison to the standard implementation where only a
finite number of hard classes are considered. This model al-
lows the coexistence of voxels belonging to one of two hard
classes and voxels belonging to a “fuzzy level” depending on
its membership to the two hard classes. While the statistical
part of the algorithm models the uncertainty of the classifica-
tion, with the assumption being that the voxel is identified but
the observed data is noisy, the fuzzy part models the impreci-
sion of the voxel’s membership, with the assumption being that
the voxel may contain both classes. One way to achieve this ex-
tension is to simultaneously use Dirac and Lesbegue measures,
considering that X in the fuzzy model takes its values in [0,1]
instead of . We define therefore a new mea-
sure on [0,1], given that and are the Dirac
measures at 0 and 1, and is the Lesbegue measure on the fuzzy
interval [0,1]. This approach is adapted for the segmentation of
PET images since they are both noisy and of low resolution. The
“noise” aspect when considering Bayesian models is the way
the values of each class to be found in the image are distributed
around a mean value. The noise model used, whose respective
mean and variance are to be determined by the estimation steps,
can therefore be adapted to image specific characteristics. Fi-
nally, the fuzzy measure facilitates a more realistic modelling
of the objects’ borders transitions between foreground and back-
ground, allowing in such a way to indirectly account for the ef-
fects of blurring associated with low resolution PET images.
Distribution of X (a priori model): Using
as a measure on [0,1], the a priori distribution of each can be
defined by a density on [0,1], with respect to . If we assume
that X is a stationary process and that the distribution of each
is uniform on the fuzzy class, this density can be written as
(2)
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where, satisfies the following normalization condition:
Using this simple modelling for the prior distribution leads to ig-
noring the spatial relationship of each voxel with respect to its
local neighborhood. Although it is possible to include such spa-
tial information using the contextual framework [15], the use of
such modelling leads to an increase in the number of parameters
to be handled, and in practice, no more than one or two neigh-
bors can be actually taken into account. Hence, the contextual
approach is not of interest since we aim to explore all the in-
formation available in the 3-D volume around each voxel, i.e.,
at least 26 neighbors (eight-connectivity extended in three di-
mensions). As an alternative, the adaptive framework [15] can
be used. In this adaptive modelling, the spatial information is
inserted into the estimation step of the algorithm (see section
parameters estimation).
Distribution of Y (Observation or Noise Model) and the
Pearson’s System: In order to define the distribution of Y
conditional on X, let us consider two independent random
variables and , associated with the two “hard” values 0
and 1, whose densities and are characterized by means
and variances and respectively. The mean
and variance of each fuzzy level are derived from the ones
estimated in the two hard classes as follows:
(3)
where is the value associated to a fuzzy level . For the case
of two fuzzy levels and were used according
to results previously published [11].
The assumption that the noise for each class of the observed
data can fit a Gaussian distribution was considered as a first
approximation as with the previous implementation of the
FHMC algorithm [11]. In this work, we propose the study of
the Pearson’s system that contains seven other distributions.
In this context, instead of using a Gaussian distribution, an
additional step is introduced to detect which laws best fit the
actual distribution of the voxels in the image, for each class
considered at a given iteration of the estimation step of the
algorithm. The theory behind the Pearson’s system has been
previously detailed in [17] and a description of its use in
mixture estimation and statistical image segmentation is given
in [13]. Here, we briefly describe the Pearson’s system in our
particular context.
A distribution density on belongs to the Pearson’s system
if it satisfies
(4)
Different shapes of distributions as well as the parameters
determining a given distribution are provided by the variations
of the coefficients , , , and . For , 2, 3, and 4, let
Fig. 1. The eight distribution families in the graph of Pearson, function of  
and   [17]. I for Beta I, II for type II, III for Gamma, IV for type IV, V for
Inverse Gamma, VI for Beta II, VII for type VII and N for Normal.
us consider the first four statistical moments of a partition
of Y defined by
(5)
We also define two parameters and as follows:
(6)
where is called “skewness” and is called “kurtosis.”
The coefficients , , , and are related to (5) and (6) by
equations that can be found in the Appendix I-A. Given
, the
eight distribution density families contained in the
system of Pearson can now be defined by a set of conditions
using , and (see Appendix I-B). These eight distribution
density families are illustrated in Fig. 1. Finally, the protocol
used for the determination of which density family best fits each
measured distribution can be found in Appendix I-C.
Parameters Estimation: The different parameters necessary
to be estimated for the segmentation process are
(7)
Both a priori and noise parameters are unknown and
may vary from one image to another. An iterative procedure
called stochastic expectation maximization (SEM) [18], a sto-
chastic version of the EM algorithm [19], is used for the estima-
tion of these parameters. This is achieved by sampling a real-
ization of X according to its posterior distribution and
computing empirical values of the parameters of interest using
this realization. The stochastic nature of this procedure makes
it less sensitive to the initial guess of the parameters using the
K-Means [20] than deterministic procedures like the EM algo-
rithm. The system of Pearson can be used as an additional step
(inside each iteration of the algorithm) in order to determine the
type of distribution to use. The posterior distribution with re-
spect to class for a given voxel used at iteration for sam-
pling the posterior realization is given by (8) at the bottom of the
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page, where, is a density whose distribution type is
chosen using the Pearson system and whose mean and variance
were estimated at iteration , and is the prior proba-
bility of voxel belonging to class estimated at iteration .
In the adaptive framework priors are reestimated using a local
neighboring window with priors depending on the position
of the voxel in the image. Although in the 2-D case, a window
centred on the voxel of interest is used [15], for our application
we use a 3-D “cube” centred on each voxel. The size of the es-
timation “cube” was experimentally determined for the specific
application of PET imaging, since it depends on the size of the
objects of interest (10–50 mm in diameter) relative to the recon-
structed voxel size ( or mm ). An estimation
cube should from one hand be small enough to yield good local
characteristics [15], while on the other hand it should not be
too large with respect to the size of the object of interest. Con-
sidering this, we tested two different estimation “cube” sizes;
namely covering and voxels.
It is worth noting that only the priors are concerned by the use
of the adaptive framework. Noise parameters are estimated the
same way as in the blind context [15]. The detailed description
of the SEM algorithm in our context is given in the Appendix II.
Segmentation: In order to perform segmentation on a voxel
by voxel basis, we need to use a criterion to classify each
voxel as either part of the background or the functional VOI.
For this purpose we use the maximum posterior likelihood
(MPL) method as suggested by [15]. To compute a solution,
the MPL method requires the parameters defining the a priori
model (priors of each class for each voxel) as well as the noisy
observation data model (mean and variance of each class),
estimated using SEM. The MPL computes the posterior density
and selects for each voxel the class that maximizes it, using the
procedure described below.
Let us consider given by (8) computed using the pa-
rameters estimated by the SEM estimation algorithm. Using
, the decision rule assigning
the class or fuzzy level to the voxel knowing the observed
value is given by the following procedure:
For each voxel, let . If
, then assign the hard class 0 or 1 to
the voxel . Else if belongs to the fuzzy domain ,
use to determine its exact value
using the quantitation of the fuzzy interval into fuzzy levels (see
Section II-A-3) and assign one of the fuzzy levels to the voxel.
In our implementation of FLAB, each can take four different
values: 0, 1/3, 2/3, and 1.
B. Alternative Approaches Used for Comparison
Thresholding: Various thresholding methodologies have
been proposed in the past for functional volume determination
[2]–[4]. For comparison purposes with the developed method-
ology, threshold at 42% of the maximum value inside the lesion
was chosen for VOI determination, based on suggestions from
previous publications [2], [3]. The methodology was imple-
mented through region growing using the voxel of maximum
intensity in the object of interest as a seed. Using a 3-D neigh-
borhood (26 neighbors) the region is iteratively increased by
adding neighboring voxels if their intensity is superior or equal
to the selected threshold value. The results derived using this
method will be denoted from here onwards as T42.
Fuzzy C-Means: The FCMs algorithm was introduced in
[21]. It was suggested for PET image segmentation in [7].
For the purpose of this study it was implemented using the
following objective function O:
(9)
where is a weighting exponent and are the centre
values of the classes. The weighting exponent controls the
fuzzy aspect of the image and is usually set to 2 (hard segmen-
tation is represented by ). The algorithm converges to the
value at which the objective function has a local maximum. The
results derived using this method will be denoted from here on-
wards as FCM.
C. Validation Studies
Datasets: Acquisitions of the IEC image quality phantom
[22], containing six different spherical lesions of 10, 13, 17,
22, 28, and 37 mm in diameter [Fig. 3(a)] were carried out
in list-mode format using a Philips GEMINI PET/CT scanner.
The spatial resolution of this system is 4.9 mm full-width at
half-maximum (FWHM) at the center of the field of view [23].
Partial volume effects are therefore expected to be significant
even for the largest sphere. The 28-mm-diameter sphere was
not considered in this study since it was replaced by a hand-
made plastic sphere whose diameter was not known precisely.
Different parameters were considered covering a large spectrum
of configurations allowing assessment of the influence of dif-
ferent parameters susceptible to affect the functional VOI de-
termination. The statistical quality of the images was varied by
considering 1, 2, or 5 min list-mode time frames. Two different
signal-to-background (S/B) ratios (4:1 and 8:1) were consid-
ered, by introducing 7.4 in the background and 29.6
or 59.2 , respectively, in the spheres. Two different
voxel sizes ( or mm ) were used in the re-
construction of each of the different statistical quality datasets
using the 3-D RAMLA algorithm, with specific parameters pre-
viously optimized for clinical use [14]. Visual illustration of the
acquired images is given in Fig. 2. In addition, an estimation of
(8)
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Fig. 2. Different images used in the segmentation study; (a) ratio 4:1, 2 min
acquisition time, 64 mm voxels, (b) ratio 8:1, 2 min, 64 mm , (c) ratio 4:1,
2 min, 8 mm , (d) ratio 8:1, 2 min, 8 mm , (e) CT acquisition, (f) voxel-by-voxel
ground-truth generated using CT image on the PET image. Note the 28 mm
sphere is in plastic and not clearly seen (since its real diameter was unknown
this sphere was excluded from any analysis in this work).
the FLAB algorithm’s reproducibility was performed by consid-
ering five different 1 min list-mode time frames acquired con-
secutively and reconstructed using 8 mm .
Finally, to test the algorithm against more clinically realistic
conditions of tumor shapes, we simulated three lesions with
nonspherical shapes and inhomogeneous activity distributions.
These lesions were generated using real lung tumor images from
three patients undergoing PET scans for radiotherapy
treatment planning purposes. A ground-truth was drawn by a
nuclear medicine physician (on a slice-by-slice basis) based on
the reconstructed patient images. In the case of the first tumor,
the simulated contrast between the region of the highest ac-
tivity concentration and the rest of the tumor was around 2.2:1
whereas in the case of the second tumor, it is closer to 1.4:1.
Finally, the third tumor is almost homogeneous. The overall
contrast between the whole tumor and the background was 6:1
and 5:1 for the first and second tumors, respectively, and less
than 2:1 for the third one. In terms of lesion size, the largest le-
sion “diameter” was 4.1, 2.9, and 1.5 cm for the first, second,
and third lesion, respectively. These lesions were subsequently
placed within the lungs of the NCAT phantom [24]. No respira-
tory or cardiac motion was considered. Normal organ FDG con-
centration was assumed for the simulation [25], with the max-
imum activity concentration in the lesions being four times the
mean activity concentration in the lungs. The NCAT emission
and attenuation maps were finally combined with a model of
the Philips PET/CT scanner previously validated with GATE
[26]. A total of 45 million coincidences were simulated corre-
sponding to the statistics of a standard clinical acquisition over
a single axial field of view of 18 cm [26]. Images were subse-
quently reconstructed from the list mode output of the simula-
tion using 8 mm . As well as using all of the simulated
true coincidences, images were reconstructed for each lesion
using only 40% and 20% of the overall detected coincidences
in order to evaluate the accuracy of the segmentation algorithms
at different noise levels (similar to the IEC phantom study using
5, 2, and 1 min acquisitions for the image reconstruction). Visual
illustration of these simulated tumor images (central slice), with
their ground-truth drawn from the corresponding patient tumors
are displayed in Figs. 7 and 8, and Fig. 9(a)–(c). Each segmen-
tation algorithm considered was applied to the lesion and the
segmentation map was compared with the ground-truth. Note
that in this framework, the ground-truth does not need to be ac-
curate with respect to the true patient image. What is important
is that we are able to compare the segmentation obtained on the
simulated image with the ground-truth used in the simulation.
The corresponding segmentation maps (central slice) for each
algorithm can be found in Figs. 7 and 8 and Fig. 9(d)–(g).
Analysis: As our goal is not lesion detection in the whole
body image but the estimation of a lesion’s volume with the
best accuracy possible, we assume that the lesion has been pre-
viously identified by the clinician and automatically or manu-
ally placed in a 3-D “box” well encompassing the object [see
Fig. 3(a)]. Although no significant impact on the segmentation
results was observed through small changes in placement or size
of the box, certain conditions must be respected. Evidently it
should be large enough to contain the entire extent of the ob-
ject of interest and a significant number of background voxels
so the algorithm is able to detect and estimate the parameters
of the background class. On the other hand it should be small
enough in order to avoid including neighboring tissues with sig-
nificant uptake that would end up being classified as functional
VOI, requiring manual postprocessing. However, the shape of
this box does not have to be perfectly cubic or with specified
dimensions (contrary to the FHMC case [11]), and as a result it
could be drawn accordingly to exclude structures in the back-
ground that are of no interest.
Subsequently, the images of the selected area were segmented
in two classes (functional VOI and background) using each of
the methods under evaluation (T42, FCM, FHMC, and FLAB).
In the FHMC and FLAB cases, considering the optimization
results obtained in [11], two fuzzy levels were considered in the
segmentation process and the functional volumes were defined
using the first hard class and the first fuzzy level. A voxel-to-
voxel ground-truth was generated for the phantom dataset using
the CT image registered with the PET reconstructed image [see
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Fig. 2(e) and (f)]. Classification errors (CE) were then computed
on a voxel-by-voxel basis following the definition used in [11]:
(10)
PCE stands for positive classification errors, including voxels
of the background that are classified as belonging to the ob-
ject of interest, and NCE stands for negative classification errors
including voxels of the object that are classified as belonging
to the background. These classification errors essentially occur
on the boundaries of the objects of interest because of activity
“spill in” and “spill out.” If the segmentation results in PCEs
and NCEs of equal amounts, the computed VOI would be very
close to the true known volume whereas the shape and position
of the object would be incorrect (this essentially occurs for ob-
jects 2 cm, while for smaller objects the errors are essentially
PCE). As shown in (10), the total number of PCEs and NCEs
is considered with respect to the number of voxels defining the
sphere (VoS). Although the size of classification errors can be
bigger than 100%, in the case where a large number of back-
ground voxels in the selected area of interest are misclassified
as belonging to the sphere, maximum classification errors con-
sidered in this paper where limited to 100%, since any such
values represent complete failure of the segmentation process.
Although the combination of PCE and NCE into CE leads to
a loss of information as far as the direction of the bias is con-
cerned, classification errors represent more pertinent informa-
tion than overall volume errors, which reflect neither accurate
magnitude nor direction of the bias for a segmented volume. For
comparison purposes overall volume errors (with respect to the
known volume of the sphere) were also computed and shown in
Fig. 6.
As far as the simulated tumors are concerned, both overall
volume errors (with respect to the known volume of the ground-
truth) and CE were computed. Since all the algorithms under
investigation in this study perform binary segmentations (i.e.,
able to distinguish between tumor tissue and background only),
no evaluation was performed of their ability to distinguish dif-
ferent regions within a given tumor.
III. RESULTS
Different segmentation maps obtained using each of the
methods under evaluation (FHMC, FLAB, T42, and FCM) are
presented in Fig. 3(c)–(f) for a slice centered on the 22 mm
sphere considering a “good quality” image (8:1 contrast and
5 min acquisition) [Fig. 3(a)] to visually illustrate the variations
of the segmentation maps obtained. Segmentation results in the
case of a “lower quality” image (4:1 contrast and 2 min acqui-
sition) and a smaller sphere (17 mm) [Fig. 3(g)] are presented
in Fig. 3(h)–(k). Both images are representative of the 8 mm
voxel size reconstructions.
In the different figures shown in this section the CE are given
for all five spheres (10, 13, 17, 22, and 37 mm) and for both
contrast ratios (4:1 on the left part of each figure, 8:1 on the
right part) considered. The error bars in the figures represent the
different results obtained for each of the three different levels
of image statistical quality considered. The top of the error
Fig. 3. (a) Graphical representation of the IEC phantom and illustration of the
3-D box selection for the 22-mm sphere and examples of segmentation maps
(only central slice is shown); (b)–(f) for the 22 mm sphere (8:1 contrast, 5 min
acquisition) and (g)–(k) for the 17 mm sphere (4:1 contrast, 2 min acquisition)
with corresponding volume errors (computed on the whole volume): (b) and
(g) PET ROI, (c) and (h) T42 map, (d) and (i) FCM map, (e) and (j) FHMC, and
(f) and (k) FLAB maps with two fuzzy levels (light and dark grey voxels). Both
images are extracted from 8 mm voxel size reconstructions.
bar is the result concerning the worst statistical quality images
(1 min acquisition), the medium one concerns the medium
quality (2 min acquisition), and the lowest one corresponds to
the superior statistical quality (5 min acquisition). The only
exception is Fig. 5 where the error bars represent the variability
of the FLAB segmentation results considering the application
of the algorithm on multiple images of 1 minute acquisitions
(five independent realizations).
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Fig. 4. Optimization of the FLAB algorithm. Classification errors for (a) Beta I distributions (detected using the Pearson’s system) or Gaussian distributions (for
the 8 mm voxel size); (b)           or        voxels for the estimation cube (for the 64 mm voxel size); (c)           or        voxels for the
estimation cube (for the 8 mm voxel size); (d) with (FLAB) or without (FLB) adaptive estimation of priors (for the 8 mm voxel size). The top of the error bar
is the result concerning the worst statistical quality images (1 min acquisition), the medium one concerns the medium quality (2 min acquisition), and the lowest
one corresponds to the superior statistical quality (5 min acquisition).
Fig. 4 contains the results on the optimization of the algo-
rithm for the specific application of lesion segmentation in PET
images. Considering the selected volume of interest around a le-
sion, the Pearson’s system systematically led to the detection of
Beta I distributions for both the background and the lesion ac-
tivity distributions (although with different parameters). How-
ever, the parameters and (see (6)) placed the estimated dis-
tributions very close to the Gaussian one in the Pearson graph [as
it can be seen in Fig. 1, the surface matching Beta I distribution
(I) is in contact with the point defining the Normal distribution
(N)]. Consequently only small changes in the volume estima-
tion results were consistently obtained using the Beta I instead
of a Gaussian distribution [Fig. 4(a)]. Considering these results
the Gaussian distribution was kept in the final implementation
of the algorithm for the description of both the background and
lesion activity distributions.
In terms of the size of the estimation “cube” used for the
re-estimation of the priors in the adaptive framework, a size of
led to consistently better results across different
lesion and voxel sizes as well as S/B contrast and noise config-
urations as shown in Fig. 4(b) and (c). Finally, Fig. 4(d) demon-
strates the impact in terms of the improved results through the
use of the adaptive estimation, for the 8 mm configuration.
In this figure the FLAB segmentation results are compared to
the results without adaptive estimation (FLB for Fuzzy Local
Bayesian, using the same fuzzy levels implementation), where
priors are the same for all the voxels of the image and are com-
puted using the entire image instead of using only the local
neighbourhood of each voxel. As is demonstrated by this figure,
the inclusion of the adaptive estimation significantly improves
the segmentation results throughout the different lesion sizes
and contrast configurations considered.
Results in relation to the FLAB algorithm’s reproducibility
can be seen in Fig. 5. In this particular figure, error bars rep-
resent the variation of the segmentation results (mean and vari-
ance) using the five different images obtained from the consecu-
tive 1 minute acquisitions. A variation of 4% in the segmented
volumes was obtained from the application of the algorithm on
the five different images for all spheres except from the 1 cm
sphere which the algorithm consistently failed to correctly seg-
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Fig. 5. Study of FLAB reproducibility using five different 1 min list-mode time
frames (reconstructed with 8 mm voxel size). The error bars represent the vari-
ability of the FLAB segmentation results considering the application of the al-
gorithm on multiple images of 1 minute acquisitions (five realizations).
ment. This segmentation failure is most probably the cause of
this larger variability observed for the segmented volume of the
1 cm sphere.
Fig. 6 presents the classification errors and corresponding
overall volume errors relative to the CT-based ground-truth
obtained using each approach, for both 64 and 8 mm
sizes [Fig. 6(a) and (b) and 6(c) and (d), respectively]. Globally,
volume errors are very closely linked to classification errors:
when the segmentation results in strictly NCE, the volume error
(underestimation) is equal to the CE. When the segmentation
results in only PCE, the volume error (overestimation) is also
equal to the CE. And when both NCE and PCE occur, the
volume error is inferior to the CE (it essentially occurs for
medium-sized spheres). FLAB led to superior results in com-
parison to all the other methodologies on the whole dataset.
The proposed algorithm gives good results (on average between
5% and 20% CE) independently of the contrast ratio and for
all spheres except from the 1 cm one for which a minimum
error of 25% was obtained for the most favorable configuration
evaluated (8:1 contrast and a 5 min. acquisition). The use of a
reconstruction voxel size of 8mm allowed an improvement in
the segmented volume errors from 10%–25% to 5%–15% for
lesions between 1 and 2 cm.
As shown in Fig. 6, T42 gave errors 20% for the three
biggest spheres with the 8:1 contrast and 64 mm size,
while for a 4:1 contrast T42 did not manage to accurately seg-
ment any of the spheres. By reducing the reconstruction voxel
size to 8 mm an improvement was obtained in the results of
the T42 with errors 15% for the three larger spheres and a
contrast 8:1, while errors of 20% were obtained for the 22
and 37 mm spheres with a 4:1 contrast ratio. In the case of the
FCM algorithm errors of 20% and 40% were seen for le-
sions larger and smaller than 2 cm, respectively. No substantial
differences were seen in these results from the reduction in the
reconstruction voxel sizes from 64 to 8 mm . Finally, FLAB per-
formed better in comparison to the previously developed fuzzy
Bayesian approach (FHMC) for all different lesion sizes and
statistical image qualities considered with a larger magnitude
effect (improvements of over 100% in the errors) observed in
the spheres with a diameter 2 cm. Relative to the FLAB re-
sults globally larger improvements in the accuracy of the seg-
mented volumes were observed for the FHMC algorithm with a
reduction in the reconstructed voxel size. On the other hand, in
percentage terms the dependence of the algorithm results to the
statistical quality of the images was similar for both the FLAB
and FHMC results.
Figs. 7–9 show visual illustration of the segmentation maps
obtained on the simulated tumors. Fig. 10 contains the results
for both classification errors (NCE+PCE divided by the number
of voxels defining the tumor ground-truth volume) and volume
errors (with respect to known overall volume of the tumor) for
each approach.
The results for the first and third tumors (Fig. 7) show the
largest differences between the four algorithms. In the case of
the first tumor, this difference can be attributed to the nonuni-
form activity distribution (the contrast between the region of
highest activity and the rest of the tumor is around 2.2:1) rel-
ative to the second tumor (closer to 1.4:1). Consequently, the
segmentation results of T42 and FCM lead to large under evalu-
ation ( 30 to 50%) of the true volume of the first tumor since
they limit themselves to the highest activity area, whereas in
the case of the second tumor they are unable to differentiate be-
tween the two regions, hence recovering the entire tumor (less
than 10% error_for all methods). On the other hand, the third
tumor despite being uniform is small with a low tumor to back-
ground ratio (1.5 cm in “diameter” and contrast 2:1). As a
result, thresholding using 42% of maximum value fails com-
pletely (the region growing never stops and expands into the en-
tire selection box) and FCM despite qualitatively satisfying re-
sults leads to a large over evaluation (from 10% to 40% volume
error depending on the image statistical quality) of the volume.
As far as FHMC and FLAB are concerned, they are both able
to recover the whole tumor in all cases with volume errors be-
tween 2% and 20% (see Fig. 10). While FLAB in compar-
ison with the FHMC performed better in terms of both the mis-
classification and the overall volume errors, FHMC results were
less competitive with decreasing tumor sizes as seen also in the
IEC phantom results (Fig. 10). Finally, the variability of the re-
sults (demonstrated by the error bars in Fig. 10) considering the
different noise levels was higher for FCM and T42, illustrating
their lower robustness to noise in comparison to the fuzzy sta-
tistical approaches.
IV. DISCUSSION
Over the past few years there has been an increasing interest
in clinical applications such as the use of PET for IMRT plan-
ning, for which an accurate estimation of the functional volume
is indispensable. Unfortunately, accurate manual delineation is
impossible to achieve due to high inter- and intra-observer vari-
ability [2] resulting from the noisy and low resolution nature
of the PET images. Current state of the art methodologies for
functional volume determination involve the use of adaptive
thresholding based on anatomical information or phantom
studies. Thresholding however is known to be sensitive to
contrast variation as well as noise [2], [4], since it does not
include any explicit modelling of noise or spatial relationship.
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Fig. 6. Comparison of performances for FLAB, FHMC, FCM, and T42 on data reconstructed with (a) classification errors and (b) volume errors, for 64 mm
and (c) classification errors and (d) volume errors, for 8 mm voxels. The top of the error bar is the result concerning the worst statistical quality images (1 min
acquisition), the medium one concerns the medium quality (2 min acquisition), and the lowest one corresponds to the superior statistical quality (5 min acquisition).
Fig. 7. (a) Real tumour used as model, (b) voxelized ground-truth (manually
drawn) and its binary version, and (c) simulated tumour. Segmentation binary
maps obtained using (d) T42, (e) FCM, (f) FHMC, and (g) FLAB are shown.
Image is 34   34 voxels with 8 mm  .
In addition, proposed adaptive thresholding methodologies
require a priori knowledge of the tumor volumes currently
obtained by CT images, based on the nonvalid assumption
that the functional and anatomical volumes are the same [3].
In addition, proposed correction methodologies accounting
Fig. 8. (a) Real tumour used as model, (b) voxelized ground-truth (manually
drawn) and its binary version, and (c) simulated tumour. Segmentation binary
maps obtained using (d) T42, (e) FCM, (f) FHMC, and (g) FLAB are shown.
Image is 30   30 voxels with 8 mm  .
for the effects of background activity levels depend on lesion
contrast and background noise as well as being imaging system
specific [4]. On the other hand, previously developed automatic
algorithms have also shown dependence on the level of noise
and lesion contrast, most frequently requiring preprocessing
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Fig. 9. (a) Real tumour used as model, (b) voxelized ground-truth (manually
drawn) and its binary version, and (c) simulated tumour. Segmentation binary
maps obtained using (d) T42, (e) FCM, (f) FHMC, and (g) FLAB are shown.
Image is 16   16 voxels with 8 mm  .
Fig. 10. Segmentation results for the three simulated tumours. (a) Classifica-
tion errors and (b) overall volume errors. The top of the error bar is the result
concerning the worst statistical quality images (20% of detected coincidences),
the medium one concerns the medium quality (40%), and the lowest one corre-
sponds to the superior statistical quality (100%).
or postprocessing steps and variable initialization parameter
values depending on image characteristics rendering their use
complicated and their performance highly variable.
We have previously developed and assessed the performance
for functional volume segmentation of a modified version of
the hidden Markov chains algorithm (FHMC) [11]. In this al-
gorithm a number of fuzzy levels have been added to introduce
the notion of imprecision allowing this way to account for the
effects of low image spatial resolution in addition to the noise
modelling (which is part of the standard HMC framework). Al-
though the algorithm was shown to accurately segment func-
tional volumes (errors 15%) for lesions 2 cm throughout dif-
ferent contrast and noise conditions, it was unable to accurately
segment lesions 2 cm. The main reason behind the failure of
FHMC concerning the segmentation of such small lesions was
the small number of voxels associated with the object of interest
in combination to image noise levels, and the Hilbert-Peano path
[12] used to transform the image into a chain. The spatial cor-
relation of such small objects is lost once the image is trans-
formed into a chain, because the voxels belonging to the object
may find themselves far away from each other in the chain, thus
resulting in transition probabilities that prevent these voxels to
form a class differentiated from the background. In addition, it
was thought that the assumption of a Gaussian noise distribu-
tion in the images to be segmented may have also been partly
responsible.
FLAB clearly improved the results of FHMC, essentially due
to the adaptive estimation of the priors using the whole 3-D
neighborhood of each voxel, as the results of Fig. 5(c) clearly
demonstrate. FLAB results obtained on the objects 2 cm were
similar to those obtained through the use of FHMC as were
their respective robustness with respect to noise levels. Finally,
FLAB resulted in faster computation times in comparison with
the FHMC.
In addition, highly reproducible results ( 4% variability, to
compare with the 8%–20% variability observed on manual seg-
mentation [2]) were obtained for different image contrast ratios
and lesion sizes 1 cm. We should emphasize here that the per-
formance of the FLAB in comparison to other segmentation al-
gorithms was evaluated in this study on images reconstructed
using a specific iterative reconstruction algorithm used today in
clinical practise. Since the FLAB segmentation algorithm has
been developed in order to better cope with variable noise and
contrast characteristics it should be the least affected by such
changes introduced as a result of using an alternative reconstruc-
tion algorithm [27]. On the other hand, the use of the system of
Pearson for the determination of image voxel value distributions
did not lead to significant changes or improvements in the results
in comparison to the Gaussian assumption. Although this was
shown to be the case for the images reconstructed using the spe-
cific iterative reconstruction algorithm used here it may not be
the case if an alternative reconstruction algorithm is used, where
potentially the use of the system of Pearson for the characteri-
sation of the image voxel values distribution may still prove to
play a role in the segmentation process and needs to be further
investigated.
By comparison the use of T42 led, as expected, to segmented
functional volumes greatly dependent on image contrast and
noise levels while being comparable to the FLAB results con-
sidering medium image statistical quality and lesions 17 mm
with an 8:1 tumor to background ratio. Finally, the resulting vol-
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umes from the application of the automatic segmentation algo-
rithm FCM were less dependent to image statistical quality but
consistently failed to segment lesions 2 cm.
In this study, as in every other phantom study presented to
date in the literature, we have firstly considered the performance
of the different algorithms for the segmentation of uniformly
filled spherical lesions. To our knowledge there has been
no study up to now specifically investigating the functional
volume segmentation task for inhomogeneous uptake lesions,
for example lesions with necrotic or partially necrotic regions.
Although it has not been the major aim of their work, Nestle et
al. demonstrated some evidence of the issues associated with
the use of either fixed or background adjusted thresholding
methodologies for lesions with inhomogeneous activity dis-
tributions and shapes in the clinical set up for non small cell
lung cancer [4]. As it was shown in this study using simulated
realistic lesions, the FLAB model is able to successfully deal
with nonuniform lesion shapes and variable activity concen-
trations in contrast with the threshold based or fuzzy C-means
segmentation algorithms considered. On the other hand, the
binary two-class modelling (background or lesion) is obviously
not adequate to permit the differentiation of multiple regions
inside the tumor with largely different activity concentrations,
as well as extracting the overall tumor in the case of strong
heterogeneity. However, whereas it seems difficult to improve
threshold-based segmentation methods in order to allow the
identification of regions with variable activity concentration
within the same functional volume of interest, the fuzzy model
of FLAB may be extended to more than two hard classes to
allow modelling a combination of inhomogeneous regions
within a given volume. This could further enhance the use of
FLAB for functional volume segmentation in future potential
clinical applications.
The objectives of this study were to address the issue of
functional volume determination and lesion segmentation. The
FLAB model, as with any other segmentation algorithms, does
not modify the values of the image voxels. As such, the use
of the functional volume obtained with the FLAB algorithm,
although is the closest to the true volume of the tumor as
demonstrated by the results in this study, does not lead to the
accurate activity concentration within the lesion. This is as a
result of including voxels whose values have been decreased
by spill-out from partial volume effects, usually leading to an
underestimation of the activity concentration whose magnitude
depends on the size of the lesion [11]. Although the segmented
volume should therefore not be used for directly recovering the
accurate activity concentration, they can be used in combina-
tion with partial volume correction methodologies potentially
allowing a more accurate correction in comparison to the use
of anatomical volumes [28].
V. CONCLUSION
A modified version of a fuzzy local Bayesian segmentation al-
gorithm has been developed. The suggested approach combines
statistical and fuzzy modelling in order to address specific is-
sues in the segmentation of low resolution noisy PET images.
It is automatic, fully 3-D and uses adaptive estimation of priors
to yield good local spatial characteristics that improve segmen-
tation of small objects of interest. Results obtained with images
of the IEC phantom reconstructed with the 3-D RAMLA iter-
ative algorithm have shown that it is more effective than the
reference thresholding methodology and other previously pro-
posed automatic algorithms such as FHMC or the FCM methods
for functional volume determination in PET images. The algo-
rithm has also been tested successfully against realistic simu-
lated tumors, using real patient tumors as model, with nonspher-
ical shape and inhomogeneous activity distributions. Future de-
velopments will concentrate on the incorporation into FLAB of
three hard classes and three different fuzzy transitions, in order
to allow the segmentation within the same lesion of variable
activity distributions in the case of highly heterogeneous func-
tional uptake in the tumor volumes. We will also evaluate the
use of different noise models in an associated robustness study
using acquisitions with different scanner models and reconstruc-
tion algorithms.
APPENDIX I
A. Relationship Between Coefficients , , , and and
(5) and (6)
B. Definition of the Eight Distribution Density Families




where is the Beta function
(with the Gamma function).
We also have the following relationships between the param-
eters and , and the mean and variance ( , denote es-
timated mean and variance) of class (this is useful to get the
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parameters and from the estimated means and variances ob-
tained through the SEM algorithm)
C. Recipe for Identification of the Best Family to Fit
Distributions of Classes
Let us consider the voxels and their partitions
and into two classes. The moments can be estimated from
empirical moments, and we use the following to detect which
family best fits each distribution.
1) Consider the partitions , of defined by
and .
2) For each class use in order to estimate the em-
pirical moments by the following.
for , 3, 4.
3) For each class , calculate and from the estimated
( , 2, 3, 4) according to (6).
4) For each class , use , and rules (Appendix I-B) to
determine which family its density belongs to.
APPENDIX II
SEM Algorithm
1) Give an initial value of the parameters
using K-Means algorithm for the noise and equal probabil-
ities for the priors.
2) At each iteration , is obtained from and the data
using:
a) Choose a distribution for the classes 0 and 1 according
to the Pearson system rules (Section II-A-3 and Ap-
pendixes I-B and I-C).
For each , compute the a posteriori probabilities
and using (8) and sample a value in the set
according to , and (
representing the fuzzy voxels). Let us denote
the posterior realization obtained through this sampling.
Let and .
• Reestimate the priors using
where is the estimation cube centred on voxel and
the Kronecker function.
• Reestimate the noise parameters using
For the means and variances of the fuzzy levels, use (3).
Repeat step 2 until stabilization of the parameters. Stabiliza-
tion is defined by a criterion of % change in the values of the pa-
rameters between two successive iterations (we used 0.1% and
the algorithm usually stops before 25 iterations) and a maximum
number of iterations if the stabilization criterion is not met (usu-
ally 50 iterations).
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Résumé
La détermination des volumes fonctionnels est une étape cruciale pour les applications en oncologie comme le suivi thérapeutique ou la
planification en radiothérapie guidée par l’image. Il n’existe pour l’instant pas de consensus dans la communauté sur la méthode appropriée pour
définir automatiquement un volume tumoral sur l’image fonctionnelle d’émission (e.g. TEP au 18F-FDG), à cause de la grande variabilité des
images obtenues dans ce contexte, en termes de bruit, de textures, de contrastes ou des formes et des fixations hétérogènes des tumeurs. Nous
proposons une méthode automatique dont la robustesse et la précision ont été validées sur des acquisitions de fantôme, des tumeurs simulées et
réelles, avec des performances très supérieures aux méthodes de référence par seuillage, constituant un outil prometteur pour les applications de
la TEP en oncologie.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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Abstract
Functional volumes determination is a crucial step for several applications in oncology like therapy assessment or image-guided radiotherapy
treatment planning. There is currently no consensus about the appropriate method for an automatic definition of the tumoural volume on functional
emission images (e.g. 18F-FDG PET), because they are characterized by a large variability of noise, textures and contrasts, as well as shapes
and uptakes of tumours. We propose a novel automatic method that was validated for robustness and accuracy on phantom acquisitions, realistic
simulations and clinical images of complex tumours. This method outperforms the reference thresholding methodologies and may have an impact
in several PET applications in oncology.
© 2009 Elsevier Masson SAS. All rights reserved.
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1. Introduction
La détermination des volumes fonctionnels est une étape
cruciale pour les applications en oncologie comme le suivi thé-
rapeutique [1] ou la planification en radiothérapie guidée par
l’image [2]. Cette tâche est généralement effectuée à la main
par les utilisateurs, a été jugée complexe et est associée à une
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très grande variabilité inter- et intra-utilisateurs [3]. Malgré le
grand nombre de méthodes ayant été proposées récemment pour
automatiser la définition des volumes tumoraux sur les images
d’émission [4–19], il n’existe pour l’instant pas de consensus
dans la communauté sur la méthode appropriée pour définir
automatiquement un volume tumoral sur l’image fonctionnelle
d’émission (e.g. TEP au 18F-FDG), du fait de leur qualité limitée
et de la faiblesse de la plupart des méthodes proposées jusqu’à
présent, inappropriées pour gérer la grande variabilité des para-
mètres en termes de bruit, de flou, de contraste ou des formes et
des fixations hétérogènes des tumeurs. La plupart des méthodes
proposées jusqu’à présent partagent également le désavantage
de ne pas bénéficier d’une validation suffisante pour convaincre
les utilisateurs finaux, par exemple en se contentant de résultats
sur fantômes simplifiés ou sur des données cliniques sans vérité
terrain.
Nous proposons une méthode automatique, robuste et pré-
cise, validée sur plusieurs ensembles de données de la simulation
à l’image clinique, pouvant être utilisée sans optimisation préa-
lable pour un scanner et un protocole spécifique et limitant
l’intervention de l’utilisateur à la détection de la tumeur.
2. Matériels et méthodes
La méthode proposée est fondée sur l’utilisation du contexte
méthodologique de la segmentation statistique d’images [20].
Plusieurs approches ont déjà tenté d’utiliser ce type de méthodo-
logies dans le cadre de l’imagerie d’émission [14,15] mais ces
dernières se limitaient à l’utilisation d’une mesure statistique
dite « dure » où seule une somme de Dirac est considérée. Cette
mesure permet de bien modéliser l’aspect bruité des images,
mais n’est pas adaptée aux images d’émission qui sont de plus
floues. En effet, l’hypothèse de la modélisation « dure » consiste
à considérer qu’un voxel appartient à une classe et que son obser-
vation est bruitée, en conséquence de quoi elle ne permet pas de
modéliser qu’un voxel puisse contenir un mélange de classes.
La modélisation que nous utilisons est fondée sur l’utilisation
d’une mesure statistique définie par un mélange de masses de
Dirac pour les classes homogènes et de mesures continues de
Lesbegue pour les transitions floues entre les régions [21]. Ceci
permet de prendre en compte simultanément les deux princi-
paux défauts des images d’émission : le bruit statistique et le
flou induit par la résolution spatiale.
Cette mesure floue a été utilisée dans le cadre d’une modé-
lisation par chaînes de Markov [19] puis d’une approche locale
adaptative [22] offrant des performances supérieures. Cette der-
nière approche a été nommée FLAB pour fuzzy locally adaptive
Bayesian et a fait l’objet d’un brevet1. De plus, en étendant
la modélisation à trois classes homogènes et trois transitions
floues différentes, la méthode est capable de prendre en compte
l’hétérogénéité de la fixation au sein des tumeurs et permet
de générer des volumes segmentés non binaires [23]. Cela est
notamment intéressant pour les applications de « dose painting »
en radiothérapie pour une optimisation de la dosimétrie [24]
1 Brevet franc¸ais référence FR08/56089.
alors que la plupart des méthodes proposées jusqu’à présent ne
considèrent que des segmentations binaires des volumes fonc-
tionnels et ne peuvent donc pas être utilisées automatiquement
dans cette optique. Dans la méthode FLAB, le contexte spa-
tial des voxels est pris en compte par un cube glissant, au sein
de l’estimation itérative des paramètres d’intérêt du modèle, à
savoir les moyennes et variances de chaque classe ainsi que les
probabilités a priori de chaque voxel d’appartenir à une classe
donnée [22], ce qui est indispensable pour une segmentation pré-
cise. Cette estimation itérative est réalisée grâce à l’algorithme
stochastic expectation maximization (SEM) [25] qui assure une
vitesse de convergence supérieure et une relative indépendance
aux conditions d’initialisation par rapport à l’algorithme expec-
tation maximization (EM) classique.
Les résultats de FLAB ont été comparés avec ceux obtenus
par des méthodes utilisant un seuillage fixe (ici 42 % du maxi-
mum comme proposé par Erdi et al. [4]) ou adaptatif prenant
en compte le signal du fond environnant [9] dont les paramètres
ont été optimisés pour les scanners considérés. Sa robustesse a
été étudiée sur des acquisitions réelles de fantôme contenant des
sphères homogènes et réalisées sur plusieurs scanners différents
(Philips Gemini et Gemini TF, Siemens Biograph, GE Disco-
very LS) avec leurs algorithmes de reconstruction (RAMLA,
TF ML-EM, OSEM) (Fig. 1). Sa précision a été validée sur
20 images de tumeurs réalistes tant en termes de formes que
de fixations, basées sur des acquisitions réelles de patients et
simulées à l’aide de Geant4 application for tomography emis-
sion (GATE) [26,27] (Fig. 2), ainsi que sur un ensemble de 18
images de tumeurs pulmonaires réelles (Fig. 3). Concernant ces
dernières, tous les patients ont été opérés et le diamètre maxi-
mal des tumeurs a été mesuré lors de l’étude macroscopique
des pièces opératoires [28]. Le diamètre maximal des tumeurs
déterminé par le pathologiste a été comparé à celui mesuré sur
les volumes segmentés par chaque méthode considérée.
Il est important de noter que la méthode proposée n’est pas
conc¸ue pour être appliquée à l’image corps entier du patient car
l’objectif n’est pas de détecter la tumeur, mais de la segmenter
avec la plus grande précision possible. Elle est appliquée à une
sélection contenant toute la tumeur, détectée et sélectionnée par
l’utilisateur. Pour l’instant, le choix d’utiliser la méthode binaire
(deux classes dures et une transition floue) ou la méthode à trois
classes (trois classes dures et trois transitions floues) repose sur
l’utilisateur en fonction de son appréciation de l’hétérogénéité
de la tumeur à segmenter, mais il est possible d’automatiser cette
initialisation, par exemple avec un algorithme de K-moyennes
flou avec sélection automatique du nombre de classes par mini-
misation de l’entropie de l’histogramme de l’image comme
proposé par Provost dans sa thèse [29].
3. Résultats
Les performances de FLAB, tant en termes de robustesse que
de précision, sont largement supérieures à celles des méthodes de
référence utilisant des seuillages. L’évaluation de la robustesse
[30] est importante, car elle permet de déterminer si une méthode
donnée peut être utilisée sur des images obtenues avec n’importe
quel scanner sans optimisation préalable, contrairement aux
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Fig. 1. Exemples d’acquisitions de fantôme sur un des scanners considérés (ici le Philips Gemini) avec différents paramètres. A. Contraste 8:1. B. Contraste 4:1 ; a :
reconstruction 4 mm3 × 4 mm3 × 4 mm3 ; b : reconstruction 2 mm3 × 2 mm3 × 2 mm3 ; 1 : cinq minutes d’acquisition ; 2 : une minute d’acquisition.
méthodes utilisant des seuillages adaptatifs, dont les paramètres
doivent être optimisés pour un scanner et une reconstruction
donnés. Comme le montrent sur la Fig. 4, l’erreur moyenne
et l’écart-type obtenus sur les sphères de 37 à 13 mm de dia-
mètre, sur l’ensemble des acquisitions, FLAB permet d’obtenir
moins de 10 % d’erreur sur les sphères, avec un écart-type de
l’ordre de 5 à 10 %. Aucune des méthodes ne permet d’obtenir
de bons résultats sur la sphère de 10 mm car on atteint ici les
limites des scanners TEP dont la résolution spatiale est limitée
à environ 5 mm de largeur à mi-hauteur, combinée à un échan-
tillonnage spatial de voxels de 2 et 5 mm de côté. Les résultats
sur fantômes sont satisfaisants pour démontrer la robustesse de
la méthode et son universalité car elle donne de bons résultats
sur différents types de textures, de bruit, d’échantillonnage spa-
tial ou de contrastes. Bien que les erreurs soient de plus faibles
concernant la détermination du volume (autour ou inférieures
à 10 %), il ne s’agit que de cas idéaux de fixations sphériques
uniformes sur un fond uniforme. Les tumeurs réelles présentent
en règle générale des structures plus complexes, tant en termes
de formes que d’hétérogénéité de fixations.
Ainsi, les résultats obtenus sur les tumeurs simulées (Fig. 5)
permettent d’apprécier la précision de la segmentation en situa-
Fig. 2. Illustration de deux tumeurs simulées et des résultantes de segmentation obtenues par les différentes approches, par rapport à la vérité terrain simulée. L’échec
complet du seuillage fixe à 42 % sur la plus petite tumeur s’explique par le fait que dans l’image, aucun voxel n’a de valeur inférieure à 42 % du maximum de la
lésion (très faible contraste).
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Fig. 3. Illustration d’une tumeur pulmonaire réelle (image anatomique et fonctionnelle) et les résultats de segmentation obtenus par différentes méthodes.
Fig. 4. Erreurs de classification voxel à voxel par rapport à la vérité terrain
obtenues par différentes méthodes (seuillages à 42 et 50 % du maximum, T42
et T50, le clustering par Fuzzy C-Means FCM et FLAB) sur l’ensemble des
acquisitions de fantôme (tous les scanners, tous les paramètres considérés).
tion plus réaliste. Les résultats sont en faveur de FLAB, avec
une erreur moyenne (calculée sur un ensemble de 20 tumeurs)
de classification voxel à voxel par rapport à la vérité terrain
simulée inférieure à 9 % et un écart-type de 8 %. Le seuillage
Fig. 5. Erreurs de classification moyenne et écart-type de chaque méthode sur
20 tumeurs simulées par rapport à la vérité terrain voxel à voxel.
Fig. 6. Erreur moyenne et écart-type par rapport au diamètre de la tumeur mesuré
en histologie, pour l’ensemble des 18 tumeurs et les différentes approches de
segmentation des images.
adaptatif et le seuillage à 42 % donnent respectivement des
erreurs moyennes et des écarts-types de 19± 15 % et 34± 20 %.
Les résultats obtenus sur la mesure du diamètre maximal des
tumeurs réelles mesurées en histologie (Fig. 6) sont également
en faveur de FLAB. En effet, bien que toutes les méthodes
obtiennent une erreur moyenne inférieure à 5 %, les écarts-
types associés au seuillage adaptatif et au seuillage fixe sont
respectivement de 10 et 20 % là où celui associé à FLAB est
inférieur à 5 %. La faible erreur moyenne obtenue s’explique
par le fait que dans les 18 tumeurs considérées, environ la moi-
tié est sous-estimée et l’autre moitié surestimée. De plus, outre
une précision accrue sur la définition des volumes tumoraux,
comme l’illustrent les Fig. 2 et 3, FLAB est capable de générer
des volumes segmentés non binaires, offrant une information
supplémentaire très importante, notamment en radiothérapie,
sur l’éventuelle hétérogénéité de la fixation au sein des tumeurs
considérées.
4. Discussion et conclusion
La position de la TEP comme outil de référence pour le diag-
nostic en oncologie a été renforcée par l’arrivée des scanners
multimodalités TEP/TDM depuis le début des années 2000. Plus
Author's personal copy
148 M. Hatt et al. / IRBM 30 (2009) 144–149
récemment, l’intérêt porté à l’imagerie fonctionnelle pour des
applications comme le suivi thérapeutique et surtout la plani-
fication de traitement en radiothérapie par l’image a motivé
le développement par de nombreux groupes de recherche, de
méthodes permettant d’améliorer la détermination automatique
des volumes fonctionnels. Il a déjà été montré que l’utilisation
de l’imagerie fonctionnelle dans le cadre de la radiothérapie per-
met, d’une part, de réduire la variabilité inter- et intra-utilisateurs
[28,31] et, d’autre part, d’inclure des volumes tumoraux qui
sont ratés, par l’utilisation de l’imagerie anatomique seule, ou
au contraire d’exclure des volumes non malins qui auraient été
inclus à tort en se basant uniquement sur l’information de densité
de tissus fournie par l’imagerie TDM [32].
La méthode que nous proposons a plusieurs avantages par
rapport aux méthodes de référence utilisant des seuillages. Elle
est d’abord plus robuste et peut être utilisée sur des images
acquises sur différents scanners et reconstruites avec diffé-
rents algorithmes, sans optimisation préalable de paramètres.
La dépendance au scanner et aux caractéristiques de l’image
est donc réduite par rapport aux seuillages adaptatifs. La pré-
cision de la méthode est supérieure, y compris et surtout sur
des cas complexes de tumeurs hétérogènes sur lesquelles les
méthodes binaires utilisant des seuillages sont inappropriées et
échouent parfois totalement. La possibilité de générer directe-
ment des volumes segmentés à trois classes permet d’envisager
l’implémentation automatique du principe de dose painting en
radiothérapie, pour une dosimétrie optimisée, ou une analyse
fine région par région de la tumeur dans le cadre du suivi thé-
rapeutique. Enfin, elle est automatique et réduit l’intervention
de l’utilisateur à la détection de la tumeur et son isolation dans
une boîte de traitement. La méthode a été validée à la fois sur
de multiples acquisitions de fantômes pour valider sa reproduc-
tibilité et sa robustesse et sur des images simulées et réelles
de tumeurs complexes et hétérogènes pour valider sa préci-
sion. Les résultats encourageants obtenus par cette approche
permettent de penser qu’il s’agit là d’une méthode pouvant avoir
un impact important dans les diverses applications de la TEP :
le diagnostic, le suivi thérapeutique et la radiothérapie, pour
lesquelles une définition automatique et précise des volumes
fonctionnels permet d’améliorer et d’accélérer l’analyse quan-
titative des images d’émission. Une étude est en cours dans le
cadre d’un projet ANR (SIFR, 2009–2010) pour renforcer la
validation de FLAB et estimer son impact dans le cadre de la
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Purpose: Accurate contouring of positron emission tomography (PET) functional volumes is now considered
crucial in image-guided radiotherapy and other oncology applications because the use of functional imaging allows
for biological target definition. In addition, the definition of variable uptake regions within the tumor itself may
facilitate dose painting for dosimetry optimization.
Methods and Materials: Current state-of-the-art algorithms for functional volume segmentation use adaptive
thresholding. We developed an approach called fuzzy locally adaptive Bayesian (FLAB), validated on homoge-
neous objects, and then improved it by allowing the use of up to three tumor classes for the delineation of inhomo-
geneous tumors (3-FLAB). Simulated and real tumors with histology data containing homogeneous and
heterogeneous activity distributions were used to assess the algorithm’s accuracy.
Results: The new 3-FLAB algorithm is able to extract the overall tumor from the background tissues and delineate
variable uptake regions within the tumors, with higher accuracy and robustness comparedwith adaptive threshold
(Tbckg) and fuzzy C-means (FCM). 3-FLAB performedwith amean classification error of less than 9%± 8%on the
simulated tumors, whereas binary-only implementation led to errors of 15% ± 11%. Tbckg and FCM led to mean
errors of 20% ± 12% and 17% ± 14%, respectively. 3-FLAB also led to more robust estimation of the maximum
diameters of tumors with histologymeasurements, with <6% standard deviation, whereas binary FLAB, Tbckg and
FCM lead to 10%, 12%, and 13%, respectively.
Conclusion: These encouraging resultswarrant further investigation in future studies thatwill investigate the impact
of 3-FLAB in radiotherapy treatment planning, diagnosis, and therapy response evaluation.  2010 Elsevier Inc.
Heterogeneous functional volumes delineation, Automatic segmentation, Image-guided radiotherapy,
Dose painting.
INTRODUCTION
Although most clinical applications of positron emission
tomography (PET) rely on manual and visual analysis, accu-
rate functional volume delineation in PET is crucial for
numerous oncology applications. These include the use of
tumor volume and associated determination of semiquantita-
tive indices of activity concentration for diagnosis and ther-
apy response evaluation (1) or the definition of target
volumes in intensity-modulated radiation therapy (IMRT)
(2). Subjective (1) and tedious manual delineation cannot
perform accurate and reproducible segmentation, particularly
when considering complex shapes and nonhomogeneous
uptake. This results from the low quality of PET images
due to statistical noise and partial volume effects (PVE)
(3), arising from the scanner’s limited spatial resolution.
Most of the previously proposed methods for PET volume
definition are semiautomatic and threshold-based, using
either fixed (30%–75% of the maximum activity) (2, 4, 5)
or adaptive approaches incorporating the background activity
(6–10). Unfortunately, these approaches often require
additional a priori information and are user- and system-
dependent. They require manual background regions of
interest (ROIs), and their performance depends on parame-
ters requiring optimization using phantom acquisitions for
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each scanner and reconstruction. Finally, all of these
approaches are strictly binary and were not validated consid-
ering heterogeneous volumes.
Numerous works have addressed PET lesion segmentation
using more advanced image segmentation methodologies
(11–19). However, the majority of these approaches often
depend on pre- or postprocessing steps such as deconvolution
or denoising, are often binary only, and are validated on
phantom acquisitions or clinical data without rigorous
ground truth.
We previously developed an algorithm for PET volume
definition by combining a fuzzy measure with a locally
adaptive Bayesian-based classification (FLAB) that has
been shown to perform better with respect to fixed threshold-
ing, fuzzy C-means (FCM), or fuzzy hidden Markov chains
(FHMC) for PET volume definition, as far as homogeneous
spheres or slightly heterogeneous and nonspherical tumors
are concerned (20). Preliminary results show that FLAB is
also robust with respect to variability of the acquisition and
reconstruction parameters (24).
Clinical tumors may be characterized by heterogeneous
uptake, thus demanding a nonbinary approach for an accurate
segmentation that may have a significant impact in defining
biological target volumes for dose painting (21). The goals
of this work were to (1) improve the FLAB model by incor-
porating the use of three hard classes and three fuzzy transi-
tions and (2) evaluate its accuracy on real (with known
diameter measured in histology) and simulated (with known
ground truth) data sets containing inhomogeneous tumors.
METHODS AND MATERIALS
Three-class fuzzy Bayesian segmentation (3-FLAB)
The 3-FLAB algorithm is an extension of our previous work
considering only a binary segmentation (20). FLAB automatically
estimates parameters of interest from the image, maximizing the
probability of each voxel to belong to one of the considered classes.
This probability is estimated for each voxel as a function of its value
and the values of its neighbors relative to the voxels’ statistical
distributions in the image, which corresponds to an estimation of
the noise within each class. Hence, each voxel of the volume is








where PðXjYÞis the probability of belonging to Class X knowing
Observation Y. This probability is obtained by the product of
PðYjXÞ and PðXÞ, corresponding to the noise model and the spatial
model, respectively. PðYjXÞ is estimated considering the statistical
distribution of the voxels within each class, whereas PðXÞ is esti-
mated using a sliding cube of 3 3 3 voxels; hence, each voxel’s
classification is influenced by its neighbors. The parameters to
estimate are the mean and variance of each class and the spatial
probabilities of each voxel with respect to its neighbors. This is
performed iteratively using a stochastic version (SEM) (25) of the
Expectation Maximization (EM) (26) initialized with K-means
(27) or fuzzy C-means (28). In addition, a fuzzy measure between
the classes was added to account for the blur between regions,
assuming each voxel may contain a mixture of classes (22, 23).
The difference between 3-FLAB and the previously developed
binary-only FLAB (20) is the use of three classes and three fuzzy
transitions within the model (see Fig. 1), to deal with both homoge-
neous and heterogeneous activity distributions. Figure 2 demon-
strates the inability of FLAB to handle highly nonuniform activity
distributions, where the lower uptake part of the lesion is errone-
ously considered as part of the background (see Fig. 2b), emphasiz-
ing the need to better model heterogeneous activity distributions.
3-FLAB should retain the accuracy and robustness of the original
model, while also being able to handle the challenging heteroge-
neous activity distributions that are frequently seen in clinical
lesions. The 3-FLAB segmentation workflow is summarized as
follows, and the implementation and mathematical details can be
found in the Appendix.
1. Initialization of both the spatial and noise models parameters:
means and variances of each class are obtained using the
K-means or fuzzy C-means. The prior probabilities are fixed at
one third for each class.
2. Iterative estimation is performed using the SEM by stochastic
sampling for each voxel according to its posterior probability.
3. Segmentation is done by selecting for each voxel the class or
fuzzy level that maximizes its posterior probability and fusion
of fuzzy levels with each hard class to generate a two- or three-
class segmentation map.
Alternative segmentation methodologies used for
comparison
We compared the results of the 3-FLAB algorithmwith the binary
FLAB approach and the fuzzy C-means (with two or three clusters)
clustering introduced by Dunn (28) and used to segment PET brain
tumors in (13), as well as an adaptive thresholding (6) (Tbckg):
Ithreshold ¼ a Imean þ Ibackground: (2)
Imean was obtained by computing the mean of all voxels contained
inside an initial threshold at 70% of the maximum and Ibackground
by computing the mean of the voxels inside a ROI manually drawn
on the background. Imean and Ibackground were subsequently used to
Fig. 1. The fuzzy scheme in the three-class fuzzy locally adaptive
Bayesian (3-FLAB) implementation.
302 I. J. Radiation Oncology d Biology d Physics Volume 77, Number 1, 2010
derive a first approximation of the source-to-background contrast.
The parameter a was optimized using phantom acquisitions on
each scanner used to obtain the data. The adaptive thresholding
algorithm was implemented using a region-growing approach with
the maximum intensity voxel as a seed and iteratively adding
three-dimensional (3D) neighboring voxels if their value was above
the threshold calculated using Eq. 2.
Validation studies
Data sets: Data Set 1 was used to evaluate the performance of the
algorithm under realistic imaging conditions. It consists of 20 3D
simulated tumors with variable levels of irregular shape and homoge-
neous or nonhomogeneous uptake distributions derived from tumors
in patients undergoing 18F-fluorodeoxyglucose PET/CT investiga-
tions for radiotherapy treatment planning purposes. These images
were acquired in 2D and 3D mode using the GE Discovery LS and
PhilipsGemini PET/CT scanners, respectively. Three of these tumors
illustrating the range of sizes, shapes, and heterogeneities considered
are shown in Fig. 4a–4c. The goal was to produce realistic images of
PET tumors while retaining a voxel-based ground truth to compute
accurate voxel-based classification errors. Half of the tumors were
simulated considering a homogeneous uptake distribution, whereas
the other half was simulated using significant heterogeneity within
the tumor. The procedure followed to generate these images is
illustrated in Fig. 3 and detailed in the following paragraphs.
Each clinical tumor is first manually delineated on the PET image
by a nuclear medicine expert, thus creating a voxelized volume that
represents the ground truth of the simulation. The activity levels
attributed to each of the tumor parts were derived from the average
activity measured in the same areas of the tumor in the correspond-
ing patient images. This ground truth tumor structure is subse-
quently transformed into a nonuniform rational B-splines
(NURBS) volume using Rhinoceros (CADLINK software, Moran-
gis, France), for insertion into the NURBS-based CArdiac-Torso
(NCAT) phantom (29) attenuation maps at the approximate position
where it was located in the patient (30). No respiratory or cardiac
motions were considered. Simulations using a model of the Philips
PET/CT scanner previously validated with Geant4 Application for
Tomography Emission (GATE) (31) were carried out. Forty-five
million coincidences were simulated corresponding to the statistics
of a clinical acquisition over a single-axial 18-cm field of view (31).
Images were subsequently reconstructed using OPL-EM (seven
iterations, one subset) (31) with two voxel sizes (4  4  4 for
the Philips Gemini and 2  2  5 mm3 for the GE Discovery LS)
to match those used in the corresponding clinical images.
Data Set 2 contains 18 images of lung tumors from patients with
histologically proven non–small cell lung cancer (clinical Stage Ib–
IIIb), acquired on the Siemens Biograph PET/CT scanner and recon-
structed using OSEM (four iterations, eight subsets), with scatter
and CT-based attenuation correction, and 5.31  5.31  3.38
mm3 voxels. These tumors were surgically extracted for a histology
study in which their maximum diameter was measured by
macroscopic examination (32). These diameters range from 15 to
90 mm (44  21). One of these tumors is shown in Fig. 4d.
Analysis: Because our goal is not the detection of a lesion in the
whole image but the accurate estimation of its volume and shape, we
assume it has been detected and isolated by the clinician within a 3D
‘‘box’’ encompassing the tumor.
Because a ground truth was available, classification errors (CE)





where ct is the classification of voxel t, and xt is the true class. Card is
the number of elements. This error measurement takes into consid-
eration the spatial distribution of the tumor by considering both
background voxels classified as object and object voxels classified
as background. Consequently, this measure is more appropriate
than simple volume estimation, which could lead to overall small
volume errors associated with largely inaccurate segmentations. In
addition, the errors are computed relatively to the size of the object,
to avoid biases relative to the size of the processing box. In the case
of a three-class ground truth, CE may be computed for each of the
three classes using Eq. 4 or with respect to a binarized ground truth
(second and third class merged) using Eq. 3.
CEc ¼
card{tjxt ¼ c; ctsc}þ card{tjxtsc; ct ¼ c}
card{tjxt ¼ c}
 100; (4)
where CEc stands for the classification error associated with a given
class c.
Fig. 2. Binary fuzzy locally adaptive Bayesian (FLAB) model applied to a heterogeneous simulated tumour (a). The
segmentation result (b) clearly misses parts of the tumour.
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Two analyses were conducted using Data Set 1. The first consid-
ered the entire data set (both homogeneous and heterogeneous
tumors) and CE computed using Eq. 3 to compare overall perfor-
mances of FLAB (binary only), 3-FLAB, FCM, and Tbckg. The
second considered only the 10 heterogeneous tumors to compute
CE2 and CE3 using Eq. 4 for 3-FLAB and FCM with three clusters.
The segmentation accuracy on the tumors with histology (Data
Set 2) was assessed by segmenting the clinical image and subse-
quently measuring the maximum diameter on the segmented
volumes to compare it with the histology measurement.
RESULTS
Figure 5 contains one axial slice of the segmentations
obtained on three simulated tumors of Data Set 1 and one
tumor of Data Set 2. Figure 6a contains the mean classifica-
tion errors and standard deviation obtained by all the methods
on the 20 tumors of Data Set 1. FLAB (binary only)
performed well on homogeneous tumors but failed as
expected on strongly heterogeneous lesions, leading to over-
all errors of 15%  11%. 3-FLAB, in contrast, produced
segmentation maps closer to the ground truth, both visually
and quantitatively, with errors between 5% and 15%
(9%  8%). FCM (with two or three clusters) was competi-
tive with respect to 3-FLAB for some tumors but showed
a higher variability (10%–40%) and mean error (20% 
12%). This translated qualitatively in FCM being unable to
differentiate two regions within the tumor as well as being
unable to detect discontinuities in the contours (e.g.,
Fig. 5d, first row). In addition, for the regions where a transi-
tion was present between the high uptake region and the
background (e.g., Fig. 4d), the 3-FLAB approach was the
only one giving accurate representation of this transition
(Fig. 5c vs. Fig. 5d, last row). Tbckg was not able to produce
satisfactory segmentation in several cases. Tumors with high
overall contrast were approximately extracted from the back-
ground (e.g., Fig. 5e, rows 2–4). However, as a binary
method, it is unable to delineate uptake distributions within
the tumor. In several cases, the heterogeneity was significant,
and Tbckg lead to significant underevaluation of the tumor
volume (CE up to 60% with a mean of 17%  14%) because
it tends to extract the high-activity region or parts of the re-
duced uptake region only (e.g., Fig. 5e, first row).
Figure 6b compares 3-FCM (using three clusters) and
3-FLAB concerning the three-class segmentation of the 10
heterogeneous simulated tumors of Data Set 1. 3-FCM is
less accurate and robust compared with 3-FLAB, especially
in the delineation of higher activity regions (third class),
with about twice the mean error and standard deviation
(24%  20%) of 3-FLAB (11%  8%).
Figure 7 contains the mean error and standard deviation
with respect to the maximum diameter, computed on the
tumor histology database (Data Set 2). Whereas all methods
gave relatively low mean errors (#3%), the standard devia-
tion associated with FCM and Tbckg (13% and 12%, respec-
tively) is about twice that of 3-FLAB (<6%), and binary
FLAB showed a standard deviation of almost 10%. The
low mean error for all these algorithms is explained by the
fact that therewere about the same amount of under- and over-
estimation of the diameters in this data set, resulting in an
overall low mean error. Here the standard deviation is a better
indicator of the accuracy obtained on the data set and demon-
strates higher accuracy and robustness for 3-FLAB.
DISCUSSION
Functional volume delineation represents an area of interest
for multiple clinical applications (routine and research) of
PET. Such areas include response to therapy studies and the
use of biological tumor volumes in radiotherapy treatment
planning. Although several fully automatic algorithms have
recently been proposed (11–20), segmentation methodolo-
gies currently used in clinical practice are based on the use
of fixed and adaptive thresholding (4–10). These algorithms
have been shown to determine functional volumes accurately
under specific imaging conditions of spherical and homoge-
neous activity distribution object in phantom studies and
have been evaluated on clinical images for which the ground
truth is unknown. In clinical practice, lesions are often hetero-
geneous in shape and uptake. To address these issues,we have
extended a previously developed algorithm to evaluate
Fig. 3. The simulation of realistic positron emission tomography images.
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lesions with nonuniform uptake and nonspherical forms. In
addition, we have proposed an evaluation framework includ-
ing both realistic simulated patient lesions and histological
assessment of tumor diameters, allowing for evaluation of
segmentation algorithms under standard imaging conditions
and the added advantage of knowing the ground truth.
The inability of the adaptive thresholding considered in
this study to segment complex tumors accurately is
demonstrated by its poor performance. This is explained by
the fact that in cases of heterogeneous uptake, the 70%
threshold used for the initial estimation of the tumor-to-back-
ground contrast may retain only the high uptake region, thus
leading to incorrect contrast estimation. However, if the
lesion is small or has a small contrast, the 70% threshold
may lead to an initial overestimation of the volume of the
tumor, and hence an underestimation of its uptake and an
incorrect estimation of the contrast, for which the subsequent
adaptive thresholding may not be able to compensate. In
addition, the background ROI is user-dependent with a poten-
tially high impact on the result, especially with heteroge-
neous background. In such cases, we systematically
selected the ROI that resulted in the lowest error. Finally,
the region growing implementation avoids incorporating
false positives of the background if they are not connected
to the main tumor, especially when the contrast is low or
the background is noisy and heterogeneous. However, it
also makes the algorithm dependent on the seed location
and can lead to missing parts of the tumor when several
high-uptake regions are connected by low-uptake regions.
FCM can produce binary or three-class segmentations, but
its robustness and accuracy are much lower compared with
FLAB because it incorporates neither spatial correlation
nor noise modeling. One advantage of the Tbckg over FCM
is its region growing implementation that makes it less sus-
ceptible than FCM to the inclusion of high-intensity voxels
of the background. Therefore, FCM usually performs poorer
than Tbckg for low-contrast lesions and noisy images but bet-
ter for heterogeneous activity distributions within the tumor.
In contrast, 3-FLAB performed accurately even under chal-
lenging contrast, noise, and heterogeneity conditions, with
Fig. 4. Data sets illustration. (a–d) Examples of clinical tumors (up) with CT (left) and PET (right), and the corresponding
simulated PET (down): (a–c) Data Set 1; (d) Data Set 2.
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overall superior performance compared with the other
algorithms considered here.
The need for more than three classes may arise for hetero-
geneous tumors on a heterogeneous background. However,
all the clinical tumors considered in this study were correctly
delineated using two or three classes because the contrasts
between the heterogeneities within the tumor are usually
much higher than those occurring in the background. Hence,
only one hard class may be sufficient to deal with the back-
ground, whereas two are required to correctly handle the
significantly different uptakes occurring inside the tumor.
Eventually the 3-FLAB algorithm could be extended to
more than three classes assuming that only pairs of hard
classes generate fuzzy transitions. One also has to keep in
mind that using more classes will lead to smaller regions,
but those regions within the tumor will subsequently be
used for quantification or radiotherapy dose boosting and/
or painting and should therefore be kept reasonably large.
The potential impact of using three classes proposed by
3-FLAB should therefore be investigated before more
complex segmentations using additional classes can be
considered.
We have already demonstrated that FLAB performs well
for small lesions down to 13 mm in diameter (20), and this
study was not designed to investigate specifically the ability
of 3-FLAB to deal with small tumors because these rarely
exhibit heterogeneous uptake that can be detected on the
PET image considering the existing resolution limits.
3-FLAB retains all the characteristics of FLAB but also has
the ability to consider a third class and therefore handle non-
uniform lesion activity distributions. Thus, 3-FLAB does not
as such improve the delineation of small (<2 cm) lesions.
However, the higher/lower uptake regions within the larger
tumors are often of small size, comparable to that of small
lesions, with PVE affecting them with respect to their ‘‘back-
ground,’’ which is, in fact, the other part of the tumor with
a different uptake. As Fig. 6b demonstrates, 3-FLAB is
capable of accurately segmenting these regions.
An application that could greatly benefit from the use of
FLAB is radiotherapy treatment planning (33). It is now
acknowledged that planning based on PET/CT volumes
improves tumor delineation by reducing inter- and intraob-
server variability (32, 34). It can also lead to the inclusion
of regions not visible on CT or the exclusion of regions with-
out significant uptake (35). Using the 3-FLAB algorithm
could help lower inter- and intraobserver variability, as
well as shorten the time-consuming delineation process
associated with currently implemented algorithms given the
need for multiple phantom studies in the use of adaptive
thresholding. 3-FLAB takes a few seconds per iteration
even for the largest tumors considered in this study (on a sin-
gle 2-Ghz core processor in C++ implementation). Further,
Fig. 5. Segmentations of the tumors in Fig. 4a–4d: (a) ground truth; (b) positron emission tomographic image; segmen-
tations for (c) three-class fuzzy locally adaptive Bayesian, (d) fuzzy C-means, and (e) adaptive threshold models.
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‘‘dose painting’’ can be facilitated by the nonbinary nature of
the proposed segmentation, allowing for automatic definition
of ROIs inside the tumor—for example, in dose-escalation
studies (36)—in addition to the external contour information
for optimized dosimetry, potentially reducing the dose deliv-
ered to healthy surrounding tissues and organs. The impact of
such improved accuracy on overall patient outcome remains
to be demonstrated in clinical studies, which are planned for
the future. Finally, FLAB robustness with respect to the noise
characteristics associated with the use of different scanners,
acquisition protocols, and reconstruction algorithms has
been demonstrated in a preliminary study (24) and should
allow its use with any type of PET images without the need
for time-consuming preprocessing optimization.
The proposed algorithm may also have an impact on
diagnosis and therapy response assessment when combined
with PVE correction (PVC) for accurate quantification.
With various PVC approaches, anatomic information from
MRI or CT is used to improve the quantitative and qualitative
accuracy of functional images (37, 38). Unfortunately, when
no anatomic image is available or no correlation exists
between the anatomic and functional structures, such
approaches are not easy to use (3). This is especially true in
cases of large heterogeneous tumors for which there is little
to no correlation between the anatomic and functional infor-
mation. A potential solution will be the use of the FLAB
result instead of the anatomic image in combination with
one of the previously proposed PVC algorithms. This should
lead to improved contrast at the object’s borders as well as
improved quantification in the regions within the tumor.
Such combination recently demonstrated encouraging
results (39) and warrants further investigation regarding the
potential impact in clinical therapy response studies.
CONCLUSION
Amodified version of the FLAB algorithm has been devel-
oped to include the estimation of three hard classes and three
fuzzy transitions. This automatic approach combines statisti-
cal and fuzzy modeling to address specific issues associated
with 3D-PET images, such as noise and PVE. Its accuracy
has been assessed on both simulated and clinical images of
complex shapes containing inhomogeneous activities and
small regions. The results demonstrate the ability of
3-FLAB to delineate such lesions, for which the threshold-
based methodologies suggested until now have failed.
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Reproducibility of 18F-FDG and
39-Deoxy-39-18F-Fluorothymidine
PET Tumor Volume Measurements
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The objective of this study was to establish the repeatability
and reproducibility limits of several volume-related PET image–
derived indices—namely tumor volume (TV), mean standard-
ized uptake value, total glycolytic volume (TGV), and total
proliferative volume (TPV)—relative to those of maximum stand-
ardized uptake value (SUVmax), commonly used in clinical prac-
tice. Methods: Fixed and adaptive thresholding, fuzzy
C-means, and fuzzy locally adaptive Bayesian methodology
were considered for TV delineation. Double-baseline 18F-FDG
(17 lesions, 14 esophageal cancer patients) and 39-deoxy-
39-18F-fluorothymidine (18F-FLT) (12 lesions, 9 breast cancer
patients) PET scans, acquired at a mean interval of 4 d and
before any treatment, were used for reproducibility evaluation.
The repeatability of each method was evaluated for the same
datasets and compared with manual delineation. Results: A
negligible variability of less than 5% was measured for all seg-
mentation approaches in comparison to manual delineation
(5%–35%). SUVmax reproducibility levels were similar to others
previously reported, with a mean percentage difference of
1.8% 6 16.7% and 20.9% 6 14.9% for the 18F-FDG and
18F-FLT lesions, respectively. The best TV, TGV, and TPV repro-
ducibility limits ranged from 221% to 31% and 230% to
37% for 18F-FDG and 18F-FLT images, respectively, whereas
the worst reproducibility limits ranged from 290% to 73%
and 268% to 52%, respectively. Conclusion: The reproduc-
ibility of estimating TV, mean standardized uptake value, and
derived TGV and TPV was found to vary among segmentation
algorithms. Some differences between 18F-FDG and 18F-FLT
scans were observed, mainly because of differences in overall
image quality. The smaller reproducibility limits for volume-
derived image indices were similar to those for SUVmax, sug-
gesting that the use of appropriate delineation tools should
allow the determination of tumor functional volumes in PET
images in a repeatable and reproducible fashion.
Key Words: oncology; PET; other; delineation; 18F-FDG; 18F-
FLT; reproducibility; tumor volume
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Most current PET clinical practices for diagnosis, stag-
ing, prognosis, therapy-response assessment, and patient
follow-up rely on manual and visual analysis (1). The index
most commonly used in PET clinical studies is the stand-
ardized uptake value (SUV). To obtain this index of activity
accumulation, a region of interest (ROI) should be deter-
mined, usually drawn manually or using some fixed thresh-
old. Although an ROI is not the only factor that can affect
the accuracy of SUVs, the type and size of an ROI are large
contributors to the variability of such measurements, as has
been previously demonstrated (2,3). A popular alternative
is the use of the pixel with the maximum activity value,
usually referred to as the maximum SUV (SUVmax). Many
studies have demonstrated the prognostic and predictive
value of SUVmax, despite the fact that it is sensitive to
image noise (4,5). On the other hand, a few, mostly recent,
studies have explored the use of overall tumor volume (TV)
as an index for prognosis and response assessment (6–8).
These studies considered the TV either alone or in combi-
nation with the mean SUV (SUVmean), to form the total
glycolytic volume (TGV) and total proliferative volume
(TPV) (for 18F-FDG and 39-deoxy-39-18F-fluorothymidine
[18F-FLT], respectively), defined as the product of TV ·
SUVmean (9–11).
The accuracy, robustness, repeatability, and reproduci-
bility of image delineation are directly responsible for the
reduced use of functional volumes derived from PET
images. On the one hand, manual delineation of functional
volumes using PET images leads to high inter- and intra-
observer variability (3), principally arising from the poor
quality of PET images. On the other hand, current state-of-
the-art algorithms for functional-volume segmentation con-
sist of fixed- (12) or adaptive-threshold approaches (13,14).
Although fixed-threshold approaches are attractive because
of their simplicity, their drawbacks are numerous given that
the value of the threshold to be used for each lesion clearly
depends on multiple factors, such as lesion contrast and size
and image noise (15). The solutions based on the use of
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adaptive thresholding consider the contrast between the
object to delineate and its surrounding background. How-
ever, adaptive thresholding requires imaging system–spe-
cific optimization using uniformly filled spheric lesions,
hence reducing the robustness of the approach, particularly
in the case of multicenter trials. In addition, this method
depends on the background ROI choice, which can in turn
lead to reduced interobserver reproducibility for functional-
volume determination. A few automatic algorithms have
been proposed (16–19). The main difference between these
algorithms and the threshold-based approaches is that the
algorithms automatically estimate the parameters of interest
and find the optimal regions’ characteristics in a given
image, without system-dependent parameters. This techni-
que may reduce issues associated with deterministic ap-
proaches based on thresholding, potentially increasing the
robustness and reproducibility of PET functional-volume
determination (20).
Establishing the level of reproducibility and repeatability
is essential in the use of any image-derived index in prog-
nostic or therapy-response studies, allowing the evaluation of
which change between 2 studies can be considered signifi-
cant. To date, only a few reproducibility studies (21–25),
almost exclusively concentrating on SUVmax and SUVmean
variability in double-baseline 18F-FDG PET scans, have
shown a relative absolute percentage difference of up to
13%, with an SD of 10%. The reproducibility of quantita-
tive indices (Patlak influx constant), associated with the
acquisition of dynamic datasets, has also been assessed
(21,22), showing similar levels of reproducibility (mean
percentage difference, 8%–10%). Studies on the reproduci-
bility of such indices in the case of 18F-FLT PET have
shown that changes larger than 15%–20% and 25%–30%
may be considered significant in SUVmean (obtained using a
41% fixed threshold) and SUVmax or Patlak influx constant,
respectively (26,27).
In most of these studies, SUVmean has been calculated
using manually drawn ROIs or a single fixed threshold
(varying from 40% to 75% of the maximum activity).
Among these studies, only 1 has considered the reproduci-
bility of metabolic functional volumes using a fixed thresh-
old. Krak et al. (3) have shown a mean percentage difference
in the ROI volumes of 23% 6 20% and 55% 6 35% for a
fixed threshold of 50% and 75%, respectively. Finally, to our
knowledge there has been no published study evaluating the
reproducibility of TGV and TPV.
To date, despite numerous studies assessing the accuracy
of different segmentation algorithms, there is a lack of
evaluation of the repeatability and reproducibility of these
algorithms relative to different threshold- and automatic-
based delineation approaches. Therefore, the main objec-
tive of this study was to assess the repeatability and
reproducibility in determining 3-dimensional (3D) func-
tional volumes and associated indices (SUVmean, TGV, and
TPV) in PET using different algorithms. The reproducibil-
ity of SUVmax was also included because it represents the
index most used today in clinical practice and facilitates a
direct comparison with previous studies. This evaluation




Four approaches were used in this work. Two different fixed
thresholds (12) were considered, at 42% (T42) and 50% (T50) of
the maximum voxel value, using a region-growing algorithm with
the maximum-intensity voxel as seed.
An adaptive-threshold method (TSBR, for threshold source–to–
background ratio) (13) was also included:




SBR is the source-to-background ratio, defined as the contrast
between a manually defined background ROI and the mean of the
maximum-intensity voxel and its 8 surrounding neighbors in the
same slice. The parameters a and b are optimized through linear
regression analysis for a given scanner using phantom acquisitions
of various sphere sizes and contrast.
For automatic-segmentation approaches, the fuzzy C-means
(FCM) (28) clustering algorithm, with 2 clusters (background and
lesion), was considered. This algorithm has been previously used
for functional-volume segmentation tasks in both brain and oncol-
ogy applications (29,30) and iteratively minimizes a cost function
of the voxel-intensity values to estimate the center of each cluster
and membership of each voxel to these clusters. The second auto-
matic algorithm considered was the fuzzy locally adaptive Baye-
sian (FLAB) (19) methodology, based on a combination of
statistical models with a fuzzy measure to simultaneously address
issues of both noise and blur resulting from partial-volume effects
in PET images. FLAB is also able to deal with strongly heteroge-
neous uptake in tumors of complex shape and generate nonbinary
segmented volumes by considering 3 classes and the associated
fuzzy transitions (31). The parameters required for the segmenta-
tion (gaussian mean and variance of each class and spatial priors
for each voxel) were estimated using the iterative stochastic
expectation maximization procedure. For all approaches, the
tumors were delineated after having been isolated in a 3D box
of interest previously defined and fixed for all segmentation meth-
odologies (manual and automatic).
Repeatability and Reproducibility: Definitions
Within the context of this study, repeatability is defined as the
ability of a given segmentation algorithm to reach the same result
regarding the definition of a functional volume when applied
multiple times on a single image. In such a task, entirely
deterministic fixed-threshold approaches (T42, T50) will always
give the same result. On the other hand, more advanced
methods—for example, the adaptive thresholding or automatic
algorithms such as FCM and FLAB considered here—are suscep-
tible to giving different results when applied multiple times on the
same image. The adaptive-threshold segmentation, for instance,
depends on a manually drawn background ROI and may thus
result in variable delineation depending on the choice of this
ROI. On the other hand, FCM and FLAB are iterative procedures
that may not converge to the same result at each execution.
Finally, manual delineation may be considered as the least repeat-
PET VOLUME DETERMINATION REPRODUCIBILITY • Hatt et al. 1369
able, even when considering a single operator (intraoperator var-
iability). A second aspect considered in this study was the impact
of a segmentation algorithm on the reproducibility of determining
functional volumes from 2 baseline PET scans.
Two different clinical datasets—comprising esophageal and
breast cancer patients scanned with 18F-FDG and 18F-FLT, respec-
tively—were used. In both cases, 2 consecutive PET scans were
acquired at an interval of a few days. We therefore studied the
differences in derived functional TVs, lesion SUVmean, and TGVs
and TPVs extracted from both images. The repeatability of meas-
uring TVs using the various delineation approaches considered in
this study was investigated for the same clinical datasets.
Validation Studies
Fourteen whole-body 18F-FDG PET/CT images acquired for
patients with esophageal cancer (n 5 17 lesions) and nine 18F-
FLT PET/CT images acquired for breast cancer patients (n 5 12
lesions) were considered. Esophageal cancer patients’ images
were acquired at 3.4 6 2.2 d on a PET/CT scanner (Gemini;
Philips), with 2-min acquisitions per bed position, 60 min after
the 18F-FDG injection (6 MBq/kg). Data were reconstructed using
a 3D row-action maximization-likelihood algorithm with standard
clinical protocol parameters (2 iterations, relaxation parameter of
0.05, 5 mm in full width at half maximum, 3D gaussian postfilter-
ing). 18F-FLT PET images were acquired for patients with breast
cancer (27); 2 scans were obtained within 2–7 d (median, 4.1 d)
before treatment. All patients received a single bolus intravenous
injection of 18F-FLT (153–381 MBq) over 30 s, and dynamic PET
was performed for 95 min. Patients were scanned on a PET scan-
ner (ECAT962/HR1; CTI/Siemens), and data were reconstructed
using ordered-subset expectation maximization (360 iterations, 6
subsets, no postfiltering).
In both cases, 2 baseline scans were acquired within an average
of 3–4 d of each other. Because no treatment was administered
between the 2 baseline scans, and considering the short time
between the 2 acquisitions, the assumption was that no significant
physiologic changes occurred in between the time the scans were
obtained. A similar assumption had been previously used in all
other studies evaluating the reproducibility and repeatability of
different SUV measurements in PET, with double-baseline scans
obtained within 5–10 d (21–25). Figure 1 shows the 2 baseline
scans—1 for an esophageal cancer (Fig. 1A) and 1 for a breast
cancer (Fig. 1B) patient.
Analysis
For the repeatability evaluation, the tumors in the first image for
each patient were segmented 10 times each with FCM, FLAB, and
TSBR. In addition, manual delineation was performed by 2
nuclear medicine experts. More specifically, the 2 experts
performed 10 different slice-by-slice manual delineations for the
different lesions considered in a randomized fashion, ensuring
a minimum of a week between 2 consecutive delineations of the
same lesion. All these manual segmentations were performed
under the same conditions as those of full-range contrast display.
The mean percentage variability and associated SD with respect to
the mean segmented volume was computed for each of the lesions
and segmentation approaches across the 10 executions and across the
10 manual delineations, to assess the repeatability of the approaches.
The repeatability of the manual delineations of the 2 experts were
compared separately (intraobserver variability) and with each other
(interobserver variability) using intraclass coefficients.
To study the relative impact of the different segmentation
algorithms on the reproducibility of deriving different PET
image indices, TVs were segmented independently on both
baseline scan images for each lesion, using the different
automatic-segmentation approaches. Subsequently, TV (in cm3),
SUVmean, TGVor TPV, and SUVmax quantitative values (M) were
computed for each delineated lesion and compared between the 2






3 100: Eq. 2
The distribution of the differences between each pair of
measurements was assessed for each index using the Kolmo-
gorov–Smirnov test, showing no significant differences from a
normal distribution (Fig. 2). Bland–Altman analysis (32) was sub-
sequently used to highlight differences between segmentation
methodologies. Mean and SD of differences and the respective
95% confidence intervals (CIs) were obtained. To define the repro-
ducibility limits (reference range of spontaneous changes), the
95% CIs for the difference between 2 measurements were com-
puted as the mean difference 6 1.96 times the SD of the differ-
ence. To investigate any potential correlations in the measured
reproducibility, the magnitude of the percentage difference for
the TV, SUVmax, and SUVmean measurements was compared with
the average of the TVs using the Pearson correlation coefficient r.
This analysis was repeated to investigate the correlation of the
reproducibility of the different parameters with the SUVmean.
RESULTS
Table 1 contains the mean variability and SD around the
mean segmented volume across the 10 manual delineations
FIGURE 1. Baseline images: 18F-FDG (esophagus) (A) and
18F-FLT (breast) (B).
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performed by each of the 2 nuclear medicine experts and 10
repeated executions of the FLAB, FCM, and TSBR algo-
rithms. Results for both clinical datasets are presented sep-
arately. FLAB demonstrated highly repeatable results in all
of the studied cases, with negligible variability (1%) around
the mean segmented 3D volumes across the different
repeated executions. FCM also led to satisfactory repeat-
ability results (1.4% 6 1.6% for the 18F-FDG cases and
2.3% 6 1.9% for the 18F-FLT cases). In comparison, the
use of the TSBR led to more than twice as high variability
(2.9% 6 2.7% and 4.7% 6 3.6% for the 18F-FDG and 18F-
FLT cases, respectively). By contrast, manual segmentation
by the 2 experts showed high intraobserver variability for
18F-FDG esophageal lesions (14.1%6 12.1% and 16.4%6
11.3% for experts 1 and 2, respectively). Interobserver var-
iability was 17.1% 6 14.3%, with an intraclass coefficient
of 0.67 (95% CI, 0.39–0.89). In the case of 18F-FLT, this
variability was even higher, with an intraobserver variabil-
ity of 22.1% 6 18.7% and 23.8% 6 17.8% for experts 1
and 2, respectively, and an interobserver variability of
27.4% 6 21.9%, with an intraclass coefficient of 0.59
(95% CI, 0.31–0.84).
Tables 2 and 3 contain a summary of the reproducibility
results for the different parameters computed from Bland–
Altman plots on the 2 consecutive baseline scans for 18F-
FDG esophageal and 18F-FLT breast lesions, respectively.
The observed reproducibility of SUVmax and SUVmean
measurements for the volumes obtained using TSBR and
FLAB is illustrated in Figure 3. The corresponding plots for
TV are shown in Figures 4A and 4B using TSBR and
FLAB, respectively.
Concerning the reproducibility of SUVmax, similar per-
centage differences were measured for the 18F-FDG and
18F-FLT datasets, with an SD of the mean percentage differ-
ence of 16.7% and 14.9%, respectively. The upper and
lower percentage reproducibility limits for the SUVmax
were 231% to 35% and 230% to 28% for the 18F-FDG
and 18F-FLT datasets, respectively. On the other hand, the
automatic approaches led to 18F-FDG TV measurement
reproducibility limits of 221% to 31% and 251% to
52% for the FLAB and the FCM algorithms, respectively.
A poorer reproducibility of the 18F-FDG TV measurements
was observed for the threshold-based approaches, with
upper and lower reproducibility limits of 290% to 51%
and 269% to 73% for the adaptive and T42, respectively.
In the case of 18F-FLT TV measurements, the reproducibil-
ity was similar to that of 18F-FDG for the threshold-based
approaches, whereas a deterioration in the reproducibility
obtained with the automatic approaches was observed, par-
ticularly for the FCM algorithm (with reproducibility limits
of 266% to 74%).
SUVmean measurements using FLAB exhibited reprodu-
cibility levels similar in magnitude to that for the TV def-
inition, with an SD of the mean percentage difference of
15.6% and 14.1% for the 18F-FDG and 18F-FLT datasets,
respectively. This was, however, not the case for the other
tumor-delineation algorithms considered, with the larger
SUVmean reproducibility limits using the FCM tumor defi-
nition (277% to 62% and 259% to 59% for the 18F-FDG
and 18F-FLT datasets, respectively). Finally, the smaller
SUVmean reproducibility for the threshold-based ap-
proaches was obtained using T50 for both the 18F-FDG
and the 18F-FLT datasets, with a mean percentage difference
of 210.5% 6 23% and 213.3% 6 16.8%, respectively.
The reproducibility of TGV and TPV, being the product
of TV and SUVmean, was dependent on the direction of
changes for both TV and SUVmean. As an increase of TV
was correlated with a decrease of SUVmean and vice versa
(P , 0.002; r 5 0.54, 0.67, and 0.72 for FLAB, TSBR, and
T42, respectively), TGV and TPV reproducibility levels
were generally similar in magnitude to the TVand SUVmean
considered separately. However, in certain cases there were
more increases or decreases of both TV and SUVmean for a
given patient, resulting in larger variability of the TGV and
TPV measurements (e.g., the TSBR measurements of the
FIGURE 2. Plots showing that distributions of differences
for SUVmean (FLAB) (A) and TV (FLAB) (B) between 2 scans
were not significantly different from normal.
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18F-FLT breast lesions, with 22.1% 6 48.9% for the TPV,
whereas TV and SUVmean were 11.3% 6 31.4% and
23.2% 6 26.5%, respectively).
The TV reproducibility results were dependent on the
measured TV, with a larger variability seen for smaller
tumors. This dependence was statistically significant for the
adaptive thresholding (r 5 0.37, P 5 0.046; Fig. 5A), with
differences higher than 30% on average (#75%) in several
of the tumors below 50 cm3. On the other hand, this depend-
ence was not significant for FLAB (r5 0.27, P5 0.16; Fig.
5B), with most differences less than 30%—irrespective of
TV—further demonstrating improved robustness, as previ-
ously shown (19,20). In terms of the SUVmax reproducibil-
ity results, no statistically significant trend with either the
lesion size (r 5 0.016, P 5 0.93; Fig. 5C) or the mean of
the 2 SUVmean measurements (r 5 0.14, P 5 0.49) was
observed. Finally, no statistically significant trends were
found for the SUVmean reproducibility depending on the
lesion size, irrespective of the segmentation algorithm used
(r 5 0.2, P 5 0.3, and r 5 0.23, P 5 0.23, for TSBR and
FLAB, respectively).
DISCUSSION
Functional-volume delineation today represents an area
of interest for multiple clinical (routine and research)
applications of PET (prognosis, response prediction, ther-
apy assessment, radiotherapy treatment planning). In all of
these applications, the repeatability and reproducibility
with which functional volumes can be determined under
different imaging conditions play a predominant role,
allowing a level of confidence to be established in the use
of such TV measurements. Volume-definition methodolo-
gies currently used in clinical practice are based on the use
of manual delineation or fixed and adaptive thresholding
(12–14), whereas several promising automatic algorithms
have been proposed (16–19). The major drawback of man-
ual delineation is high inter- and intraobserver variability;
in addition, the approach is time-consuming. On the other
TABLE 1. Repeatability Evaluation
Method
Esophageal lesion Breast lesion
Mean variability (%) SD Mean variability (%) SD
FLAB 0.6 0.3 1.1 0.7
FCM 1.4 1.6 2.3 1.9
Fixed threshold 0 0 0 0
Adaptive threshold 2.9 2.7 4.7 3.6
Manual delineation (expert 1) 14.1 12.2 22.1 18.7
Manual delineation (expert 2) 16.4 11.3 23.8 17.8
Manual delineation (expert 2 with respect to 1) 17.1 14.3 27.4 21.9
Data are mean variability and SD around mean segmented volume for repeated delineations of 17 esophageal and 12 breast lesions
on first baseline 18F-FDG and 18F-FLT scans, respectively.
TABLE 2. Reproducibility Results Using 18F-FDG for Esophageal Lesions
Method Parameter Mean 6 SD 95% CI LRL 95% CI for LRL URL 95% CI for URL
SUVmax 1.8 6 16.7 26.8 to 10.4 230.9 245.9 to 216 34.6 19.9–49.6
FLAB TV 5 6 13.3 21.8 to 11.9 221.1 233 to 29.1 31.1 19.2–43
SUVmean 0 6 15.6 28 to 8 230.5 244.4 to 216.6 30.5 16.5–44.4
TGV 5.1 6 10.6 20.4 to 10.5 215.8 225.3 to 26.3 25.9 16.4–35.5
FCM TV 0.4 6 26.4 213.2 to 14 251.4 275.1 to 227.7 52.2 28.5–75.9
SUVmean 27.8 6 35.5 226 to 10.5 277.4 2109.2 to 245.5 61.8 30–93.7
TGV 27.4 6 30.2 222.9 to 8.2 266.6 293.7 to 239.5 51.9 24.8–78.9
TSBR TV 219.4 6 36 237.9 to 20.9 289.9 2122.1 to 257.6 51.1 18.9–83.3
SUVmean 6.3 6 27.4 27.8 to 20.4 247.4 272 to 222.8 60.1 35.5–84.6
TGV 213 6 28.2 227.5 to 1.5 268.2 293.4 to 242.9 42.2 17–67.4
T42 TV 2.1 6 36.1 216.5 to 20.7 268.7 2101.2 to 236.3 72.9 40.5–105.3
SUVmean 210.5 6 30 225.9 to 5 269.3 296.2 to 242.4 48.4 21.5–75.3
TGV 28.4 6 23.4 220.5 to 3.6 254.3 275.3 to 233.3 37.5 16.5–58.5
T50 TV 0.9 6 32.9 216 to 17.8 263.5 292.9 to 234 65.3 35.9–94.8
SUVmean 210.5 6 23 222.6 to 1.6 256.5 277.6 to 235.5 35.6 14.5–56.6
TGV 29.5 6 23.1 221.4 to 2.4 254.9 275.6 to 34.1 35.8 15.1–56.6
LRL 5 lower reproducibility limit; URL 5 upper reproducibility limit.
Data are percentage differences between scan 2 and scan 1 measurements.
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hand, currently considered state-of-the art adaptive thresh-
old–based algorithms have been shown to accurately define
functional volumes under certain imaging conditions of
spheric and homogeneous-activity-distribution lesions.
However, adaptive-threshold approaches usually involve
some user interaction to select background ROIs, which
can potentially lead to user-introduced variability. Although
signal intensity reproducibility, predominantly considering
the use of SUVmax, has been previously assessed, the poten-
tial of new indices such as TV or TGV and TPV can be
considered only after the assessment of their reproducibil-
ity, which has not been previously widely assessed. There-
fore, in this study the reproducibility limits of these indices,
in comparison to other indices considered as the current
gold standard, have been assessed using different tumor-
delineation methodologies on double-baseline 18F-FDG
and 18F-FLT datasets.
In terms of repeatability, all algorithms exhibited mean
differences of less than 5%, with automatic approaches
coming closer to the perfect repeatability that can be
achieved by deterministic approaches such as a fixed
threshold. The repeatability of both threshold and auto-
matic-segmentation approaches was superior to that of
manual delineation. This should, of course, be considered
within the context of the limited absolute accuracy of
thresholding, particularly for lesions not homogeneous in
form and activity distribution (31).
The variability in the SUVmax observed in this work is
similar to that measured in previous reproducibility studies,
with comparable percentage differences for 18F-FDG and
18F-FLT datasets. These percentage differences suggest that
differences larger than 230% can be considered as signifi-
cant in treatment response, whereas changes above 35%
(30% for 18F-FLT) may be indicative of no response.
Depending on the delineation algorithm used, the mean
percentage difference and corresponding SD for TV mea-
sured on the 2 baseline scans varied from 5% 6 13% to
219% 6 36% for the 18F-FDG and from 4% 6 16% to
10% 6 35% for the 18F-FLT datasets. The smallest TV
reproducibility limits obtained were similar to those for
SUVmax. These limits ranged from 221% to 31% and
227% to 35% for 18F-FDG and 18F-FLT, respectively, sug-
gesting in turn that, depending on the segmentation algo-
rithm used and similar to SUVmax, CIs may be considered
for monitoring therapy response based on functional TV.
Similarly, in the case of TGV and TPV the smallest repro-
ducibility limits measured were between216% to 26% and
230% to 37% for 18F-FDG and 18F-FLT, respectively. On
the other hand, the largest reproducibility limits for the 18F-
FDG TV and TGV ranged from 290% to 73% and from
268% to 52%, respectively.
Reproducibility ranges obtained for the 18F-FDG esoph-
ageal lesions were almost systematically smaller than the
ones obtained on the 18F-FLT breast lesions—which can be
attributed to the higher level of noise and overall lower
contrast observed in the 18F-FLT cases, resulting in less
robust delineations. In addition, 18F-FDG esophageal
lesions tended to appear more homogeneous than breast
lesions. For instance, FCM—which incorporates neither
noise nor spatial modeling—is associated with a larger
mean TV variability of the 18F-FLT dataset relative to
18F-FDG, whereas FLAB exhibited similar reproducibility
levels for both. The variability in reproducibility highlights
the need for a robust delineation tool ensuring high repro-
ducibility in an environment of substantial image-quality
variability—likely, for example, to be encountered in multi-
center trials in which the use of functional TV as a measure
of response to therapy may be considered.
T50 uses a more restrictive threshold than 42% and is
therefore less prone to large overevaluation of low contrast
TABLE 3. Reproducibility Results Using 18F-FLT for Breast Lesions
Method Parameter Mean 6 SD 95% CI LRL 95% CI for LRL URL 95% CI for URL
SUVmax 20.9 6 14.9 210.4 to 8.5 230 246.6 to 213.4 28.2 11.6–44.8
FLAB TV 4.3 6 15.7 25.7 to 14.3 226.5 244.1 to 28.9 35.2 17.6–52.8
SUVmean 20.6 6 14.1 29.6 to 8.3 228.2 244 to 212.5 27 11.2–42.7
TGV 3.7 6 17.2 27.2 to 14.6 230 249.2 to 210.8 37.4 18.2–56.6
FCM TV 4.2 6 35.7 218.4 to 26.9 265.6 2105.5 to 225.8 74.1 34.3–114
SUVmean 0.3 6 30.1 218.8 to 19.4 258.6 292.2 to 225 59.2 25.6–92.8
TGV 4.6 6 29.8 214.3 to 23.6 253.9 287.2 to 220.5 63.1 29.7–96.4
TSBR TV 11.3 6 31.4 28.7 to 31.2 250.4 285.5 to 215.2 72.8 37.7–108
SUVmean 23.2 6 26.5 220 to 16.6 255.1 284.7 to 225.5 48.7 19.1–78.3
TGV 22.1 6 48.9 29 to 53.2 273.8 2128.5 to 219.1 118 63.3–172.7
T42 TV 9.8 6 35 212.4 to 32.1 258.7 297.8 to 219.6 78.4 39.3–117.5
SUVmean 29.4 6 20.9 222.7 to 3.9 250.3 273.7 to 227 31.6 8.2–54.9
TGV 0.7 6 27.3 216.7 to 18 252.8 283.3 to 222.3 54.1 23.6–84.6
T50 TV 11.2 6 31.4 28.8 to 31.1 250.5 285.6 to 215.3 72.8 37.6–107.9
SUVmean 213 6 16.8 224 to 22.7 246.2 264.9 to 227.4 19.5 0.8–38.3
TGV 21.8 6 26 218.4 to 14.7 252.8 281.9 to 223.7 49.1 20.1–78.2
LRL 5 lower reproducibility limit; URL 5 upper reproducibility limit.
Data are percentage differences between scan 2 and scan 1 measurements.
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(,4:1) or small-size (,2 cm in diameter) TVs. T50 led to
systematically lower variability than T42. Finally, the adap-
tive-threshold methodology did not demonstrate better
reproducibility than did fixed thresholding, which can be
attributed to the use of the background ROI placed man-
ually on both scans, combined with the fact that back-
ground activity may also vary between the 2 scans.
Although a potential criticism for the current study can be
the lack of ground-truth for the functional volumes, the aim
of this work was not to assess the absolute accuracy of
algorithms, which has been assessed previously for the
approaches used in this work (19,31). The objective was to
assess the reproducibility limits of functional-volume–
related indices that can be attained depending on the
algorithm. Within this context, the repeated studies of the
double-baseline acquisitions have been performed within an
FIGURE 3. Bland–Altman plots of SUVmax (A), SUVmean
using adaptive thresholding (B), and SUVmean using FLAB
(C) for both 18F-FDG and 18F-FLT lesions. Lines show
combined mean, 95% CI, and upper and lower
reproducibility limits. Individual values for 18F-FDG and 18F-
FLT lesions are shown in Tables 2 and 3, respectively. LRL 5
lower reproducibility limit; URL 5 upper reproducibility limit.
FIGURE 4. Bland–Altman plots of TV using adaptive
thresholding (A) and TV using FLAB (B) for both 18F-FDG
and 18F-FLT lesions. Lines show combined mean, 95% CI,
and upper and lower reproducibility limits. Individual values
for 18F-FDG and 18F-FLT lesions are shown in Tables 2 and
3, respectively. LRL 5 lower reproducibility limit; URL 5
upper reproducibility limit.
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average of 3–4 d, without any treatment between them,
matching the method used by all other reproducibility studies
to date (21–25). Finally, the reproducibility of SUVmax was
included in this work as the current gold standard, facilitat-
ing at the same time the comparison of our reproducibility
study to those performed previously. The SUVmax reprodu-
cibility limits obtained in this work for both 18F-FDG and
18F-FLT agree closely with those of previous studies.
CONCLUSION
The smaller reproducibility ranges obtained for the
different image indices considered in this study, similar to
those of SUVmax, suggest that new automatic-segmentation
approaches may facilitate the introduction of TVs or a
combination of TVs and signal intensity in the form of
TGVs and TPVs derived from PET images for therapy-
response studies. However, our results also demonstrate that
the reproducibility of different quantitative parameters
associated with functional volumes depends significantly
on the delineation approach.
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Abstract
Purpose Current state-of-the-art algorithms for functional
uptake volume segmentation in PET imaging consist of
threshold-based approaches, whose parameters often re-
quire specific optimization for a given scanner and
associated reconstruction algorithms. Different advanced
image segmentation approaches previously proposed and
extensively validated, such as among others fuzzy C-means
(FCM) clustering, or fuzzy locally adaptive bayesian
(FLAB) algorithm have the potential to improve the
robustness of functional uptake volume measurements.
The objective of this study was to investigate robustness
and repeatability with respect to various scanner models,
reconstruction algorithms and acquisition conditions.
Methods and materials Robustness was evaluated using a
series of IEC phantom acquisitions carried out on different
PET/CT scanners (Philips Gemini and Gemini Time-of-
Flight, Siemens Biograph and GE Discovery LS) with their
associated reconstruction algorithms (RAMLA, TF MLEM,
OSEM). A range of acquisition parameters (contrast,
duration) and reconstruction parameters (voxel size) were
considered for each scanner model, and the repeatability of
each method was evaluated on simulated and clinical
tumours and compared to manual delineation.
Results For all the scanner models, acquisition parameters
and reconstruction algorithms considered, the FLAB algo-
rithm demonstrated higher robustness in delineation of the
spheres with low mean errors (10%) and variability (5%),
with respect to threshold-based methodologies and FCM.
The repeatability provided by all segmentation algorithms
considered was very high with a negligible variability
of <5% in comparison to that associated with manual
delineation (5–35%).
Conclusion The use of advanced image segmentation
algorithms may not only allow high accuracy as previously
demonstrated, but also provide a robust and repeatable tool
to aid physicians as an initial guess in determining
functional volumes in PET.
Keywords PET uptake volume determination .
Robustness . Repeatability . FLAB . Thresholding
Introduction
Accurate, robust, reproducible and fast delineation of
functional tumour uptake volumes in three dimensions
using positron emission tomography (PET) has been
identified as a pressing challenge for an increasing number
of oncology applications, such as image-guided radiother-
apy [1–3], diagnosis, prognosis and therapy response
assessment [4, 5]. On the one hand, manual delineation of
functional uptake volumes using PET images is tedious and
associated with very low repeatability due to high inter- and
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intraobserver variability [4], principally arising from the
poor quality of PET images. On the other hand, current
state-of-the-art algorithms for functional uptake volume
segmentation using PET images consist of fixed [6] or
adaptive thresholding approaches [7, 8]. Regarding the use
of a fixed threshold, numerous studies have shown the need
for a variable threshold, depending on numerous factors,
such as among others, lesion contrast, lesion size, and
image noise [9]. As a solution, in the case of adaptive
thresholding, the applied threshold depends on the mea-
sured contrast between the object delineated and its
surrounding background, as well as parameters requiring
optimization on phantom acquisitions. This optimization
has to be performed for each scanner model and associated
reconstruction and correction algorithms, making these
approaches system-dependent. In addition, recent studies
have shown that even for the same scanner model, a
significant variation in the “ideal” threshold may exist due
to differences in clinical acquisition and reconstruction
protocols [10] underlining the possibility that such deter-
ministic approaches may not be sufficiently robust and
reproducible for functional uptake volume determination.
Recently several advanced image segmentation algo-
rithms have been proposed in the literature for PET volume
delineation [11–16]. The physical accuracy of these
algorithms in differentiating the uptake signal from its
surrounding background has, in most cases, already been
assessed with respect to ground-truth, provided by a
combination of realistic simulated or acquired phantom
images as well as, in some cases, clinical tumours with
associated histopathology measurements.
However, apart from physical accuracy, different char-
acteristics can be equally important in terms of assessing
the performance of such advanced image segmentation
algorithms, which in principle have the potential to be more
robust and repeatable than “threshold-based” approaches. A
robust and repeatable performance may facilitate their use
with images acquired on different scanner models without
any previous optimization to individual image quality,
providing a less hardware-dependent solution to the
problem of 3-D functional uptake segmentation. However,
none of these methodologies have been shown to be
system-independent, considering the potential variability
that can be observed in PET image characteristics depend-
ing on the scanner or associated reconstruction and
correction algorithms used. Such an evaluation is essential
for the efficient application of these approaches to the
different clinical applications targeted, not simply within a
given institution but also with regard to their use within a
multicentre trial context.
Finally, such a robustness analysis could provide some
insight into the potential behaviour of a given segmentation
algorithm with the use of different tracers. On the one hand,
the PET scanner properties in terms of spatial resolution
will be similar for acquisitions performed with the same
radioisotope, therefore resulting in partial volume effects of
similar magnitude. On the other hand, acquisitions per-
formed using different radiotracers show different uptake
intensities and therefore subsequent different contrast and
noise level characteristics for a given tumour uptake. For
instance, 18F-FLT and 18F-FMISO images are usually
characterized by higher noise levels and reduced tumour
uptake contrast than 18F-FDG images [17, 18]. Therefore,
studying the behaviour of automated algorithms dedicated
to the delineation of elevated activity in 18F-FDG images,
considering variable contrast and noise levels, could
provide an insight into the potential behaviour of such
algorithms when applied to other 18F-labelled PET tracers.
The objectives of this study were (1) to provide a
robustness and repeatability evaluation framework, and (2)
to assess within this framework the performance of
different advanced and threshold-based segmentation algo-




Threshold-based and more advanced approaches were
considered in this work. Two different fixed thresholds
were considered, at 42% (T42) and 50% (T50) of the
maximum tumour value, using a region growing algorithm
with the maximum intensity voxel as seed [4]. An adaptive
thresholding (TSBR, for threshold source-to-background
ratio) approach [7] was also included:




where SBR is the tumour-to-background ratio determined
by ROI analysis, and the parameters a and b are optimized
for each scanner using phantom acquisitions of spheres.
In terms of more advanced image segmentation
approaches, the fuzzy C-means (FCM) [16] clustering,
previously used for functional volume segmentation tasks
in both brain and oncology applications [14, 15, 19, 20],
was considered. This algorithm iteratively estimates cluster
“centroids” (centres of mass) in the image, computing a
voxel’s membership between 0 and 1 to a given cluster
depending on the distance between the voxel’s value and
the cluster centroids. However, the FCM algorithm lacks
explicit noise and spatial correlation modelling. The second
advanced algorithm considered was an unsupervised bayes-
ian segmentation, known as the fuzzy locally adaptive
bayesian (FLAB) algorithm [14, 15]. It computes, for each
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voxel, a probability of belonging to a given “class” (for
instance, tumour, background or a given uptake level within
a tumour). This probability takes into account the voxel
intensity, spatial correlation with surrounding voxels (the
assumption being that voxels of similar intensities and close
to each other have higher probability of belonging to the
same class) as well as the overall statistical distributions in
the regions of the image by estimating the mean and
variance for each class. The FLAB algorithm automatically
estimates the parameters of interest (number of classes,
class mean and variance, spatial correlation of each voxel)
within a stochastic expectation maximization (SEM) frame-
work [21].
In order to deal with the inherent blurry properties of
PET images due to the limited spatial resolution of
scanners, the algorithm considers that each voxel may
contain a mixture of classes by modelling both spatial
correlation and statistical distributions with a combination
of Dirac “hard” and Lebesgue “fuzzy” measures. This
enables a classification of voxels as belonging to what we
denote as “hard classes” or “fuzzy transitions”, the first
referring to fairly homogeneous regions, the second to
blurred areas occurring at the frontier between two
homogeneous regions. The FLAB algorithm is therefore
able to accurately differentiate if necessary both the overall
tumour spatial extent from its surrounding background as
well as tumour subvolumes with different uptakes. The
accuracy of the FLAB algorithm has been previously
extensively investigated for both homogeneous [14] and
heterogeneous nonspherical tumours [15] and has demon-
strated satisfactory accuracy even for small (<2 cm diam-
eter) volumes of interest (both overall tumours and tumour
subvolumes), short acquisition durations (associated with
higher noise levels) and low (<4:1) contrast (both for
overall tumours with respect to their surrounding back-
ground and between a tumour and its smaller subvolumes).
Accuracy, robustness, repeatability: definitions
For a given segmentation algorithm we define accuracy as
the precision in retrieving the true 3-D object spatial extent,
shape and volume based on the reconstructed activity
distribution in a PET image, irrespective of the correlation
between this distribution and the underlying physiological
process. Thus an image segmentation algorithm would not
be expected to differentiate specific from nonspecific tracer
uptake (for example inflammation and tumour in the case of
FDG) if they are of the same intensity. The defined
accuracy of each of the methodologies considered was
determined as in previous studies [14, 15] by calculating
the classification errors (see section Analysis).
We define robustness as the ability of a given
methodology to generate accurate segmented volumes
under varying acquisition and image reconstruction
conditions. This robustness is determined as the variabil-
ity of the segmentation results when a method is applied
without prior optimization to images acquired using
various scanners, and for each scanner under various
contrast and noise conditions, using different reconstruc-
tion and associated correction algorithms. A dataset
consisting of multiple phantom acquisitions performed
on various scanner models (see section Validation
studies) was used for this task. These phantom studies
were used to assess robustness as they are consistently
employed for optimization purposes with most of the
functional volume segmentation algorithms.
Within the context of this study, repeatability is defined
as the ability of a given algorithm to reach the same result
when applied multiple times to a single image. In such a
task, deterministic fixed threshold approaches will always
give the same result. On the other hand, more advanced
methods may give different results when applied multiple
times to the same image. For example, adaptive thresh-
olding segmentation may depend on a manually drawn
background ROI and may thus result in variable delinea-
tions depending on the choice of this ROI. Finally, manual
delineation may be considered as the least repeatable, even
when considering a single operator (intraoperator variabil-
ity). In order to compare the performances of the different
segmentation algorithms in terms of repeatability, we used a
series of simulated tumour images [22], as well as 15
different clinical cases (see section Validation studies).
Validation studies
Four different PET/CT scanners currently used in clinical
practice were used for the robustness study: namely, the
Philips Gemini and Gemini TF (Philips Medical Systems,
Cleveland, OH), the Siemens Biograph (SIEMENS Medical
Solutions, Knoxville, TN) and the GE Discovery LS (GE
Healthcare, Milwaukee, WI). In each case, scans of the IEC
phantom containing spheres of various diameters (10, 13,
17, 22, 28, 37 mm) filled with 18F and placed on a hot
uniform background were acquired. A standard protocol
was designed to generate the following acquisitions for
each scanner model: (a) two different SBRs (4:1 and 8:1),
(b) three different scan durations (1, 2 and 5 min) to study
the effect of noise, and (c) two different voxel volumes
used in the reconstruction (between 2×2×2 mm and 4.3×
4.3×4.25 mm). All scans were performed in 3-D mode and
list-mode format facilitating the generation of 1-, 2- and 5-
min realizations from one single 5-min acquisition. In
addition to the standard CT acquisition used for attenuation
correction, a CT scan at high resolution was acquired for
each PET/CT acquisition in order to generate (after
registration) a ground-truth defining the true spatial extent
Eur J Nucl Med Mol Imaging (2011) 38:663–672 665
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(the interior of the sphere) of the tracer uptake at the voxel-
by-voxel level [14]. This is subsequently used to compute
the accuracy of each algorithm through classification errors
(see section Analysis).
Routine clinical image reconstruction protocols were
used for all scanners. For the Philips GEMINI and
GEMINI TF, data were reconstructed using the RAMLA
3D (two iterations, relaxation parameter 0.05, and 5-mm
FWHM 3-D gaussian postfiltering) and the TF ML-EM
algorithm, respectively. In the case of the Siemens
Biograph and GE Discovery LS, images were recon-
structed with Fourier rebinning (FORE) followed by
OSEM (four iterations and eight subsets, with 5-mm
FWHM 3-D gaussian postfiltering, and two iterations
and eight subsets, respectively). All acquisitions were
corrected for attenuation (using the corresponding CT
image), as well as for scatter and random coincidences.
A summary of the parameters for each of the datasets
obtained using the different scanners is shown in Table 1.
Figures 1 and 2 illustrate the various images obtained.
Note that in the case of the Philips GEMINI acquisitions,
the 37-mm sphere was not in the same plane as the others,
and thus appears visually smaller in the selected slice,
while the 28-mm sphere was missing in the phantom used
for the GE Discovery LS acquisitions.
Regarding the repeatability study, two different datasets
were used. The first one consisted of ten tumours extracted
from a database of realistically simulated PET scans based
on clinical whole-body images using the NCAT (NURBS
cardiac-torso) phantom, a model of the Philips GEMINI
PET/CT system Contrast Voxel size (mm) Duration (min) Reconstruction protocol
Philips Gemini 4:1 2×2×2 1, 2, 5 RAMLA 3D
8:1 4×4×4
Philips Gemini TF 4:1 2×2×2 1, 2, 5 TF ML-EM
8:1 4×4×4
Siemens Biograph 4:1 2×2×2 1, 2, 5 FORE-OSEM
8:1 5.33×5.33×2
GE Discovery LS 4:1 1.95×1.95×4.25 1, 2, 5 FORE-OSEM
8:1 4.3×4.3×4.25
Table 1 Overview of the acqui-
sition parameters used for each
scanner model
Philips Gemini Philips Gemini TF




(a) (b) (a) (b)
(B)
Fig. 1 2-D phantom slices
through the centre of the spheres
for the different systems and
imaging conditions. Contrast
ratios: rows (A) 4:1, rows (B)
8:1. Voxel sizes: columns (a)
small voxels, columns (b) large
voxels (see Table 1)
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scanner and GATE (Geant4 Application for Tomography
Emission). The procedure for the generation of these
images, reconstructed using OPL-EM (seven iterations,
one subset) with 4×4×4 mm3 voxels, has been previously
described in detail [22]. In the second part of the
repeatability study a number of clinical cases were selected
from datasets acquired on various scanner models: four
oesophagus lymphomas and four follicular lymphomas
were scanned on the Philips GEMINI PET/CT scanner
(2 min per bed position, 60 min after injection of 6 MBq/kg
18F-FDG); and three non-small-cell lung cancers were
scanned on the Siemens Biograph (5 min per bed position,
45 min after injection of 5 MBq/kg 18F-FDG) and on the
GE Discovery LS (3 min per bed position, 60 min after
injection of 5 MBq/kg 18F-FDG).
Analysis
For the phantom images used in the robustness study
each sphere was processed separately. The images
corresponding to the region containing each sphere were
segmented in two classes (sphere and background), using
each of the methods under evaluation (FCM, FLAB, T42
and T50). A voxel-to-voxel ground-truth based on the
corresponding CT datasets as described previously [14]
was used in the robustness evaluation of the different
methodologies considered through the determination of
the segmentation accuracy with the computation of the
classification errors (CE):
CE ¼
card tjct 6¼ xtf g
card tjxt ¼ 1f g
 100 ð2Þ
where, ct is the class assigned by the classification of
voxel t, and xt is its true class (xt=1 for the sphere and xt=
0 for the background) and card{} is the cardinal. The
errors are computed based on all misclassified voxels,
either background voxels classified as sphere voxels or
vice versa, divided by the total number of voxels defining
the sphere volume.
The mean classification error and associated standard
deviation (SD) were obtained for each sphere and for each
segmentation approach, thus providing a measure of the
robustness of the different segmentation algorithms when
applied without specific optimization for a given scanner
model or associated reconstruction algorithm under differ-
ent imaging conditions (contrast and noise). The 10-mm
sphere was not included in the analysis because it was not
clearly visible in several of the phantom acquisitions and
was therefore not possible to segment particularly when
using 4×4×4 mm3 and 5×5×5 mm3 reconstruction voxel
sizes by any of the segmentation algorithms considered.
Adaptive thresholding could not be compared directly with




(B) (C) (D)Fig. 2 Variability for the 17-mm sphere across all four scan-
ner models for two different
configurations. Rows (a): con-
trast 4:1, small voxels and 1-min
acquisition. Rows (b): contrast
8:1, large voxels and 5 min
acquisition. Columns (A) Philips
Gemini, (B) Philips Gemini TF,
(C) Siemens Biograph, and (D)
GE Discovery LS
Table 2 Optimized parameters a and b of the adaptive thresholding (TSBR) approach for each scanner model, with the minimum mean
classification errors and their associated standard deviations across the entire range of configurations




Parameter a Parameter b
Philips Gemini 40.1 59.7 10.8 3.3
Philips Gemini TF 38.6 61.4 9.7 2.8
Siemens Biograph 41.7 57.6 13.1 5.2
GE Discovery LS 42.0 56.8 11.1 3.7
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individual scanner datasets, with the parameters a and b
optimized for each imaging device shown in Table 2.
However, in order to assess the robustness of these
approaches depending on the imaging system used we
applied adaptive thresholding using the parameters opti-
mized on other scanners to the image datasets acquired with
the Siemens Biograph.
For the repeatability evaluation, the simulated and
clinical tumours were segmented ten times each with the
FCM, FLAB and TSBR algorithms (fixed thresholding was
not included since it always gives the same volume). In
addition, manual delineation was carried out by two nuclear
medicine experts with similar experience (more than
10 years) and training. More specifically the two experts
were instructed to delineate the elevated uptakes in the
images by performing ten different slice-by-slice manual
delineations for the different lesions considered in a
randomized fashion, ensuring a minimum of 1 week
between two consecutive segmentations of the same lesion.
All these manual segmentations were carried out under the
same conditions of full range contrast display. The mean
percentage variability and associated standard deviation
with respect to the mean segmented volume was computed
for each of the lesions and segmentation approaches across
the ten executions and across the ten manual delineations in
order to assess the repeatability of the approaches for each
of the images. The repeatability of the manual delineations
from the two experts were compared separately (intra-
observer variability) and with each other (interobserver
variability).
Results
Classification errors representing segmentation accuracy
computed for each sphere are shown in Fig. 3a, considering
the entire range of systems used for acquisition and the
different parameters in terms of contrast, acquisition
duration and voxel size. For all the systems considered,
the relative impact of the different acquisition (contrast,
duration) and reconstruction (voxel size) parameters is
demonstrated in Fig. 3b, c and d, respectively. Table 3
shows the mean errors and standard deviations computed
across the different spheres taken separately (as shown in
Fig. 3a) and all together for the different imaging devices
and acquisition configurations considered.
For the entire range of sphere sizes (37 to 13 mm), the
FLAB algorithm showed better accuracy and variability
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Fig. 3 Mean classification errors and standard deviations (error bars)
for each methodology with respect to (a) sphere diameter, (b) contrast,
(c) acquisition duration and (d) voxel size, computed across the
different scanner models
b
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than the other advanced segmentation algorithm FCM
(27.8±25.6%) as well as relative to the fixed threshold
approaches T50 (20.3±18.5%) and T42 (42.6±51.6%).
These latter were also more sensitive to variations in the
parameters as shown in Fig. 3a. The T50 algorithm was
clearly more robust than T42 algorithm (SD 19% compared
to 52%). This is explained by the fact that the 50%
threshold is more restrictive and hence leads to lower over-
estimation for the smallest sphere volumes, and that the
42% threshold may lead to a gross over-estimate (>100%
errors for the most challenging imaging conditions). On the
other hand, the T50 algorithm was associated with a larger
classification error for the two larger spheres, as it tended to
under-estimate their volumes by only including the central
high-intensity voxels of the sphere. The FCM algorithm
was unable to accurately segment spheres smaller than 2 cm
in diameter, leading to large overall mean errors when
considering its performance over all sphere sizes, although
it exhibited a lower variability than the fixed threshold
approaches for the majority of the spheres with a size
of >2 cm.
As shown in Fig. 3b, the FLAB algorithm exhibited
low variability with respect to contrast changes, and all
other methodologies, especially the T42 and FCM algo-
rithms, exhibited higher sensitivity to such changes. The
T50 algorithm, on the other hand, was less sensitive to
contrast changes with respect to the mean error but
exhibited larger variability for lower contrast. Figure 3c
illustrates the resilience to shorter acquisitions (hence
higher noise levels) for each methodology. The FLAB
algorithm demonstrates very low variability with shorter
acquisitions, whereas all other methodologies showed
higher variability with significantly larger mean errors
and standard deviations. Finally, only small improvements
were seen for each methodology (except for T50) when
using smaller voxels (see Fig. 3d).
The optimized parameters a and b of the TSBR approach
for each scanner model are shown in Table 2. The mean
classification error across all the spheres (range 13–37 mm)
associated with each scanner was between 9.7% and 13.1%
with associated standard deviations from 2.8% to 5.2%.
When applying the parameters a and b of the Philips
GEMINI, Philips GEMINI TF and Discovery LS datasets
to the Siemens Biograph dataset, the mean error increased
from 13.1±5.2% to 21.7±7.1%, 23.4±7.6% and 19.1±6.4%,
respectively.
Concerning repeatability, Table 4 shows the mean
variability and SD around the mean segmented volume
across the ten manual delineations performed by the two
nuclear medicine experts, and ten repeated executions of
Sphere diameter (mm) Classification error (%)
T42 T50 FCM FLAB
Mean SD Mean SD Mean SD Mean SD
37–13 (all spheres) 42.6 51.6 20.3 18.5 27.8 25.6 8.7 4.5
37 10.5 5.3 16 7.9 11.4 5.3 8.4 2.8
28 17 13.8 15.9 7.5 11.7 5.7 8.4 3.6
22 23 20.7 15.6 9.8 13.4 7.1 7.9 3.3
17 49.1 35 21.5 13.8 31.6 12.7 7.2 4.9
13 113.6 62.1 32.7 33.1 70.9 20.9 11.6 5.9
Table 3 Robustness evaluation:
mean classification error and
associated standard deviation
computed for each methodology
across the entire range of sphere
phantom acquisitions
Method Variability (%)
Simulated cases Clinical cases
Mean SD Mean SD
FLAB 0.5 0.3 0.9 0.5
FCM 0.8 0.6 1.7 1.9
Fixed thresholding 0 0 0 0
Adaptive thresholding 3.4 2.8 3.8 3.1
Manual delineation
Expert 1 13.4 17.3 19.6 15.2
Expert 2 11.7 18.4 22.1 13.6
Expert 2 with respect to expert 1 16.4 21.8 24.7 17.5
Table 4 Repeatability evalua-
tion: variability and standard
deviation around the mean seg-
mented volume for repeated (10
times) delineations of simulated
and clinical tumours
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the FLAB, FCM and TSBR algorithms. The FLAB
algorithm demonstrated highly repeatable results in all of
the studied cases, with negligible variability (<1%) around
the mean segmented 3-D volume across the different
repeated executions for both the simulated and the clinical
datasets. The FCM algorithm also led to satisfactory
repeatability results (0.8±0.6% for the simulated tumours
and 1.7±1.9% for the clinical cases). However, the
variability with the TSBR algorithm was more than double
(3.4±2.8% for the simulated tumours and 3.8±3.1% for the
clinical cases) which was most probably due to the manual
definition of the background ROI. By contrast manual
segmentation performed by the two experts showed high
intraobserver variability for simulated tumours (13.4±17.3%
and 11.7±18.4% for expert 1 and 2, respectively), and even
larger variability for the clinical images (19.6±15.2% and
22.1±13.6% for expert 1 and 2, respectively). Interobserver
variability was 16.4±21.8% and 24.7±17.6% for the simulated
tumours and clinical cases, respectively. Figure 4 shows
examples of delineations obtained by manual segmentation
and the automatic approaches.
Discussion
Functional tumour uptake volume delineation is today an
area of interest for multiple clinical (routine and
research) applications of PET imaging, such as studying
response to therapy and radiotherapy treatment planning.
In all of these applications, the robustness and repeat-
ability with which functional uptake volumes can be
determined under different imaging conditions play a
predominant role in allowing the level of confidence to
be established with the use of such tumour volume
measurements in clinical practice [18]. Although several
promising advanced algorithms have recently been pro-
posed [11–15, 20], methodologies currently used in
clinical practice are based on the use of manual delinea-
tion or fixed and adaptive thresholding [6–8]. The major
drawback of manual delineation is its high inter- and
intraobserver variability, in addition to being time con-
suming. On the other hand, the currently considered state-
of-the-art adaptive threshold-based algorithms have been
shown to accurately define functional volumes under
certain imaging conditions of spherical lesions with a
homogeneous activity distribution. However, they require
specific parameter optimization and are thus system-
dependent. In addition, the adaptive thresholding
approaches usually involve some user interaction to select
background regions of interest, which can potentially lead
to user-introduced variability. In the present study we
focused on the evaluation under different imaging con-
ditions of the level of robustness and repeatability of
different functional volume segmentation algorithms,
including those used in current clinical practice.
In terms of robustness, the use of images from different
commercial PET/CT systems acquired under typical clinical
acquisition conditions resulted in large variability in the
performance of the different segmentation algorithms evalu-
ated. Across all of the images and spheres considered, a fixed
threshold of 42% of the maximum resulted in the largest
variability of the segmented functional volumes (±15–60%)
across the different images considered for spheres <3 cm in
diameter. On the other hand, the variability using a fixed
threshold of 50% was closer (±20%) to that of one of the
advanced segmentation algorithms included in this work
(FCM). Finally, the FLAB algorithm was the most robust of
all the evaluated algorithms leading to the lowest variability
(±5%), with no particular dependence on acquisition (dura-
tion, contrast) and processing parameters (reconstructed voxel
size). The 42% fixed threshold and the FCM algorithm were
the most sensitive to contrast and acquisition duration across
the different scanners used. In terms of variability across the
different images used, the 50% fixed threshold demonstrated
the most significant dependence of variability on lesion
contrast. Finally, applying adaptive thresholding (TSBR) to
Fig. 4 Tumour delineations on the same image slice: a delineation by
adaptive thresholding with two different background ROIs (6%
difference); b delineation by the FLAB method; c two manual
delineations by the same observer (fairly consistent, 9% difference);
d two manual delineations by different observers (highly different,
37% difference)
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acquisitions performed on a different scanner than the one
used to optimize its parameters led to higher mean errors
of <25%.
In terms of repeatability, all algorithms considered
exhibited mean differences of <5%, although only the
FLAB algorithm came close to the perfect repeatability that
can be achieved by a deterministic approach such as a fixed
threshold. Finally, the repeatability of both threshold and
automatic segmentation approaches was superior to that of
manual delineation (variability >15–20% for both the
clinical and simulated tumours).
The overall better accuracy (lower mean errors) and
lower variability (lower standard deviations) associated
with the FLAB algorithm across the different images
considered demonstrates its ability, without the need of
any scanner-specific optimization, to robustly deal with the
different image qualities resulting from the use of different
reconstruction and correction algorithms as well as sensi-
tivities associated with different systems. This of course
should be considered within the context of the limited
absolute accuracy of binary threshold-based approaches
shown in this and previous studies. The accuracy of
threshold-based approaches is particularly limited for
lesions with a nonhomogeneous form and activity distribu-
tion. In such cases it may result, as previously shown [15],
in large under- or over-estimation of the overall tumour
spatial extent.
The present study also demonstrated that the use of any
of the segmentation algorithms significantly reduced intra-
and interobserver variability associated with manual delin-
eation. However, one should keep in mind that automated
segmentation algorithms are not able to differentiate
between similar levels of physiological and pathological
elevated tracer uptakes. Therefore physician involvement is
still imperative and desirable, especially regarding the
detection and selection of elevated tracer uptakes
corresponding to pathological findings that are to be
subsequently accurately delineated.
Conclusion
This study demonstrated significant differences in the
robustness and reproducibility of functional volume meas-
urements depending on the segmentation algorithm used.
The advantage of employing advanced segmentation
algorithms is an improvement in overall elevated activity
delineation across the range of image qualities that can be
encountered today in clinical practice, without the need for
system-dependent optimization procedures. In addition,
their high level of repeatability allows performance similar
to that of deterministic threshold-based approaches to be
achieved. Therefore such advanced image segmentation
algorithms may provide robust and reliable tools to aid
physicians as an initial guess in determining functional
volumes on PET images.
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Abstract
Purpose 18F-fluorodeoxyglucose (FDG) positron emission
tomography (PET) image-derived parameters, such as
standardized uptake value (SUV), functional tumour length
(TL) and tumour volume (TV) or total lesion glycolysis
(TLG), may be useful for determining prognosis in patients
with oesophageal carcinoma. The objectives of this work
were to investigate the prognostic value of these indices in
oesophageal cancer patients undergoing combined chemo-
radiotherapy treatment and the impact of TV delineation
strategies.
Methods A total of 45 patients were retrospectively analysed.
Tumours were delineated on pretreatment 18F-FDG scans
using adaptive threshold and automatic (fuzzy locally
adaptive Bayesian, FLAB) methodologies. The maximum
standardized uptake value (SUVmax), SUVpeak, SUVmean,
TL, TV and TLG were computed. The prognostic value of
each parameter for overall survival was investigated using
Kaplan-Meier and Cox regression models for univariate and
multivariate analyses, respectively.
Results Large differences were observed between method-
ologies (from −140 to +50% for TV). SUV measurements
were not significant prognostic factors for overall survival,
whereas TV, TL and TLG were, irrespective of the
segmentation strategy. After multivariate analysis including
standard tumour staging, only TV (p<0.002) and TL (p=
0.042) determined using FLAB were independent prognos-
tic factors.
Conclusion Whereas no SUV measurement was a signifi-
cant prognostic factor, TV, TL and TLG were significant
prognostic factors for overall survival, irrespective of the
delineation methodology. Only functional TV and TL
derived using FLAB were independent prognostic factors,
highlighting the need for accurate and robust PET tumour
delineation tools for oncology applications.
Keywords PET. Tumour volume . Tumour segmentation .
Oesophageal cancer . Survival
Introduction
The incidence of oesophageal cancer is increasing and
despite advances in therapy, the diagnosis still carries a
poor prognosis [1]. As with all tumours, the outcome for
patients is strongly associated with the stage at initial
diagnosis. The TNM (tumour, node, metastasis) system
currently in use for the staging of oesophageal cancer does
not take into account non-anatomical factors such as
histopathological type, grade or various biomarkers that
may be important determinants of prognosis. The patho-
logical stage is given by surgery but this procedure is not
possible for all patients because it is associated with a high
risk of mortality and morbidity. Therefore a noninvasive
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staging method would be of great interest, and within this
context the primary role of 18F-fluorodeoxyglucose (FDG)
positron emission tomography (PET) in oesophageal cancer
is the detection of distant metastases [24]. This modality is
also gaining acceptance in oesophageal cancer for the
assessment of therapy response [5, 6] or for radiotherapy
treatment planning [79]. Lately, some authors have also
suggested that different parameters derived from initial 18F-
FDG PET images could have a role as independent
prognostic factors [1014]. The parameters studied include
standardized uptake value (SUVmax as the maximum uptake
in the primary tumour or in the combined primary and
regional area), tumour functional longitudinal length (TL),
tumour functional volume (TV), nodal uptake or FDG-avid
metastases [1014]. Although a few studies have demon-
strated the interest of these indices for determining
prognosis, there are conflicting results concerning the
independent prognostic value of each of these indices. For
example, Hyun et al. [12], analysing results from 151
patients with principally squamous cell carcinoma (SCC),
have recently suggested that primary tumour SUVmax is not
an independent prognostic factor, in agreement with other
studies [10, 15, 16]. On the other hand, Kato et al. [17]
based on the analysis of 184 patients with oesophageal SCC
have shown that SUVmax of the primary tumour is an
independent prognostic factor for overall survival, in
agreement with other studies [1820]. These conflicting
results can be potentially caused by differences in the
methodology used for the analysis of the PET images.
Although SUVmax is less sensitive to tumour size, the
conflicting results considering its value as an independent
prognostic factor may also be due to variability in the
tumour sizes considered in the different studies.
Pathological TL has been shown to be an independent
prognostic factor in oesophageal carcinoma [21]. Therefore,
determining the functional TL in 18F-FDG PET images may
be a good surrogate. The use of different thresholds for the
determination of the functional TL in the existing studies may
be responsible for the conflicting results regarding its value as
a predictor of response to chemoradiotherapy [11, 22], while
it has been shown to be an independent predictor in patients
undergoing surgery [10]. On the other hand, functional TV
may be more representative of overall tumour burden. The
value of the functional TV has been only recently explored in
a single study of patients with oesophageal carcinoma
considering a heterogeneous treatment regime (76 and 24%
treated by surgery and combined radiochemotherapy, respec-
tively) [12]. In this study both the presence of metastases and
the TV were found to be independent prognostic factors for
overall patient survival. Tumours were delineated based on a
three fixed threshold scale depending on the tumour SUVmax.
Although such an approach may be simple to implement in
clinical practice, the use of a fixed threshold for functional
TV determination suffers from multiple shortcomings which
have been highlighted in different studies [23, 24]. In
addition, the proposed scale is not universally applicable to
the different clinical settings spanning from the acquisition
protocols to the scanning systems used and variable
associated image qualities.
Therefore, despite early evidence that functional TL and
TV may be useful parameters in predicting survival and
response to therapy, there is a clear need to assess the
influence of the methodology used in obtaining these indices.
Finally, the determination of functional TV may allow the
calculation of alternative image-derived indices such as the
total glycolytic lesion index (TLG) (g), defined as the product
of the TV (ml) and its associated mean activity (SUVmean)
(g/ml) [25], whose value has not as yet been explored in
predicting response to therapy or as a prognostic factor for
survival using 18F-FDG in oesophageal carcinoma.
The objective of this study was therefore to retrospec-
tively investigate the prognostic value of 18F-FDG PET in
45 oesophageal cancer patients treated with concomitant
radiochemotherapy, considering for the first time in a single
study all of the commonly used PET-derived parameters
such as functional TL, TV, SUV measurements (max, peak,
mean) and TLG. In addition, the impact of different tumour
delineation strategies was assessed.
Materials and methods
Patients
A total of 45 patients with newly diagnosed oesophageal
cancer treated between 2004 and 2008 with concomitant
radiochemotherapy and without surgery were included in this
study. The characteristics of the patients are given in Table 1.
Of the patients, 41 were male (91%), and the mean age at the
time of diagnosis was 66±10 years. Most of the tumours
were SCC (73%) and originated from the middle and lower
oesophagus (76%). All patients were referred before treat-
ment for an 18F-FDG PET study as part of a routine
procedure for the initial staging in oesophageal cancer. The
treatment included three courses of 5-fluorouracil/cisplatin
and a median radiation dose of 60 Gy given in 180-cGy
daily fractions delivered once daily, 5 days a week for
67 weeks. Follow-up data were prospectively collected in a
database for further analysis and overall survival was
calculated. The current analysis was carried out after an
approval by the Institutional Ethics Review Board.
18F-FDG PET acquisitions
18F-FDG PET studies were carried out prior to the
treatment. Patients were instructed to fast for a minimum
Eur J Nucl Med Mol Imaging
of 6 h before the injection of 18F-FDG. The administered
dose was 5 MBq/kg, and static emission images were
acquired (2 min per bed position) from head to thigh
beginning 60 min after injection on a Philips GEMINI PET/
CT system (Philips Medical Systems, Cleveland, OH,
USA). In addition to the emission PET scan, a low-dose
CT scan without IV or oral contrast was acquired for
attenuation correction. Images were reconstructed with the
3-D row action maximum likelihood algorithm (RAMLA)
using standard clinical protocol parameters: 2 iterations,
relaxation parameter of 0.05, 5-mm 3-D Gaussian post-
filtering and 4×4×4 mm3 voxels grid sampling.
PET image analysis
The following parameters were extracted from each PET
image: SUVmax, SUVpeak defined as the mean of SUVmax
and its 26 neighbours, mean SUV within the delineated
tumour (SUVmean), functional TL in longitudinal direction,
functional TV and TLG. SUVpeak, usually defined as a
1-cm circle or sphere [26] [we used a 3×3×3 cube of
4×4×4 mm3 voxels which roughly corresponds to the same
region of interest (ROI)], was considered in order to
investigate the impact of reducing the potential bias in the
SUVmax measurements as a result of its sensitivity to noise.
Whereas SUVmax and SUVpeak are independent on the
tumour delineation strategy used, TL, TV, SUVmean and the
derived TLG were determined on delineations performed
using two strategies. First, an adaptive threshold [23] using
a background ROI manually chosen by two experienced
nuclear medicine physicians led to two different results
Tbckgrd
1 and Tbckgrd
2. Observers were instructed to choose
the ROI in the mediastinum at a sufficient distance from the
lesion to avoid any overlapping. However, they were
allowed to choose the size, shape and exact placement of
the ROI. Finally the automatic fuzzy locally adaptive
Bayesian (FLAB) algorithm [24, 27] was considered.
Statistical analysis
All quantitative data were expressed as mean±1 standard
deviation (SD) and summary statistics are given in Table 2.
The correlation between all parameters extracted using
the different methodologies was computed with Pearson
coefficients. The differences between methodologies were
assessed using Bland-Altman analysis [28] to define bias as
the mean error, and agreement intervals (upper and lower
limits) as 1.96 times the SD. Kaplan-Meier methods were
used to estimate the survival distributions [29]. Overall
survival was calculated from the date of initial diagnosis to
the date of death or most recent follow-up in cases of
patients still alive. Survival curves were generated for each
parameter considered. The most discriminating threshold
value allowing differentiation of the two groups of patients
was selected using receiver-operating characteristic (ROC)
methodology [30]. The prognostic value of each parameter
in terms of overall survival was assessed by the log-rank
test. The significance of the following factors was tested:
age, gender, histology type, T, N, M classifications,
American Joint Committee on Cancer (AJCC) stage [31],
TL, TV, SUVmax, SUVpeak, SUVmean and TLG. Indepen-
dent prognostic factors for overall survival were determined
using multivariate Cox regression analysis [32] by incor-
porating in the model all parameters that were deemed
significant in the univariate analysis. However, the indices
obtained by each delineation (Tbckgrd
1, Tbckgrd
2 and FLAB)
Table 1 Patient demographic and clinical characteristics
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were incorporated in the multivariate analysis separately
since they were found to be highly correlated (Pearson r>
0.8, r2>0.66; see the Correlation between image-derived
indices and between methodologies section). All tests
were carried out using MedCalc™ (MedCalc Software,
Mariakerke, Belgium); p values <0.05 were considered
statistically significant.
Results
All primary lesions were detected by 18F-FDG PET. The
intensity of maximum 18F-FDG uptake in the primary
lesion was quite high with a normally distributed SUVmax
of 10±3.8. As expected, SUVpeak measurements were
comparatively lower (8±3). Measurements related to the
dimensions of the tumours were less uniformly distributed
than SUV measurements, with a larger SD with respect to
the mean. For example the TV (FLAB) was 35±33 cm3.
Correlation between image-derived indices
and between methodologies
TL measurements were correlated with TV (p<0.0001)
although with moderate coefficients (r=0.69, 0.58 and 0.6
for FLAB, Tbckgrd
1 and Tbckgrd
2, respectively). No signifi-
cant correlation was found between any SUV measurement
(SUVmax, SUVpeak, SUVmean) and TV (p>0.2, r<0.3),
irrespective of the delineation strategy, in line with results
of other studies such as van Heijl et al. [33].
All SUVmean measurements derived from TV delineation
performed using the two different methodologies considered
were highly correlated (p<0.0001) with coefficients >0.97.
TV (r>0.82), TL (r>0.91) and TLG (r>0.95) results were
also highly correlated (p<0.0001) for both methodologies.
Despite high correlation coefficients, large differences
were observed for several patients between measure-
ments using the two delineation methodologies consid-
ered, and between the two users of the same adaptive
thresholding. Figure 1a, b illustrates such differences. In
the case of adaptive thresholding these differences were
the result of the two users placing the background ROI
differently.
A summary of the Bland-Altman analysis carried out to
compare the delineation methods and highlight potential
differences is presented in Fig. 2c, d and complete results
are given in Table 3. The largest differences between
methodologies were observed for TV with a bias of up to
50% between the adaptative thresholding and FLAB: both
users yielded globally smaller volumes (bias of −50±50%
and −21±54% for Tbckgrd
1 and Tbckgrd
2, respectively).
Agreement intervals (upper and lower limits) were large
for all parameters and for all comparisons, up to +80 and
−140% (see Fig. 2b). Even between the two users of the
same adaptive thresholding method (see Fig. 2a), mean
differences of −30±35% were seen and limits of agreement
were large, from −100 to +45%. No significant trend was
found regarding the correlation between TV and differences
between methodologies (r<0.2, p>0.1).
Better agreement was observed for TL and SUVmean;
however, intervals of agreement were large (−50 to −25%
lower limit and +20 to +40% upper limit for TL; −80
to −10% lower limit and +10 to +80% upper limit for
SUVmean).
Due to the combined effect of TV and SUVmean, TLG
differences were in between, with moderate bias but still
Table 2 Parameters definition and statistics
Definition Notation Mean ± SD Range
Highest SUV within the tumour SUVmax 10±3.8 2.219.7
Mean of SUVmax and its 26 neighbours SUVpeak 8.2±3.3 1.816.1
Mean SUV of tumour defined by Adaptive threshold 1st user SUVmean (Tbckgrd
1) 6.6±2.6 1.813.7
2nd user SUVmean (Tbckgrd
2) 6.2±2.7 1.613.8
FLAB SUVmean (FLAB) 6.0±2.4 1.713.2
Functional TV defined by Adaptive threshold 1st user TV (Tbckgrd
1) 22.6±23.8 1.892.0
2nd user TV (Tbckgrd
2) 29.2±29.7 2.4133.9
FLAB TV (FLAB) 36.3±33.7 3.0139.7
Functional TL defined by Adaptive threshold 1st user TL (Tbckgrd
1) 5.9±3.0 1.615.6
2nd user TL (Tbckgrd
2) 5.6±2.9 1.614.4
FLAB TL (FLAB) 6.2±2.9 2.015.6
SUVmean (Tbckgrd
1)×TV (Tbckgrd




2) (g) TLG (Tbckgrd
2) 198.8±209.4 6.9921.3
SUVmean (FLAB)×TV (FLAB) (g) TLG (FLAB) 221.6±225.8 5.3882.7
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large agreement intervals (upper and lower limits of −120
to −75% and +40 to +90%, respectively).
Survival analysis
At the time of last follow-up, 10 patients were alive with no
evidence of disease, 9 were alive with recurrent oesopha-
geal cancer and 26 had died from the disease. With a
median follow-up of 60 months (range 982), the overall
median survival was 15 months. The 1-year and 2-year
survival rates were 63 and 34%, respectively.
The results of the log-rank analysis of significant
parameters for overall survival in univariate analysis are
given in Table 4. Table 5 summarizes the prognostic value
of all the parameters under investigation in this study.
Age, gender and histology types were not significant
prognostic factors in the univariate analysis. Neither were T
and N classifications. In the univariate analysis, the
presence of metastases [median survival of 26 months
(M0) versus 12 months (M1), p=0.01)] and the clinical
AJCC stage (p<0.001) were significant prognostic factors.
Although there was a trend observed, neither SUVmax nor
SUVpeak were significant prognostic factors. A SUVmax <5
or <8 tended to be a factor for better outcome with a median
survival of 14 vs 7 months (p=0.08) or 21 vs 13 months
(p=0.1), respectively (see Fig. 3a).
Fig. 1 Illustration of differences
in tumour delineation depending
on the methodology for a a
small (<8 cm3) and low
contrast (approximately 2:1)
tumour and b a larger (30 cm3)
and higher contrast
(approximately 7:1) tumour
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Mean SUVs in the tumour were not significant prog-
nostic factors in univariate analysis. There was however a
trend for shorter survival associated with higher SUVmean.
For example, the median survival was reduced by a factor
of 2 for patients with an SUVmean higher than 5 (13 months
vs 21 months, p=0.06). This was however observed only
when the FLAB methodology was used to define TV, while
no similar trend was observed with SUVmean parameters
obtained with adaptive thresholding.
Functional TV was a significant prognostic factor for
overall survival, whatever methodology was used (p<0.001
using FLAB and p=0.004 for both Tbckgrd
1 and Tbckgrd
2, see
Fig. 3b, c). In addition, using the TV, and independently of
the delineation approach used, allowed us to separate our
population into three groups with significantly different
outcome (p=0.002, p=0.02 and p=0.004 for FLAB,
Tbckgrd
1 and Tbckgrd
2, respectively). For instance, volumes
defined by FLAB less than 14 cm3, between 14 and 85 cm3
or superior to 85 cm3 were respectively associated with a
median survival of 49 (19 patients), 15 (21 patients) and 5.5
(6 patients) months as illustrated in Fig. 3d. In Fig. 4ac
three examples of 18F-FDG PET baseline images of patients
belonging to each of these three groups are presented.
Functional TL was also a significant prognostic factor
with results similar to TV (p=0.01, p=0.02 and p=0.04 for
FLAB, Tbckgrd
1 and Tbckgrd
2, respectively), apart from not
being possible to significantly differentiate three groups of
patients with different outcome, independently of the
strategy.
Similarly, TLG was also a significant prognostic factor
whatever methodology was used, while it was equally not
possible to significantly differentiate three groups. The
Fig. 2 Bland-Altman analysis




Tbckgrd and FLAB, for each
parameter (TL, TV, SUVmean,
TLG). Grey columns and error
bars represent the mean
differences (bias) and associated
SD, respectively. Bold arrows
up and down denote upper and
lower limits, respectively; 95%
confidence intervals for each are
given in Table 3
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median overall survival was 10 months for patients with a
TLG (FLAB) >180 g and increased to 21 months for
patients with a TLG<180 g (p=0.01). Similar results were
obtained with adaptive thresholding (20 versus 8 and 20
versus 10 months for Tbckgrd
1 and Tbckgrd
2, respectively).
After multivariate analysis, considering each delineation
methodology separately, only TVobtained using FLAB and
AJCC stage were found to be independent significant
prognostic factors (p=0.0017 and 0.0021 for TV and
AJCC, respectively), whereas only AJCC stage was an
independent significant prognostic factor (p<0.002) when
considering TV obtained by adaptive thresholding.
Similar results were obtained when replacing TV by TL,
with both TL and clinical AJCC staging found to be
independent significant prognostic factors in the case of
FLAB (p=0.017 and p=0.042 for AJCC stage and TL,
respectively), whereas in the case of adaptive thresholding
only AJCC staging was an independent significant prog-
nostic factor (p=0.0021).
On the other hand, in the case of TLG only the AJCC
staging was an independent significant prognostic factor
(p<0.002), whatever delineation strategy was considered.
Discussion
An accurate staging in oesophageal cancer is essential for
guiding therapy. The standard conventional modalities are
endoscopic ultrasonography and computed tomography
even if this combined approach suffers from several
Table 3 Bland-Altman analysis results comparing delineation strategies for all parameters
Parameter Mean±SD 95% CI of mean LL 95% CI of LL UL 95% CI of UL
% difference between Tbckgrd
1 and Tbckgrd
2
TL 6.7±18 1.3 to 12.1 −28.6 −37.9 to −19.3 41.9 32.6 to 51.2
TV −29±37.3 −40.2 to −17.8 −102 −121.3 to −82.8 44.1 24.8 to 63.4
SUVmean −6.3±9 −9 to −3.6 −23.9 −28.5 to −19.3 11.2 6.6 to 15.8
TLG −23.5±32.3 −33.2 to −13.8 −86.8 −103.5 to −70.1 39.7 23 to 56.4
% difference between Tbckgrd and FLAB
TL Tbckgrd
1
−5.9±15.3 −10.4 to −1.4 −35.8 −43.6 to −28 24 16.2 to 31.8
Tbckgrd
2
−12±7 −18.3 to 7.1 −49.4 −59 to −39.9 24.1 14.5 to 33.6
TV Tbckgrd
1
−48.8±48.8 −63.3 to −34.3 −144.5 −169.5 to −120 46.9 21.9 to 71.9
Tbckgrd
2
−22±53.9 −38.1 to −6.0 −127.7 −155.3 to −100 83.6 56.1 to 111.2
SUVmean Tbckgrd
1 11.5±36.2 0.7 to 22.2 −59.5 −78 to −41 82.4 63.8 to 100.9
Tbckgrd
2 7.1±35.8 −3.6 to 17.7 −63.1 −81.4 to −44.8 77.2 58.9 to 95.5
TLG Tbckgrd
1
−34.5±25.6 −42 to −26.9 −84.6 −97.6 to −71.5 15.7 2.6 to 28.7
Tbckgrd
2
−10.6±33.2 −20.4 to −0.7 −75.6 −92.5 to −58.6 54.4 37.5 to 71.4
SD standard deviation, CI confidence interval, UL upper limit, LL lower limit
Parameter HR HR 95% CI p Median survival (months)
AJCC stage 0.281 0.0900.881 0.0008 26 vs 8
M stage 0.402 0.1720.940 0.01 26 vs 12
TL (Tbckgrd
1) 0.318 0.1330.761 0.02 21 vs 10
TL (Tbckgrd
2) 0.393 0.1640.939 0.04 21 vs 10
TL (FLAB) 0.163 0.0520.510 0.01 21 vs 10
TV (Tbckgrd
1) 0.212 0.0202.280 0.004 16 vs 5
NA NA 0.02 21 vs 10 vs 9
TV (Tbckgrd
2) 0.212 0.0202.280 0.004 16 vs 5
NA NA 0.004 49 vs 14 vs 5
TV (FLAB) 0.236 0.0500.909 0.0005 20 vs 5.5
NA NA 0.002 49 vs 15 vs 5.5
TLG (Tbckgrd
1) 0.217 0.0640.735 0.007 20 vs 8
TLG (Tbckgrd
2 ) 0.202 0.0630.645 0.01 20 vs 10
TLG (FLAB) 0.337 0.1470.772 0.02 21 vs 10
Table 4 Parameters with
significant prognostic value
after univariate analysis
HR hazard ratio, CI confidence
interval
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shortcomings. 18F-FDG PET is more and more often
included in the initial staging because it allows a more
accurate disease assessment, especially regarding the
detection of distant metastases [24]. Since no patient
underwent surgery in our study, anatomopathology data
were not available. Therefore TNM classifications and
AJCC stages were determined using suboptimal conven-
tional staging and this could explain the poor prognostic
value of T or N classification in our population.
As found in our study, 18F-FDG uptake is always present
in oesophageal cancer if extended at least to submucosa
[34]. Some authors suggested that the intensity of 18F-FDG
uptake could be related to prognosis in oesophageal cancer,
based on the good correlation existing between hexokinase
activity or poor differentiation and tumour uptake [35] and
also because increasing SUVmax values seem to correlate
with T classification, which is part of the TNM staging
[36].
In our study, SUV measurements were not significant
prognostic factors for overall survival. While various cutoff
values of SUVmax tend to be associated with a poor
prognosis, none led to statistically significant differentia-
tion. Swisher et al. reported similar results in a uniform
group of highly selected patients with locally advanced
oesophageal cancer treated by neoadjuvant radiochemo-
therapy [37]. On the other hand, these results could appear
in contrast with our previous report [18], where we initially
reported that an SUVmax cutoff value of 9 had an
independent prognostic value of overall survival, but this
difference may be explained by the different patient
characteristics considered in the two studies. We previously
considered [18] a daily practice population, half of which
underwent curative surgery, while we included here only
patients with advanced disease exclusively treated by
combined radiochemotherapy.
TL established by pathological examination has been
demonstrated to be an independent prognostic factor for
long-term survival [21]. Some authors proposed estimating
TL based on 18F-FDG PET images using different thresh-
olds [38]. Functional TL has been studied as a predictor of
response to neoadjuvant chemoradiotherapy with
conflicting results [11, 22]. In a group of 69 patients with
oesophageal SCC undergoing curative surgery, Choi et al.
demonstrated that functional TL was an independent
prognostic factor [10]. However, one may argue that
functional TL is a parameter that does not reflect the real
volume of the tumour but only its longitudinal extension
and could be therefore considered as only a surrogate of
tumour spatial extent. This argument can be supported by
the data shown in this work, where only a moderate
correlation (r<0.7) was found between TV and TL,
suggesting that functional TV may be more accurate in
assessing actual tumour burden. In our study we also
compared the prognostic value of TL with that of TV. Both
Variable Significant prognostic factor
in univariate analysis
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TLG (FLAB) Yes No
Table 5 Prognostic value of all
parameters
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Fig. 3 Kaplan-Meier survival curves obtained using SUVmax (a), TV measured by FLAB (b) and Tbckgrd
1 (c), and defining three groups using TV
measured by FLAB (d)
Fig. 4 18F-FDG PET images
(axial, coronal and sagittal
views from top to bottom) of
patients with a a small tumour
(11 cm3, 54 months survival), b
medium size tumour (22 cm3,
18 months survival) and c larger
tumour (92 cm3, 5 months
survival)
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parameters were found to be significant prognostic factors
irrespective of the functional volume delineation strategy.
In addition, both TV and TL were independent prognostic
factors for survival in the multivariate analysis. However,
this result was found to be dependent on the segmentation
algorithm, with both parameters being independent survival
prognostic factors only when determined using the auto-
matic FLAB segmentation. This may be related to the
higher overall accuracy of FLAB with respect to adaptive
thresholding for tumour delineation as previously reported
[24, 27, 39]. Despite the similar prognostic values of TL
and TV, only TV allowed a statistically significant
stratification of patients into three groups, irrespective of
the segmentation methodology. More specifically, two
different cutoff values (85 and 14 cm3) resulted in
significant differentiation of two groups among the patients
with median overall survival of 56 vs 20 months
(p=0.0005) and 49 vs 13 months (p=0.036) for 85 and
14 cm3, respectively. Being able to provide such a finer
stratification of patient groups could be of value in clinical
trials assessing new therapeutic regimes.
SUVmean measured in a volume determined using the
different tumour delineation approaches considered was not
found to be a prognostic factor for overall survival,
although a trend was seen for SUVmean associated with
TV defined with FLAB, which tended to differentiate
patients with poor and better prognosis (13 vs 21 months,
p=0.06).
A fundamental biological question underlying 18F-FDG
PET prognostic value is whether the total volume or the
metabolically active portion of the tumour is most impor-
tant. Intuitively both would seem important and desirable to
determine. In our study, both functional TL and TV
(representative of the tumour functional spatial extent) were
significant prognostic factors compared to SUVmean (repre-
sentative of the tumour glycolytic metabolism) which was
not. Combining both parameters into total lesion glycolysis
index (TLG) was a prognostic factor for overall survival
whatever methodology was used for tumour delineation.
However, it was not an independent significant prognostic
factor in the multivariate analysis. Only very few data are
available on the potential clinical value of TLG in different
cancer models. Xie et al. reported on the prognostic value
of TLG in head and neck cancer for long-term survival
[40], while Cazaentre et al. demonstrated the usefulness of
TLG for predicting response to radioimmunotherapy in
lymphoma [41]. To date, the limited use of TV and TLG in
clinical studies could be explained by the poor accuracy,
robustness and reproducibility of available tumour delinea-
tion tools affecting the clinical value of resulting measure-
ments. The fact that TLG was not an independent
prognostic factor, whereas TV alone was, suggests that the
prognostic value of TLG mainly comes from the volume
information and is impaired by the low prognostic value of
SUVmean measurements. In addition, the value of TLG
might be reduced by a loss of information when combining
the TV and the SUVmean into one parameter by simple
product, since large tumours with low uptake might result
in the same TLG as small tumours with high uptake.
Finally, the lack of partial volume effects (PVE) correction
might also play a role in the reduced prognostic value of all
SUV measurements as well as the resulting TLG, since
tumour volumes across the patients range from quite small
and significantly affected by PVE (<2 cm in diameter) to
very large tumours for which PVE have smaller quantitative
impact.
As expected, results concerning parameters dependent
on the tumour delineation process were well correlated. On
the other hand, our results also highlighted the potential
impact of differences between existing tumour delineation
methods, with TV and TL being independent survival
prognostic factors only when determined using FLAB. This
approach has been previously shown to be both robust and
accurate [24, 27]. At present most commonly used methods
are based on fixed or adaptive thresholds. Fixed thresh-
olding has been demonstrated to be both inaccurate and
non-robust [23, 24, 27, 39] and was therefore not
considered in this study.
Regarding the adaptive thresholding performance, results
from one observer (Tbckgrd
2) were closer to these of FLAB
compared to the other one (Tbckgrd
1), with however
significant differences, as shown in Fig. 2b and Table 3.
Neither TV (Tbckgrd
1) nor TV (Tbckgrd
2) were independent
prognostic factors contrary to TV (FLAB). This can be
explained by the behaviour of adaptive thresholding
(independently of the user) for several tumours. Most of
the tumours exhibited simple shapes and homogeneous
tracer uptake. However, some were more complex and
exhibited higher heterogeneity, or were small (<23 cm)
with low contrast. Adaptive thresholding has been demon-
strated to provide unsatisfactory delineation for such cases
[24], because its final threshold is based on the ratio
between an isocontour at 70% of the maximum and the
background ROI. Such an isocontour tends to overestimate
(respectively underestimate) the actual value of the entire
tumour for heterogeneous uptake (respectively small
tumours will low contrast).
Hence the adaptive thresholding led to significant
underevaluation of larger heterogeneous tumours in our
study, e.g. a patient with a survival of 6 months had a TV
defined by FLAB of almost 97 cm3, whereas TV (Tbckgrd
1)
and TV (Tbckgrd
2) were 38 cm3 (−61%) and 50 cm3 (−50%),
respectively, clearly missing parts of the tumour. On the
other hand, the dependency on the background ROI is
higher regarding small tumours with low contrast, e.g. for a
patient with 21 months survival, TV (FLAB) was 5.8 cm3,
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whereas TV (Tbckgrd
1) and TV (Tbckgrd
2) were 1.9 cm3
(−67%) and 26.9 cm3 (+364%), respectively. Several
patients were therefore incorporated in the wrong survival
curve, mostly patients with large volumes that were under-
estimated by the adaptive threshold.
In addition, adaptive thresholding was found to be
highly user dependent, since we observed a bias up to
30% between the two users measuring TV, the agreement
interval being too large for clinical applications (−110 to
+45%). This seems to be in agreement with results
concerning the level of reproducibility in measuring
functional TV from 18F-FDG imaging which can vary from
21 to 90% using automatic and threshold-based approaches,
respectively [42]. If advanced segmentation algorithms are
not available, the use of adaptive thresholding approaches
should be preferred to manual or fixed threshold-based
delineation. Automated background ROI determination
could reduce the interobserver variability observed in this
work.
The limits of this study are its retrospective nature and
the limited number of patients. Our results need to be
confirmed through a prospective study on a larger cohort of
patients. It is finally worth noting that overall survival
might have been affected by other factors such as
subsequent treatment for patients who relapsed, although
this should have minor impact on the results of this study
since it applies to all parameters considered. Other outcome
measures such as progression-free survival were not
investigated in this study.
Conclusion
Our results suggest that the functional tumour volume followed
by length has additional value compared to commonly used
SUV measurements (SUVmax, SUVpeak, SUVmean) for prog-
nosis in patients with locally advanced oesophageal cancer
treated with exclusive concomitant radiochemotherapy. Both
parameters were significant prognostic factors for overall
survival, independently of the approach used to delineate the
tumours. However, only the automatic FLAB algorithm
allowed TV and TL to be independent prognostic factors for
survival in a multivariate analysis that included standard
tumour staging. In addition, the total lesion glycolysis index
was a statistically significant, but not independent, prognostic
factor irrespective of the delineation algorithm used. Our
findings confirm the potential value of 18F-FDG PET to give
a useful orientation for patient management purposes in
oesophageal cancer, but they also highlight the influence of
the methodology used on the degree of pertinence of these
PET image-derived parameters of interest as their accuracy
and their clinical significance increase if they are computed
using more reliable and robust tumour segmentation methods.
Conflicts of interest None.
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Abstract
Purpose The objectives of this study were to investigate the
predictive value of tumour measurements on 2-deoxy-2-[18F]
fluoro-D-glucose (18F-FDG) positron emission tomography
(PET) pretreatment scan regarding therapy response in
oesophageal cancer and to evaluate the impact of tumour
delineation strategies.
Methods Fifty patients with oesophageal cancer treated
with concomitant radiochemotherapy between 2004 and 2008
were retrospectively considered and classified as complete,
partial or non-responders (including stable and progressive
disease) according to Response Evaluation Criteria in Solid
Tumors (RECIST). The classification of partial and complete
responders was confirmed by biopsy. Tumours were delineat-
ed on the 18F-FDG pretreatment scan using an adaptive
threshold and the automatic fuzzy locally adaptive Bayesian
(FLAB) methodologies. Several parameters were then
extracted: maximum and peak standardized uptake value
(SUV), tumour longitudinal length (TL) and volume (TV),
SUVmean, and total lesion glycolysis (TLG = TV ×
SUVmean). The correlation between each parameter and
response was investigated using Kruskal-Wallis tests, and
receiver-operating characteristic methodology was used to
assess performance of the parameters to differentiate patients.
Results Whereas commonly used parameters such as SUV
measurements were not significant predictive factors of the
response, parameters related to tumour functional spatial
extent (TL, TV, TLG) allowed significant differentiation of
all three groups of patients, independently of the delineation
strategy, and could identify complete and non-responders with
sensitivity above 75% and specificity above 85%. A system-
atic although not statistically significant trend was observed
regarding the hierarchy of the delineation methodologies and
the parameters considered, with slightly higher predictive
value obtained with FLAB over adaptive thresholding, and
TLG over TV and TL.
Conclusion TLG is a promising predictive factor of
concomitant radiochemotherapy response with statistically
higher predictive value than SUV measurements in advanced
oesophageal cancer.
Keywords Oesophageal cancer . Response to therapy . PET
scan . Tumour volume . Total lesion glycolysis
Introduction
Oesophageal cancer is the third most common malignancy
of the digestive tract and a leading cause of cancer mortality
worldwide with an estimated 5-year survival of 15% [1].
Despite the progress made to better understand this disease,
its incidence is steadily increasing and there is a growing
concern regarding its effective management [2]. The best
chance for cure remains surgical resection. However, many
patients have already an advanced disease (locally advanced
oesophageal carcinoma, LAEC) at diagnosis and may benefit
in terms of survival from neoadjuvant therapy prior to
surgery [3]. The maximum benefit is for those patients who
achieve a complete pathological response with no residual
cancer cells in the primary tumour or lymph nodes [4]. A
complete response occurs only in 15–30% of cases and is
M. Hatt (*) :D. Visvikis :O. Pradier :C. Cheze-le Rest





Department of Radiotherapy, CHU Morvan,
Brest, France
Eur J Nucl Med Mol Imaging (2011) 38:15951606
DOI 10.1007/s00259-011-1834-9
Author's personal copy
associated with an increased overall survival [5]. On the other
hand, patients who do not respond to therapy may be
unnecessarily affected by toxicity of an inefficient therapy
[6]. Therefore, the development of a diagnostic test offering
noninvasive response to therapy prediction early in the course
of treatment is of great interest, allowing potential personal-
ization of patient management such as for inoperable tumours;
chemotherapy and/or radiation therapy remains the only
option. Such an assessment becomes more critical when one
considers new targeted drugs that could be tested with higher
efficiency if applied early [7]. For oesophageal cancer several
histological markers, such as the tumour suppressor factor
gene p53, the proliferative marker Ki-67 and the epidermal
growth factor receptor, have been evaluated for the prediction
of the therapeutic response prior to neoadjuvant therapy. None
of these markers or a combination of them can currently
predict response with sufficient accuracy [8, 9]. Positron
emission tomography (PET) imaging with 2-deoxy-2-[18F]
fluoro-D-glucose (18F-FDG) allows the visualization of the
enhanced glucose metabolism in viable oesophageal cancer
cells and may be of interest within this context. 18F-FDG PET
is already well established for staging of oesophageal cancer
with a better sensitivity and specificity than the combined use
of CT and endoscopic ultrasonography (EUS) to detect distant
metastases [10]. PET has also been shown to be promising in
assessing response to therapy [11]. Several studies have
shown that the reduction of the tumour’s metabolic activity as
measured by the standardized uptake value (SUV) from the
baseline to the end of therapy uptake is predictive of a better
outcome with however a large variability in the sensitivity and
specificity [12]. In addition, a correlation between clinical
outcome and a metabolic response observed as early as within
the first 2 weeks of treatment has been demonstrated [13].
These findings suggest that tumour activity concentration
differences measured on serial 18F-FDG PET scans could
possibly be used to individualize treatment. However, it could
be more cost-effective and beneficial to the patient to be able
to predict therapy response from a single baseline PET scan
acquired before the initiation of the treatment. The current
study was therefore carried out to investigate the potential
value of baseline 18F-FDG PET image-derived parameters for
the prediction of response to combined radiochemotherapy in
oesophageal cancer. A secondary objective was to investigate
the potential influence of the method used to delineate the
tumour on the prediction results.
Materials and methods
Patients
Fifty consecutive patients with newly diagnosed oesophageal
cancer treated with exclusive concomitant radiochemotherapy
between 2004 and 2008 were included in this study. As part of
the routine procedure for the initial staging in oesophageal
cancer, each patient was referred for an 18F-FDG PET study
before treatment. It included three courses of 5-fluorouracil/
cisplatin and a median radiation dose of 60 Gy given in 180-
cGy daily fractions delivered once daily, 5 days a week for
6–7 weeks. The characteristics of the patients are given in
Table 1. Most of them (45 of 50) were male, aged 65±
9 years at the time of diagnosis; 74% of the tumours, most of
which were squamous cell carcinoma (72%), originated from
the middle and lower oesophagus. Response to therapy was
evaluated 1 month after the completion of the concomitant
radiochemotherapy using conventional thoraco-abdominal
Table 1 Patient demographic and clinical characteristics








Upper oesophagus 13 (26)
Middle oesophagus 20 (40)
Lower oesophagus 17 (34)
Histology type
Adenocarcinoma 14 (28)
Squamous cell carcinoma 36 (72)
Histology differentiation
Well differentiated 14(28)
Moderately differentiated 12 (24)
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CT and endoscopy. Patients were classified as non-
responders (NR) including stable and progressive disease,
partial responders (PR) or complete responders (CR).
Response evaluation was based on CT evolution between
pretreatment and post-treatment scans using Response
Evaluation Criteria in Solid Tumors (RECIST) [14]. Patients
also underwent fibroscopy in cases of partial or complete
response. Complete response was confirmed by the absence
of visible disease in the high endoscopy and no viable
tumour on biopsy. Partial CT response was confirmed by
macroscopic residual (>10% viable) on biopsy. No discor-
dance was observed between pathological, when available,
and CT evaluation.
The current analysis was carried out after an approval by
the Institutional Ethics Review Board.
18F-FDG PET acquisitions
All 18F-FDG PET studies were carried out prior to the
initiation of treatment. Patients were instructed to fast for at
least 6 h before the 18F-FDG administration (5 MBq/kg).
Static emission images were acquired from head to thigh
(2 min per bed position) beginning 60 min after injection on
a Philips GEMINI PET/CT system (Philips Medical
Systems, Cleveland, OH, USA). Images were reconstructed
using the RAMLA 3D algorithm and CT based attenuation
correction. Optimized reconstruction parameters were used
for the 3-D row action maximum likelihood algorithm
(RAMLA) based on the standard optimized clinical
protocol (2 iterations, relaxation parameter of 0.05, 5 mm
3-D Gaussian post-filtering, 4×4×4 mm3 voxels grid
sampling). The PET images were corrected for attenuation
using CT-based attenuation correction.
PET image analysis
All parameters considered were extracted from the
baseline PET images only. For each patient, the primary
tumour was identified on the baseline pretreatment
PET images by a nuclear physician. Three different
SUV measurements and three parameters related to the
tumour functional dimensions, namely the tumour
volume (TV), tumour longitudinal length (TL) and total
lesion glycolysis (TLG) [15], were extracted for each
primary lesion. SUV measurements considered were
SUVmax, SUVpeak defined as the mean of SUVmax and
its 26 neighbours [roughly similar to a 1-cm region of
interest (ROI)] and mean SUV within the delineated
tumour (SUVmean). Whereas SUVmax and SUVpeak are
clearly independent of the tumour delineation strategy
used, TL, TV, SUVmean and the derived TLG values might
depend on the delineation process. To study the impact of
this step, we considered two different approaches, namely the
automatic fuzzy locally adaptive Bayesian (FLAB) algorithm
[16, 17] and an adaptive threshold algorithm [18] optimized
for the GEMINI PET/CT scanner. Although the first
approach is fully automatic, adaptive thresholding requires
a manually defined background ROI. Therefore, two
experienced nuclear medicine physicians were considered
in the background ROI definition, leading to two series of
results denoted as TA1 and TA2. TL was determined in
longitudinal direction by multiplying the number of slices in
the delineated TV by the PET image slice thickness (4 mm).
TV was defined as the sum of all voxels contained in the
delineated volumes multiplied by the image voxels volume
(64 mm3). Finally, TLG was determined by multiplying the
SUVmean and associated TV.
Definition Notation Mean±SD
Highest SUV SUVmax 9.7±3.9
Mean of SUVmax and its
26 neighbours
SUVpeak 8.0±3.3
Mean SUV within tumour
defined by
Adaptive threshold User 1 SUVmean(TA1) 6.4±2.5
User 2 SUVmean(TA2) 6.0±2.6
FLAB SUVmean(FLAB) 5.5±2.3
TL (cm) defined by Adaptive threshold User 1 TL(TA1) 5.8±2.9
User 2 TL(TA2) 5.5±2.8
FLAB TL(FLAB) 6.0±2.8
TV (cm3) defined by Adaptive threshold User 1 TV(TA1) 27.2±25.6
User 2 TV(TA2) 34.8±30.7
FLAB TV(FLAB) 39.4±34.9
SUVmean TA1ð Þ  TV TA1ð Þ gð Þ TLG(TA1) 175.6±178.9
SUVmean TA2ð Þ  TV TA2ð Þ gð Þ TLG(TA2) 206.9±203.4
SUVmean FLABð Þ  TV FLABð Þ gð Þ TLG(FLAB) 207.3±192.0
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Statistical analysis
The relation between response to therapy and each parameter
distribution was studied using the Kruskal-Wallis test [19] as
recommended for small, not normally distributed samples.
Receiver-operating characteristic (ROC) methodology
[20] was used to assess the performance of each parameter
to differentiate patients. Two classification tasks were
considered: differentiating CR patients from PR and NR,
or NR patients from CR and PR. Evaluation was performed
Fig. 1 Illustration of
differences in tumour delinea-
tion depending on the
methodology for two patients
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in terms of the area under the curve (AUC) as well as
specificity and sensitivity.
The significance of the following factors was tested: age,
gender, T, N andM classifications, American Joint Committee
on Cancer (AJCC) stage, histology types, SUVmax, SUVpeak,
TL, TV, SUVmean and TLG. All tests were two-sided and
p values <0.05 were considered statistically significant.
Results
The range of values for the different image-derived indices as
well as the mean and standard deviation for the patient
population considered are given in Table 2. All primary
lesions were detected by 18F-FDG PET exhibiting a rather
high uptake with an SUVmax of 9.7±3.9. SUVpeak and
SUVmean measurements were comparatively lower (8.0±3.3
and 5.8±2.4, respectively).
Correlation between image-derived indices
and between methodologies
TVand TLmeasurements weremoderately correlated (r=0.77,
0.68 and 0.60 for FLAB, TA1 and TA2 respectively,
p<0.0001). On the other hand, no significant correlation
was found between TV and any of the SUV measure-
ments (r<0.2, p>0.1), irrespective of the delineation
approach used. High correlations were observed between
the TV (r>0.89), TL (r>0.90) or TLG (r>0.93) measure-
ments obtained with the two delineation strategies
(p<0.0001). Even higher correlation coefficients
(r>0.97, p<0.0001) were observed for the SUVmean
measurements derived using the two different tumour
segmentation approaches (FLAB and adaptive thresh-
olding). Despite these correlations, certain large differ-
ences were observed for a few patients between the
delineation results of the two segmentation algorithms
considered, examples of which are illustrated in Fig. 1.
Response to therapy analysis
Of the 50 patients included in the study, 25 were classified as
PR, while there were 12 CR and 13 NR. Results concerning
the predictive value of all parameters considered are summa-
rized in Tables 3 and 4 containing the results of the Kruskal-
Wallis tests and that of the ROC analysis (considering the
AUC, specificity and sensitivity regarding the classification
tasks), respectively.
Kruskal-Wallis tests







Age 0.4 0.83 No No No
Gender 4.0 0.14 No No No
T 4.9 0.09 No No No
N 2.7 0.26 No No No
M 3.6 0.17 No No No
AJCC stage 5.9 0.052 Yes No Yes
Histology type 2.3 0.32 No No No
SUVmax 2.5 0.29 No No No
SUVpeak 3.9 0.14 No No No
SUVmean TA1 3.3 0.197 No No No
TA2 3.2 0.199 No No No
FLAB 2.6 0.270 No No No
TL TA1 14.5 0.0007 Yes Yes Yes
TA2 12.4 0.0020 Yes Yes Yes
FLAB 15.6 0.0004 Yes Yes Yes
TV TA1 13.9 0.0010 Yes Yes Yes
TA2 12.9 0.0016 Yes Yes Yes
FLAB 16.2 0.0003 Yes Yes Yes
TLG TA1 14.6 0.0007 Yes Yes Yes
TA2 14.6 0.0007 Yes Yes Yes
FLAB 21.1 <0.0001 Yes Yes Yes
Table 3 Kruskal-Wallis
test results for each parameter
considering the ability to
differentiate (p<0.05) each
pair of response group
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Age, gender or T, N and M classifications did not allow
significant prediction of the response to treatment. The
AJCC stage was not significantly (p>0.05) associated with
the type of response, despite the fact that all NR were at
least stage IIB and could be statistically differentiated from
both PR and CR (p<0.05). However, AJCC stage could not
differentiate PR from CR (p>0.05). Finally, there was no
statistical correlation between histology type and response
(p=0.3).
Figure 2 shows a graphical comparison of the Kruskal-
Wallis results considering the predictive value of the
different SUV parameters considered. Initial SUVmax
(Fig. 2a) was not predictive of response to therapy
(p=0.29) although CR tended to have smaller SUVmax
(8.1±4.1) than PR and NR (10.2±3.7 and 10.2±3.9,
respectively). Similarly, SUVpeak (Fig. 2b) was not predic-
tive of response to therapy with a mean value of 6.5±3.5 in
CR, whereas both PR and NR were characterized by similar
higher SUVpeak values (8.5±3.1 and 8.4±3.3, respectively)
(p=0.14). None of the SUVmean measurements, whatever
delineation strategy was used, could significantly predict
response to therapy (p>0.19).
On the contrary, all parameters related to tumour spatial
extent (TL, TV and TLG) measurements allowed significant
(p<0.002) differentiation of the three response groups,
irrespective of the segmentation methodology (see Fig. 3a–c).
For instance, TV as measured by FLAB was 20±25, 32±24
and 72±40 cm3 for CR, PR and NR patients, respectively.
The parameter that allowed the best differentiation between
the three patient groups was TLG measured by FLAB
(Kruskal-Wallis test p<0.0001, see Fig. 3c), with a TLG of
74±75, 179±143 and 385±226 g for CR, PR and NR
patients, respectively. Figure 4 shows examples of one CR,
one PR and one NR patient with corresponding TLG values.
The ROC analysis results confirmed the limited predic-
tive value of most SUV measurements for the accurate
classification of either CR vs PR and NR, or NR vs PR and
CR (AUC<0.70 and <0.56, respectively). Differences
between ROC analysis associated with SUV measurements
and those associated with TL, TV and TLG were significant
(p<0.05) for both tasks (see examples in Fig. 5). Better
predictive performances were obtained with TL, TV and
TLG measurements with significantly higher AUC (from
0.74 to 0.86) for both tasks (p<0.05). For instance, using
FLAB a TLG <58 g allowed identifying CRs with a
sensitivity of 75% and a specificity of 92%, and a
TLG >196 g identified NRs with a sensitivity of 76% and
a specificity of 85%. However, in terms of predictive
performance no significant differences were obtained
between TL, TV and TLG measurements for both tasks.
Parameter ROC analysis
NR&PR (n=38) vs CR (n=12) NR (n=13) vs PR&CR (n=37)
AUC 95% CI Se (%) Sp (%) AUC 95% CI Se (%) Sp (%)
Age 0.51 0.32–0.70 83.3 31.6 0.55 0.35–0.75 86.5 36.5
Gender 0.61 0.46–0.75] 27.3 94.3 0.51 0.41–0.62 90.9 11.4
T 0.70 0.47–0.93 60.0 89.3 0.64 0.49–0.78 100.0 33.3
N 0.64 0.46–0.83 60.0 68.8 0.55 0.38–0.73 70.0 40.6
M 0.56 0.38–0.73 70.0 41.2 0.70 0.53–0.87 70.0 70.6
AJCC stage 0.63 0.43–0.84 54.6 73.5 0.72 0.57–0.88 87.5 46.2
Histology type 0.51 0.35–0.66 72.7 28.2 0.60 0.46–0.75 42.9 77.8
SUVmax 0.65 0.45–0.85 33.3 94.7 0.54 0.34–0.73 30.8 89.2
SUVpeak 0.69 0.49–0.89 75.0 63.2 0.54 0.35–0.73 30.8 86.5
SUVmean TA1 0.67 0.47–0.87 50.0 84.2 0.54 0.35–0.74 89.2 38.0
TA2 0.67 0.45–0.88 50.0 94.7 0.51 0.32–0.70 100.0 16.2
FLAB 0.65 0.43–0.87 58.3 84.2 0.51 0.32–0.70 100.0 13.5
TL TA1 0.81 0.65–0.97 83.3 79.0 0.78 0.63–0.93 59.5 92.3
TA2 0.79 0.63–0.96 83.3 73.3 0.75 0.61–0.90 75.7 69.2
FLAB 0.79 0.64–0.94 83.3 65.8 0.82 0.70–0.94 59.5 92.3
TV TA1 0.79 0.65–0.89 75.0 81.6 0.79 0.65–0.93 78.4 69.2
TA2 0.74 0.59–0.85 83.3 57.9 0.81 0.67–0.95 94.6 53.9
FLAB 0.78 0.64–0.88 75.0 79.0 0.84 0.72–0.96 75.7 76.9
TLG TA1 0.81 0.62–1.00 66.7 92.1 0.78 0.65–0.92 92.3 56.8
TA2 0.80 0.61–0.99 75.0 86.8 0.80 0.67–0.93 69.2 81.1
FLAB 0.85 0.73–0.98 75.0 92.1 0.86 0.75–0.98 84.6 75.7
Table 4 ROC analysis results
with AUC and associated 95%
confidence intervals (CI),
specificity (Sp) and sensitivity
(Se) for each parameter
regarding the two classification
tasks

































Fig. 3 Distributions of NR, PR and CR patients and associated
Kruskal-Wallis tests for TV-related image-derived indices: TL (TA2)




































Fig. 2 Distributions of NR, PR and CR patients and associated Kruskal-
Wallis tests for SUV-based image-derived indices: SUVmax (a) and
SUVpeak (b)
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In terms of an observed trend, better results were obtained
for TLG over TV and TL whatever tumour delineation
approach was used (Tables 3 and 4). In addition, there was
a systematic although not statistically significant trend of
better performance for those parameters when obtained
with FLAB compared to the use of the adaptive threshold,
as demonstrated by higher AUC and smaller confidence
intervals, as well as higher sensitivity and specificity for
both classification tasks (Table 4).
The analysis with respect to histology type (adenocarci-
noma vs squamous cell carcinoma) led to results similar to
what was observed when considering the entire population.
Within the same context no statistically significant differ-
ences were observed between the two patient groups in the
hierarchy of parameters and results derived using the
different functional TV delineation methods.
The predictive value of TLG, combining TV and
SUVmean into one single parameter, was higher than the
one of TV, despite the non-significant value of SUVmean
alone. Considering together TV and SUVmean, one is able to
differentiate different treatment response patient groups (see
Fig. 6). On the one hand, TLG increased the differentiation
between CR and NR, as all NR had either a TV above
50 cm3 (8/13) or an SUVmean above 5 (8/13), while 10 of
12 CR had either a small TV (<15 cm3) (9/12) or SUVmean
(<5) (7/12), and half of them (6/12) had both. On the other
hand, PR had either a higher SUVmean than CR for volumes
below 25 cm3 (6.5±2.7 vs 4.5±2.4) or lower SUVmean than
NR for TV of 25–50 cm3 (5.8±1.8 vs 7.1±0.9). Therefore,
the use of TLG increased the differentiation between PR
and CR, as well as between PR and NR for volumes below
15 cm3 and between 25 and 50 cm3, respectively.
Discussion
Assessment of response to therapy early during treatment
plays an important role in patient management as well as
in drug development and new criteria including PET
have been suggested for this task [21, 22]. However,
being able to predict response to therapy before the
initiation of the treatment would be even more powerful
for patient management. In this context, either patient or
tumour characteristics could be considered. In our study
we focused on functional imaging and different image-
derived parameters related to tumour uptake using PET.
The results of our study demonstrate that TV-based
parameters derived from baseline 18F-FDG PET images
in oesophageal cancer are good predictors of response to
therapy, with high TL, TV and TLG being associated with
poor response to combined radiochemotherapy. On the
contrary, more commonly used parameters such as tumour
SUVs were not predictors of response to therapy consid-
ering only the baseline 18F-FDG PET images. These
results further demonstrate the value of TV-based PET
image-derived parameters, since we have previously
demonstrated a superior prognostic value of baseline
functional TL, TV and TLG over SUV measurements for
Fig. 4 18F-FDG PET axial,
coronal and sagittal images of a
complete responder with 20 g
TLG (a), partial responder
with 100 g TLG (b) and non-
responder with 750 g TLG (c)
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overall survival in a similar group of oesophageal cancer
patients [23].
FDG PET has been previously used for the prediction of
response to therapy or prognosis in a variety of malignan-
cies [24]. Considering the predictive value of baseline FDG
uptake for therapy response in oesophageal cancer, only
few data showing conflicting results are available [12].
Levine et al. and Rizk et al. reported a high initial SUVmax
being associated with good response [25, 26], whereas
Makino et al. and Kato et al. found the opposite [27, 28].
These conflicting results can be potentially attributed to
differences in patient populations, tumour histology types,
as well as treatment, but could also suggest that SUV
measurements are unreliable in this context. Although
similarly to the results of Kato et al. and Makino et al.
our results suggest that lower values of SUVmax are
associated with a complete response, this trend was not
significant. In addition, SUVmean or SUVpeak, considered
more robust to potential noise bias associated with SUVmax,
were also not significant predictors of response to therapy
in our study.
One of the demonstrated independent predictors of long-
term survival in oesophageal cancer is longitudinal tumour
extension established by pathological examination [29]. It
has been previously demonstrated that TL measured on CT
images leads to a weak correlation with the pathological
TL, associated with a large overestimation [30]. Some
authors proposed the estimation of metabolic TL as a
surrogate of pathological TL using various thresholds of
18F-FDG PET uptake [31]; however, conflicting results
concerning the predictive value of metabolic TL for
response to neoadjuvant radiochemotherapy have been
observed [32, 33]. One may argue that TL does not reflect
the entire volume of the tumour and could therefore be only
considered as a limited surrogate measure of tumour
functional spatial extent. This assumption is partly sup-
ported by our data, in which only a moderate correlation (r
between 0.6 and 0.77) was found between TV and TL,
suggesting that TV may bring additional information
compared to TL in assessing overall tumour burden. In
our study both TV and TL were found to be significant
predictive factors of response to therapy, irrespective of the
functional volume delineation strategy, with only a small
and non-significant improvement of the predictive value of
TV over TL.
TV and TLG measured on PET are 3-D measurements
incorporating metabolically active TV not available from
CT data [34]. It has already been demonstrated that a
decrease of the TVand TLG can predict response to therapy
[35, 36]. These studies however have explored differences
in indices derived from serial PET images. The value of
such indices obtained on the baseline scan only within the
context of therapy response prediction in oesophageal
cancer has not previously been explored. Because these
parameters reflect metabolic information in the entire
tumour, they may be more accurate for tumour character-
ization than a single voxel measure and this may explain
why TV and TLG were good predictors of therapy response
as demonstrated in our study. Our results are consistent
with recent studies in pleural mesothelioma and lymphoma













Fig. 5 Examples of ROC curves obtained for classification tasks of
differentiating CR from NR&PR (a) or NR from PR&CR (b).
Comparison of ROC curves for SUV measurements (SUVmax in red,
SUVpeak in orange and SUVmean in yellow) and TL, TV and TLG
measured with FLAB (in light blue, blue and dark blue, respectively)
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indices extracted from baseline 18F-FDG PET scan to
predict response to therapy [37, 38].
Despite a great potential value, such indices have been
only of limited use to date, which can be explained by the
limited accuracy, robustness and reproducibility of the
available tumour delineation tools [39, 40]. In oesophageal
cancer only the prognostic value of TV has been studied
[23, 41], while there are limited data on the value of TLG
[23]. In our study TLG allowed identifying complete
responders and non-responders with moderate sensitivity
(75 and 76%, respectively) and high specificity (92 and
85%, respectively). Prospective studies with a larger patient
population using a predictive model built upon our results
should now be carried out to demonstrate the ability of the
parameters to discriminate responders from non-responders
on a patient by patient basis.
In our study, TNM stage and AJCC classification were
not good predictors of therapy response. This could be
explained by our suboptimal staging procedure. Since we
considered only patients referred for exclusive radioche-
motherapy, no patient underwent surgery, and therefore no
pathological data were available. Staging was routinely
performed using EUS and CT which are known to have
limited staging performances [10].
Our present study has limitations. Firstly, we considered
a group of only 50 patients with predominantly squamous
cell carcinomas since it is the most common histological
type of oesophageal cancer in European countries. An
analysis based on the tumour histology type considering
our patient population did not reveal statistically significant
differences, although due to the small number of patients
with adenocarcinomas, these results would obviously need
to be confirmed. Secondly, our study was inherently limited
by its retrospective design and as such some selection bias
might be present. However, the treatment regime was
homogeneous throughout the recruited patients since all were
treated in a single institution. In addition, within this patient
population no particular selection criteria were applied.
Thirdly, the impact of partial volume effects in the measured
SUVs was not assessed in this study. The lack of partial
volume correction might have played a role in the reduced
predictive value of some of the SUV measurements, although
it is unlikely because of the large TVs considered in this work
(40±35 cm3). Lastly, we did consider only primary tumours
since the measurements used are simpler to perform in
routine clinical practice compared to measurement of overall
tumour burden including primary and metastatic lesions.
However, given the respective size of metastatic lesions and
primary tumours, adding metastatic lesions to the overall
TLG would not significantly alter the resulting values and
associated conclusions.
Conclusion
Our results demonstrated that 18F-FDG baseline image-
derived parameters related to the metabolic tumour spatial
extent (TL, TVand TLG) are good predictors of response to
therapy in oesophageal cancer with sensitivity above 75%
and specificity above 85%. Commonly used SUV measure-
ments (max, peak, mean) on the pretreatment 18F-FDG PET
image did not allow statistically significant differentiation
of the different response patient groups.
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Impact of Tumor Size and Tracer Uptake Heterogeneity
in 18F-FDG PET and CT Non–Small Cell Lung Cancer
Tumor Delineation
Mathieu Hatt1, Catherine Cheze-le Rest1, Angela van Baardwijk2, Philippe Lambin2, Olivier Pradier1,3,
and Dimitris Visvikis1
1INSERM, U650 LaTIM, CHRU Morvan, Brest, France; 2MAASTricht Radiation Oncology Clinic, Maastricht, The Netherlands; and
3Department of Radiotherapy, CHRU Morvan, Brest, France
The objectives of this study were to investigate the relationship
between CT- and 18F-FDG PET–based tumor volumes in non–
small cell lung cancer (NSCLC) and the impact of tumor size
and uptake heterogeneity on various approaches to delineating
uptake on PET images. Methods: Twenty-five NSCLC cancer
patients with 18F-FDG PET/CT were considered. Seventeen
underwent surgical resection of their tumor, and the maximum
diameter was measured. Two observers manually delineated
the tumors on the CT images and the tumor uptake on the
corresponding PET images, using a fixed threshold at 50% of
the maximum (T50), an adaptive threshold methodology, and the
fuzzy locally adaptive Bayesian (FLAB) algorithm. Maximum
diameters of the delineated volumes were compared with the
histopathology reference when available. The volumes of the
tumors were compared, and correlations between the anatomic
volume and PET uptake heterogeneity and the differences
between delineations were investigated. Results: All maximum
diameters measured on PET and CT images significantly corre-
lated with the histopathology reference (r . 0.89, P , 0.0001).
Significant differences were observed among the approaches:
CT delineation resulted in large overestimation (132% 6 37%),
whereas all delineations on PET images resulted in underesti-
mation (from 215% 6 17% for T50 to 24% 6 8% for FLAB)
except manual delineation (18% 6 17%). Overall, CT volumes
were significantly larger than PET volumes (55 6 74 cm3 for CT
vs. from 18 6 25 to 47 6 76 cm3 for PET). A significant corre-
lation was found between anatomic tumor size and heteroge-
neity (larger lesions were more heterogeneous). Finally, the
more heterogeneous the tumor uptake, the larger was the
underestimation of PET volumes by threshold-based techni-
ques. Conclusion: Volumes based on CT images were larger
than those based on PET images. Tumor size and tracer uptake
heterogeneity have an impact on threshold-based methods,
which should not be used for the delineation of cases of large
heterogeneous NSCLC, as these methods tend to largely
underestimate the spatial extent of the functional tumor in such
cases. For an accurate delineation of PET volumes in NSCLC,
advanced image segmentation algorithms able to deal with
tracer uptake heterogeneity should be preferred.
Key Words: NSCLC; 18F-FDG; tumor delineation; tumor volumes;
tumor size; uptake heterogeneity
J Nucl Med 2011; 52:1–8
DOI: 10.2967/jnumed.111.092767
The use of 18F-FDG PET, with the addition of CT since
the development of PET/CT devices, has been increasing
for staging non–small cell lung cancer (NSCLC) (1). In
addition, the use of 18F-FDG PET/CT in radiotherapy
treatment planning for the definition of gross tumor vol-
ume has been similarly growing (2). Manual contouring of
the tumor boundaries on the CT images is still the conven-
tional methodology for target volume definition. On the
other hand, and despite a high spatial resolution, the de-
lineation on CT alone may be biased by insufficient con-
trast between tumor and healthy tissues (e.g., in cases of
atelectasis, pleural effusion, and fibrosis or for tumors
attached to the chest wall or mediastinum). Several studies
have investigated the impact of delineation performed
on fused 18F-FDG PET/CT images and have found signifi-
cant modifications of the treatment plan (size, location, or
shape of the gross tumor volume) (3) and reduced inter-
and intraobserver variability (4). Additional benefits from
the use of PET relative to CT include the potential to
image cellular proliferation and tumor hypoxia using
tracers such as 39-deoxy-39-18F-fluorothymidine and 18F-
fluoromisonidazole or 64Cu-diacetyl-bis(N4-methythiose-
micarbazone), respectively.
However, the integration of PET within radiotherapy
planning is complex, especially because there is neither
consensus nor guidelines regarding the delineation of 18F-
FDG PET tumor uptake or how to subsequently use the
delineated functional volumes. Most previously published
studies have investigated the use of a specific threshold of
PET uptake to define the metabolically active tumor volume
(MATV, the tumor volume that can be seen and delineated
on an 18F-FDG PET image) or spatial extent, with a large
variability in the recommended threshold and resulting
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volumes (5–8). A few recent studies have investigated the
correlation between tumor histopathology measurements
and the threshold of PET uptake (4,9–12). For example,
the study of Yu et al. (12) on 15 patients proposed an
optimal threshold of 31% 6 11% of the PET maximum
uptake within the tumor for a good correlation with the
corresponding histopathology-derived tumor maximum di-
ameter. Considering 3-dimensional reconstructed histopa-
thology volumes instead of only the maximum diameter,
Stroom et al. (10) recommended a fixed threshold of 42%
of the maximum PET uptake based on their findings in a
group of 5 patients with rather small tumors. Finally, in the
study by Wu et al. (11) on 31 patients, 50% of the max-
imum (T50) was proposed as the best threshold for PET
uptake delineation in NSCLC with respect to the histopa-
thologic maximum diameter. This conclusion was reached
by comparing the results obtained using a range of different
fixed thresholds (from 20% to 55%), although only non-
statistically significant differences were found with the
other tested values. The same authors subsequently showed
that such a threshold was less appropriate than manual
delineation, which led to incorrect delineation in some
cases (13). Manual contouring is far from ideal, as it suffers
from large intra- and interobserver variability (14) and is
also a tedious and time-consuming procedure, especially in
3 dimensions.
Alternatively, other authors have considered the use of
adaptive thresholding approaches taking into account the
tumor-to-background ratio instead of a fixed threshold but
requiring the determination of a background region of
interest, as well as optimization for a given scanner model,
acquisition protocol, and image reconstruction using phan-
tom acquisitions (8,15,16). Using such an approach, van
Baardwijk et al. (4) obtained a significant correlation with
histopathology measurements for 23 NSCLC tumors, as
well as reduced interobserver variability. Finally, the use
of more advanced image segmentation methodologies to
automatically delineate MATV has been proposed in sev-
eral studies (17–24), with variable levels of validation. For
example, we have already demonstrated that such auto-
mated image segmentation approaches can offer higher
accuracy (18,21), robustness (25), and reproducibility (14)
than threshold-based (fixed or adaptive) methods.
Some previous studies investigating NSCLC tumor
delineation on PET/CT hypothesized a significant influence
of the anatomic or metabolic lesion size and activity dis-
tribution heterogeneity on both the results and the observed
differences between delineation methodologies (8). How-
ever, those studies neither quantified this heterogeneity nor
thoroughly investigated such a correlation with respect to
the anatomic tumor and functional uptake sizes. The main
objective of our study was therefore to investigate the cor-
relation among anatomic tumor size as determined on CT,
the 18F-FDG uptake level of heterogeneity, and the differ-




Twenty-five patients with confirmed NSCLC, stage Ib–IIIb,
were included in this study. All patients underwent an 18F-FDG
PET/CT examination for staging purposes before treatment.
Patients were instructed to fast for a minimum of 6 h before
examination. Free-breathing PET and CT images were acquired
45–60 min after 18F-FDG injection. A total of seven 5-min bed
positions with overlap were used for whole-body PET (Biograph
PET/CT; Siemens) acquisitions, which were corrected for attenu-
ation using the CT data and iteratively reconstructed using the
ordered-subsets expectation maximization algorithm (4 iterations,
8 subsets). Within a week after PET/CT acquisitions, 17 of the 25
patients underwent surgery (lobectomy), which allowed further
macroscopic examination. All specimens were processed in the
same way; namely the fresh specimens were put on ice, and
1 pathologist measured the maximum diameter of the tumor in
3 dimensions (4). Specimen shrinkage, estimated at about 10%,
was not considered since the measurements were performed
before fixation in formalin, allowing subsequent immunohisto-
chemical examination, for which the biopsy specimens were par-
affin-embedded.
This study was approved by the Institutional Ethics Review
Board, and informed written consent was obtained from all
patients before their inclusion in the study.
PET and CT Tumor Delineation
PET images were first up-sampled using a cubic B-spline
interpolation scheme (26), in such a way that the voxels were of
the same size as the associated CT images ( ½Fig: 1Fig. 1). Because the
goal of this study was to compare anatomic and MATVas seen and
delineated on CT and 18F-FDG PET images, respectively, manual
delineation on fused PET/CT images was not considered. Only
primary tumors were delineated on both CT and PET images in-
dependently. Tumor anatomic volumes were manually delineated
on CT without knowledge of the PET information by 2 observers,
both with more than 10 y experience in PET and CT. Functional
tumor volumes were manually delineated on PET images by one
of the observers (and checked by the other observer) (13), as
well as using semi- or fully automatic image segmentation tools.
A fixed threshold at T50 as suggested by Wu et al. (11), and an
adaptive threshold taking into account the background uptake (8),
were considered. The adaptive threshold approach was optimized
on phantom acquisitions performed on the same PET/CT scanner
that was used for the patient acquisitions. The method requires the
definition of a manual background region of interest defining the
FIGURE 1. Illustration of up-sampled PET images (central axial
slice). Original PET image with voxel size of 5.31 · 5.31 · 5 mm
(A) and PET image up-sampled with voxel size equal to CT (0.98 ·
0.98 · 5 mm) (B) using cubic B-spline interpolation.
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background uptake to compute a first approximation of the tumor-
to-background contrast. Both observers were therefore instructed
to place this background region of interest in the lungs, at a dis-
tance of several centimeters from the boundaries of the tumors.
They were, however, free to choose the actual size and position of
the region of interest, which led to 2 different results, denoted A1
and A2. Finally, the fuzzy locally adaptive Bayesian (FLAB) algo-
rithm (18,21) was also used. This algorithm allows automatic
tumor delineation by computing a probability of belonging to a
given class (e.g., tumor or background) for each voxel. This pro-
bability is determined by taking into account the voxel intensity
with respect to the statistical distributions (characterized by their
mean and variance) of the voxels in the various regions of the
image, as well as spatial correlation with neighboring voxels.
FLAB has demonstrated its ability to accurately differentiate, if
necessary, both the overall tumor spatial extent from its surround-
ing background and the tumor subvolumes with different uptakes
(18).
Investigated Parameters and Analysis
First, for the 17 patients for whom macroscopic measurements
were available, the maximum diameters were measured as the
largest dimension in any orientation, considering the different
volume delineations (manual on CT and PET, T50, A1 and A2, and
FLAB), and compared with the histopathology reference. We
reported both absolute (in cm) and relative (%) errors with respect
to the maximum diameter to establish a hierarchy between the
different methods. Second, for all patients the anatomic tumor
volumes defined on CT images and the MATV obtained by each
delineation approach were compared with each other. Delineations
on original non–up-sampled PET images were performed to verify
that the up-sampling would not bias the results of the various
methods. Finally, the 18F-FDG uptake heterogeneity was esti-
mated using the coefficient of variation (COV), defined as the ratio
between the SD of the standardized uptake values and the mean
standardized uptake value within the delineated MATV. Two dif-
ferent volumes were used to calculate COV. The first was the one
obtained using FLAB (COVFLAB), since it was found to be the
most accurate with respect to histology measurements, whereas
the second was the CT-based volume (COVCT) copied onto the
PET images.
Summary statistics are expressed as mean 6 SD. Pearson coef-
ficients were used to estimate correlations between parameters.
Paired t tests were used to assess the differences between the
tumor volume distributions obtained with the various delineation
approaches. As most distributions were not normally distributed,
they were log-transformed before analysis. All tests were 2-sided,
and P values of less than 0.05 were considered statistically sig-
nificant.
RESULTS
Comparison with Maximum Diameter
(Histopathology Reference)
½Table 1Table 1 shows the maximum measured diameters of the
17 tumors based on either macroscopic examination or PET
and CT images. All measured diameters correlated strongly
with macroscopic measurements for all delineation ap-
proaches considered (r from 0.89 for T50 to 0.99 for FLAB,
P , 0.0001) ( ½Fig: 2Figs. 2A–2C). Despite high correlations
with maximum diameter for all methodologies as shown
TABLE 1
Maximum-Diameter Measurements on Pathology and Image Delineations for All 17 Patients
Measurement (cm)
Patient no. Pathologic CT1 (manual) CT2 (manual) PET (manual) PET (T50) PET (A1) PET (A2) PET (FLAB)
1 6.2 6.6 6.7 5.7 4.6 5 4.8 5.8
2 2.7 3.3 3.3 3.4 2.8 3.1 2.8 3
3 9 10.5 10.1 8.9 7 7.5 7.7 9.2
4 1.5 1.8 1.9 2.1 1.3 1.6 1.3 1.5
5 1.8 3.4 3.4 2 1.2 1.4 1.3 1.6
6 3.1 4 3.9 3.2 2.4 2.6 2.5 2.8
7 4.3 5 5.1 4.5 3.8 3.9 3.8 3.9
8 3.1 5.7 5.7 5.1 2.8 4 3.7 3.5
9 3.5 3.9 4 3.4 2.7 2.9 3 3.1
10 5.7 7.6 7.7 7.4 7.5 4.7 6.7 5.4
11 5 5.1 5.3 4.7 2.7 3 2.9 4.6
12 2.8 3.5 3.2 3.2 2.4 2.5 2.6 2.8
13 4.1 5.2 5.1 4.3 3.2 3.3 3.3 4
14 4 4.8 4.9 3.7 3.2 3.4 3.2 3.9
15 7 7.4 7.4 5.8 6.2 6.5 6.3 6.7
16 2.3 2.3 2.4 2.1 1.8 1.7 1.9 2.1
17 2.5 6 5.9 4.5 2.5 2.7 2.6 2.2
Mean 6 SD 4.0 6 2.0 5.1 6 2.2 5.1 6 2.1 4.2 6 1.9 3.4 6 1.9 3.5 6 1.6 3.6 6 1.8 3.9 6 2.0
Median 3.5 5.0 5.1 3.7 2.8 3.1 3.0 3.5
Range 1.5–9 1.8–10.5 1.9–10.1 1.9–8.9 1.2–7.5 1.4–7.5 1.3–7.7 1.5–9.2
Pearson r — 0.90 0.91 0.95 0.89 0.95 0.93 0.99
95% CI for r — 0.74–0.96 0.76–0.96 0.86–0.98 0.72–0.96 0.85–0.98 0.81–0.98 0.98–1.00
CI 5 confidence interval.
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in Table 1 and Figure 2, significant differences were
observed among the delineations (½Fig: 3 Figs. 3A and 3B). On
the one hand, CT delineation consistently overestimated
the maximum diameter of all tumors (132% 6 37%), with
errors up to 3.5 cm (1140%). Manual delineation on PET
images led to no significant bias but a high SD (mean error,
8% 6 17%), with maximum errors of 21.5 cm (217%)
and 11.2 cm (139%). On the other hand, PET automatic
delineations mostly led to underestimation of the real diam-
eter. T50 led to the largest underestimation (215% 6 17%),
with errors up to 11.8 cm (132%) and 22.3 cm (246%).
Adaptive thresholding led to better accuracy, with similar
results for both observers (211% 6 17% and 212% 6
16% for A1 and A2, respectively) and errors up to 22
cm (240%). FLAB was associated with the most accurate
results (24% 6 8%), with no error above 60.4 cm
(613%).
Comparison of Tumor Volumes
½Table 2Table 2 shows the tumor volumes for all patients. No
significant differences in volume determination on CTwere
found between the 2 observers (P . 0.08). Therefore, the
results for only 1 observer will be considered. No signifi-
cant difference was observed between volumes obtained on
original or up-sampled PET images.
Anatomic tumor volumes delineated on CT images were
the largest (55 6 74 cm3) and were significantly different
from all volumes defined on PET images (P , 0.0001). In
addition, all PET-based methodologies resulted in volumes
that were significantly different from one another (P ,
0.0001). Among the PET-defined tumor volumes, and con-
FIGURE 2. Correlations with manual delineations on CT (A) and
PET (B) and with FLAB delineations on PET (C).
FIGURE 3. Absolute (in cm) differences (A) and relative (%) errors
(B) between pathology measurements and image-based delinea-
tions.
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sistent with what was observed according to the maximum
diameters, the smallest volumes were obtained with T50 (186
25 cm3), followed by the adaptive threshold (23 6 33 cm3),
FLAB (40 6 71 cm3), and manual (47 6 76 cm3).
Regarding the overlap in delineated volumes, the larger
CT volumes almost systematically enclosed the PET-based
volumes, except for 8 cases in which small regions of PET
uptake were just outside the anatomic volume, involving
small margins comprising only a few voxels. The smallest
PET uptake volumes generated with T50 were also almost
systematically enclosed within the volumes defined by the
adaptive thresholding, which in turn were mostly enclosed
within the FLAB-based volumes.½Fig: 4 Figure 4 illustrates 3 dif-
ferent cases representative of the various situations encoun-
tered.
Correlation of 18F-FDG Uptake Heterogeneity with
Tumor Size and Impact on Delineation
The calculated COVs using the 2 different delineated
tumor volumes (COVFLAB and COVCT) correlated strongly
(r 5 0.98, P , 0.0001). The heterogeneity of PET uptake
in these lung tumors was moderate to high, with a mean
COVFLAB of 0.26 6 0.06 and a range of 0.21–0.48. COVCT
was higher, with a mean of 0.37 6 0.08 (range, 0.3–0.6).
Twenty-two of 25 tumors were characterized by a
COVFLAB of 0.2–0.3 (0.25–0.4 for COVCT), and the 3 most
heterogeneous were characterized by a COVFLAB of 0.32,
0.36, and 0.48 (0.46, 0.48, and 0.69, respectively, for
COVCT).½Fig: 5 Figure 5 shows 2 different lesions and their asso-
ciated COVCT and COVFLAB. A moderate but significant
correlation was found between CT volumes and PET het-
erogeneity, as larger anatomic volumes exhibited higher
heterogeneity (r 5 0.44 and r 5 0.5 for COVCT and
COVFLAB, respectively, P , 0.03). A similar correlation
was found between MATVs and the corresponding hetero-
geneity, as larger functional volumes also exhibited signi-
ficantly higher heterogeneity (r 5 0.51 and r 5 0.58 for
COVCT and COVFLAB, respectively, P , 0.002).
Tumor size had an impact on the differences observed
between the delineation results using the different images
and segmentation approaches considered. A moderate (r 5
0.44) correlation was observed between anatomic tumor
volumes and the differences between FLAB and T50 results
(½Fig: 6 Fig. 6A). The larger the anatomic size of the lesion, the
larger were the differences between FLAB and T50 volumes
(P 5 0.025). Similar nonsignificant trends were observed
for differences between adaptive thresholding volumes or
manual delineation and FLAB (r , 0.4, P . 0.08). No
correlation was found between anatomic tumor size and
the differences between CT volumes and all of the PET
volumes determined with the different segmentation ap-
proaches considered.
The impact of PET uptake heterogeneity was more
significant than anatomic tumor size on the resulting MATV
differences using the PET delineation methodologies
considered. As illustrated in Figure 6B, differences between
MATV obtained with T50 and FLAB correlated strongly
(r, 20.8) with PET heterogeneity (P , 0.0001) estimated
either with COVCT or COVFLAB. The higher the heteroge-
neity within the tumor, the smaller was the MATVobtained
with T50 compared with that derived by FLAB. A similar
correlation was observed for the differences between FLAB
and A1 (r , 20.7, P , 0.0001), as well as between FLAB
and manual delineation (r , 0.6, P , 0.001).
DISCUSSION
Interest in the use of MATV delineation on PET for
NSCLC has been growing for several years, especially for
radiotherapy applications such as dose redistribution,
boosting, and painting, for which MATV is not used in
place of anatomic volume but rather as a complement to
TABLE 2
Tumor Volumes Measured on CT and PET Images (n 5 25)
Tumor volume
(cm3) (n 5 25) Mean 6 SD Median Range
CT1 (manual) 54.5 6 74.0 28.2 1.9–338.9
CT2 (manual) 55.1 6 74.8 29.1 1.8–339.4
PET (manual) 47.3 6 76.4 21.3 2.1–356.2
PET (T50) 17.7 6 25.1 9.2 8.5–125.8
PET (A1) 22.6 6 33.2 11.9 1.2–166.9
PET (A2) 21.8 6 33.9 11.3 0.9–172.4
PET (FLAB) 39.5 6 70.5 15.8 1.1–345.1
FIGURE 4. Small lesions (,2 cm in diameter) (A) and larger lesions
with moderate (COVFLAB5 0.23) (B) and higher (COVFLAB5 0.30) (C)
heterogeneity. For readability, A1 contours are not shown in B and C
and manual PET contours are not shown in B as they were similar to
FLAB and T50. White 5 manual on CT; blue 5 T50; purple 5 A1;
green 5 FLAB.
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increase or redistribute dose within the lesion (27–29).
These techniques are of interest especially for large tumors
characterized by heterogeneous uptake within the MATV.
However, the optimal MATV delineation methodology is
still subject to debate, especially for these tumor cases.
Our results confirm that large discrepancies can be
observed in image-based determination of NSCLC tumor
volumes according to the methodology used for tumor
delineation. Using morphologic imaging and manual delin-
eation, we saw a large overestimation of tumor volume as
previously described by several authors (13). Using a fixed
threshold of 50% as recommended by Wu et al. (11), the
estimation of the maximum tumor diameter on PET images
was not correct. We observed a constant underestimation of
the maximum diameter—a finding that differs from those of
Wu et al., who reported mostly overestimations of the max-
imum diameter of the tumor. This difference is most pro-
bably related to the size of the tumors considered in the 2
studies. Wu et al. included mostly small tumors (median
diameter, 2 cm; range, 1.1–6.5 cm) whereas we considered
larger tumors (4 6 2 cm; range, 1.5–9 cm). The discordant
results could be explained by the failure of binary threshold
approaches to deal with heterogeneity, which is more
present in larger tumors.
On the other hand, we found differences between CT and
PET volumes similar to those found by Wu et al. in their
subsequent study (13). CT volumes were significantly
larger than PET-based volumes in both studies, despite
the differences in tumor sizes considered. In our group of
patients, we mostly observed that the MATV was com-
pletely enclosed in the larger anatomic tumor volumes.
Only in a few cases was elevated tracer uptake observed
outside the limits of the anatomic tumor, and only a few
voxels were involved. This marginal difference may be
explained either by imperfect spatial registration between
PET and CT or by the impact of respiratory motion.
Using the adaptive thresholding methodology as
described by Nestle et al. (8), PET tumor sizes did correlate
well with the histopathology-based gold standard, albeit
with an underestimation of the maximum diameters in
our group of lung tumors. Our results agree with those
of Van Baardjwick et al. (4), who previously investigated
a slightly different semiautomatic methodology first pro-
posed by Daisne et al. (16).
In the current study, results from the 2 observers using
adaptive thresholding were not significantly different,
contrary to what was previously observed in the case of
esophageal tumors (30,31). However, unlike the rather het-
erogeneous uptake in the mediastinum surrounding esoph-
ageal tumors, the lung uptake is more homogeneous, thus
leading to negligible variability in the manually determined
background values. Manual delineation was less dependent
on the heterogeneity within MATV than were threshold-
based methods, leading to satisfactory results with no sig-
nificant bias (mean error , 10%), although there was a
large SD (17%) as some MATV were either largely over-
estimated (mostly the smaller lesions with lower contrast)
or underestimated (some of the most heterogeneous ones
with complex shapes). Overall, manual delineation corre-
lated strongly with FLAB (r 5 0.96).
Automatic delineation on PET images using FLAB
provided the best estimation of tumor diameters, in ac-
cordance with our previous evaluation of FLAB perform-
FIGURE 5. Heterogeneity estimation for 2 tumors.
FIGURE 6. Correlation between anatomic volume (A) or uptake
heterogeneity (B) and differences between T50 and FLAB volumes.
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ance (18). Other advanced segmentation algorithms able to
deal with heterogeneous MATV could potentially yield
similar satisfactory results (22,32). In our previous study,
FLAB was compared with a fixed threshold at 42%, instead
of 50%, but with similar trends in the observed results.
Furthermore, in our previous work the segmentation algo-
rithms were applied to the original PET images without up-
sampling and therefore with larger voxels. In the present
study, resampling was performed for an easier comparison
with CT delineations and overlap estimation. This approach
resulted in a more accurate estimation of the differences
between PET- and CT-based delineation methodologies,
without, however, significant differences in the resulting
volumes with respect to delineation performed on nonre-
sampled images.
Tracer uptake heterogeneity within the MATV has been
recognized as an important factor and a plausible explan-
ation of failed cancer treatments (33). Also in malignancies
such as sarcomas, esophageal cancer, cervical cancer, and
head and neck cancer, studies have shown that local and
regional tracer uptake heterogeneity assessment with PET
can predict outcome (34–36). In NSCLC, Nestle et al. has
already observed a larger variability between MATV delin-
eations due to spatial tracer uptake heterogeneity, without,
however, quantifying this heterogeneity and the associated
correlation with the MATV results (8). The impact of het-
erogeneity on MATV delineation results can be observed
and reach statistically significant levels only for objects
larger than a few centimeters in diameter, since the limited
PET spatial resolution cannot provide accurate imaging of
tracer heterogeneity in smaller volumes of interest. These
larger tumors are also most frequently encountered in radio-
therapy treatment, for which an accurate delineation of the
overall MATV may be advantageous, particularly if one
considers treatment scenarios involving dose painting or
boosting.
Although limited by the small sample of patients and the
need to confirm the results in a larger group, our study
added several elements to the existing knowledge on the
correlation between anatomic tumor size and 18F-FDG PET
uptake in NSCLC. Our results suggest that the larger the
tumor, the more heterogeneous the 18F-FDG PET uptake is
likely to be. This suggestion is in agreement with the
expected evolution of NSCLC, since necrosis, hemorrhage,
or myxoid changes, known to cause areas of low attenua-
tion on CT images, are more likely to appear in larger
tumors. A large, heterogeneous MATV is less likely to be
accurately delineated using simple fixed or even adaptive
binary threshold methods.
In this study, we used the COV to quantify the
heterogeneity of PET tracer uptake within the tumor. This
heterogeneity factor does not offer any information on the
spatial distribution of the heterogeneity and could poten-
tially result in the same value for very different heteroge-
neous distributions. However, this simple parameter that
provides a global measure of heterogeneity is sufficient for
the purposes and objectives targeted in this study, allowing
us to observe significant correlations between tracer uptake
heterogeneity and differences in the MATV segmentation
results, either with COVFLAB or COVCT. The most hetero-
geneous lesions were characterized by COVFLAB values
above 0.3; however, values from 0.2 to 0.3 were distributed
in a rather continuous fashion, making it hard to set a thresh-
old value allowing the differentiation of homogeneous from
heterogeneous distributions. A more detailed characteriza-
tion of the spatial distribution of tumor heterogeneity, which
was outside the scope of this study, can be obtained using,
for instance, local and regional textural features (35).
In studies such as the present one and those published
previously within the same context, a common limitation is
the lack of respiratory gating. Four-dimensional PET can
provide solutions to improve subvolume delineation for
dose-painting applications (37). However, in our dataset the
large size of the tumors should have reduced the potential
impact of respiratory motion on the results. In theory, the
MATV could have been overestimated for the smallest
lesions by both respiratory motion and partial-volume
effects. In practice, in our patients only a small fraction
of the lesions (10%–20%) were smaller than 2–3 cm.
Finally, a second limitation of our study was the de-
termination of tumor extent based on the measurement of
maximum diameter and not the entire volume. Errors in
maximum diameter may translate into significantly larger
errors with respect to the entire functional volume, especially
when heterogeneous uptake distributions are considered. It
is indeed possible to obtain an accurate maximum diameter
with inaccurate 3-dimensional delineations, especially for
complex shapes. Unfortunately full-volume histopathology
datasets, for which protocols and corresponding volume
estimations are associated with numerous approximations
and inaccuracies, are not available yet for NSCLC. Hence,
the maximum diameter measurements can be considered as
a satisfactory surrogate and have been used in most clinical
studies.
CONCLUSION
Volumes based on CT images were systematically and
significantly larger than those based on PET images. In
addition, tumor size and PET uptake heterogeneity had a
significant impact on the MATV PET delineation results
using semi- or fully automatic image segmentation tools.
Our results indicate that for a case of large, heterogeneous
NSCLC, fixed and adaptive thresholding should not be
used for the MATV delineation of 18F-FDG PET uptake.
These methods inherently assume homogeneous uptake in
both background and MATV and therefore tend to largely
underestimate the spatial extent of the functional tumor
in such cases. The use of thresholding approaches should
be restricted to smaller lesions with sufficient tumor-to-
background contrast or for larger tumors exhibiting homo-
geneous uptake. For an accurate automatic delineation of
MATV in NSCLC, advanced image segmentation algo-
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rithms able to deal with tracer uptake heterogeneity should
be used.
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Impact of Partial-Volume Effect Correction on the Predictive
and Prognostic Value of Baseline 18F-FDG PET Images in
Esophageal Cancer
Mathieu Hatt1, Adrien Le Pogam1,2, Dimitris Visvikis1, Olivier Pradier1,3, and Catherine Cheze Le Rest1
1INSERM, U650 LaTIM, CHRU Morvan, Brest, France; 2MRC Clinical Sciences Centre, Hammersmith Hospital, London, United
Kingdom; and 3Department of Radiotherapy, CHRU Morvan, Brest, France
The objective of this study was to investigate the clinical impact of
partial-volume effect (PVE) correction on the predictive and
prognostic value of metabolically active tumor volume (MATV)
measurements on 18F-FDG PET baseline scans for therapy re-
sponse and overall survival in esophageal cancer patients.Meth-
ods: Fifty patients with esophageal cancer treated with
concomitant radiochemotherapy between 2004 and 2008 were
retrospectively considered. PET baseline scans were corrected
for PVE with iterative deconvolution incorporating wavelet denois-
ing. MATV delineation on both original and corrected images was
performed using the automatic fuzzy locally adaptive Bayesian
methodology. Several parameters were extracted considering
the original and corrected images: maximum and peak standard-
ized uptake value (SUV), mean SUV, MATV, and total lesion gly-
colysis (TLG) (TLG 5 MATV · mean SUV). The predictive value of
each parameter with or without correction was investigated using
Kruskal–Wallis tests, and the prognostic value was determined
with Kaplan–Meier curves. Results: Whereas PVE correction
had a significant quantitative impact on the absolute values of
the investigated parameters, their clinical value within the clinical
context of interest was not significantly modified—a result that
was observed for both overall survival and response to therapy.
The hierarchy between parameters was the same before and after
correction. SUV measurements (maximum, peak, and mean) had
nonsignificant (P . 0.05) predictive or prognostic value, whereas
functional tumor-related measurements (MATV and TLG) were
significant (P , 0.002) predictors of response and independent
prognostic factors. Conclusion: PVE correction does not improve
the predictive and prognostic value of baseline PET image–
derived parameters in esophageal cancer patients.
Key Words: esophageal cancer; response to therapy; overall
survival; PET; partial volume effects; SUV; tumor volume; total
lesion glycolysis
J Nucl Med 2012; 53:12–20
DOI: 10.2967/jnumed.111.092775
With a worldwide estimated 5-y survival of only 15%
(1), esophageal cancer is the third most common malignancy
of the digestive tract and is a leading cause of cancer mor-
tality. Its incidence is still increasing, and there is a growing
concern regarding its effective management (2). Surgical re-
section remains the most effective treatment; however, many
patients have a locally advanced esophageal carcinoma at
diagnosis and neoadjuvant therapy before surgery has dem-
onstrated improved survival in such cases (3). The maximum
improvement in terms of increased overall survival from
neoadjuvant treatment is observed for patients who achieve
a complete pathologic response (only 15%–30% of cases),
with no residual cancer cells in the primary tumor or lymph
nodes (4). On the other hand, nonresponders (NRs) may be
unnecessarily affected by toxicity (5). The development of
an early diagnostic test offering noninvasive prediction of the
response to therapy or survival is therefore of great interest.
For tumors that cannot be surgically removed, combined
radiochemotherapy is the preferred treatment. In this case
too, early assessment of response to therapy would allow
a modification in the management of nonresponding patients
early during treatment. Such a response assessment becomes
even more critical when one considers the availability of new
targeted drugs that could be tested with higher efficiency if
applied early (6).
Along with the standardized uptake values (SUVs)
(maximum SUV [SUVmax] or peak SUV [SUVpeak]) usu-
ally considered in clinical practice, other parameters de-
scribing functional lesions—such as metabolically active
tumor volume (MATV, defined as the tumor volume that
can be seen and delineated on an 18F-FDG PET image) (7),
mean SUV (SUVmean), and total lesion glycolysis (TLG,
defined as the product of MATVand its associated SUVmean)
(8)—have been investigated. The prognostic value of these
parameters in esophageal cancer patients for overall or dis-
ease-free survival has been demonstrated (9–12). On the
other hand regarding therapy prediction, several studies on
different cancer models have recently suggested using
the baseline scan only, instead of the comparison of pre-
treatment and posttreatment scans (late assessment) or
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during-treatment scans (early assessment) (13). Such inves-
tigations were, for instance, performed in pleural mesothe-
lioma (14), non-Hodgkin lymphoma (15), and esophageal
cancer (7,16), demonstrating higher statistical value for
MATV-based parameters than SUV measurements, whose
predictive value has been found to be conflicting (17).
However, in most of these studies, no partial-volume
effect (PVE) correction was applied, possibly explaining
the observed limited value of SUV. The impact of PVE
correction on the clinical value of SUV measurements has
been investigated by a limited number of authors. Hoetjes
et al. (18) investigated the impact of 4 PVE correction
strategies on 15 breast cancer patients, regarding the early
metabolic PET response after 1 cycle of chemotherapy. The
SUV decrease between the pretreatment scan and the scan
early during treatment was found to be lower after PVE
correction (26%–27% vs. 31%) for the first 3 methods but
not for the fourth one based on binary tumor masks (30%).
Van Heijl et al. (19) recently demonstrated a nonsignificant
impact of PVE correction on the correlation between dis-
ease-free survival and 18F-FDG PET SUV measurements in
52 esophageal cancer patients. In this study, a PVE correc-
tion method based on binary tumor masks generated with
adaptive thresholding delineation was used, and disease-
free survival was the only clinical endpoint investigated.
Both the use of adaptive thresholding and the PVE correc-
tion method based on tumor masks assume a homogeneous
tracer distribution in both tumor and background and are
therefore likely to provide only approximate correction
(20). On the other hand, no data are currently available
regarding the impact of PVE correction on the value of
baseline 18F-FDG PET–based measurements for the predic-
tion of overall survival and response to therapy in esopha-
geal cancer.
The current study was therefore performed to investigate
the impact of an advanced PVE correction methodology
and the use of an accurate MATV delineation approach on
both the predictive and the prognostic value of baseline
18F-FDG PET scan–derived parameters.
MATERIALS AND METHODS
Patients
Fifty consecutive patients with newly diagnosed esophageal
cancer were included and retrospectively analyzed. The char-
acteristics of the patients are given in Table 1. Most of the
patients (45 of 50) were men, aged 65 6 9 y at the time of
diagnosis. Seventy-four percent of the tumors originated from
the middle and lower esophagus, and 72% were squamous cell
carcinoma. None of the patients underwent surgery, and all
were treated with concomitant radiochemotherapy between
2004 and 2009. The therapy regime included 3 courses of 5-
fluorouracil and cisplatin and a median radiation dose of 60 Gy
given in 180-cGy fractions delivered once daily, 5 d a week for
6–7 wk. As part of the routine procedure for the initial staging
in esophageal cancer, each patient was referred for an 18F-FDG
PET study before treatment, and these baseline scans were used
in this study.
Overall survival was determined as the time between initial
diagnosis and last follow-up or death. Response to therapy was
evaluated 1 mo after the completion of the concomitant radio-
chemotherapy using conventional thoracoabdominal CT and
endoscopy. Patients were classified as NRs (including stable and
progressive disease), partial responders (PRs), or complete
responders (CRs). Response evaluation was based on CT evolution
between pretreatment and posttreatment scans using response
evaluation criteria in solid tumors (21). Patients also underwent
fibroscopy in the case of partial or complete response. Complete
response was confirmed by the absence of visible disease in the
endoscopy and no viable tumor on biopsy. Partial CT response was
confirmed by macroscopic residual (disease .10% viable) on bi-
opsy. No discordance was observed between pathologic, when
available, and CT evaluation. The current analysis was performed
after an approval by the institutional ethics review board.
18F-FDG PET Acquisitions
18F-FDG PET studies were performed before the treatment.
Patients were instructed to fast for at least 6 h before an in-
jection of 18F-FDG (5 MBq/kg). Static emission images were
acquired from head to thigh beginning 60 min after injection
and with 2 min per bed position, on a Gemini PET/CT system
(Philips). Images were reconstructed using the row-action
TABLE 1








Upper esophagus 13 (26)
Middle esophagus 20 (40)
Lower esophagus 17 (34)
Histology type
Adenocarcinoma 14 (28)
Squamous cell carcinoma 36 (72)
Histologic differentiation
Well differentiated 14 (28)
Moderately differentiated 12 (24)

















Age range of patients was 45–84 y, and median was 69 y. Data
in parentheses are percentages.
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maximum-likelihood 3-dimensional algorithm according to
standard clinical protocol: 2 iterations, relaxation parameter
of 0.05, 5-mm 3-dimensional gaussian postfiltering, a 4 · 4 ·
4 mm voxel grid sampling, and attenuation correction based on
a low-dose CT scan.
PET Image PVE Correction and Image Analysis
Images were corrected for PVE using an iterative deconvolution
methodology that has been previously validated (22). Its principle
is to iteratively estimate the inversion of the scanner’s point spread
function, which is assumed to be known and spatially invariant in
the field of view. The considered lesions were all in the same body
region, and this approximation should therefore not significantly
affect the applied correction on a patient-by-patient comparison
basis. Iterative deconvolution methods, such as those of Lucy-
Richardson (L-R) (23,24) or Van Cittert (25), are known for the
amplification of noise associated with an increasing number of
iterations. To solve this issue, wavelet-based denoising of the re-
sidual was introduced within the iterative L-R deconvolution using
Bayeshrink filtering (26), leading to images corrected for PVE
without significant noise addition. The following are advantages
of this methodology: it is able to generate entire whole-body cor-
rected images independently of any manual or automatic segmen-
tation of regions of interest, and it is voxel-based and therefore
does not assume homogeneous regional radiotracer distributions
for the tumor or surrounding background.
Tumor Delineation and Parameter Extraction
For each patient, the tumor was identified on the baseline
pretreatment PET images by an experienced nuclear physician. It
was then delineated using the fuzzy locally adaptive Bayesian
algorithm (20,27) on both the original (without PVE correction) and
the PVE-corrected images. This segmentation approach has been
shown to give both robust and reproducible functional volume
delineations under variable image noise characteristics (28,29).
The following parameters were subsequently extracted from
each baseline image with or without correction for PVE: SUVmax,
SUVpeak (defined as the mean of SUVmax and its 26 neighbors
[roughly corresponding to a 1-cm region of interest]), SUVmean
within the volume, MATV, and TLG (determined by multiplying
SUVmean with the corresponding MATV).
Statistical Analysis
Pearson coefficients were used to estimate correlation between
the image-derived parameters, and paired t tests were used to
characterize the differences between uncorrected and corrected
parameters. The correlation between response to therapy and each
parameter was investigated using the Kruskal–Wallis test as a non-
parametric statistic allowing the comparison of parameter distri-
butions associated with each category of response (CR, PR, and
NR). This test does not assume a normal distribution of variables,
and the computation of its statistic H is based on ranks instead of
absolute values of variables (30). Regarding survival, for each
considered parameter, Kaplan–Meier survival curves were gener-
ated (31) for which the most discriminating threshold value allow-
ing differentiation of the groups of patients was identified using
receiver-operating-characteristic methodology (32). The prognos-
tic value of each parameter in terms of overall survival was
assessed by the log-rank test.
The significance of the following factors (with or without
correction) was tested: SUVmax, SUVpeak, MATV, SUVmean, and
TLG. All tests were performed 2-sided using the MedCalc statis-
tical software (MedCalc Software), and P values below 0.05 were
considered statistically significant.
RESULTS
Impact of PVE Correction on
Image-Derived Parameters
The PVE correction affected the images that could be
assessed visually, with a higher contrast between the tumor
and the surrounding tissues, as can be seen in Figure 1 and
is illustrated using profiles in Figure 2. Table 2 provides the
distributions of volumes and associated parameters mea-
sured in original and corrected images.
MATVs delineated on original images and images cor-
rected for PVE were highly correlated (r. 0.998; confidence
FIGURE 1. Illustration of iterative decon-
volution PVE correction on whole-body
18F-FDG PET image, with original image (A)
and corrected image (B).
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interval, 0.997–0.999; P , 0.0001). However, MATVs de-
lineated on PVE-corrected images were systematically
smaller (P , 0.001) by on average 210% 6 5% (range,
21.5% to 222.4%), resulting in a mean volume difference
of 24 6 3 cm3 (40 6 36 cm3 vs. 36 6 34 cm3). This
difference is illustrated on 3 different tumors in Figure 3.
There was no significant correlation between these differen-
ces and the PET lesion volumes (r , 0.2, P . 0.18).
All primary lesions were detected by 18F-FDG PET and
exhibited a rather high uptake with a mean SUVmax of 10 6
4. As expected, SUVpeak and SUVmean measurements were
comparatively lower (8 6 3 and 6 6 2, respectively). All
SUV measurements are summarized in Table 2. After it-
erative deconvolution, SUVmax, SUVpeak, and SUVmean
were 15 6 6, 10 6 4, and 7 6 3, respectively. All were
significantly higher than noncorrected values (P , 0.05).
SUVmax increased by 54% 6 23% (range, 18%–157%),
whereas the impact on SUVpeak and SUVmean was lower,
with a mean increase of 27% 6 10% (range, 8%–51%)
and 28% 6 11% (range, 9%–59%), respectively. Consid-
ering the PVE correction–induced decrease of MATV
(210% 6 5%) and increase of corresponding SUVmean
FIGURE 2. Qualitative differences between original and corrected PET images of esophageal lesion of MATV above 25 cm3 using profiles
on axial, sagittal, and coronal planes.
TABLE 2
Distributions of Parameters With and Without PVE Correction
Definition Notation Original mean 6 SD PVE correction mean 6 SD
Highest SUV SUVmax 9.7 6 3.9 14.9 6 6.1
Mean of SUVmax and its 26 neighbors SUVpeak 8.0 6 3.3 10.1 6 4.0
SUVmean within MATV SUVmean 5.8 6 2.4 7.4 6 3.1
MATV (cm3) MATV 39.9 6 36.1 36.2 6 33.7
Total lesion glycolysis (g) TLG 218.1 6 208.3 235.8 6 218.1
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(128% 6 11%), PVE correction resulted in significantly
higher TLG values (114% 6 12%; range, 22 to 150%)
(P , 0.0001).
The increases of SUVmax and SUVpeak after PVE correc-
tion did not correlate with MATV (r , 0.2, P . 0.2),
whereas the increase of SUVmean correlated inversely with
MATV (r 5 20.79, P , 0.0001), with higher increases
observed for smaller volumes.
Impact of PVE Correction on Predictive and
Prognostic Values
Twenty-five patients were classified as PR, 11 were CR,
and 14 were NR (including stable and progressive disease).
With a median follow-up of 60 mo (range, 10–84 mo), the
median overall survival was 12 mo and the 1-y and 2-y
survival rates were 60% and 35%, respectively. At the time
of last follow-up, 10 patients were alive with no evidence of
disease, 9 were alive with recurrent disease, and 31 had
died. Survival was significantly correlated with response,
as overall survival was 24 6 15 (median, 21), 22 6 20
(median, 14), and 9 6 4 (median, 10) months for CR,
PR, and NR, respectively (P , 0.01). Results concerning
the prognostic and predictive values of all considered
parameters with and without PVE correction are summa-
rized in Tables 3 and 4.
Initial SUVmax, whether corrected for PVE or not, was
not predictive of response to therapy (P 5 0.2 and 0.3 for
SUVmax and SUVmax with PVE correction, respectively),
although CRs tend to have a smaller SUVmax (7.86 4.2 and
12.26 6.6 after PVE correction) than PRs and NRs (10.2 6
3.7 and 10.36 3.8 for PR and NR, respectively, and 15.96
6.0 and 15.56 5.7, respectively, after PVE correction) (Fig.
4A). SUVpeak led to slightly more differentiated groups of
response without reaching statistical significance (P 5
0.08), with a mean value of 6.2 6 3.6 in CRs, whereas both
PRs and NRs were characterized by a similarly higher
SUVpeak (8.5 6 3.1 and 8.5 6 3.2 for PRs and NRs, re-
spectively). After PVE correction, the results using SUVpeak
were similar, with 7.86 4.4, 10.76 3.7, and 10.86 3.9 for
CRs, PRs, and NRs, respectively (P 5 0.1). The SUVmean
measurements could not significantly predict response (P5
0.07), and the differentiation between the 3 groups of re-
sponse considered on the basis of SUVmean was still not
possible after PVE correction (P . 0.14).
None of the SUV measurements was a significant
prognostic factor in the univariate analysis, despite a trend
for longer survival associated with lower SUV (maximum,
peak, or mean). For instance, an SUVmax below a threshold
of 8 or an SUVmean under 6.5 tend to be associated with
a better outcome and a median survival of 20 versus 13 mo
TABLE 3
Kruskal–Wallis Test Results
Response differentiation? (P , 0.05)
Parameter H P CR (n 5 11)/NR (n 5 14) CR (n 5 11)/PR (n 5 25) PR (n 5 25)/NR (n 5 14)
SUVmax 3.6 0.17 No No No
SUVmax with PVE correction 2.4 0.31 No No No
SUVpeak 5.1 0.08 No No No
SUVpeak with PVE correction 4.7 0.10 No No No
SUVmean 5.5 0.07 No No No
SUVmean with PVE correction 3.9 0.14 No No No
MATV (cm3) 20.7 ,0.0001 Yes Yes Yes
MATV with PVE correction (cm3) 20.7 ,0.0001 Yes Yes Yes
TLG (g) 25.1 ,0.0001 Yes Yes Yes
TLG with PVE correction (g) 25.2 ,0.0001 Yes Yes Yes
H statistic and associated P value are given for each parameter, with ability to differentiate (P , 0.05) each pair of response groups
among patients.
FIGURE 3. Examples of fuzzy locally adaptive Bayesian delinea-
tion results (blue contours) on original (left) and corrected (right) PET
images with large, slightly heterogeneous MATV (A); MATV with
necrotic core (B); and small, homogeneous MATV (C).
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(P 5 0.3) and 16 versus 10 mo (P 5 0.15), respectively.
Similarly, after PVE correction no threshold value could
significantly differentiate groups of patients regarding their
survival (Figs. 5A and 5B).
Contrary to SUV measurements with or without PVE
correction, the parameters related to functional volume
(MATV and TLG) allowed significant (P , 0.0001) differ-
entiation of the 3 response groups and were significant
prognostic factors (P , 0.002), as illustrated in Figure
4C. No significant differences were found using the original
or PVE-corrected values.
The parameter that allowed for the best differentiation of
patient groups was the TLG (P , 0.0001). CRs were charac-
terized by a TLG of 55 6 45 g, whereas PRs and NRs had
a TLG of 1786 143 and 4166 238 g, respectively. After PVE
correction, the absolute values of each group rose to 62 6 45,
200 6 155, and 437 6 249 g for CRs, PRs, and NRs, re-
spectively, leading to the same discrimination between groups
of response (P , 0.0001). Although slightly less efficient than
TLG, the use of MATV allowed a statistically significant dif-
ferentiation of the 3 response groups (P , 0.0001). Use of the
MATV values extracted from PVE correction images led to
exactly the same discriminating power (P , 0.0001).
MATV and TLG were also good prognostic factors, with
high MATV and TLG values being significantly associated
with shorter survival, with hazard ratios between 3 and 4 (Table
3). AMATVabove 85 cm3was identified as a predictor of poor
outcome, with a median survival of only 6 mo, versus 20 mo
for patients with a smaller MATV (P 5 0.0004), as illustrated
in Figure 5C. In addition, a MATV below 15 cm3 was associ-
ated (P 5 0.009) with longer survival (49 mo) than a larger
MATV (11 mo). Similar results were obtained using the
MATVsmeasured on the PVE-corrected images, with a median
survival of 20 mo for patients with tumor volume with PVE
correction below 80 cm3 versus 10 mo for patients with MATV
above 80 cm3 (P, 0.002). Regarding TLG, a threshold of 260
g was found to be a good discriminating factor for outcome (21
vs. 10 mo, P 5 0.0012), whereas using PVE-corrected TLG
led to similar results, with a slightly higher threshold (TLG
with PVE correction 5 280 g, 21 vs. 10 mo, P 5 0.0004).
DISCUSSION
Our study investigated the impact of PVE correction on
the predictive and prognostic values of different parameters
derived using the baseline pretreatment PET images. Our
results confirmed that PVE correction significantly affects
quantitative SUVs, with an average increase of above 50%
for SUVmax, in agreement with previous studies (18,19),
and a lower increase (,30%) for SUVpeak and SUVmean.
The lower increase observed for SUVpeak and SUVmean is
related to the fact that the L-R deconvolution is a voxel-
by-voxel process leading to enhancement of contrasts be-
tween subvolumes within the MATV and both lower- and
higher-voxels SUVs included in the averaging associated
with the calculation of SUVmean and SUVpeak. PVE correc-
tion did not significantly affect the delineation of the
MATV. Overall, MATVs delineated on the corrected
images were only slightly smaller than those determined
on the original images. The mean reduction of 10% was
within the reproducibility limits of confidence intervals re-
garding tumor volume measurements on double-baseline
PET scans using fuzzy locally adaptive Bayesian algorithm
method (630%) (29). This limited impact of PVE correc-
tion on MATV can be explained by the fact that PVE is
dependent on tumor size and is more pronounced on small
lesions (33). In our group of patients, the tumors were
rather large (40 6 30 cm3); therefore, the relative variation
of volumes with respect to the entire volume is small.
Twelve patients (25%) had an MATV of around 10 cm3
or smaller. In addition, the use of a robust delineation ap-
proach instead of threshold-based methods in various con-
figurations of blur and noise (28,34) ensured a limited
variability in the MATV delineation results between origi-
nal and corrected images.
As previously demonstrated (7,12), MATV and TLG
extracted from noncorrected 18F-FDG PET pretreatment
acquisitions had high clinical value. In contrast, none of
the usual SUV measurements (maximum, peak, or mean)
considered in clinical practice was significantly associated
with therapy response or survival, as also reported in the 2
largest available prospective trials (35,36).
TABLE 4
Univariate Analysis Results Using Kaplan–Meier Survival Curves
Parameter Threshold HR
HR 95% confidence
interval P Median survival (mo)
SUVmax 8 1.5 0.7–3.1 0.28 20 vs. 13
SUVmax with PVE correction 11 1.6 0.7–3.2 0.26 20 vs. 13
SUVpeak 7 1.4 0.7–2.8 0.31 16 vs. 10
SUVpeak with PVE correction 9 1.8 0.9–3.6 0.11 20 vs. 11
SUVmean 6.5 1.7 0.8–3.6 0.15 16 vs. 10
SUVmean with PVE correction 7.5 1.7 0.8–3.5 0.12 20 vs. 10
MATV (cm3) 85 3.9 1.0–15.2 0.0004 20 vs. 6
MATV with PVE correction (cm3) 80 3.4 0.9–11.7 0.0024 16 vs. 10
TLG (g) 260 2.9 1.2–6.8 0.0012 21 vs. 10
TLG with PVE correction (g) 280 3.2 1.3–7.6 0.0004 21 vs. 10
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Regarding response to therapy prediction using SUVs,
we found that PVE correction did not improve the already
demonstrated low discriminating power of any of the SUV
measurements considered (7). This can be explained by the
combination of several factors. First, without PVE correc-
tion, the trend of low SUV being associated with better
outcome may have been exaggerated by an underestimation
of SUV, because CRs had also smaller volumes in addition
to low SUVmax. Second, after PVE correction all 3 response
groups had increased SUVmax but with still no significant
FIGURE 4. Examples of distributions of NRs, PRs, and CRs and
associated Kruskal–Wallis test results: SUVmax and SUVmax with
PVE correction (A), MATV and MATV with PVE correction (B), and
TLG and TLG with PVE correction (C). MATVPVC 5 MATV with PVE
correction; SUVmax
PVC 5 SUV with PVE correction; TLGPVC 5 TLG
with PVE correction.
FIGURE 5. Examples of Kaplan–Meier survival curves obtained
using SUVpeak (A), SUVpeak with PVE correction (B), and MATV (C).
SUVpeak
PVC 5 SUVpeak with PVE correction.
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difference between the groups. We have demonstrated that
SUVmean increase after PVE correction was inversely cor-
related with tumor volume (r 5 0.8, P , 0.0001), with
smaller volumes being characterized by higher SUVmean
increases after PVE correction than larger volumes. The
SUVmean within the MATV of PRs and NRs was therefore
increased by a smaller amount (120% 6 9%) than those
within the MATV of CRs (134% 6 13%), which were
associated with smaller tumor volumes. The mean tumor
SUVs of CRs were therefore closer to the SUVmean of PRs
and NRs after correction. Hence, the discriminating power
of SUVmean was reduced by PVE correction. A similar
trend was observed for SUVmax and SUVpeak, although it
was less significant because their respective increase was
not correlated with the MATV. Therefore, PVE correction
might have further reduced the clinical value of SUV mea-
surements in this context. This effect has been previously
suggested as a limitation to the prognostic value of SUVmax
in early-stage non–small cell lung cancer (37).
Similar conclusions can be drawn from the results
regarding the impact of PVE correction on the prognostic
value of the SUV parameters. Indeed, as already demon-
strated (12), extreme MATV values were significantly asso-
ciated with longer or shorter overall survival for very small
(49 mo for MATV below 15 cm3 vs. 11 mo for MATVabove
15 cm3) or very large MATV (6 mo for tumor volume above
85 cm3 vs. 20 mo for MATV below 80 cm3), respectively.
On the other hand, SUV measurements without correction
cannot significantly differentiate between the patients with
longer or shorter survival (P . 0.05 for all SUV measure-
ments), although a trend for longer survival was associated
with lower SUVs. After correction, this differentiation was
not significantly improved, because SUVs associated with
the smaller volumes were closer to SUVs associated with
larger volumes. Therefore, the discrimination was again re-
duced by PVE correction. To our knowledge there are no
similar data available on the impact of PVE correction on
SUV predictive value in the literature, but our results are in
agreement with previous findings that demonstrated no sig-
nificant changes in disease-free survival correlation between
original and corrected SUVs in esophageal cancer using
alternative less accurate methodologies for both PVE cor-
rection and functional volume segmentation (19).
As previously demonstrated (7,12), MATV and associated
TLG values were good predictors of response (7) and inde-
pendent prognostic factors of overall survival (12). After PVE
correction, the already high clinical value of MATVand TLG
was not significantly altered. Considering the thresholds used
to differentiate patient groups, there was no need for adjust-
ment regarding MATV measurements because MATVs were
not significantly modified by PVE correction. On the other
hand, TLG thresholds needed to be adjusted, considering that
PVE correction led to significantly increased SUVmean and
resulting TLG values. The determined threshold values for
each parameter regarding prognosis or prediction of response
were found using receiver-operating-characteristic analysis
on the current patient cohort and would therefore require
larger prospective studies to be validated.
The rather large tumor volumes (40 6 30 cm3) in our
patient dataset might be considered as a limitation of this
study, because PVEs are usually considered significant for
volumes around or below 10 cm3 (33). First, 25% of the
tumors in this dataset were within this volume range. In
addition, the shape of the primary esophageal lesions is
not spheric but mostly cylindric, with a small diameter
(,2 cm) in the transaxial direction. Therefore, esopha-
geal lesions can be significantly affected by PVEs despite
the overall large metabolic volumes, as can be seen in
Figure 2 for a lesion with a MATVabove 25 cm3. Finally,
the patient population used in this study was typical of
routine clinical practice and was not selected on the basis
of the overall primary MATVs.
CONCLUSION
The results of this study demonstrate that PVE correction
does not add any value to parameters derived from MATVs
such as MATV and TLG measured on 18F-FDG PET base-
line acquisitions. PVE correction did not alter the already
demonstrated clinical value of both parameters as predic-
tive factors of the response to concomitant radiochemother-
apy or as prognostic factors of overall survival in locally
advanced esophageal cancer. Similarly, although PVE cor-
rection led to increases in all SUV measurements (maxi-
mum, peak, or mean) considered in clinical practice, the
corrected values were still not significantly associated with
either therapy response or prognosis. Finally, our study is in
agreement with previous investigations using simpler tools,
showing limited interest in PVE correction in this specific
context. However, the potential impact of PVE correction in
other applications such as diagnosis or lesion detectability
remains to be evaluated. In addition, the value of PVE
correction in patient follow-up using serial PET scans needs
to be further demonstrated.
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Abstract
Partial volume effects (PVE) are consequences of the limited spatial resolution
in emission tomography. They lead to a loss of signal in tissues of size
similar to the point spread function and induce activity spillover between
regions. Although PVE can be corrected for by using algorithms that
provide the correct radioactivity concentration in a series of regions of interest
(ROIs), so far little attention has been given to the possibility of creating
improved images as a result of PVE correction. Potential advantages of PVE-
corrected images include the ability to accurately delineate functional volumes
as well as improving tumour-to-background ratio, resulting in an associated
improvement in the analysis of response to therapy studies and diagnostic
examinations, respectively. The objective of our study was therefore to develop
a methodology for PVE correction not only to enable the accurate recuperation
of activity concentrations, but also to generate PVE-corrected images. In
the multiresolution analysis that we define here, details of a high-resolution
image H (MRI or CT) are extracted, transformed and integrated in a low-
resolution image L (PET or SPECT). A discrete wavelet transform of both H
and L images is performed by using the ‘a` trous’ algorithm, which allows the
spatial frequencies (details, edges, textures) to be obtained easily at a level of
resolution common to H and L. A model is then inferred to build the lacking
details of L from the high-frequency details in H. The process was successfully
tested on synthetic and simulated data, proving the ability to obtain accurately
corrected images. Quantitative PVE correction was found to be comparable
with a method considered as a reference but limited to ROI analyses. Visual
improvement and quantitative correction were also obtained in two examples of
clinical images, the first using a combined PET/CT scanner with a lymphoma
patient and the second using a FDG brain PET and corresponding T1-weighted
MRI in an epileptic patient.
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1. Introduction
Partial volume effects (PVE) are well-known consequences of the limited spatial resolution
in emission tomography. PVE is characterized by the loss of signal in tissues of size similar
to the point spread function (PSF). In addition, PVE induces a signal cross-contamination in
adjacent structures with different amounts of radioactivity (Aston et al 2002, Du et al 2005).
In this latter phenomenon, sometimes referred to as spillover, the high activity in a given
region can spread out and contaminate a bordering area of lower activity, leading to either
underestimated or overestimated activity concentration measurements.
These effects can be corrected for by using a number of different algorithms that often
rely on the use of the PSF of the imaging device and a priori anatomical knowledge provided
by computed tomography (CT) or magnetic resonance imaging (MRI) (Meltzer et al 1990,
Muller-Gartner et al 1992, Rousset et al 2000, Aston et al 2002, Matsuda et al 2003, Baete
et al 2004, Bencherif et al 2004, Quarantelli et al 2004, Kusano et al 2005, Rota Kops and
Krause 2005). The large majority of these algorithms, which have been evaluated mostly in
the context of cerebral imaging, require a segmentation step to delineate the different parts
from anatomical images. This step renders their accuracy dependent on the segmentation
algorithm used as well as making their application on other clinical investigations outside the
brain challenging (Feuardent et al 2003). For example, the pixel-based approach of Meltzer
et al (1990) is restricted indeed to brain metabolism or neuroreceptor binding, and requires
compartmental analysis (Meltzer et al 1999). As a rare example, Pretorius and King (2004)
proposed an application of PVE correction for cardiac SPECT. Furthermore, and similar to the
great majority of PVE correction methods (except in the interesting approach of Kennedy et al
using Taylor expansion (Kennedy et al 2005)), these algorithms offer quantitative correction of
ROI (region of interest) intensities without considering the construction of enhanced images.
On the other hand, resolution compensation or resolution recovery algorithms can also be used
to reduce PVE in emission tomography. However, the majority of these algorithms suffer from
being reconstruction algorithm specific (Ardekani et al 1996, Som et al 1998, Somayajula
et al 2005), as well as being only tested in limited clinical context such as cardiac SPECT
(Hutton and Lau 1998) or FDG PET in the human brain (Baete et al 2004).
One of the reference methods (referred to from here onwards as RSF for regional spread
function) described by Rousset et al (1998, 2000) and recently improved (Frouin et al 2002,
Du et al 2005) was also developed in the brain context and allows estimating the true
mean signal in any user-defined series of n homogeneous regions of interest (ROIs), but
the images themselves are not enhanced. This approach relies on the inversion of an n ×
n matrix called geometric transfer matrix (GTM). The elements wij of the GTM are the
coefficients of activity spillage from ROI i to ROI j, and the true activity Ti in ROI i can be
deduced from the measured activity ti by inverting the equation [t] = [GTM] × [T ], where [t]
and [T ] are the vectors containing the ti and Ti values, respectively. The use of this approach
is theoretically possible in various clinical applications even if it was originally designed for
cerebral studies where generally only three ROIs are required (white matter, grey matter,
cerebrospinal fluid). Actually, the method works satisfactorily when the image is segmented
into a series of ROIs that constitute a partition. In other words, ROIs must not overlap and at
the same time considering all ROIs together must cover the entire image. As a consequence,
when studying tumours in whole-body images, the number of ROIs can dramatically increase
(Feuardent et al 2003), thus hampering the clinical use of this methodology.
In general, the aim of all these methods is to provide the user with correct radioactivity
concentration estimates in a given ROI. To date however, except in very specific applications
(Baete et al 2004), little attention has been given to the challenging possibility of creating
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improved images through a generic approach. In this paper, a new PVE correction
methodology is proposed, based on the multiresolution analysis of images of different spatial
resolutions. The main advantage of the proposed methodology is that it not only enables
the accurate recuperation of activity concentrations, but is also capable of simultaneously
generating PVE-corrected images. This improvement allows (a) performing a visual control
of the correction, (b) improving clinical diagnostic studies through a better visual assessment of
the images, and most important (c) allowing further image processing (such as, for example,
functional volume estimate of tumours, location of epiletogenic foci in cerebral imaging
(Boussion et al 2003), or wall motion and ejection fraction in cardiac imaging (Hickey et al
2004)). Furthermore, the method is not restricted to a particular organ and does not require
tedious and time-consuming ROI delineation.
In the following section, a concise presentation of the wavelet transform and the
multiresolution analysis serves as an introduction to section 2. The developed PVE algorithm
is described in detail including a description of the test images and overall methodology used
to validate the developed algorithm.
2. Materials and methods
2.1. Multiresolution image analysis and wavelet transform
Although the theoretical foundations of multiresolution analysis do not constitute the main
topic of this study, it is constructive to introduce the basic concepts of the wavelet transform
which is an important part of the proposed methodology. Actually, the wavelet transform can
be introduced by comparison with the more common Fourier transform with which it has a
number of similarities. While the Fourier transform provides global information about the
spatial frequencies in an image, the wavelet transform leads to a local representation of these
spectral properties. From an image processing point of view, the Fourier transform permits one
to switch between the spatial and the frequency domains while the wavelet transform allows
one to bring them together in one single image. In practice, the wavelet transform of a given
image is another image presenting the areas where one may find either more or less important
contrast. In addition, one of the interests of the wavelet transform in image processing is that
it enables work at different levels of spatial resolution, operating as a tool of multiresolution
analysis. Multiresolution analysis allows retrieving the layers of details that have different
sizes by separating the spatial frequencies that the image contains. Basically, a medical image
at a given spatial resolution R contains information at different scales, from large structures to
small details. For instance, in a cerebral MRI the sharp edges between white and grey matters
will be lost when a low-pass filter is applied, but at the same time the skull will stay clearly
separated from the brain. Accessing and separating these structures of different sizes is the
scope of multiresolution analysis.
If we now consider the mathematic point of view, the wavelet transform allows expressing
a signal according to a basis of elementary functions called wavelets. This basis is built from
a ‘mother’ wavelet ψ (also referred to as analysing wavelet) on which are applied dilation










(a > 0). (1)
a is called the scale parameter and is linked to the frequency domain, while b is the position
parameter linked to time or space.
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The wavelet transform W(a, b) of the function f (x) is defined as










where ψ∗ stands for the complex conjugate of the analysing wavelet ψ . W is linear, shift
invariant and also invariant by dilation. These latter two properties are of interest in image
processing involving combination of different images. Actually, on the one hand, shift
invariance limits the unavoidable consequences of inaccurate superimposition of images. On
the other hand, dilation invariance is valuable for observing ‘objects’ of different sizes in a
given signal without changing the analysing wavelet.
There are many algorithms available to perform the discrete wavelet transform of an
image. All have particular interests and drawbacks but they must be chosen carefully because
the passage to the discrete approach can lead to the loss of interesting properties such as
invariance mentioned above. A widely used approach is the pyramidal methodology which
consists of reducing the size of the image iteratively to get smoother and smoother versions of
the initial image. This is the widespread multiresolution approach that Mallat (1989) developed
through his algorithm that permits compression of data by decimating the image. This method
is anisotropic in the sense that horizontal, diagonal and vertical details are separated during
the process. Another common approach is the algorithm ‘a` trous’ (French term that means
‘with holes’). This is an undecimated method inducing shift invariance which is of particular
interest when investigating image comparison. The transformation is not pyramidal since the
initial image and the images of coarser spatial resolution have identical sizes. For this reason,
this particular algorithm is redundant and is of reduced interest in image compression. This
algorithm forms however the basis of our PVE correction methodology as it presents several
practical advantages, namely (a) the implementation is straightforward and the initial image
can be perfectly reconstructed without loss of any kind, (b) there is no selection of specific
directions during the analysis since the process is isotropic, (c) the transform is known for
each pixel improving accuracy of further processing, and (d) navigation is easy between the
different levels of resolution.
This discrete wavelet transform algorithm called ‘a` trous’ was introduced by Dutilleux
(1987), developed by Holdschneider et al (1989) and detailed by Starck et al (1998). The
process gives an image sequence of coarser and coarser spatial resolution by performing
successive convolutions with a low-pass filter h obtained from a scaling function φ. At each





h(m, n)Ij (k + m2j , l + n2j ). (3)
As already pointed out, there is no decimation involved in the process, which means that all
Ij approximations have the size of the initial image I0. However, only one pixel out of 2j
is considered during the filtering process, leading to inclusion of zeros in the rows and the
columns of the mask. This feature gives its name to the algorithm, i.e. ‘with holes’, and it also
explains why the process is dyadic, where the successive approximations Ij have resolutions
decreasing by powers of 2.
The difference Ij − Ij+1 is the wavelet coefficients wj+1 containing the details (edges,
texture) at a resolution level between Ij and Ij+1. Note that the undecimation permits one to
follow the local information at a pixel level for any Ij, that is, navigation through all Ij images
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is possible at any pixel location. The synthesis procedure that reconstructs the original image
from its layers of details wk is given by




with N the number of iterations from the initial image I0 to the final approximation IN of spatial
resolution decreased by 2N. A pixel at location (x, y) can be expressed as the sum of the
wavelet coefficients at this position plus the smoothed array at the same (x, y) coordinates:




The ‘a` trous’ algorithm can easily be implemented by performing the following steps (Starck
et al 1998):
(1) Initialize j to 0: start with the original image I0.
(2) Increment j and carry out a convolution of Ij−1 with the low-pass filter h. The distance
between the central pixel and the adjacent ones is 2j−1.
(3) The wavelet coefficients wj at this level of resolution are given by Ij−1 − Ij .
(4) If j is less than the required number N of resolutions, go to step 2.
(5) The set W = {w1, w2, . . . , wN , IN } is the wavelet transform of I0.
Provided they satisfy a limited number of properties (compacity, regularity, symmetry) and
according to suitable prerequisites, different scaling functions can be constructed. However,
several already exist possessing interesting characteristics. The most widely used filters in
the ‘a` trous’ algorithm are based on linear interpolation and B-splines interpolation. For
instance, the bicubic spline is a very smooth function, well suited for isolation of large image
structures. On the other hand, linear interpolation is a good compromise, enabling work with
both small and large scale characteristics. Another filter, sometimes called low-scale filter, is a
sharply peaked function that performs well in isolating very small structures. The normalized
coefficients of these different filters are presented in the appendix. Each of these filters were
tested under different image characteristics in order to evaluate their behaviour and choose the
most appropriate one in the framework of the developed PVE correction algorithm.
2.2. Description of the algorithm implementation
The process employed in the developed algorithm comes from the field of data fusion (Luo
et al 2002) and as stated above it relies on a wavelet-based image merging. Actually, new
approaches to image merging that uses multiresolution analysis procedures based upon the
discrete wavelet transform have been proposed recently in as different domains as texture
classification (Li and Shawe-Taylor 2005), forensic science (Wen and Chen 2004) or aerial
images (Ranchin and Wald 2000). The multiscale fusion that we define here is the process
whereby details of a high-resolution image H (MRI or CT typically) are extracted, transformed
according to a given model and integrated in a low-resolution image L like PET or SPECT
for instance. The challenge is to preserve the global functional characteristic of L while
incorporating additional data in it and the mandatory hypothesis is that the tissues examined
by L are also present in the high-resolution image H. Contrary to all other applications that have
been studied till now, such as aerial imaging or forensic sciences, the visual enhancement is
not here the unique goal of the process. Our primary objective is the quantitative improvement
of the recovered activity concentrations. This latter is possible by adding detail layers of
different resolutions that all have a zero-mean signal.
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Figure 1. (a) The high-resolution H image with discs of various sizes and intensities. The five
horizontal discs have identical intensities and decreasing sizes in order to evaluate the correction of
tissue-fraction effects. The six vertical discs have decreasing intensities to allow studying spillover
effects. (b) Low-resolution image L corresponding to the degradation of high-resolution image H
after 10-standard-deviation Gaussian noise addition and low-pass filtering. (c) L image after PVE
correction using the developed wavelet-based algorithm.
Wavelet analysis allows the spatial frequencies to be obtained easily at any level of
resolution, in particular at a level of resolution common to H and L. A model is then inferred
to compute the lacking details of L from the high-frequency details’ layers of H. If the level of
resolution of H is q, referred to as Hq, and that of L is r= q + p, referred to as Lr, we can write
Lr(x, y) = Lq+p(x, y) = Lq+p+1(x, y) + wLq+p+1(x, y) (6)
and




The lacking details of L are the wavelet coefficients wLi with q  i  q + p. However, we do
possess wLq+p+1 and wHq+p+1 and we assume that there exists a more or less simple link between
them like wLq+p+1 = α × wHq+p+1, α ∈ IR∗ for instance. Although, different models can be
envisaged, in this study a simple linear model is used where the parameter α is considered
equal to the mean pixel-by-pixel division of wLq+p+1 by wHq+p+1.
Lq can now be reconstructed from Lr by taking wLi (q  i  q + p) into account. They
are calculated as wLi = α × wHi (q  i  q + p) leading to





2.3.1. Synthetic and simulated images. The developed algorithm was firstly validated using
different synthetic and simulated datasets. Synthetic images were composed of a circular
container (intensity 50) including discs of different sizes and contrast ratios (figure 1(a)). A first
series of five horizontal discs of decreasing diameter (30 mm, 20 mm, 15 mm, 10 mm, 5 mm)
and constant intensity (70) was built up to specifically examine the tissue-fraction effect and the
recovering of small areas. A second series of six vertical discs of constant diameter (10 mm)
but decreasing intensity (70, 60, 40, 30, 20 and 10) was designed specifically to consider
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spillover effects. This image of high spatial resolution (1 mm) corresponded to H as stated
in the previous section. A n-standard-deviation (SD) Gaussian noise was added (n ranging
from 1 to 10) and a 6 mm FWHM Gaussian blur was convolved in order to simulate the L
images (figure 1(b)) with a uniform 6 mm spatial resolution (the letter n in n-standard deviation
corresponds to the amount of noise added on a given pixel; the Gaussian law built with a zero
mean and a standard deviation equal to n times the standard deviation calculated in a 5 ×
5 pixel ROI around the pixel to treat). The convolution induced a contamination of signal
between homogeneous areas of the synthetic images very similar to partial volume effects,
and the levels of resolution for L and H were chosen according to those of typical PET and
MRI studies, respectively. The different amounts of noise in L, introduced by the variable SD
Gaussian noise, aimed at investigating the performance of the correction algorithm in PET
images of variable statistical quality.
The mean intensity in the discs inside the container was calculated before and after PVE
correction in each one of the ten L images and then compared with actual values in H. In
practice, ROIs delineating discs in L were obtained automatically by copying the masks of
exact discs in H. The mean intensity in the discs of L images was then calculated inside
these exact ROIs. These results were also compared with those obtained by applying the RSF
method (Rousset et al 1998) often considered as the reference numerical approach (Frouin et al
2002, Quarantelli et al 2004) for PVE correction in emission tomography.
The robustness of the developed algorithm to spatial misalignment between the H and L
images was also studied by introducing artificial displacements of L with regards to H. A set of
20 configurations was created, namely 1, 2 and 3 pixels (each pixel 1 mm of size) translation
errors in the four directions (up, down, left, right), 1, 2 and 3 degrees of rotations clockwise
and anticlockwise, and finally, two scaling errors of 99% and 101%. The L image with 6 SD
Gaussian noise was considered for this specific investigation. The error in intensity recovery
was calculated in the 11 discs for each of the 20 configurations of misalignment produced,
after applying either the RSF PVE correction or our wavelet-based method.
The synthetic images were also used to assess the proposed methodology in cases where
image contents no longer correlate. As already mentioned, one of the mandatory prerequisites
to the application of the correction method proposed in this paper is the similarity of tissues
in the images we are dealing with. For this purpose, and without altering the low-resolution
image, we modified the synthetic ‘CT’ image to create two grossly unfavourable configurations.
In the first one, the horizontal series of five discs was completely removed from the synthetic
‘CT’ image (figure 2(a)), and in the second one (figure 2(c)) the intensity of the first disc in
this same series was set to 20 (cold intensity) instead of 70 (hot intensity, as in the ‘PET’
image).
Finally, simulated images were also included in our study. They consisted of a simplified
numerical version (figure 3(a)) of the physical IEC phantom (IEC Publication 61675-1 1998).
This phantom consists of a 20 cm diameter by 20 cm long cylinder, containing six spheres of
37 mm, 28 mm, 22 mm, 17 mm, 13 mm and 10 mm in diameter. The numerical version of this
phantom was produced as a set of 64 contiguous planes of 64 × 64 square pixels of 4 mm ×
4 mm in size. This phantom was subsequently combined with a Monte Carlo based simulation
of the Philips Allegro PET scanner using GATE (Lamare et al 2006). A total of 60 million
coincidences were simulated considering a sphere/cylinder activity concentration ratio of 5/1.
Images were subsequently reconstructed using the OPLEM algorithm (11 iterations) (Reader
et al 2002). The high-resolution image serving for PVE correction was the numerical phantom
in which values were arbitrarily set to 1000 for the background, 2000 for the cylindrical
container and 3000 for the spheres, leading to a 1.5 sphere/cylinder intensity ratio. These
realistic ratios in the numerical phantom and in the simulated PET image were chosen in order




Figure 2. Synthetic images with no tissue correlation between high- and low-resolution images;
only the high-resolution image is altered. (a) First configuration, without horizontal discs in the
high-resolution image, and (b) corresponding PVE-corrected low-resolution image. (c) Second
configuration, with contrast modified in the first horizontal disc only, and (d) corresponding PVE-
corrected low-resolution image. A local application of the proposed algorithm is shown in (e),
with the region of interest surrounding the disc to be corrected, and (f) the whole image after PVE
correction demonstrating that only the part inside the specified region of interest is PVE corrected.
to investigate the behaviour of the developed PVE correction methodology in more realistic
conditions than the synthetic images.
2.3.2. Quantitative and qualitative assessment of the developed methodology on clinical
images. In order to demonstrate the use of the developed algorithm in the clinical context,
the technique was applied on two different sets of patients’ images. The first one consisted
of a whole-body FDG PET and corresponding CT images figure 4 acquired on a lymphoma
patient using a dedicated combined PET/CT scanner (GE Discovery LS), while the second
dataset consisted of a FDG brain PET and corresponding T1-weighted MRI images acquired
during pre-surgical evaluation of refractory epilepsy figure 5. The MRI and PET cerebral
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Figure 4. Clinical PET/CT patient study of the thorax acquired on a combined PET/CT scanner.
(a) Original emission PET FDG image. (b) Corresponding CT image at the same anatomical
location (identical slice level). (c) FDG PET after PVE correction.
images were acquired separately and spatially co-registered by using mutual information
maximization (Wells et al 1996) and affine transformation (rotation, translation, scaling).
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Figure 5. (a) Transaxial brain PET image obtained with FDG in an epilepsy follow-up study.
(b) Corresponding MRI slice (the skull has been removed). (c) Same transaxial plane as in (a),
here shown after PVE correction by using the developed wavelet-based multiresolution analysis
algorithm.
Apart from the qualitative assessment of the corrected images, a ROI analysis was also
performed to quantify the impact of the PVE correction. Different regions were drawn
in both the original and corrected whole-body PET images, namely four circular ROIs of
30 mm in diameter placed at the middle of the right lung corresponding to a normal area with
homogeneous intensity (ROIlung), two circular ROIs of 20 mm in diameter inside the heart in
a normal but visually inhomogeneous area (ROIheart) and a ROI surrounding the lesion in left
lung (ROIlesion, size 20 mm× 8 mm). A similar quantitative investigation was performed in the
FDG brain PET, in which grey matter and white matter intensities were calculated before and
after PVE correction. As a first step, grey and white matters were delineated automatically in
the T1-weighted MRI using the SPM software (Ashburner and Friston 2000), and in a second
step the two obtained segmented areas were superimposed on the PET image. They both
served as ROIs in which mean intensities were calculated.
3. Results
Figure 1(b) shows an example of the synthetic image L used to assess the developed
methodology. The corresponding PVE-corrected image of L is given in figure 1(c), where it
can be noted that, aside from quantitative considerations, edges are visually enhanced. Figure 6
illustrates the PVE correction in a semi-quantitative fashion. Profiles across the five horizontal
discs in uncorrected and corrected L images along with the related wavelet coefficients built
from the H image and representing the correction values are presented. In the profile presented
in figure 6(a), one can note that the discs are represented by five coarse Gaussian shapes, the
last being so attenuated that it is hardly visible. The corresponding profile in figure 6(b) shows
that the correction required for this disc is the most significant among the five discs, leading
at the end to equal corrected values as demonstrated by figure 6(c). As a consequence, the
process does not only enhance the edges of objects but also increases the global intensity level
when needed, especially for smaller objects.
The global recovery of intensity in the low-resolution synthetic images, considering the
ten different levels of image noise described in section 2.3.1, is represented in figure 7, where
results concerning tissue-fraction and spillover effects are separated in figures 7(a) and 7(b),
respectively. As figure 7(a) demonstrates, the intensity level in the five discs with diminishing
sizes in the uncorrected L images was found to dramatically decrease clearly demonstrating
the tissue-fraction effects. For example, the intensity in disc 1 (30 mm diameter) and disc 5
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Figure 6. A semi-quantitative assessment of the results obtained from the application of the
developed PVE methodology on the synthetic images (considering the L image with 5-standard-
deviation Gaussian noise). A ‘plot profile’ is generated along a line crossing the five horizontal
discs, in the uncorrected image (a), in the wavelet-based correction image (b) and in the corrected
image which is the pixel-to-pixel addition of the first two (c).
(5 mm diameter) decreased from 70 to 67.2 (−4.0%) and 56.7 (−19.0%), respectively.
The spillover effect is illustrated by the six vertical discs, whose intensities were either
underestimated or overestimated depending on their initial signal-to-background (S/B) ratios
(figure 7(b)). For example, the intensity in disc 6 (10 mm in diameter, initial S/B = 1.4)
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Figure 7. Quantitative performance assessment of the PVE correction. The results from the L
synthetic images of the ten different noise levels considered are summarized in this figure, namely
(a) mean intensity recovery in the five discs of diminishing sizes, with the errors bars representing
the standard deviation in the mean taking into account the ten different noise levels considered
(the actual intensity is 70), (b) mean intensity in the six discs of decreasing intensities (the actual
values are 70, 60, 40, 30, 20 and 10 for discs 6–11, respectively).
decreased by 11.4% and the intensity in disc 11 (10 mm in diameter, initial S/B = 0.2)
increased by 158.0% (from 10 to 25.8). Following the application of the developed algorithm,
both phenomena were corrected for as also illustrated in figure 7. It is however of significance
to observe the dependence of the correction upon the choice of the filter. In figure 8, for
example, the results of the correction are shown for the 11 discs simulating the tissue-fraction
effect and spillover, according to the four filters described in section 2.1 and the appendix.
For this purpose, we call recovery error the difference between the expected disc intensity
(for example, 70 in the discs 1–5) and the intensity in the same disc after PVE correction.
A perfect PVE correction would then lead to a recovery error equal to 0. It is clear that the
bicubic spline filter and the 5× 5 linear filter perform better than the other two. For discs 1–5,
the percentage of recovery error was less than 1% for these two filters, while the low-scale
filter led to error greater than 4%. For discs 9–11, the percentage of recovery error exceeded
20% with this low-scale filter. According to these results, the bicubic spline filter or the
5 × 5 linear filter should be preferred. Consequently, all results presented in this paper were
obtained with the bicubic spline filter.
The good noise characteristics of the developed algorithm are shown in figure 9 where the
percentage of correction error is plotted against the different L images considering variable
noise levels. As far as tissue-fraction effects are considered (figure 9(a)), a negligible
overestimation error was found, globally increasing with respect to the amount of noise.
However, errors never exceeded 1% in the set of images considered. Concerning the spillover,
the correction slightly underestimated the true values, with an error up to 4% in high noise
conditions figure 9(b). Finally, the comparison with the RSF method is given in figure 10. The
graphs show that the two methods have very similar behaviours in correcting for both tissue-
fraction effects (discs 1–5) and spillover (discs 6–11) since the two graphic representations
almost perfectly overlap. However, a closer comparison reveals a slight difference in favour of
the wavelet method. For the discs 4 and 5, which are highly subjected to tissue-fraction effect
on account of their small sizes, the errors in intensity recovery are, respectively, 0.07% and
0.33% for the wavelet approach against 0.34% and 0.92% for the RSF method. The difference
is more significant when considering the disc 11 which undergoes substantial spill-in from
the surrounding area: 0.47% of error for the proposed method against 4.27% for the RSF
approach.
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Figure 8. Influence of the filter used in the ‘a` trous’ algorithm on the percentage of recovery
error. Results are presented for the 11 discs of the synthetic images, dedicated to the study of
tissue-fraction effects (discs 1–5) and spillover (discs 6–11). Values are mean percentages obtained
from all ten different noise level synthetic images.
Figure 11 summarizes the results on the effects of spatial registration errors, demonstrating
that the developed algorithm behaves similarly to the RSF method. Both methods gave
satisfactory PVE correction of tissue-fraction effects (discs 1–5). The correction of PVE
in discs simulating spillover seemed to be more dependant upon co-registration than the
correction of tissue-fraction effects (discs 6–11). However, as figure 11 demonstrates the
developed algorithm performed better in correcting spillover effects than the RSF method,
since, in some cases, the latter led to errors exceeding 100% for discs 10 and 11.
The effects of grossly unfavourable configurations for the methodology described in this
work, where tissues greatly differ between high- and low-resolution images, are demonstrated
in figure 2. The image in figure 2(a) corresponds to the case where horizontal discs are erased
in the high-resolution image. As a result, in the corresponding corrected image figure 2(b)
vertical discs are PVE corrected as is the contour of the container, but the horizontal series
of discs stays unmodified since no corresponding information exists in the high-resolution
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Figure 9. Robustness of the wavelet-based PVE correction according to noise. (a) Error percentage
of intensity recovery in the five discs of decreasing sizes, and (b) error percentage of intensity
recovery in the six discs of decreasing intensities.
Figure 10. Comparison of the wavelet-based PVE correction with the RSF approach of Rousset
et al, presented in terms of percentage of recovery error. Results are mean values obtained in the
set of ten L images with different levels of noise. For the sake of clarity, the standard deviations
(error bars) are presented for the wavelet-based method only.
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Figure 11. Robustness of the correction according to the alignment accuracy of the images.
Twenty different configurations were tested (12 translation movements, 6 rotation movements and
2 inadequate scalings). For each disc, the value presented is the mean error of intensity recovery
obtained in the set of 20 configurations considered.
image. In terms of quantitative accuracy, there has been no alteration in the values of the
horizontal spheres independently of their sizes. Therefore, the complete lack of a given tissue
in the high-resolution image does not modify the corresponding part in the low-resolution
image. The image in figure 2(c) relates to the second case where the intensity in an isolated
disc is altered compared to the other discs (‘cold spot’ rather than a ‘hot spot’). This leads
to a local artefact in the corrected image corresponding to the limits of the ‘cold sphere’ in
the high-resolution image, mainly due to a local inverse contrast in the high-resolution image
compared to the same area in the low-resolution image (figure 2(d)). The quantitative errors
are also local to the visual artefact with values not altered in the rest of the sphere.
The transaxial slice of the reconstructed PET image of the numerical IEC phantom
containing all the lesions is shown in figure 3(a). The corresponding PVE-corrected image
is given in figure 3(b), while the quantitative results (an expected ratio between spheres and
background of 5/1, irrespective of lesion size) are presented in figure 12. As this latter figure
demonstrates, although both correction methods lead to an improvement in the sphere/cylinder
ratios, the wavelet-based correction performed better in all spheres, particularly for the smallest
ones. For example, the ratios for the 13 mm and 10 mm diameter spheres were improved from
2.19 to 5.93 and from 2.03 to 5.96, respectively, using the wavelet-based algorithm, against
9.08 and 9.80 with the RSF method.
Finally, figures 4(c) and 5(c) clearly demonstrate the visual image quality improvement
achieved in both oncology and brain clinical applications, permitted by the generation of PVE-
corrected images using the developed algorithm. Aside from these visual improvements, ROI
analyses were performed to get a quantitative insight of the correction in clinical images. In the
whole-body PET image and before PVE correction, the average intensities in ROIlung, ROIheart
and ROIlesion were 35.1, 245.2 and 109.2, respectively. After correction with the proposed
multiresolution method, these mean intensities changed to 36.4 (+3.7%), 240.0 (−2.1%) and
129.2 (+18.3%), respectively. This led to an increase of lesion-to-lung ratio of 16.1%. In the
brain PET image, the mean intensity in white matter was 113.8 before correction and 90.7
after PVE correction. In the grey matter, the values were 126.6 before correction and 162.3
after correction, representing a 28.2% increase.
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Figure 12. Sphere-to-background ratio in each of the different diameter spheres in the transaxial
reconstructed slice of the simulated IEC phantom, before PVE correction and after PVE correction
by either the RSF method or the developed wavelet-based algorithm. Expected ratios are equal
to 5.
4. Discussion
The development of spatial co-registration algorithms in the last decade has allowed the
automated and reliable superimposition of multimodality images in a day-to-day practice, in
as different domains as neurology or cardiology. Moreover, since the advent of combined
PET/CT and more recently SPECT/CT scanners, there has been a widespread acceptance
of this new technology. This development has lead to easier and direct superimposition of
functional and anatomical images (Vogel et al 2004) for oncology applications. Consequently,
the use of anatomical data has naturally become one of the keys in addressing the problem of
partial volume effects in emission tomography. However, the current PVE correction methods
focus mainly on cerebral imaging, while PVE remains a major problem in other applications
notably in oncology and whole-body studies. Actually, the size of tumours is often close to
the PSF of PET scanners and consequently they are significantly exposed to PVE (Soret et al
2001). In this case, the activity and the dimension of tumours, which are critical parameters
in quantitative accuracy for applications such as response to therapy or radiotherapy treatment
planning (Caldwell et al 2003), become difficult to assess.
As previously stated, most of the different methods of correction that have been published
till now suffer from the need to perform a segmentation of the anatomical information of
interest and their subsequent specificity to brain imaging, with very few procedures having
been tested on other organs. In addition, the vast majority of developed algorithms focus on the
recuperation of accurate activity concentrations and not on yielding PVE-corrected images.
The methodology developed by Rousset et al (1998) and referred to throughout this paper as
the RSF method remains indeed the most widely used approach because it is straightforward
to implement and it only requires the knowledge of the PSF. Like many other approaches it
however also needs the segmentation of anatomical structures, which may become tedious and
time consuming when no automatic algorithm is available. It is important as well to underline
that this algorithm needs the ROIs to be accurately delineated (Frouin et al 2002, Zaidi et al
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2005) which may be uncertain in the case of manual segmentation such as may be the case in
whole-body PET.
In this paper, a novel approach aiming at overcoming these limitations was proposed.
The general concept of the technique is a mutual multiresolution analysis of functional and
anatomical images that are supposed to be correctly co-registered. During the process, the
details in the high-resolution image are automatically extracted, altered according to a model
and introduced in the PET image by using a simple pixel-to-pixel addition. The correction
image containing these modified details is built from wavelet coefficients and consequently
has a zero mean. As a result, the algorithm adjusts the intensity in boundaries of the organs
and greatly enhances the smallest parts like lesions or tumours, but at the same time it hardly
modifies the intensity in large and homogeneous structures.
The performance of the developed algorithm was assessed through the use of synthetic and
simulated images in direct comparison with the most popular PVE correction methodology
developed by Rousset et al in the first instance for brain imaging applications. The data
obtained from the use of synthetic images demonstrated the correction ability of both aspects
of PVE, that is to say tissue-fraction effects and spillover, with as good accuracy as the RSF
method. In addition to the quantitatively accurate results, the developed methodology allowed
the derivation of enhanced images. One may argue that the synthetic high-resolution image
H had ideal properties since the L images were derived from it. Actually, the intensity in the
different parts of H was rigorously the same as that we wanted to retrieve in L. However, the
simple model that we defined between the wavelet coefficients of L and H allowed us to obtain
similar corrected values in L by flipping the contrast in H, illustrating the robustness of the
model against the nature of the high-resolution image. Similarly, good results were obtained
using simulated PET images of the IEC phantom, considering the presence of lesions from
10 mm to 40 mm in diameter, with the developed methodology leading to a larger improvement
in comparison to the RSF method, particularly for smaller lesions. Finally, the improvement
that can be derived from the developed technique in the clinical setting was demonstrated
by the enhanced PVE-corrected PET images produced as a result of the developed algorithm
considering both brain and oncology applications. Such enhanced images may allow a more
accurate lesion delineation providing solutions in clinical PET applications of increasing
importance such as response to therapy studies and use for radiotherapy treatment planning.
In the whole-body PET image, indeed, the improved visual delineation of the lesion came
with an increase of intensity leading to a 16% increase of lesion-to-lung ratio. As far as brain
PET is considered, the PVE correction induced compensation for both spill-in and spillover
effects. The intensity in the white matter decreased in the benefit of grey matter acting as a
redistribution of activity from an overestimated area to an underestimated one. The accuracy
and the precision of these quantitative results are difficult to evaluate but the global behaviour
of the correction is in accordance with an expected ‘inverse’ cross-contamination.
However, the improvement in grey matter uptake seems to be lower than that obtained in
simulated images as described by Quarantelli et al (2004). Even if the comparison of results
from real and simulated images is questionable, this point justifies some discussion. First,
the proposed PVE correction operates in 2D since the wavelet transform that we use (the
‘a` trous’ algorithm) is restricted to 2D images. This is a notable weakness but a potential
solution would consist in taking into account the 3D nature of PET images, for example by
performing the ‘a` trous’ algorithm in coronal and sagittal slices in addition to the transverse
plane. In the same way, the 16% increase of lesion-to-lung ratio in the whole-body PET
image may appear moderate. Potential improvement in this domain could be foreseen by
performing the multiresolution analysis in a limited ROI surrounding the lesion instead of
the whole image containing very different tissues and organs. The simple and global linear
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model that was presented in this study (allowing us to build lacking details of the PET image
from the details of the CT or MRI images, see section 2.2) may indeed not be adapted to very
extended regions presenting with heterogeneous structures, typically like abdominal images
where clearly certain structures such as intestines appear differently in CT and PET. Therefore,
although a simple and global model may be better adapted to a visual improvement alone, a
quantitative study under clinical imaging conditions could potentially benefit from considering
a more restricted field of view. In support of this statement, it is worth considering the results
that were obtained in the second unfavourable configuration of synthetic images (figures 2(c)
and (d)). In this latter case, an intense local artefact was observed after applying our algorithm,
thus leading to a corrupted correction. However, if we operate our method in a limited area
surrounding the given disc as demonstrated in figure 2(e), the algorithm results in the expected
partial volume correction for the specified region of interest (figure 2(f)). Obviously, the
remainder of the image is not PVE corrected. It is also important to note that the same kind
of artefact as that shown in figure 2(d) will appear in a corrected PET image, considering the
use of the global linear model, when a given tissue is present in the CT and not in the PET.
A potential solution to this particular case will be the use of a restricted field of view for the
application of the global model in combination with the introduction of a measure of similarity
between the wavelet components of the high- and low-resolution images within the particular
ROI. However, one must keep in mind that the aim is to correct for PVE in a part of the PET
image corresponding to an actual tissue of interest. If there is no structure of interest present
in PET, there is no associated interest in PVE correction.
Finally, only circular and homogeneous lesions were tested in the synthetic and simulated
images that were presented in this paper. In clinical practice concerning whole-body imaging
for example, lesions can obviously be of different shape and have non-uniform activity
concentration. Here again, a more sophisticated model rather than the linear model used
in the implemented algorithm in combination with its application in a more limited region
may be more appropriate.
5. Conclusion
In this paper, a novel technique to correct emission tomography for partial volume effects
using multiresolution analysis has been presented. The advantages of this approach are three-
fold and can be summarized as follows. According to various tests on synthetic images, the
efficiency of the correction proved to be as good as a reference method based on regional
spread functions. On the other hand, the wavelet-based correction leads to better results in
simulated images. In addition, and contrary to the RSF method, the process allows enhancing
the images themselves to perform further processing, without any time-consuming step of
ROI delineation. Finally, images of any kind of tissues, organs, functions and metabolisms
are likely to be corrected, provided an anatomical image of the same object is available and
correctly aligned. A simple linear and global link between the wavelet coefficients of the
emission image and those of the anatomical one has been defined in this study. Under certain
imaging conditions, a local model, defining only a limited area around the tissue of interest,
may be more appropriate and will be considered in future developments.
Acknowledgment
This work has been financially supported by the Region of Brittany.
A multiresolution image based approach for correction of partial volume effects in emission tomography 19
Appendix
5× 5 bicubic spline :


1/256 1/64 3/128 1/64 1/256
1/64 1/16 3/32 1/16 1/64
3/128 3/32 9/64 3/32 3/128
1/64 1/16 3/32 1/16 1/64
1/256 1/64 3/128 1/64 1/256

 .
5× 5 linear interpolation :


1/100 1/50 3/25 1/50 1/100
1/50 1/25 2/25 1/25 1/50
1/25 2/25 4/25 2/25 1/25
1/50 1/25 2/25 1/25 1/50
1/100 1/50 1/25 1/25 1/100

 .
3× 3 linear interpolation :





3× 3 low scale :

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Abstract
This paper deals with a recent statistical model based on fuzzy Markov random chains for image segmentation, in the context of sta-
tionary and non-stationary data. On one hand, fuzzy scheme takes into account discrete and continuous classes through the modeling of
hidden data imprecision and on the other hand, Markovian Bayesian scheme models the uncertainty on the observed data. A non-sta-
tionary fuzzy Markov chain model is proposed in an unsupervised way, based on a recent Markov triplet approach. The method is com-
pared with the stationary fuzzy Markovian chain model. Both stationary and non-stationary methods are enriched with a parameterized
joint density, which governs the attractiveness of the neighbored states. Segmentation task is processed with Bayesian tools, such as the
well known MPM (Mode of Posterior Marginals) criterion. To validate both models, we perform and compare the segmentation on syn-
thetic images and raw optical patterns which present diﬀuse structures.
 2007 Elsevier B.V. All rights reserved.
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1. Introduction
The fuzzy segmentation problem consists of estimating
the hidden realization x = (xs)16s6N, for a given set of
D observations Y ¼ y ¼ fys 2 R
Dg, where xs = (e1(s),
e2(s), . . ., eK(s)). Each component ei(s) represents the contri-
bution of each classxi in a ﬁnite discrete setX = {x1, . . .,xK}
of K hard classes. The fuzzy belonging of each pixel respects
the normalization condition: e1(s) + e2(s) +    + eK(s) = 1.
In the context of two ‘‘hard’’ classes, a set X = {0,1} yields
xs 2 [0, 1]. Then, all values xs 2 [0,1] model the proportion
of the class ‘‘0’’ in the pixel related toXs, whereas 1  xs cor-
responds to the proportion of the class ‘‘1’’. The distribution
at each random variable Xs is given by a density hs with
respect to a measure m including discrete components (Dirac
functions d0, d1 on {0,1}) and a continuous component (the
Lebesgue measure l on ]0,1[) (Caillol et al., 1993):
m ¼ d0 þ d1 þ l: ð1Þ
The discrete components of m are associated with the hard
classes, whereas the continuous component l is associated
with the fuzzy feature. In this paper, we will consider the
case D = N (mono-spectral context). When X is a Markov
chain called ‘‘fuzzy Markov chain’’ (FMC) and the vari-
able Y is independent conditionally on X, it is possible to
express the joint distribution p(x,y) with respect to a mea-
sure mN  lN, as follows:
pðx; yÞ ¼ pðx1Þpðx2jx1Þ    pðxN jxN1Þpðy1jx1Þ    pðyN jxNÞ:
ð2Þ
In particular, the posterior ﬁeld X conditional on Y is Mar-
kovian. Thus, one can process the posterior realizations of
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the hidden variable X, called Hidden Fuzzy Markov Chain
(HFMC). Generally the distribution p(x,y) depends on un-
known parameter h = (hX,hY) where the prior parameters
hX deﬁne the prior density of the Markov chain and the
parameters hY deﬁne the distribution parameters of the dri-
ven data conditional on X. Algorithms like ‘‘Expectation
Maximization’’ (EM) (McLachlan and Krishnan, 1997)
or its stochastic version (SEM) (Celeux and Diebolt,
1985) are eﬃcient to estimate the hyper-parameter when
hX does not vary locally, i.e., when the variable X is station-
ary. Recent studies have focused on unsupervised segmen-
tation of Markov chain in the fuzzy context (Avrachenkov
and Sanchez, 2002; Mohammed and Gader, 2000; Carin-
cotte et al., 2004). In particular, we derive hX from the prior
joint density p(xs,xs+1) at each neighbored sites. We pres-
ent here a new model based on a parameterized joint den-
sity, which governs locally the attractiveness between two
neighbored states. Unfortunately, when hX does not vary
locally, these approaches are sometimes badly adapted.
Thus one has to introduce a new fuzzy hidden Markov
chain model which represents non-stationary data. In this
work we model the non-stationarity by a third auxiliary
process U, which governs the changing values of hX in
the hidden process. A such method has been successfully
applied in the hard context (Hughes et al., 1999; Lanchan-
tin and Pieczynski, 2004), and we propose in this article to
extend non-stationary Markov chain to the fuzzy case. The
solution proposed in (Lanchantin and Pieczynski, 2004) is
derived from a recent triplet Markov chain model (Pieczyn-
ski, 2002) which can be described in the following manner:
the pairwise process Z = (X,U) is assumed to be Markov-
ian, X and U separately are not necessary Markovian. The
triplet process T = (X,U,Y) is then a particular triplet
Markov chain. In Section 2, we present the stationary fuzzy
Markov chain (SFMC) with and without a parameterized
joint density (P-SFMC versus NP-SFMC). We brieﬂy
introduce the stationary fuzzy Markov ﬁeld (SFMF) (Sal-
zenstein and Pieczynski, 1997), which is used in the exper-
imental part to enrich the comparisons. In the next
Section3 we generalize the non-stationary model of Lanch-
antin and Pieczynski (2004) presenting a new fuzzy model
in the context of non-stationary Markov chain (NSFMC)
with a possibly joint parameterized density (P-NSFMC
versus NP-NSFMC). We describe the noise model used
(Section 4), the MPM segmentation procedure applied to
the S/NS-FMC methods (Section 5) and the associated
hyper-parameter estimation step (Section 6). Finally we
show the eﬃciency of the new method though synthetic
images (Section 7) and real images (Section 8).
2. The stationary fuzzy Markov chain (SFMC)
Let us consider now a Markov chain X = (xs)16s6N with
continuous statements, i.e., Xs 2 [0, 1]. To deﬁne the distri-
bution p(x) of the variable X, we need the density p(x1) of
the initial distribution, and the transition densities
p(xsjxs1)16s6N:
pðx1; x2; . . . ; xN Þ ¼ pðx1Þ  pðx2jx1Þ    pðxN jxN1Þ: ð3Þ
When the chain is stationary, all prior distributions can be
deduced from a joint density. The prior joint density
p(xs,xs+1) is deﬁned on the pairwise (xs,xs+1) 2 [0,1]
2.





pðu; vÞdðm mÞðu; vÞ ¼ 1: ð4Þ
We propose a general model to deﬁne it
pðe1; e2Þ ¼ a  /ðe1; e2Þ þ b with /ðe1; e2Þ
¼ /ðe2; e1Þ; ða; bÞ 2 R
2: ð5Þ
The function /(e1, e2), is applied when at least one label is
fuzzy, i.e., e1 or e1 2 ]0, 1[. If both labels are hard, we note
p(0,0) = p00, p(1,1) = p11, p(0,1) = p01, p(1,0) = p10. We
model a parameterized function / as follows:
/ðe1; e2Þ ¼ ð1 je1  e2jÞ
r
r 2 R: ð6Þ
When r increases, the probability of having two similar
neighbored pixels increases: thus, the parameter r governs
the homogeneity of the image, i.e., the attractiveness be-
tween the diﬀerent states. Moreover, the limit conditions
that we impose yield
pð0; 1Þ ¼ pð1; 0Þ ¼ b ¼ p01 ¼ p10: ð7Þ
Applying Eq. (4) yields to the general condition:












pðu; vÞdudv ¼ 1: ð8Þ
This gives a relationship between all prior parameters
(p00,p11,p01,p10,a,b). When the prior joint density is de-
ﬁned by the function (6), we compute (8) using a quantiza-
tion of the interval [0,1] into M equidistant values:
fe0 ¼ 0; e1 ¼
1
M
. . . ; ei ¼
i
M
; . . . ; eM ¼ 1g. Then, we derive










In this section we brieﬂy described a new fuzzy Markov
random chain model based on a parameterized joint den-
sity associated to the transition probabilities. The station-
ary fuzzy chain associated with a non-parameterized
density is named NP-SFMC. The stationary fuzzy chain
associated with a parameterized density is named P-SFMC.
It is also possible to deﬁne in the same way, the stationary
Markovian random ﬁeld (SFMF) (Salzenstein and Piec-
zynski, 1997) X 2 [0,1]N, for which the distribution pX with
respect to a measure mN is given by Salzenstein and Pieczyn-
ski (1997)




 eU f ðxÞ; ð10Þ






where (xs,xt) 2 [0,1]
2 represents a pairwise of neighbored
pixels (Geman and Geman, 1984) in the image (vertical,
diagonal or horizontal neighborhood), and the associated
functions UC deﬁned on [0,1]
2. Let us notice, the SFMF
procedure is time consuming: on has to compute several
realizations of X according to its posterior distribution,
using a Gibbs sampling (Geman and Geman, 1984). In
the opposite way, the Markov chain model provides an eﬃ-
cient tool: one can compute directly the posterior density
using the forward/backward procedure (Devijver, 1985).
In order to use the HMC procedure, it is possible to extract
the 2D signal as mono-dimensional data using the Hilbert-
Peano path. This technique preserves the neighborhood
information. Let us describe now a non-stationary fuzzy
Markov chain model.
3. The non-stationary fuzzy Markov chain (NSFMC)
Authors (Lanchantin and Pieczynski, 2004) propose to
add to an initial process X an additional process U,
which takes its values in a ﬁnite set K = {k1,k2, . . .,kK}.
The couple Z = (X,U) = {(x1,u1), (x2,u2), . . ., (xN,uN)} is
supposed to be a stationary Markov chain, where X is an
interested non-stationary process, and U models auxiliary
states:
pðzs ¼ ðxs; usÞjzs1; zs2; . . . ; z1Þ ¼ pðzsjzs1Þ: ð12Þ
In (Lanchantin and Pieczynski, 2004), X and U take their
values into discrete classes. We propose to generalize this
model by labeling each component Xs into a continuous
set [0, 1]. The intermediate variable U takes its values into
a ﬁnite set, in order to deﬁne stationary partitions of the
variable X. The chain Z is deﬁned by a prior joint density
pðzs; zsþ1Þ ¼ pðxs; xsþ1; us; usþ1Þ;









the initial probability is computed by






pð; g; ks; ksþ1Þdðm mÞð; gÞ; ð13Þ
with Is  [0,1] and Is+1  [0,1]. As in the stationary case, it
is possible to deﬁne a parameterized and non-parameter-
ized joint density, provided that the normalization condi-








pð; g; ki; kjÞdðm mÞð; gÞ ¼ 1: ð14Þ









gð; g; ki; kjÞdðm mÞð; gÞ ¼ P ½ki; kj ¼ P ij: ð16Þ
Thus, it is possible to construct a parameterized mode of









pð0; 0; ki; kjÞ ¼ p
ij
00; pð0; 1; ki; kjÞ ¼ p
ij
01; ð17Þ
pð1; 0; ki; kjÞ ¼ p
ij
10; pð1; 1; ki; kjÞ ¼ p
ij
11: ð18Þ
When 1 or 2 2 ]0, 1[, let us express aij, bij and the auxiliary
function / deﬁned by (6)
pð1; 2; ki; kjÞ ¼ aij  /ð1; 2Þ þ bij: ð19Þ
Moreover, we impose limit conditions (20)










11. The other parameters p
ij
10, bij and
aij are computed by the conditions (15), (16), (20). The
non-stationary Markov chain based on a parameterized
joint density will be named P-NSFMC whereas the model
based on a non-parameterized density is named NP-
NSFMC. In this section we introduced a new fuzzy non-
stationary Markov random chain model. We deﬁned the
associated prior joint density, initial and transition proba-
bilities. Let us now describe the segmentation task.
4. Model of the observations in a non-stationary context
The joint process Z = (X,U) being assumed to be Mar-
kovian, the aim of our paper is to process multispectral
data. We observe D realizations (y(1),y(2), . . .,y(D)) of the
random vector Y = (Y(1),Y(2), . . .,Y(D)). They represent
a single scene observed at diﬀerent wavelengths or from
diﬀerent sensors. For each ﬁeld Y(i), the variables




2 ; . . . ; Y
ðiÞ
N g are spatially independent condi-
tionally on Z. One has the following relationships (Lanch-




pðY ðiÞs jZÞ; ð21Þ
pðY ðiÞs jZÞ ¼ pðY
ðiÞ
s jZsÞ; ð22Þ
pðY ðiÞs jZsÞ ¼ pðY
ðiÞ
s jX sÞ: ð23Þ
According to the third condition, the data driven parame-
ter are stationary. Hence the parameter hX varies locally,
whereas the parameter hY stays global. The distribution
fxsðysÞ of ys according to Xs = es 2 [0,1] is a Gaussian mul-








tC1es ðysles Þð Þ ð24Þ
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where les ¼ ½l
ð1Þ
es
; . . . ; lðDÞes 
t and Ces 2 R
D  RD, respectively,
deﬁne a mean vector and variance–covariance matrix, at
each fuzzy/hard site. Let be (l0,l1) and (C0,C1) the mean
vectors and variance–covariance matrix related to the hard
classes ‘‘0’’ and ‘‘1’’. For each fuzzy site Xs = es, the related
mean vector and covariance matrix les and Ces are written
les ¼ ð1 esÞ  l0 þ es  l1; ð25Þ
Ces ¼ ð1 esÞ
2
 C0 þ e
2
s  C1: ð26Þ
5. Segmentation procedure
5.1. Segmentation of the SFMC
Given the set of observations Y = y, we wish to estimate
one realization X = x 2 [0,1]N. It is possible to adapt the
MPM criterion (Maroquin et al., 1987) to the fuzzy context
(Salzenstein and Pieczynski, 1997). For a such approach,
the ﬁnal decision process is performed as following: given
a realization Y = y, the bayesian decision bds such thatbdsðY ÞÞ ¼ cX s , will involve minimizing a conditional expec-
tation (27) at each location s, in order to obtain an optimal
value of Xs
x^opts ¼ arg minbX s¼x^s E½LsðX s;cX sÞjY ¼ y: ð27Þ
The loss function Ls ðbxs ; xsÞmodels the severity of attributing
the value bxs instead of a true one xs to the pixel. Although
there are numerous possibilities in the choice of the loss
function, the ‘absolute distance’ Lsðxs; x^sÞ ¼ jxs  x^sj, gives
eﬃcient results for segmentation tasks. For a stationary var-
iable X, the error rate is approximated by





The calculus of (27) requires the knowledge of the posterior
distribution pYX s at each Xs:








Segmentation is performed by aﬀecting to each pixel a
value cX s 2 ½0; 1 which minimizes (29). When the hidden
process X is a Markov chain, one can compute the
posterior density using the forward/backward procedure
(Devijver, 1985) in the fuzzy context. The forward and
backward densities as(xs),bs(xs) are deﬁned by
asðxsÞ ¼ pðxs; y1; . . . ; ysÞ; ð30Þ
bsðxsÞ ¼
pðysþ1; . . . ; yN jxsÞ
pðysþ1; . . . ; yN jy1; . . . ; ysÞ
: ð31Þ
The recurrence formula providing these quantities, are













minimization of (29). Moreover, as in the hard context, it
is possible to simulate posterior realizations of the variable
X using the posterior transition pysþ1ðxsþ1jxsÞ and initial
densities pYX sðxsÞ i.e., for any (xs,xs+1) 2 [0,1]
2:
pYX sðxsÞ ¼ asðxsÞ  bsðxsÞ; ð34Þ
pysþ1ðxsþ1jxsÞ ¼




5.2. Segmentation of the NSFMC
The segmentation problem consists then in estimating a
realization of an hidden process X = x, which is not neces-
sary Markovian, given a set Y = y. In order to estimate the
fuzzy process X, one has to minimize the conditional expec-
tation (27). In order to estimate the hidden auxiliary pro-
cess U, we apply the classic decision task (36)
corresponding to the local ‘‘0–1’’ loss function:
bU opts ¼ arg minbU s¼u^s P ½U sjY ¼ y: ð36Þ
Thus, it is necessary to compute the posterior densities
p[XsjY = y] and p[UsjY = y] in order to perform the deci-
sion processes (27) and (36). They correspond to the mar-










Z = (X,U) being a pairwise Markov chain, it is possible to
compute the posterior distribution p(zsjy) by the means of













bsþ1ðe; kÞpðysþ1je; kÞpðe; kjzsÞdmðeÞ: ð39Þ
Using the hypothesis related to the observed data, we sim-












bsþ1ðe; kÞpðysþ1jeÞpðe; kjzsÞdmðeÞ: ð41Þ
At each step, we compute the posterior distribution
pðxs; usjyÞ ¼ asðxs; usÞ  bsðxs; usÞ: ð42Þ
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In the same manner as we have seen in Section 5.1, it is pos-
sible to simulate hidden realizations of the variable
Z = (X,U) according to the posterior initial and transition
densities. This allows us to estimate hyper-parameters by
using the well known SEM procedure.
6. Hyper-parameter estimation
We focus in this section on the estimation of the param-
eter h in the context of a non-stationary variable. Actually,
the stationary context is a particular case, for which U
owns one discrete state i.e., CardK = 1. The ﬁnal segmen-
tation step requires the parameter set h = (hZ,hY) where
the prior parameters hZ deﬁne the prior density of the Mar-







11; aij; bijÞ for the P-SFMC and P-NSFMC
approaches. The parameters hY = ((l0,l1); (r0,r1)) deﬁne
the distribution of the data driven conditional on X. For
each posterior realization of the ﬁeld Z = (X,U), an SEM
estimator (empirical frequencies and moments) is used to
estimate the hyper-parameters. When the sequence h[p]
approaches steady state – for example 1% of the relative
change in the values – we stop the procedure. Let us con-
sider now the problem in estimating hZ and hY separately.
6.1. Data driven parameter estimation
Let us suppose now, we observe a realization (x,y) of the
pairwise (X,Y). In ahard classiﬁcation the empiricalmoment
estimator h^Y ðX ; Y Þ of hY corresponds to the maximum like-
lihood under conditional Gaussian laws assumption. When
we use a fuzzy classiﬁcation, it is enough to estimate the
parameters dealing with hard classes. We generalize the
method proposed in (Salzenstein and Pieczynski, 1997)
applying the empirical moments to the hard pixels. Let be
Qp = {s 2 S/Xs = p}, p = 0, 1 the sets of pixels which belong
to the hard classes. Our aim is to estimate the set of parame-

























6.2. Prior parameter estimation
Let us consider an hidden chain Z = (X,U) simulated by
its posterior distribution, according to the procedure
described in Section 5.1. The prior parameter hZ corre-
sponds to the initial and transition densities. They can be
deduced from the joint density, as seen in Section 3. We
consider two hypothesis: (i) the joint density is a non-
parameterized density. (ii) It depends on a parameterized
function /.
(i) NP-NSFMC: We compute the empirical M2 · K2
joint probabilities (45) according to diﬀerent neigh-
borhood conﬁgurations






pðes; esþ1; kp; kqÞdðm mÞes; esþ1Þ ð45Þ
We deduce the joint density from these probabilities.

























 P ½X s
2 I i;X sþ1 2 I j;U s ¼ kp;U sþ1 ¼ kq: ð46Þ
(ii) P-NSFMC: when the joint density is parameterized,


































01, aij and bij are deduced by conditions (15), (16),
(20).
Fig. 1. (a) A non-stationary fuzzy Markov chain X; (b) its related states
U; (c) its noisy version Y.
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7. Results on synthetic images
We simulated a non-stationary fuzzy Markov chain
on M = 10 discrete fuzzy levels, with two homogeneous
states (CardK = 2) and r = 1. The variables X and U are
represented in Fig. 1a and b. The class ‘‘0’’ (in black) of
U corresponds to an hard-dominating area in X
ðp1100 ¼ p
11
11 ¼ 0:2Þ, where as the class ‘‘1’’ (in white) corre-
sponds to a fuzzy area in X ðp1100 ¼ p
11
11 ¼ 0:05Þ. A noisy ver-
sion is represented in Fig. 1c. We give below the following





















ðl0; l1Þ ¼ ð120; 142Þ ðr0; r1Þ ¼ ð4; 4Þ:
Fig. 2a and b gives the segmented ﬁelds X corresponding to
the non-stationary (CardK = 2) case when one considers
respectively the parameterized (P-NSFMC with r = 1)
and non-parameterized (NP-NSFMC) approaches.
Fig. 2c–e corresponds to the stationary algorithm
(CardK = 1) applied to the image, respectively by the
means of a parameterized (P-SFMC), non-parameterized
(NP-SFMC) fuzzy Markov chain. Another stationary
method used is based on a fuzzy Markov ﬁeld (SFMF),
brieﬂy presented in Section 2. For the non-stationary ap-
proaches with two states, the segmented ﬁeld U is repre-
sented in Fig. 3a and b. Moreover, the estimated prior
parameters are indicated in Table 1, where as the noise
parameters for NSFMC, SFMC and SFMF are given,
respectively, in Tables 2 and 3. Finally the error rates com-
puted by (28) are given for all NP/P-(N)SFMC and SFMF
procedures in Table 4. The stationary method based on
FMC or FMF give higher rates of error than the non-sta-
tionary methods. The highest rate is given by the SFMF.
Fig. 2. Segmented images of X. (a) P-NSFMC; (b) NP-NSFMC;
(c) P-SFMC; (d) NP-SFMC; (e) SFMF.
Fig. 3. Segmented images of U. (a) P-NSFMC; (b) NP-NSFMC.
Table 1























Estimated data driven parameters for the non-stationary procedures
Parameters P-NSFMC NP-NSFMC
ðl^0; l^1Þ (119.99,142.12) (120.10,141.97)
ðr^0; r^1Þ (4.07,3.62) (4.1,3.72)
Table 3
Estimated data driven parameters for the stationary procedures
Parameters P-SFMC NP-SFMC SFMF
ðl^0; l^1Þ (121.02,141.25) (120.30,141.89) (1119.21,142.09)
ðr^0; r^1Þ (4.86,4.10) (4.24,3.76) (3.75,3.83)
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The SFMC are staying competitive but do not provide any
accuracy information concerning the homogeneity of the
image. Actually, the non-stationary procedure estimates
correctly the homogeneous areas (see Fig. 3a and b). Let
us notice the method using a non-parameterized neighbor-
hood density stay competitive facing the parameterized
assumption. Further studies must be performed in order
to measure the inﬂuence of the parameter r.
8. Results on real images
We wish to identify diﬀerent homogeneous regions
inside an image. We processed here our images in the
mono-spectral context. We present in Fig. 4a and b two
images of Oakland typically exhibiting a such situation.
Fig. 4a contains a sea area and the city, which appear to
be inhomogeneous on the picture, noticing that the distri-
bution of this part of the image behaves diﬀerently from
the distribution of the sea part. Fig. 4b contains a cloudy
area and a town area. We processed ﬁrst all images
Fig. 4a and b using a stationary approach. The results
are given in Fig. 4c–f, respectively by the FMC and the
FMF algorithm. These methods do not provide the ﬁne
details and give comparable results. It is then necessary
to take into account the stationary information, initializing
the algorithm with more than two stationary states (K > 2).
The segmented ﬁelds X and U are represented, respectively,
in Fig. 5a–d. In particular, the class ‘‘0’’ of U indicates the
high density region i.e., the city part. Our procedure
ensures a convergence of the stationary ﬁeld towards
K = 2 classes, which suits the initial hypothesis of both
groundtruth models i.e., city/sea areas for Fig. 4a and
city/cloud areas for Fig. 4b. The results given by the hidden
realizations X are less convenient because the method tends
to lose some details, concerning the lower homogeneous
regions. In order to enrich the information providing by
this ﬁeld, we propose to combine the NP-FMC and NP-
NSFMC approaches into an algorithm as follows:
• (i) Perform the NP-NSFMC method to the observed
data.
• (ii) For each stationary state Ui, i = 1,2, . . .,K, apply a
stationary NP-FMC method. For each state i, the data
corresponding to Uj, j5 i are processed as missing data:
one has to suppress them in the Hilbert-Peano path
(Salzenstein and Collet, 2006).
Table 4
Rates of error for the stationary and non-stationary procedures
P-SFMC NP-SFMC P-NSFMC NP-NSFMC SFMF
5.85% 6.01% 5.18% 5.35% 6.79%
Fig. 4. (a, b) The observation; (c, d) segmented images using SFMC; (e, f)
segmented images using SFMF.
Fig. 5. Segmented images of Fig. 4a and b, using a non-stationary
method. (a, b) Realizations of X; (c, d) associated U containing two states
K = 2.
F. Salzenstein et al. / Pattern Recognition Letters 28 (2007) 2201–2208 2207
Consequently, we applied the method separately for each
stationary parts of Fig. 4a and b. The segmented data cor-
responding are given in Fig. 6. Although the interpretation
is more delicate, requiring separate graylevels/pictures, the
ﬁnal results provide more detailed groundtruth.
9. Conclusion
We presented in this paper a new fuzzy Markov chain
model based on a non-stationary approach. On one hand
we modeled the prior parameters of a stationary chain
using a parameterized joint density deﬁned on neighbored
sites. On the other hand, we used an intermediate ﬁeld U
in order to govern the switching in the distribution of X.
Here the classes in U are discrete while the classes in X
are continuous. The proposed method merges the fuzzy
processing technique and a recent technique that has been
used to describe non-stationary images for hard classiﬁca-
tion. This model is more ﬂexible than the single chain based
procedure, in the following manner: (i) the pairwise (X,U)
is a Markov chain, but X is not necessary Markovian; (ii)
the stationary model is a particular case with one discrete
state in U. The fuzzy context should be better adapted than
the hard approach when the scene owns diﬀuse structure.
In order to take into account the complexity of multiple
real situations, it worths to extend this model to the
multi-sensors context and non-Gaussian data driven
distributions.
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a b s t r a c t
The display of image fusion is well accepted as a powerful tool in visual image analysis
and comparison. In clinical practice, this is a mandatory step when studying images from a
dual PET/CT scanner. However, the display methods that are implemented on most work-
stations simply show both images side by side, in separate and synchronized windows.
Sometimes images are presented superimposed in a single window, preventing the user
from doing quantitative analysis. In this article a new image fusion scheme is presented,
allowing performing quantitative analysis directly on the fused images.
Methods:The objective is to preserve the functional information provided by PETwhile incor-
porating details of higher resolution from the CT image. The process relies on a discrete
wavelet-based image merging: both images are decomposed into successive details layers
by using the “a` trous” transform. This algorithm performs wavelet decomposition of images
and provides coarser and coarser spatial resolution versions of them. The high-spatial fre-
quencies of the CT, or details, can be easily obtained at any level of resolution. A simple
model is then inferred to compute the lacking details of the PET scan from the high fre-
quency detail layers of the CT. These details are then incorporated in the PET image on a
voxel-to-voxel basis, giving the fused PET/CT image.
Results:Aside from the expected visual enhancement, quantitative comparison of initial PET
and CT images with fused images was performed in 12 patients. The obtained results were
in accordance with the objectives of the study, in the sense that the organs’ mean intensity
in PET was preserved in the fused image.
Conclusion:This alternative approach to PET/CT fusiondisplay shouldbeof interest for people
interested in a more quantitative aspect of image fusion. The proposed method is actually
complementary to more classical visualization tools.
© 2008 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Multimodality imaging has become a mandatory exploration
in many clinical applications. PET/CT hybrid scanners con-
stitute today a necessary tool in diagnosis, treatment and
staging of cancer [1–3]. The complementary information pro-
∗ Corresponding author. Tel.: +33 298018105.
E-mail address: nboussion@yahoo.fr (N. Boussion).
vided by this kind of dual imaging device allows revealing the
physiological state of malignant tumours by PET while in the
same time, the CT image offers anatomical accuracy through
high-spatial resolution. One of the specific uses of PET/CT
that currently encounters increasing interest is intensity-
modulated radiotherapy (IMRT). Recent works tend to prove
0169-2607/$ – see front matter © 2008 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.cmpb.2007.12.009
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indeed that PET/CT-guided IMRT improves treatment planning
while reducing tissue doses, for example in head and neck
cancer [4].
Aside from the problem of spatial co-registration of PET
and CT images, which permits their superposition on a voxel-
to-voxel basis, the effective management of images in a
day-to-day clinical use consists of their visualization. This
step is of great importance since it allows comparing the
images and making an accurate judgment according to func-
tional and morphological complementarity. Two main types
of visualization techniques exist [5]. In the first one, the two
images are displayed side by side in two separate windows,
with synchronized commands and cursors. This method of
display presents the advantage of preserving information but
the efficient visual comparison of structures remains diffi-
cult. The second visualization approach is the overlay of both
images in a single window. Several approaches can be cho-
sen but most of them require two look-up-tables, generally
a grey level one for the CT image and a colour one for the
PET image. An easy way to proceed is to display a voxel of
each image alternately, like a mosaic. Another approach is
to blend the images using a single look-up-table but then
the intensity in a voxel is a weighted sum of PET and CT
intensities in the given voxel. Recent works in this domain
include multi-image voxel composting [6] in which the CT
image is decomposed into several layers with different ranges
of contrast adjustments, each one corresponding to a particu-
lar tissue (bone, lungs, soft tissues, etc.). These layers are then
weighted and mixed together, finally been blended with the
PET image.
In oncology staging or treatment planning it is of decisive
importance to follow the evolution of both tumour activity
and size. However, such quantitative measurements cannot
be directly derived from the fused images since the intensity
in a voxel is a mixture of corresponding PET and CT inten-
sities. Even if the anatomical information is preserved to a
certain extent, it is impossible to measure the PET intensity
in a given region of interest. Moreover, the complementarity
aspect of fusion display loses its interest in the sense that it is
limited to visual inspection.
By enlarging the field of investigation, one may notice that
image fusion concerns many fields, like geosciences [7], food
safety [8], fingerprints analysis [9], biometric imaging [10] or
forensic investigations [11]. Nevertheless, the objective of all
these studies remains largely in the scope of visual enhance-
ment of images without considering the quantitative aspect
which is of outmost importance in medical imaging. Some
general surveys have been also performed but mostly tackling
without specific attention the medical aspect of image fusion
algorithms [12].
In this article, we introduce a new fusion display scheme
able to preserve the quantitative functional information pro-
vided by PET, and in the same time, able to maintain
morphological details of the CT. The algorithm is based
on multi-resolution analysis of the PET and CT images
using wavelets. After presenting the theory and implemen-
tation of this method, we apply it on a number of clinical
whole-body example imagedatasets andperformquantitative
analysis to demonstrate its potential for preserving relevant
information.
2. Background
2.1. Basic theory on continuous wavelet transform
(CWT)
For the sake of clarity, definitions are given for an 1D func-
tion f, but a more general theory can be found in [14]. The
wavelet transformW of an 1D, real, square-integrable function










where a is the scale of the analysis and b is the parameter of
translation corresponding to the position of the wavelet  ( *
stands for the complex conjugate of ). W(a, b) is the inner

















W may also be seen as a measure of similarity between
the function f and the basis functions a,b which are derived
from the so-calledmother wavelet  . Here, similarity refers to
a comparable frequency content, at the current scale a. The
wavelet analysis can then be seen as a mathematical micro-
scope which does not depend on the magnification once the
optical  is chosen.
The reconstruction formula is












(ˆ is the Fourier transform of  ).
2.2. Discrete wavelet transform (DWT)
The discrete wavelets that have been introduced are no longer
continuously translatable and scalable but can simply be











This very general solution has been proposed by
Daubechies [13], who also suggested the choice of a=2
and b=1 (dyadic sampling) to obtain orthogonal basis func-
tions for certain  wavelets (Daubechies wavelets). The
multi-resolution analysis developed by Mallat [14] allows to
implement this discrete approach by using high-pass and
low-pass filtering and sub-sampling. However, this algorithm
cancels shift invariance which may be a problem when deal-
ing with several images like in image fusion. The resulting
wavelet transform is no longer shift invariant, which means
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that the wavelet transforms of an image and of a shifted ver-
sion of the same image are not simply shifted versions of each
other. For this reason we have chosen to use the undecimated
“a` trous” algorithm which is totally shift invariant and also
easier to implement. It also has the advantage of leading to
wavelet images of same size as the original image, allowing to
compare details at different scales on a voxel-to-voxel basis.
The general theory linked to this algorithm is extensively pre-
sented in [15], where accurate comparison with the Mallat
implementation of DWT is also provided.
3. Design considerations
In this section we present the iterative “a` trous” algorithm
which can be easily implemented on a given image I. This
discrete wavelet transform algorithm was introduced by
Dutilleux [16], developed by Holdschneider [17] and detailed
by Starck et al. [18]. The process gives an image sequence of
coarser and coarser spatial resolution by performing succes-
sive convolutions with a low-pass filter h. At each iteration j,
the spatial resolution of the approximation image appj−1 is





The first approximation image app0 is taken as I, the
original image. The difference appj−1−appj is the wavelet
coefficientswj containing the details (edges, texture) at a reso-
lution level between appj−1 and appj. The synthesis procedure
that reconstructs the original image from its layers of details
wk is given by




with N the number of iterations from the initial image I to the
final approximation IN of spatial resolution decreased by 2N.
The algorithm can be easily implemented by performing
the following steps [18]:
1. Initialize j to 0: start with the original image I=app0 (app
stands for approximation).
2. Increment j and carry out a convolution of appj−1 with
a low-pass filter h in order to obtain appj (the distance
between the central voxel and the adjacent ones is 2j−1).
3. The wavelet coefficients w(j) at this level of resolution are
given by appj−1−appj.
4. If j is less than the required number N of resolutions go to
step 2.
5. The set W =
{




Practically, at each iteration, zeros are inserted between
lines and columns of the filter h giving its name to the algo-
rithm “a` trous” which in French means “with holes”. In this
work, the chosen low-pass filter h(k) = (1/16, 1/4, 3/8, 1/4, 1/16)
Fig. 1 – Illustration of the PET enhancement process on simulated images (a) wavelet transform of the original simulated CT
image (resolution level q); (b) wavelet transform of the original simulated PET image (resolution level q+2); the lacking
details of the PET image, WPETq+1(x) and W
PET




q+2(x) of the CT
images which are modified according to the model defined between existing details of both CT and PET at a lower but
common level of resolution; (c) the enhanced PET image is the voxel-to-voxel addition of the original PET image with the
retrieved details WPETq+1(x) and W
PET
q+2(x).
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is deduced from the spline function of order 3 [19]:
(x) = 1
12
(|x− 2|3 − 4|x− 1|3 + 6|x|3 − 4|x+ 1|3 + |x− 2|3).
In 2D we have 2D(x, y) =(x)(y) thus leading to h2D(k,




1/256 1/64 3/128 1/64 1/256
1/64 1/16 3/32 1/16 1/64
3/128 3/32 9/64 3/32 3/128
1/64 1/16 3/32 1/16 1/64




This filter is isotropic, has a Gaussian-like shape and can
be convolved in two steps (columns and then lines).
4. System description
4.1. Alternative “a` trous” implementation and
combination process
Themethod relies on the fact that PET and CT images are spa-
tially co-registered, i.e. both images can be superimposed and
are reconstructedwith the same voxel size. The fusion display
approach presented here aims at preserving relevant infor-
mation provided by each modality: anatomical details and
high-spatial resolution from CT on the one hand, and func-
tional data from the PET on the other hand. For this purpose
the anatomical details provided by the CT and correspond-
ing to resolution levels that are not present in the PET are
detected, extracted, modified and injected in the PET image
on a voxel-to-voxel basis.
Wavelet analysis allows the spatial frequencies to be eas-
ily obtained, in particular at a level of resolution common to
the CT and PET images. A model is then inferred to estimate
the lacking details of PET from the high frequency details lay-
ers of CT. If the level of resolution of CT is q, referred to as
CTq, and the one of PET is r=q+p, referred to as PETr, we can
write






The lacking details of PET are the wavelet coeffi-
cients wPET
i
(r) with q≤ i≤q + p; however we do possess
wPETq+p+1(r) and wCTq+p+1(r) and we assume that there exists
a more or less simple link between them like wPETq+p+1(r) =
˛×wCTq+p+1(r), ˛∈ IR∗ for instance. Although, different models
can be envisaged, in this study a simple linear model is used
Fig. 2 – An example of CT decomposition using dyadic and linear transformation (“a` trous” algorithm). (a) original CT image
of resolution 1mm; (b)-(e) wavelet layers corresponding to details of resolution 1mm-2mm, 2mm-4mm, 4mm-5mm and
5mm-6mm, respectively; (f) residual approximation image; (g) reconstructed CT image corresponding to the pixel-to-pixel
addition of wavelet layers (b)–(e) and residual image (f); (h)difference between original CT image (a) and reconstructed CT
image (g).
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where the parameter alpha is considered equal to the mean
voxel-to-voxel division of wPETq+p+1(r) by wCTq+p+1(r).
PETq cannowbe reconstructed fromPETr by taking thewPETi










As stated above, the undecimated “a` trous” implementa-
tion of the DWT is dyadic which means that the resolution
decreases by a factor of two at each iteration. Thus if the res-
olution of CT is 1mm and the one of PET is 8mm the process
is able to separate the wavelet images of CT in the sequence
w1–2mm,w2–4mm, andw4–8mm, and the resulting CT approxi-
mation has a resolution of 8mm, exactly the same as the PET.
However, if the resolution of PET is 6mm, it is impossible to
obtain a CT approximation with a resolution equal to 6mm.
The resolutions that can be obtained are only 2mm, 4mm,
8mm, 16mm and so on. For this reason we modified the clas-
sical implementation of the algorithm to make any discrete
resolution level available. In the normal implementation, the
sampling of the image to be convolved is widened by a fac-
tor of 2 at each iteration. This is done indirectly by inserting
zeros in thefiltermask: thedistance between the studied voxel
and its neighbours is 2j−1. This sampling scheme is manda-
Fig. 3 – Example of PET contrast enhancement by combination with CT. First column: CT images (transverse, sagittal,
coronal); second column: PET images; third column: enhanced PET images. The combination scheme was dyadic + linear
decomposition.
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Fig. 4 – Supplementary example of fusion, here on a restricted area corresponding to lungs (Patient 6). From left to right: CT,
PET, enhanced PET.
tory to get perfect reconstruction, but the CT reconstruction
is not our final objective. The aim is to extract wavelet lay-
ers of details corresponding to resolution levels higher than
the resolution of the PET image. Consequently, we modified
the “a` trous” algorithm to get a linear version instead of a
dyadic one. The sampling is then performed differently in the
sense that zeros are still inserted in the filter, but the dis-
tance between the centre voxel and its neighbours becomes
j instead of 2j−1. The obtained series of resolution levels is
then 2mm, 3mm, 4mm, 5mm and so on. From this alterna-
tive implementation one can also deduce a third approach as
amixture of the two and referred to as “dyadic + linear”. In this
method, the dyadic implementation is performed first, lead-
ing to the series of resolutions 2mm, 4mm for instance, and
then the linear approach is performed giving resolutions of
5mm, 6mm, etc. The main interest consists of a gain in com-
putation time in comparison with a linear implementation
alone.
In this study, the model between details of PET and CT at
their common level of resolution is the mean voxel-to-voxel
division of the layer images containing wavelet coefficients.
The obtained parameter is then multiplied to each wavelet
Fig. 5 – Mutual information (MI) between initial and fused images, for the three presented methods (dyadic, linear,
dyadic + linear). Left: MI between CT and PET/CT fused images. Right: MI between PET and PET/CT fused images.
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image (always on a voxel-to-voxel basis) of the first CT decom-
position. These modified images containing high-resolution
details not present in the PET are added to the said PET giving
the actual fused image. A graphical description of the whole
process is shown in Fig. 1 in order to facilitate the understand-
ing of the method.
4.2. Clinical images and quantitative assessment
The presented algorithm and its different implementations
were tested on 12 clinical images. They consisted of whole-
body FDG PET and CT images of patients under oncological
follow-up. Images were obtained on a dedicated PET/CT scan-
ner (GE DLS) using a 5-min per bed position for the emission
acquisition (2D mode) and a CT scan (140kV, 80mA) over the
same area acquired under shallow breathing. Images were
Fig. 6 – Percentage of intensity variation between PET and
fused PET/CT in a series of ROIs (lungs, heart, liver). (a)
Dyadic analysis; (b) linear analysis; (c) dyadic + linear.
reconstructed using ordered subsets expectation maximisa-
tion (OSEM) with two iterations and 28 subsets. The CT maps
were used for attenuation correction [19] after being reduced
to 128×128 with a reconstruction slice interval of 4.25 to
match the in-slice resolution and the slice thickness of the
PET reconstructed images.
To our knowledge, there exists no “gold standard” approach
for evaluating a fusion display apart from visual assessment.
In this study considering the proposed methodology we have
chosen quantitative indices to evaluate the algorithm perfor-
mance andmore particularly to assess its specificity regarding
preservation of PET information.We have therefore compared
the intensity in regions of interest (ROI) corresponding to dif-
ferent tissues, in the PET images and then in the fused one,
for each patient. The regions investigated were lungs, liver
and heart and the ROIs were drawn manually on the PET and
reported automatically onto the fused image. Mean signal and
standard deviation in these ROIs were then calculated and
compared.
On the other hand in order to evaluate the fusion aspect
of the display we calculated also the mutual information
between PET and CT on the one hand and PET and the fused
image on the other. Given two images M and N, their mutual









where, p(M, N) is the joint histogram of M and N and p(M) and
p(N) the histograms of M and N, respectively. I(M, N) can be
seen as the amount of information that is common to M and
N. Consequentlywe calculated I(PET,CT), I(PET, fused) and I(CT,
fused).
As a last part, we calculated themean contrast along linear
plot profiles placed at two kinds of tissue boundaries. The first
group of profiles was put at the interface between lungs and
soft tissue (liver or heart) and the second group consisted of
profiles put across small tumours (10–40mm) inside homoge-
neous regions, mainly lungs and liver. In each obtained profile
the contrast was calculated using the following formula:
contrast = 100× |xj− xi|
xj+ xi ,
where xi and xj are the values of two adjacent pixels along
the slope of the profile. The local contrast was calculated on
each pixel of the slope and the mean contrast was the mean
of these values.
5. Status report
An example of CT image decomposition using the “a` trous”
algorithm (version using dyadic then linear transformation)
is shown in Fig. 2. The reconstructed CT image (Fig. 2g) is
very similar to the original one (Fig. 2a) since their voxel-
to-voxel difference (Fig. 2h) has only zero values apart from
a limited number of voxels. The quantitative measurements
on Fig. 2h give mean value 1.9×10−10±7.4×10−7, min value
−1.5×10−5 and max value 1.5×10−5 (mean of the absolute
values 5.4×10−6±5.7×10−6) while the same investigation
when using only dyadic decomposition would lead to a zero
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Fig. 7 – Example of PET/CT fusion (Patient 10) and location of two lines of interest (arrows) for calculating contrast. Intensity
profiles along these two lines are given in Fig. 8. Top: lungs-soft tissue; bottom: isolated tumour.
mean exactly. Fig. 3 shows the fusion results for Patient 5,
where CT and FDG PET images are illustrated as well as their
fusion, in the three planes of space (transverse, coronal, sagit-
tal). Patient 6 is shown in Fig. 4 where one can see with more
details the upper thoracic part of the body corresponding to
the lungs. Visually, the fusion allows a contrast improvement
of the PET image with details and boundaries better delin-
eated. In the same time, while detailed structures of the CT
appear in the fusion image the global intensity of PET is pre-
served.
Quantitative results are given in Figs. 5 and 6. In Fig. 5 one
can see the values ofmutual information between PET, CT and
fused PET/CT providing a degree of similarity between images.
The curves’ shapes in Fig. 5a and b are similar and show that
the degree of similarity between PET or CT and PET/CT fused
images is much larger than the one between PET and CT (MI
mean increase 87%). A number of points can bemade based on
this result; namely that both initial images have contributed
to the fused image, and that the fused image contains more
information than the PET alone and the CT alone, which is
in accordance with the aim of a fusion process. On the other
hand, still considering themutual information, it appears that
the threemethods of analysis presented in Section 4.1, that is,
dyadic, linear, and dyadic + linear gave comparable similarity
values between images.
The variation of intensity between PET and fused PET/CT
images are given in Fig. 6 inwhich results are given also for the
three proposed methods (dyadic, linear and dyadic + linear).
One can see that concerning heart and liver, the differ-
ence never reaches 6% for the dyadic and dyadic + linear
approaches, while it remains under 10% for the linear
approach. As far as the lung results are concerned, the dif-
ference in intensity between PET and fused PET/CT is larger,
attaining 25% for Patient 6 when using the linear approach
(Fig. 6b). However, the mean activity in lungs stays relatively
stable (variation less than 10%)when using the dyadicmethod
(Fig. 6a), and stays below 5% of variation when using the
dyadic + linear analysis (Fig. 6c).
Plot profiles along lines crossing tissue boundaries were
used to qualitatively evaluate the gain in contrast. Two exam-
ples are given in Figs. 7 and 8 where lines of interest are
given (for Patient 10) as well as their corresponding inten-
sity profiles. One can notice that the slope of the curves is
increased after PET/CT fusion (Fig. 8), proving that not only
the PET image is improved visually, but also in the same time
contrast at boundaries is increased. Quantitatively, the mean
contrast at boundaries between large regions (lungs–soft tis-
sues) was increased by +74.5% ±21.4% (min 36.1%, max 88.8%,
three profiles by patient, total 36 profiles). In the set of profiles
across isolated tumours inside homogeneous areas, the con-
trast increase was +52.5% ±19.5% (min 29.1%, max 81.3%, 27
tumours in total).
6. Lessons learned
In this article a new approach to PET/CT image fusion has
been proposed for whole-body imaging. Contrary to the great
majority of existing methods, the aim of the presented work
was to provide the user with a fused image preserving both
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Fig. 8 – Intensity profiles along segments of line shown in
Fig. 7 (Patient 10). After PET/CT fusion, one can observe that
slopes are sharper, which corresponds to an improvement
of contrast. At lungs–soft tissue boundaries; (b) across
tumour of the neck.
anatomical and functional data. The objective is therefore
different from simply presenting two images in a visually con-
venient fusion display in the sense that quantitative analysis
is also here considered as a possible step. In the proposed
methodology the anatomical information is present in terms
of improved contrast while the intensity in the organs is
comparable with the functional information presented by the
PET. This is of paramount importance in cancer staging and
treatment follow-up for instance, where quantitative assess-
ment of activity uptake is necessary. Furthermore, when using
PET/CT-guided IMRT the complementarity provided by the
image fusion proposed in this article may be of key interest.
Indeed, when considering day-to-day clinical use, this algo-
rithm is more user-friendly and allows physicians to gain a lot
of time when making diagnosis and treatment planning for
radiotherapy.
The method here described is rather simple to implement
and consists of introducing the high-resolution details of the
CT in the PET image by using wavelet transform. The discrete
implementation of the wavelet transform is performed using
original and alternative versions of the “a` trous” algorithm.
Actually, since the reconstruction of images is less important
in this application relative to accessing the wavelet images
corresponding to details, we modified the original algorithm
in such a way that all levels of resolution are accessible. This
alteration allows degrading the CT image to the exact level of
the PET resolution. Unfortunately, the discrete wavelet trans-
form prevents us from using real resolution values that are
more precise than integer values. Even if satisfying results
were obtained in this study, it would be valuable in futurework
to take into account actual resolution values.
Concerning the different versions of the “a` trous” algo-
rithm that are presented, it appears that the “dyadic + linear”
approach gives the best quantitative results. As a matter of
fact, the mean signal in the lungs before and after fusion
seems to change less than with the other two approaches
(dyadic alone or linear alone). Nevertheless, it is worth men-
tioning that in the present study the ratio between spatial
resolutions (CT and PET) was 6:1. Consequently, for the dyadic
approach, it was impossible to obtain CT details at the reso-
lution 6mm and we had to stop the decomposition at a level
of resolution equal to 8mm. This point may of course explain
why dyadic results were not as good as those obtained with
the dyadic + linear approach.
The change in intensity in the lungs could be explained
by the incorporation of the pulmonary vasculature present
in the CT and not in the PET (Fig. 9). Also, the model that
is used to modify the detail layers (images of wavelet coef-
ficient) obtained in the CT decomposition may be considered
too simplistic (mean voxel-to-voxel division). A more sophis-
ticated model would be preferable and one can consider that
adopting a local model may bemore appropriate, in particular
for limiting artifacts coming from structures present in the CT
only.
The methodology itself is of course not restricted to
whole-body imaging in the oncology domain. Provided two
co-registered images are available, one functional and the
other anatomical, the process can be applied in a wide range
of clinical areas. As an illustration (Fig. 10) we provide an
example of contrast enhancement of an FDG brain image pro-
vided by the fusion with the corresponding T1-weighted MRI.
Similar observations made on the whole body images results
can be also made in this particular case. Contrast is signifi-
cantly improved in the enhanced FDG PET, particularly at the
interface betweenwhitematter and graymatter. Furthermore,
mean activity in gray matter is preserved in such a way that
further image processing could be performed.
For interested readers, the algorithm is available upon
simple request by e-mailing the corresponding author. The
program is written in JAVA and can easily be added to the
free ImageJ software as an independent plug-in with simple
graphical user interface.
7. Future plans
Concerning the algorithm, it would be of great interest to
define a local model instead of a global one in order to modify
the detail layers of the CT. This improvement could lead to the
elimination of artifacts corresponding to structures present
in the CT but not in the PET. The results presented in this
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Fig. 9 – Potential influence of the pulmonary “network”. Left: PET before fusion; right: PET enhanced by integration of CT
details. The arrow shows that small structures like bronchioles present in the CT may locally but significantly alter the
intensity in lungs after combination with PET.
study were obtained using 2D calculation only. Indeed, most
discrete wavelet transforms still perform in 2D and 3D imple-
mentations do not exist or are not well validated yet. However,
a potential improvement could consist in applying the 2D
approach to each plane (sagittal, coronal and transverse) and
then making an average from the three obtained images.
To conclude, we have defined a new approach to medical
image fusion that allows performing quantitative analysis by
means of multi-resolution analysis. The intensity of voxels in
the PET image is indeed globally preserved while details of
high resolution coming from CT are introduced. As a result,
boundaries are better delineated and contrast is enhanced. A
Fig. 10 – Application of the proposed image enhancement in the cerebral context. Brain FDG PET image; (b) corresponding
T1-weighted MRI; (c) enhanced FDG PET after fusion of MRI.
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larger andmore comprehensive clinical evaluation of the pro-
posed method should be considered in order to evaluate the
potential impact of such a method, for instance in the staging
of cancer or treatment planning.
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Abstract
Purpose Partial volume effects (PVEs) are consequences of
the limited resolution of emission tomography. The aim of
the present study was to compare two new voxel-wise PVE
correction algorithms based on deconvolution and wavelet-
based denoising.
Materials and methods Deconvolution was performed
using the Lucy-Richardson and the Van-Cittert algorithms.
Both of these methods were tested using simulated and real
FDG PET images. Wavelet-based denoising was incorpo-
rated into the process in order to eliminate the noise
observed in classical deconvolution methods.
Results Both deconvolution approaches led to significant
intensity recovery, but the Van-Cittert algorithm provided
images of inferior qualitative appearance. Furthermore, this
method added massive levels of noise, even with the
associated use of wavelet-denoising. On the other hand, the
Lucy-Richardson algorithm combined with the same
denoising process gave the best compromise between
intensity recovery, noise attenuation and qualitative aspect
of the images.
Conclusion The appropriate combination of deconvolution
and wavelet-based denoising is an efficient method for
reducing PVEs in emission tomography.
Keywords FDG-PET. Image processing . Partial volume
correction .Whole-body PET
Introduction
Partial volume effects (PVEs) in emission tomography are a
well-known consequence of the limited spatial resolution
affecting both qualitative and quantitative accuracy of the
image. In this work, we refer to spatial resolution as the ability
to separate two small objects and, more precisely, the full-
width at half-maximum of the point spread function (PSF).
PVEs can be divided into three classes; namely (1) attenuation
of intensity in small structures compared with the PSF size,
(2) spill-in and spill-out affecting bordering organs or, more
simply, reciprocal intensity spread from one tissue to another,
and (3) tissue mixing in boundaries due to the discrete
sampling of images into finite voxels. The last one of these
three points is very general as it is a problem in a wide range
of medical imaging modalities, both functional or morpho-
logical. The voxel size is indeed a physical limit no modality
can overcome, whatever its intrinsic spatial resolution. On the
other hand, the first two points are more specifically related to
quantitative and functional imaging in general and to
emission tomography in particular. For this reason, in the
present work, we focus only on these two effects.
There exists a wide variety of algorithms aiming at
correcting PVEs in emission tomography the vast majority
of which have been evaluated in both single photon
emission tomography (SPECT) and positron emission
tomography (PET). Most of them are based on the use of
a priori information provided either by MRI or CT, and
remain, even in recent works, restricted to cerebral
applications [1–4]. One of these methods, described by
Rousset et al. [5], allows an estimation of the real mean
signal in any homogeneous tissue providing that its true
boundaries are known. This can be achieved by a manual
contouring or automatic segmentation (mostly used in brain
imaging) of the tissue of interest on the CT or MR image
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[6]. However, the assumption related to the tissue homoge-
neity in the region of interest (ROI) remains questionable and
relies mostly on visual analysis of the emission tomography
images. Furthermore, adequate tissue correlation between
SPECT/PET and MRI or CT cannot be achieved in certain
circumstances because of physiological motion in the patient
as well as uncontrollable movement of the patient in a more
general sense between and during image acquisitions. This is
mostly the case in oncology, where images are acquired
across the whole body. Unfortunately in this domain
structures of interest can be small (tumours) and therefore
PVEs significantly alter quantification. For this reason the
willingness to incorporate effective PVE correction into
PET/CT scanners dedicated to oncology remains of high
interest as recently discussed by Basu and Alavi [7].
Furthermore, problems in the use of anatomical information
for PVE correction include differences in the appearance
and size of some tumours (or structures in general) between
the functional and the anatomical images (for example
functional necrosis seen on PET may not necessarily be
observed on CT). This challenging problem has been
widely discussed recently [8].
In an attempt to obviate the need for drawing or
segmenting ROIs as well as producing PVE-corrected
images that can be used for further processing, we have
previously proposed and described a novel voxel-wise PVE
correction method for a broad range of clinical applications
[9]. On the other hand, this methodology involves mutual
analysis of PET and a coregistered anatomical image, and
consequently suffers from the limitations related to the
tissue spatial correlation already described. In a couple of
recent papers, alternative approaches to PVE correction in
PET using iterative deconvolution of emission data only
have been proposed. The first study was restricted to the
cerebral domain [10] and in the second the method was
ROI-based only [11]. An interesting third approach using
voxel-based deconvolution has also been proposed [12].
This method is based on the MLEM reconstruction
algorithm and requires the determination and the optimiza-
tion of eight parameters, most of them depending on the
image quality or the PET scanner properties. Despite the
fact that standard deconvolution algorithms are easy to
implement, they suffer from significant noise propagation
as a result of the additive (or multiplicative) approach in the
regularization component. These noise properties force the
application of deconvolution algorithms to specific ROIs,
where activity concentration values are calculated and
subsequently improved iteratively.
The aim of this study was to compare the performance of
two alternative deconvolution methodologies (Lucy-
Richardson and Van-Cittert) in combination with the
introduction of dedicated wavelet-based denoising algo-
rithms. The main objective of this work was to reduce the
noise introduced by the deconvolution process and subse-
quently improve quantitative accuracy for voxel-wise PVE
correction in whole-body imaging. The different algorithms
considered were tested on various datasets, including















where I is the observed image, O is the real object, PSF is the
degrading PSF, N is an additive noise and⊗ the convolution
operator. Teo et al. in [11] used the Van Cittert algorithm
[13] according to which it is possible to iteratively retrieve
the actual object O from the observed data I (the emission
tomography image in our case) and PSF, by writing:
O nþ1ð Þ r
!
 
¼ O nð Þ r
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 










where α is a converging parameter generally taken as 1. In
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is
called the residual because it is obtained by subtraction and
it converges towards noise. Considering this notation, the
Van Cittert algorithm may be rewritten as:
O nþ1ð Þ r!
 
¼ O nð Þ r!
 
þ aRes nð Þ r!
 
ð3Þ
For this reason the regularization step is additive.
There are a number of classical deconvolution algo-
rithms, each one with specific characteristics. In the Lucy-
Richardson deconvolution approach (see, for example,
references [14] and [15]), the regularization step is
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Considering the previous notation concerning the resid-
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Compared with the Van-Cittert approach, this multipli-
cative process has the advantage of limiting noise propa-
gation. For this reason, our investigation included the
implementation of this technique for PVE correction in
PET imaging in comparison to the Van-Cittert methodolo-
gy, which was also included in this study.
Wavelet-based denoising
In order to reduce noise introduced by the deconvolution
process and thus facilitate the use of deconvolution based
on the image rather than ROI for PVE correction in PET,
we propose in this work the integration of wavelet-based
denoising in the deconvolution process.
When considering image processing from a general point
of view, wavelet denoising is one of the most powerful
denoising methods and is the theme of numerous publica-
tions. The procedure consists of three steps, and the main







contains the true signal S with noise N. These three
steps are described by the following equations:
Y ¼ W Ið Þ ð6Þ
J ¼ T Y; tð Þ ð7Þ
Sest ¼W
1 Jð Þ ð8Þ
where W and W−1 are the direct and inverse wavelet
transform operators, T(t) is the denoising operator depend-
ing on the threshold t. In terms of the implementation of the
denoising operator T and/or the threshold t selection
different algorithms may be considered. In this work one
of the most robust algorithms, the BayesShrink [16]
described below, was used.
BayesShrink
Given threshold t for any data w, the rule:
T w; tð Þ ¼ sgn wð Þmax 0; wj j  tð Þ ð9Þ
defines the simplest version of thresholding, known as
nonlinear soft thresholding. The operator T nulls all values
of w for which wj j  t and shrink towards the origin by an
amount t all values of w for which wj j > t. Considering the
context of use in the present study w stands for the wavelet
values that we wish to threshold. For this reason, the soft
thresholding rule in the wavelet domain is often referred to as
wavelet shrinkage denoising. Most work concerning
wavelet-based denoising is due to Donoho [17], with one
of the primary developments being a method called
Visushrink [18]. In this latter, a general threshold, now





with N being the sample size and σ the
noise expressed as the standard deviation of the wavelet
transform values. Although in most common situations it is
impossible to measure σ from the corrupted (noisy) image,
it is possible to estimate it from the first subband of the
wavelet transform as:
s¼
Median wij jð Þ
0:6745
; wi 2 first sub band ð10Þ
Without challenging the soft-thresholding strategy, alter-
native threshold value selections have been also proposed.
Assuming a generalized gaussian distribution of the wavelet
coefficients, Chang et al. proposed a method based on the
Bayes theory, referred to as BayesShrink [16]. This
approach performs soft-thresholding with a data-driven,





ing the noise variance estimated using the median operator
already described, and sX ¼
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and n2 is the size of the considered subband.
The main interest in this robust method is because of the
fact that the filtering threshold is adapted to different levels
of resolution where noise properties can be very different.
Actually, because of the limited PSF, the noise in emission
images is not white but coloured and therefore noise
variance changes across subbands.
The wavelet transform
Wavelets have already been used in different domains and
different applications of emission tomography [9, 19, 20].
In this section we consider the choice of the wavelet
transform provided that some requirements are met
concerning the specific application of interest. First, the
kind of images we are concerned with may be large and
thus require a substantial amount of computer memory.
Furthermore, the overall processing time should remain
reasonable since use in the clinical domain is the aim. At
last, a crucial point is the fact that we need to reconstruct
the image from its altered (filtered) wavelet coefficients.
For this reason, the so-called Decimated Wavelet Trans-
forms (for example the pyramidal algorithm of Mallat) are
not well adapted for our application due to the loss of the
translation-invariance property [21, 22]. The elimination of
the decimation process leads to wavelet transforms of size
exactly equal to the original image, as in the dyadic “à
trous” algorithm. This latter approach to wavelet transform
is called Undecimated Wavelet Transform (UWT). At each
iteration, which decreases spatial resolution while preserv-
ing image size, three images are generated presenting edges
and details in horizontal, vertical and diagonal directions
respectively. Equivalence between the UWT and Mallat’s
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algorithm has been previously demonstrated by Shensa
[23]. In some applications, as in the one we are dealing
with, the direction may appear of reduced practical interest.
By choosing adequate filters it is possible however to
obtain a single isotropic wavelet image instead of three
directional ones allowing a gain in both memory require-
ment and computing time. This approach is called Isotropic
Undecimated Wavelet Transform (IUWT) and was chosen
for our denoising problem. From a theoretical point of view,
its similarity with Mallat’s algorithm has been recently
proved by Starck et al. [24]. A 2-D wavelet decomposition
was chosen for the sake of simplicity.
Algorithm
The IUWT of the image I, performed using the filter f, leads
to the set W = {w1, w2,…, wi, IJ}, where wi are the wavelet
coefficients at scale i and IJ is a smoothed version of I, that
is I at scale J. The passage from one level of resolution, or
scale, to the next which is reduced by half (dyadic
progression) is performed as follows:
Iiþ1 x; yð Þ¼ f  Ii ¼
X
u;v
f u; vð ÞIi xþ 2
i u; yþ 2iv
 
ð11Þ
The corresponding wavelet coefficients, on which actual
denoising is performed, are hence obtained by a simple
pixel-to-pixel subtraction:
wiþ1 x; yð Þ¼ Ii x; yð ÞIiþ1 x; yð Þ ð12Þ
Finally, the original image I is reconstructed without any
loss by adding all wavelet images to the final smoothed IJ:
I x; yð Þ ¼ I0 x; yð Þ ¼ IJ x; yð Þ þ
XJ
j¼1
wj x; yð Þ ð13Þ
PVE correction by integrating wavelet-based denoising
into iterative deconvolution
In the previous sections we have introduced the different
tools to be employed for the implementation of the
proposed voxel-wise PVE correction in such a way that
the complete methodology can now be described in detail.
The algorithm consists of only two nested steps.
In the first step the image we wish to correct for PVEs
undergoes deconvolution using either the Van-Cittert or the
Lucy-Richardson algorithm. The denoising phase is per-
formed concomitantly by applying wavelet-based thresh-
olding to the residual Res (Eqs. 3 and 5 for the Van-Cittert
and the Lucy-Richardson algorithms, respectively) at each
iteration of the deconvolution process. Thus, before
addition or multiplication, Res undergoes IUWT (section
The wavelet transform) and the obtained wavelet images
are denoised according to the BayesShrink method (section
BayesShrink). In the present study, the IUWT was
performed using the bicubic-spline filter and up to J=3,
which means that three wavelet images (or subbands) were
obtained. Each of these was denoised and the obtained
altered wavelet values were used to reconstruct a noise-
attenuated residual Res. One of the limitations of wavelet-
based thresholding is the 2-D aspect. To circumvent this
limitation the denoising process was applied on the three
planes of the space (axial, coronal, sagittal) and the final
thresholded Res image was obtained by averaging the three
sets of data on a voxel-by-voxel basis. For comparison
purposes, deconvolution without denoising was also per-
formed using both the Van-Cittert and Lucy-Richardson
methodologies.
Deconvolution algorithms assume that the PSF is known
and stationary across the field of view (FOV), or at least
inside the whole image to be analysed. This is not the case
in emission tomography where the PSF can vary in the
three directions of the FOV. Although an accurate measure
of the PSF is possible by acquiring images of line sources
at different positions throughout a system’s FOV, one can
only use a single PSF in the deconvolution process. This
could potentially induce errors when considering the
accuracy of the PVE correction in different regions of a
given image. In the previous work by Teo et al. [11], it was
shown that a 1-mm error in the PSF would lead to a
negligible impact on standard uptake values measured
inside homogeneous areas. This study concerned the Van-
Cittert algorithm only and no denoising technique was
incorporated into the deconvolution process. We further
investigated this potential issue in our study considering an
image simulated with a 6-mm PSF and containing a 15-mm
diameter sphere. The sphere-to-background ratio (SBR)
was modelled as 8:1 (before degrading by Poisson noise
and a 6-mm PSF). SBR was finally measured after
deconvolution using the different algorithms considered in
this study with different PSF values, ranging from 4 mm to
8 mm, in 1-mm increments.
All programs were implemented using C on a Pentium 4,
single processor, 2 Gb memory personal computer.
Test images
Different images were used to test and compare both the
Van-Cittert and Lucy-Richardson algorithms, with and
without wavelet denoising. Simulated and phantom data
were used to assess the behaviour of the algorithms and to
quantify their properties, considering perfectly known
object intensity and sizes.
The aim of the first image dataset was to appreciate the
global behaviour of the techniques and was manually
designed from a real heterogeneous liver tumour isolated
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from a clinical FDG scan. The tumour was extracted from
the original image and then manually segmented into three
classes (necrosis, active tissue, background). Activity
values were attributed to each class based on the relative
activity levels in the original image and Poisson noise was
added with mean value equal to each considered class
value. The obtained image was then blurred by a 6.5 mm ×
6.5 mm × 7 mm 3D- Gaussian kernel, giving the final
synthetic tumour PET image. The same kernel size was
used in the deconvolution algorithms.
The second dataset comprised real acquisitions from a
FDG-filled cylinder phantom (IEC) containing six spheres
with diameters ranging from 10 mm to 37 mm. Acquis-
itions were carried-out in the list-mode format using a
Philips GEMINI GXL PET/CT scanner (Philips Medical
Systems, Cleveland, OH). The SBR was set to 8:1 by
introducing 7.4 kBq.cm−3 and 59.2 kBq.cm−3 in the
background and in the spheres, respectively. Three different
statistical qualities were obtained by reconstructing 1-min,
2-min and 5-min list-mode time frames using the 3-D
RAMLA algorithm (voxel sizes of 2 cm×2 cm×2 cm).
These phantom images were also used to assess the impact
of the accuracy of the PSF size to the overall performance
of the deconvolution algorithms considered (see also
section PVE correction by integrating wavelet-based
denoising into iterative deconvolution).
The third set of images comprised clinical FDG whole-
body images of 13 patients undergoing oncological
staging. Images were acquired on a Philips GEMINI
GXL PET/CT scanner (seven patients) at an average of
54 min after injection of an average of 380 MBq with an
acquisition of 3 min per bed position, and on a GE
Discovery LS (GE Healthcare, UK) scanner (six patients)
after an injection of an average of 366 MBq and an
acquisition time per bed position of 5 min. Lesions were
localized in the lungs and/or in the abdomen. Images of
the patients acquired with the Philips and GE systems
were reconstructed using optimized parameters for the
RAMLA 3-D [25] and OSEM (two iterations, 28 subsets,
4.3×4.3×4.25-mm voxels) respectively.
Data collection and analysis
Intensity was computed as the mean signal inside ROIs. For
the simulated tumour and the cylindrical phantom, the size
of the ROIs was known exactly and their actual boundaries
were used to calculate mean intensities. The level of noise
inside these ROIs was calculated as the standard deviation
of the signal. For this purpose we used smaller ROIs in
order to estimate the noise in areas as homogeneous as
possible. The aim was to eliminate the regions close to the
boundaries where on the one hand PVEs are known to
produce large intensity gradients and where on the other
hand voxels contain a mixture of tissues due to discrete
sampling (tissue fraction effect).
Considering the clinical data we first evaluated the
intensity inside large and visually uniform areas including
the lungs, the liver and other soft tissues. The selection of
these ROIs was made assuming that PVEs were either null
or negligible inside them. In total 45 ROIs were manually
drawn. The mean intensity and the noise were thus
calculated inside areas of identical sizes, contrary to the
lesions where the same approach as for the simulated/
phantom data was used. Nevertheless, the exact size of the
lesions was obviously unknown. As a consequence they
were manually segmented by an expert in the field of
clinical nuclear medicine imaging.
Results
The different PVE correction methods implemented in this
study, i.e. Van-Cittert with and without BayesShrink
denoising, and Lucy-Richardson with and without Bayes-
Shrink denoising, are referred to from here onwards as
VC_B, VC, LR_B and LR, respectively. Images in Fig. 1
show the synthetic tumour simulated from an actual liver
tumour, before and after using the different deconvolution
algorithms. One of the things to notice is the very noisy
aspect of the image generated by the Van-Cittert deconvo-
lution alone (Fig. 1b). When incorporating wavelet-based
denoising in this algorithm, noise is drastically reduced but
artefacts present in the originally deconvolved images (see
Fig. 1b) persist, manifested by underestimated activity
regions appearing around high-intensity tissues (see arrow,
Fig. 1c, and plot profile, Fig. 1f). On the contrary, the Lucy-
Richardson algorithm provided artefact-free images, with a
far less significant noise even without denoising (Fig. 1d,
e). The quantitative results, which are given in Fig. 2, show
that both deconvolution methods added noise to the
corrected image. Nevertheless, the use of the Van-Cittert
algorithm alone always led to the largest amount of noise
while the combination of Lucy-Richardson and wavelet-based
denoising provided less noisy images (in certain circum-
stances approaching the noise levels of the original image; for
example, tissue 1 in Fig. 2a). Considering the accuracy of the
PVE correction (i.e. the ability to retrieve the original
intensity in a given tissue), the percentage of intensity loss
is shown in Fig. 2b. Tissue 1 (expected intensity 20,000) and
tissue 2 (expected intensity 50,000) intensity losses due to
PVEs are 10% and 15%, respectively, while the application
of the LR_B protocol led to 3.8% and −0.6%, respectively,
which are the best results among all the PVE correction
methods under investigation.
The same PVE correction processes were applied to the
IEC cylinder phantom images containing spheres of
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different diameters (expected SBR of 8:1). Qualitatively
similar remarks as for the synthetic tumour can be made
(Fig. 3). Van-Cittert deconvolution alone generated elevated
noise levels both in the background and in the spheres
(Fig. 3b). Adding wavelet-based denoising significantly
attenuated these effects (Fig. 3c), although LR_B method
provided the best visual results in this example (Fig. 3e).
The SNRs (calculated as mean/SD) in the background area






Fig. 1 Synthetic tumour simu-
lated from the manual segmen-
tation of a real liver tumour. a
The uncorrected image shows
two classes of different active
tissues surrounding a necrotic
area. b–e Images after applica-
tion of the VC method (b),
VC_B method (c), LR method
(d) and LR_B method (e). f Plot
profile across the area shown by
the arrow in c. Note the signif-
icant overcorrection induced by
the VC_B method
Fig. 2 Quantitative measures in the tissues of the synthetic tumour. a
Noise amount expressed as the standard deviation of the intensity in
each tissue. b Accuracy of the intensity recovery expressed as the
error percentage between the expected intensity (20,000 and 50,000
for tissue 1 and tissue 2, respectively) and the measured mean
intensity in each tissue
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of the cylinder for the uncorrected image, the VC image,
the VC_B image, the LR image and the LR_B image were:
9.54, 3.23, 3.96, 5.51 and 6.67, respectively, for the 1-min
time frame acquisition; 12.08, 4.87, 5.91, 7.61 and 8.63,
respectively, for the 2-min time frame acquisition; and
16.41, 6.90, 8.13, 10.82 and 12.34, respectively, for the
5-min time frame acquisition. These values support the
visual impression that the use of the Van-Cittert deconvo-
lution alone leads to large noise levels, significantly
compromising any potential PVE correction for the deriva-
tion of improved images.
SBRs and percentage noise increase are shown on
Fig. 4. In this particular set of phantom data the percentage
of SBR recovery was found to be comparable whatever the
algorithm used, either with or without denoising. The
intensity recovery difference in the spheres considering
the different algorithms under investigation was at a
maximum between the images corrected with the VC and
the LR_B algorithms (difference between 5% and 20%
increasing with decreasing lesion size). These results were
generally uniform whatever the level of statistical noise in
the images as a result of evaluating different time
acquisitions (1, 2 and 5 min; Fig. 4a, Fig. 4b and Fig. 4c,
respectively). We also observed that no method was able to
retrieve the original 8:1 SBR, with the absolute 8:1 ratio
being more closely approached for large than for small
spheres. The percentage of SBR increase was significant,
ranging from 10.1±1.9% (largest sphere) to 40.9±2.0%
(smallest sphere). The impact of the denoising step on the
actual PVE correction was found to be negligible. More
specifically we measured a global SBR decrease of only
1.2±0.4 when passing from a deconvolution method
without denoising to the same method with denoising.
The results concerning the level of noise in the PVE-
corrected images are shown in Figs. 4d–f. Several obser-
vations can be made. Firstly, the statistical quality of the
original (uncorrected) images depending on the acquisition
time (from 1 min to 5 min) appears to have no correlation
with the level of noise introduced by deconvolution. In
contrast, the size of the object of interest appeared to be
more correlated with noise introduction since a greater
noise increase was seen for the three largest spheres in
comparison to the three smallest ones. Another important
result concerns the actual noise levels in PVE-corrected
images. The VC algorithm led to an increase in noise of
between 82% and 362% (see Fig. 4e). The LR method
always performed better, even if significant noise levels
were also introduced in some cases. The use of wavelet-
based denoising in the VC deconvolution led to a reduction
in the amount of noise (absolute percentage decrease of
−12% to −94%, mean decrease −37±24%).
It is important to note that the Lucy-Richardson
deconvolution performed better even without denoising
and in all the cases included in the study. LR-corrected
images showed 121±30% less noise than VC_B-corrected
images. In three cases (Fig. 4e, f) LR correction led to the
generation of images with even less noise than the original
(uncorrected) images. The incorporation of wavelet-based
denoising into the LR iterative process led to the lowest
levels of noise among all cases, whatever the statistics of
the initial image and the sphere diameter. The average noise
percentage difference between the LR and LR_B methods,
considering all the different phantom configurations under
evaluation (such as acquisition time and sphere size;
Fig. 4), was 26%. In summary, (1) VC and LR led to the
same level of PVE correction, (2) LR outperformed VC in
Fig. 3 IEC phantom containing
spheres. a Uncorrected image,
transverse view. b–e Transverse
views after application of the
VC method (b), VC_B method
(c), LR method (d) and LR_B
method (e)
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terms of noise propagation, and (3) wavelet-based denois-
ing was effective in reducing overall noise without altering
the quantitative intensity recovery.
Figure 5 shows the results obtained using the FDG
whole-body images from one of the 13 patients. Consider-
ing the ROIs in large and visually uniform tissues (for
example lung and liver) the application of the LR_B
method to the whole-body images led to an average change
of 0.6±2.8% in the mean intensity of large and uniform
areas. The results obtained with the other methods were 7.2
Fig. 4 SBR (a–c) and noise increase percentage (d–f) in the six spheres of the IEC phantom. a, d 1-min time frame acquisition image; b, e 2-min
time frame acquisition image; c, f 5-min time frame acquisition image
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±21.4% for the VC method, 6.7±16.6% for VC_B method
and 0.8±2.6% for the LR method. A similar trend was seen
for the noise levels (expressed as standard deviation) in the
same set of ROIs. Applying the Van-Cittert algorithm to the
whole-body images led to an increase by as much as three
times in noise levels relative to the original (uncorrected)
image (+195±112%). Although wavelet denoising reduced
the introduced noise by a factor of nearly 2, there was still a
significant increase (+113±97%) relative to the original
(uncorrected) images. On the other hand, relative to the
uncorrected images, the amounts of noise amplification as a
result of the use of the LR and the LR_B algorithms were
+29.3±14.1% and +19.1±13.4% respectively. Similar con-
clusions in terms of both intensity recovery and noise
propagation can be drawn for the set of ROIs in the patient
lesions (22 ROIs in total, mean size 38±26 cm3). The mean
increases in intensity for these ROIs were 59.1±25.5%,
39.5±17.2%, 37.4±13.8% and 27.5±8.8% for the VC,
VC_B, LR and LR_B methods, respectively. Concerning
noise the observed values were 260.8±101.1%, 124.0±
64.4%, 100.9±42.1% and 49.2±14.4%, respectively.
Knowledge of the PSF is the only requirement for the
algorithms presented in this study. It is thus necessary to
evaluate the influence of the PSF on the quantitative results
obtained. The data obtained by varying the PSF size are
shown in Fig. 6. Firstly, the effect of the PSF value on the
SBR accuracy appear linear since underestimation of the
PSF leads to underestimation of the SBR while overesti-
a) b) c) d) e) 
f) g) h) i) j)
Fig. 5 Clinical images: examples of PVE correction using the
proposed approaches. a–e Patient 1, coronal view (mediastinal and
pulmonary lesions).f–j Patient 2, sagittal view (head and neck lesion).
a, f Uncorrected images. b–e, g–j Images after application of the VC
method (b, g), VC_B method (c, h), LR method (d, i) and LR_B
method (e, j). For patient 1, using LR_B, the mean intensity in the
small lesion (e arrow) is increased by 23% and at the same time the
image quality is preserved
Fig. 6 Relative SBR expressed as percentage errors, obtained with
different PSF values. The expected SBR value corresponds to that
obtained with the actual PSF (6 mm). For example, the use of a 4 mm
PSF instead of the actual value in the Lucy-Richardson algorithm
leads to a 5% SBR underestimation
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mation of the PSF leads to overestimation of the SBR. A
significant point also not illustrated here is the fact that
incorporating wavelet-based denoising in either of the two
deconvolution algorithms considered did not modify the
PSF dependence compared with deconvolution without
denoising. Thus there was no effect of denoising on the
PSF value or on SBR estimation. The second point is that
an error of up to 2 mm in the PSF led to a maximum 5%
error in the SBR estimation when using the Lucy-
Richardson deconvolution. In comparison, an error of
1 mm in the PSF led to a 5% error in the SBR estimation
when using the Van Cittert algorithm, which is in
accordance with the study of Teo et al. [11].
The results of the same study in each sphere of the IEC
physical phantom are shown in Fig. 7. Although similar
results were seen, a supplementary point can be underlined.
When investigating small lesions (less than 15 mm in
diameter), one should pay attention to the estimation of the
PSF because even with the L-R algorithm a ±1 mm error in
the PSF estimation may lead to a 5–7% error in the SBR
estimation, although under the same imaging conditions the
error is nearly 20% with the VC algorithm.
Discussion
PVEs are difficult to overcome and remain a major problem
in emission tomography, in particular when investigating
small lesions. This is typically the case in FDG whole-body
studies, which are today an essential tool in the manage-
ment of patients with a tumour. Most PVE correction
algorithms are, however, restricted to brain imaging
because of the mandatory use of anatomical information
provided by MRI. This morphological requirement is
difficult to transpose to whole-body imaging since small
structures are not easy to superimpose even with dedicated
PET/CT scanners. This is mainly because of both internal
(physiological) and external patient motion during and
between acquisitions. For these reasons, classical PVE
correction methods cannot be applied in whole-body
imaging with a sufficient degree of reliability.
Recently, iterative deconvolution-based algorithms have
been proposed for tumour imaging [10–12]. In the study by
Teo et al. [11], only the Van Cittert algorithm was tested
and showed the introduction of high levels of noise, which
led the authors to propose the application of the algorithm
only to specific ROIs (such as a well-delineated tumour). In
the study by Tohka and Reilhac [10], two different
deconvolution algorithms were tested, but only in the
specific case of raclopride brain PET imaging. In the study
by Kirov et al. [12], the method did not require anatomical
images and noise was not added during the process, and the
method required few parameters to be manually defined by
the user. The objectives of our study were to assess two
fully automatic and iterative deconvolution algorithms for
whole-body PET imaging, and to introduce modifications
to limit noise propagation without significantly affecting
the PVE correction aspects.
The findings of the present study regarding the use of
iterative deconvolution algorithms in oncology PET imag-
ing allow us to draw several conclusions. First, automatic
PVE attenuation can be achieved at a voxel level with a
fairly limited noise increase. The intensity recovery in
relatively small areas is indeed significant enough to accept
the moderate noise addition inherent to iterative deconvo-
lution. However, on the other hand our results suggest that
the choice of algorithm is crucial. In our investigation, the
Van-Cittert approach led to larger increases in signal
recovery (by a factor of up to 40%) in comparison to the
Lucy-Richardson approach. On the other hand, an increase
Fig. 7 Relative SBR obtained in the IEC phantom for different PSF values. For a given sphere, the expected SBR value corresponds to the one
obtained with the actual PSF (6.5 mm). a Van-Cittert algorithm; b Lucy-Richardson algorithm
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of >250% in the image noise levels was also measured with
the use of the Van-Cittert algorithm in comparison to the
uncorrected images, while the noise introduced with the use
of the Lucy-Richardson was smaller by a factor of three
relative to the Van-Cittert algorithm. The levels of noise
associated with the Van-Cittert algorithm led to images
which were visually difficult to interpret, while artefacts
were also observed around high-intensity regions. Finally,
changes in intensity were also observed in areas of the body
where uniform activity distributions are usually observed
(for example, the normal lung and liver).
All these factors suggest that the Van-Cittert algorithm
strongly and systematically alters the actual intensity in
regions irrespective of their size. This bias affecting the voxel
values in both a random and a systematic fashion clearly
indicates that the use of the Van-Cittert algorithm for
quantitative purposes should be avoided, a point that is also
in accordance with the qualitative assessment of images.
Comparatively, the Lucy-Richardson deconvolution provid-
ed not only good qualitative performance but also satisfactory
quantitative improvement as well. Unlike the Van-Cittert
method, the Lucy-Richardson method led to more consistent
results in both qualitative and quantitative assessments
irrespective of the imaging conditions (noise level, lesion
size). These specific conclusions apply to both simulated and
clinical images. Finally, it is worth noting that the Lucy-
Richardson algorithm is as easy to implement as the Van-
Cittert method (the only difference is in the iteration step
which is multiplicative in the Lucy-Richardson method and
additive in the Van-Cittert method).
One of the major developments presented here concerns
the introduction of a denoising step during regularization of
the deconvolution process, in an attempt to minimize noise
propagation by the algorithms. The denoising procedure
was implemented in the wavelet domain in an attempt to
minimize the potential parallel loss of pertinent signal
leading to an associated loss in resolution. Although a 2-D
wavelet decomposition was employed, the denoising
operation was performed on the three planes (axial, coronal,
sagittal) with the final thresholded residual image obtained
by averaging the three sets of data on a voxel-by-voxel
basis. The BayesShrink method was chosen for the
selection of the denoising operator and threshold values.
This approach has the benefit of adapting the threshold to
the noise properties observed at different levels of resolu-
tion [16]. However it should be noted that depending on the
image reconstruction algorithm used, the noise within each
level of resolution (wavelet subbands) considered may not
be homogeneous (particularly in the case of iterative
reconstruction algorithms). This heterogeneity in noise will
not be accounted for by the adaptive threshold of the
denoising operator proposed here, although it is expected to
have a limited impact on the results obtained. A possible
way to account for such noise heterogeneity in the different
subbands is the use of more recent denoising approaches
[26]. Our results clearly demonstrate that the inclusion of
denoising as proposed here has the potential to significantly
reduce (by a factor of >100%) the level of noise introduced
by the deconvolution process.
As a final point in relation to this study, one can say that
the Lucy-Richardson algorithm was less sensitive to the
PSF value than the Van Cittert algorithm, and an error of up
to 2 mm remains tolerable regarding the associated changes
in SBR. Thus the Lucy–Richardson algorithm is expected
to be less sensitive to changes in the PSF that can be
observed throughout a system’s FOV.
Conclusion
We have shown that deconvolution algorithms for the
correction of PVEs must be used with care. The application
of a denoising step following deconvolution appears
mandatory in order to be able to perform reliable voxel-
wise quantitative analyses. In particular, the use of the Van
Cittert deconvolution alone was shown to propagate noise
to an amount that prevented reliable quantitative evaluation.
A significant bias was also observed in some cases leading
to over-correction, while the process always led to visual
degradation of the images. The use of the Lucy-Richardson
algorithm together with wavelet-based denoising appeared
to give more robust and consistent results in both accuracy
and precision, while preserving the visual aspect of the
images.
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Computed data, that describes the anatomy and breathing-motion of
individual cancer patients, is used to increase the realism of
computer models that represent the patients bodies.
By Amandine Le Maitre, William Paul Segars, Member IEEE,
Simon Marache, Anthonin Reilhac, Mathieu Hatt, Member IEEE,
Sandrine Tomei, Carole Lartizien, and Dimitris Visvikis, Senior Member IEEE
ABSTRACT | The purpose of the work described in this paper
was the development of a framework for the creation of a
realistic positron emission tomography (PET) simulated data-
base incorporating patient-specific variability. The ground
truth used was therefore based on clinical PET/computed
tomography (CT) data of oncology patients. In the first step, the
NURBS-based cardiac-torso phantom was adapted to the
patient’s CT acquisitions to reproduce their specific anatomy
while the corresponding PET acquisitions were used to derive
the activity distribution of each organ of interest. Secondly,
realistic tumor shapes with homogeneous or heterogeneous
activity distributions were modeled based on segmentation of
the PET tumor volume and incorporated in the patient-specific
models obtained at the first step. Lastly, patient-specific
respiratory motion was also modeled. The derived patient-
specific models were subsequently combined with the PET
SORTEO Monte Carlo simulation tool for the simulation of the
whole-body PET acquisition process. The accuracy of the
simulated datasets was assessed in comparison to the original
clinical patient images. In addition, a couple of applications for
such simulated images were also demonstrated. Future work
will focus on the creation of a comprehensive database of
simulated raw data and reconstructed whole-body images,
facilitating the rigorous evaluation of image-processing algo-
rithms in PET for oncology applications.
KEYWORDS | Database; Monte Carlo simulation; positron
emission tomography (PET); SORTEO
I . INTRODUCTION
Positron emission tomography (PET) functional imaging
using 18F-FDG is widely considered as the state of the art
in diagnosis for a number of oncology applications [1]. In
addition, current interest within the clinical context con-
centrates on further extending the impact of PET imaging
in other applications, such as patient follow-up during
treatment and assessment of tumor response to therapy
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(either chemotherapy or radiotherapy) [2]. In order to
optimize the quantitative use of PET in clinical practice,
data- and image-processing methods are also a field of
intense interest and development. The evaluation of such
methods often relies on the use of simulated data and
images since these offer control of the ground truth.
Monte Carlo (MC) simulations are widely used for PET
simulation since they take into account all the random
processes involved in PET imaging, from the emission of
the positron to the detection of the photons by the
detectors. In general, MC simulations play an important
role for different clinical applications, notably in the
domains of medical imaging and radiotherapy [3]–[6]. In
the field of medical imaging, simulations are primarily
used for the design and optimization of new and existing
imaging devices at the level of detectors and associated
electronics systems [3], [7]. The second area of interest lies
in the use of simulations for the assessment of acquisition
and subsequent processing protocols involving the pro-
duction of raw datasets and corresponding reconstructed
images. Numerous simulation packages are now available
to create such datasets, like GATE [8], SimSET [9], or
SORTEO [10]. GATE offers additional precision consider-
ing physics modelling but is also much more computa-
tionally demanding. SimSET, on the other hand, is faster
despite the use of a precise physical modelling but is
limited in terms of the geometry of the detectors it can
model. PET-SORTEO has the advantage of being fast with
a precise geometry modelling but is less precise than GATE
as far as the physics modelling is concerned. A complete
review of available simulation tools for emission tomog-
raphy can be found in [11].
In the area of emission tomography, simulated raw
datasets can be used for the optimization of reconstruction
algorithms and associated correction strategies such as, for
example, those for scattered detected events [12], [13].
Based on these simulated datasets, reconstructed PET
images are often used to test various image-processing
algorithms, examples of which include partial volume
effects correction [14], denoising [15], automated detec-
tion [16], and segmentation [17]. Using MC simulated
datasets is the most reliable approach to validate and assess
the performance of such algorithms since they include an
accurate modelling of all physical processes associated
with the acquisition process. In addition, the advantage of
using simulated data over clinical data is that it allows
control of the ground truth that is usually not available in
the case of patient studies. However, phantoms offer
limited shapes and realism, and the use of more realistic
and clinically relevant datasets, in terms of geometry and
activity distribution, should improve the evaluation of
methodologies destined to be used in clinical practice.
Within this context a few simulated PET databases already
exist. A first one was developed by Reilhac et al. using PET-
SORTEO [10], [18]. It contains brain images modelling
tracer kinetics based on the use of different radiopharma-
ceuticals. A second one was developed by Castiglioni et al.
[19] containing several images of simulated brain and
thorax parts of the Zubal phantom [20] as well as cylind-
rical phantoms generated using various simulation tools.
Aristophanous et al. [21] have created a single whole-body
phantom simulation based on the use of the Zubal phan-
tom in combination with the SimSET code, incorporating
nonuniform lesions in the lungs. However, no patient
variability in terms of anatomical and functional activity
distribution or physiological motion (such as respiration)
was considered. More recently, a third database of FDG
whole-body images was developed by Tomei et al. [22]
using PET-SORTEO. This database is based on the use of
the Zubal phantom including spherical lesions of various
sizes with different contrast using a model of lesion extent
based on the clinical description of lymphoma patients.
The aim of this work is to improve the realism of
simulated whole-body PET images through the incorpora-
tion of both anatomical and functional uptake variability
considering different disease models. Within this context,
the simulated images include variability from patient to
patient, taking into consideration the anatomy of each
patient as well as specific 18F-FDG distribution in organs
and lesions. In addition, the proposed database includes
the effects of respiratory motion through the simulation of
four-dimensional (4-D) whole-body PET images based on
the respiratory signals of individual patients.
II . MATERIALS AND METHODS
The simulation process consists of two major steps. As a
first step, the model of the patient’s anatomy is created,
followed by the simulation of the PET acquisition based on
the developed patient’s model. This simulation requires
the model of a scanner geometry. The individual steps are
explained in the following sections.
A. Clinical Data
The datasets to be simulated are based on whole-body
clinical images. The objective is to simulate images which
are as realistic as possible, modelling the anatomical varia-
bility and corresponding tumors from the original clinical
images. The clinical images used up to date were acquired
on a PET/CT Philips GEMINI system (Philips Medical
Systems, Cleveland, OH). The total injected activity was
between 2:78 105 kBq and 5:10 105 kBq and the
images were acquired 1 h postinjection. The scan time for
each bed position is 2 min. These clinical images were
reconstructed with the iterative reconstruction algorithm
RAMLA [23] used in Philips GEMINI scanners and stan-
dard clinical protocol parameters previously optimized
(two iterations, a Gaussian postfiltering with 3-D full width
at half-maximum (FWHM) of 5 mm and a relaxation pa-
rameter of 0.05) [24]. CT scan acquisitions were carried
out using 120 kV and 100 mA for tube settings, resulting in
CTDI from 600 to 800 mGy. The voxel size of the CT
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images was 1:17 1:17 5 mm3 with dimensions of 512 
512 N (N slices depending on the patient’s axial cov-
erage). The voxel size of the PET images was 4 4 
4 mm3 with dimensions of 144 144  M (M also
depending on the patient’s axial coverage). We selected
ten patients (six men and four women) with different
shapes of tumors at different positions in the body and with
homogeneous and heterogeneous activity distributions.
The different patient data with corresponding injected
activity and tumor characteristics are summarized in
Table 1. The CT images were used for the anatomy
modelling and the PET images for the activity distribution
modelling.
The model obtained by the following procedure is a
voxel-based description of the patient’s anatomy. Each
organ is designated by one label. These labels have to be
associated with both an activity concentration and an
attenuation coefficient in order for the simulation tool to
reproduce the process of radioactive disintegration,
particle interaction, and photon detection.
B. Modelling of the Anatomy
1) Organ Shape: The anatomical and activity distribution
models were constructed using the nonuniform rational
basis splines (NURBS)-based cardiac-torso (NCAT) phan-
tom [25] as a basis. This model achieves a good balance
between flexibility and realism thanks to the use of
NURBS surfaces for the organ shape modelling. In order to
take into account the interpatient anatomical variability,
we used an interactive software application [26], which
allows the modification of the NCAT phantom’s anatomy.
We thus modified the NCAT model based on specific
patient anatomy using the CT clinical images acquired
during the corresponding patient PET/CT studies as a
guide. Two-dimensional slices of the NCAT phantom were
overlaid with corresponding slices of the CT clinical
images. The organ shapes were modified by changing the
position of the control points associated to the NURBS
surfaces of each organ. Within this process, the first step
involved the use of simple transformations like rotations,
translations, or scaling applied to one or several organs via
their respective control points. This first step allows for a
global adaptation of the phantom to the anatomy of a given
patient. A finer adjustment was subsequently applied by a
displacement of individual control points to more accu-
rately reshape the organs of interest. The majority of the
different organ shapes were adapted to those of the specific
patients, although some differences still remained for
some complex organs of the abdomen. We found, in par-
ticular, that the intestines are difficult to match with those
of specific patient acquisitions because of large differences
between the modelled shape in the NCAT phantom and
the real shape in combination with large interpatient
variability in both shape and form. A potential improve-
ment for the matching of organs, such as the intestines,
between the model and specific patient will be the use of
deformable models, which have not been explored in
this work.
2) Activity Distribution: The clinical PET images were
employed in order to accurately model the variable FDG
distributions. A region of interest (ROI) analysis was per-
formed for the different organs (liver, lungs, kidneys, etc.)
of each patient in order to identify mean and standard
deviation of activity concentrations per organ. In addition,
these activity concentrations were compared to the stan-
dardized uptake values (SUVs) available in already pub-
lished work of normal organ uptakes in FDG PET imaging
[27] and used to assign the activities for the different
organs in the NCAT patient specific emission maps used in
the simulation.
Table 2 illustrates for four different organs (liver,
lungs, stomach, and spleen) the comparison of the theo-
retical SUV (column 1) and the clinical SUV (column 2)
obtained from the ROI analysis. For the ROI analysis, we
considered 17 different organs: liver, lungs, heart wall,
heart chamber, stomach, kidneys, spleen, spine bone,
other bone, pelvis, bladder, intestines, rectum, ovaries/
prostate, urethra, brain, and body (including muscle).
Table 1 Summary of the Ten Clinical Scans Used for the Simulation
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3) Attenuation Map: The attenuation map was con-
structed using the same labelled phantom model as the one
for the emission map. Each label of the phantom was
associated with the corresponding attenuation coefficient
at 511 keV. The different attenuation coefficients of the
organs were approximated with those of seven struc-
tures: water (0.096033 cm1), bone (0.151108 cm1),
lung (0.024667 cm1), brain (0.098530 cm1), fat
(0.087718 cm1), air (0.000111 cm1), and muscle
(0.098731 cm1).
C. Tumor Modelling
The next step consisted in adding the tumor to the
healthy patient model. The NCAT phantom allows the in-
corporation of homogeneous spherical tumors into the
model. However, in order to simulate realistic patient-
specific phantoms, we frequently need to incorporate
modelling of complex tumor shapes and heterogeneous
distributions. For this purpose, a new process for the
incorporation of nonuniform shape and activity distribu-
tion lesions was developed in order to model lesion hete-
rogeneity within the NCAT phantom.
The following steps were considered in this process.
Initially, the tumors were manually segmented from the
clinical PET images considering variable activity distribu-
tions and shapes. A 3-D reconstruction was subsequently
derived using the segmented structures to obtain a mesh
using AMIRA.1 The organs in the NCAT phantom are
modelled with NURBS. These types of surfaces allow more
flexibility as well as the incorporation of respiratory
motion. Since one of our aims is to include the simulation
of patient-specific respiratory motion effects, the tumor
surfaces were also modelled using NURBS for compatibil-
ity. The last step of tumor modelling is therefore the
conversion of the mesh into a NURBS surface, for which
Rhinoceros (CADLINK software) was used. More specifi-
cally, section curves were first extracted from the mesh of
the tumor, and cubic NURBS surfaces were then fitted to
these contours. The number of curves and the distance
between them as well as the number of control points to
use depend on the tumor shape. The more complex the
shape is, the more curves and control points are needed for
a realistic modelling. These parameters were therefore
chosen in order to achieve the best match between each
tumor mesh and its corresponding NURBS surface. Within
two consecutive curves, a normal distribution is consid-
ered for the interpolation. The complete procedure is
illustrated in Fig. 1.
In order to model tumor nonuniformities, as many
NURBS surfaces as levels of activity identified within the
tumors were created. During the creation of the voxelized
phantom, each NURBS surface is associated with a specific
level of activity. For the patients included to date in the
simulated database under construction, only tumors with
one or two levels of activity were modelled, since it was
found to be sufficient for the adequate modelling of the
nonuniform activity distributions encountered. However,
the extension of the approach to include higher levels of
nonuniformity in the modelled lesions is straightforward.
In the work described in this paper, the decision regarding
the number of activity levels to be included in the
modelling of heterogeneity was based on a combination of
visual and ROI assessments. ROIs were manually drawn
within the visually distinguishable nonhomogeneous
regions within the tumors, and the standard deviation
with respect to the mean was measured. The standard
deviations around the mean values within the ROIs were
usually smaller than 10%. Additional activity regions
would have hence led to insignificant nonuniform activity
contrast differences with the main tumor.
Fig. 2 illustrates the result of the two first steps; it
shows the coronal slices of a CT clinical image, the
corresponding clinical PET slice, and the labelled phantom
obtained by the procedure described above with the tumor
incorporated in the right lung.
D. Respiratory Motion
The default respiratory cycle of the NCAT phantom is a
sinusoid [28]. In order to take into consideration the
nonuniform nature of realistic respiratory signals, we
replaced this cycle by patient specific respiratory signals.
These were acquired during a 4-D PET/CT acquisition with
an external sensor placed on the patient’s thorax [29]. This
resulting respiratory cycle is therefore nonregular in both
phase and amplitude. It is characterized by a nonregular
period and nonregular inspiration and expiration phases,
contrary to the default NCAT respiratory cycle.
Each respiratory cycle was divided into N bins, and one
phantom was created for each of the N instances of the
respiratory cycle.
E. Data Simulation
1) Simulation Process: The simulations of the images
presented in this paper were carried out using the PET-
SORTEO simulation tool that has been fully validated for
the ECAT HR+ scanner geometry [10]. Six bed fields, each
corresponding to the dimension of the scanner’s axial field
of view (FoV), were used during the simulation to achieve
whole-body coverage (see Fig. 2), with the scanner1http://www.amiravis.com/.
Table 2 Comparison of Theoretical SUV and Clinical SUV Measured on
the Ten Clinical Datasets Used in the Study
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operating in 3-D. An overlap of 2.91 cm (corresponding to
12 reconstructed slices) was considered between two
consecutive beds to compensate for the loss of sensitivity
on both extremities of the axial FoV.
For the studies without the inclusion of respiratory
motion, simulations were carried out approximating
clinical acquisitions of 3–15 min per bed position in order
to provide whole-body images of variable statistical quality.
For the simulations with respiratory motion, the acquisi-
tion time per bed position used in static simulation
ðTacqTotÞ was divided by the number of respiratory cycles
ðNbinsÞ and the number of bins per respiratory cycle
ðNbinsÞ to obtain the acquisition time per bed position at





So the total acquisition time per bed position remains
the same for simulations with or without the inclusion of
Fig. 2. Coronal slice of (a) a clinical CT image, (b) the corresponding clinical PET image, and (c) the corresponding slice of the adapted labelled
NCAT phantom model. The six bed positions used for the simulation process are illustrated on the labelled phantom.
Fig. 1. Illustration of the tumor modelling process. The steps are: 1) tumor segmentation, 2) 3-D reconstruction of the tumor, 3) extraction of
section curves from the mesh, and 4) reconstruction of a NURBS surface from the section curves.
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respiratory motion. In order to obtain the gated simulated
data, the sinograms at the same instance of the respiratory
cycle were added before reconstruction. To obtain the
respiratory average patient acquisition, all the sinograms
were added before reconstruction.
Even considering the use of a simulation platform such
as SORTEO, which is significantly faster than other
alternatives, heavy load is put on computing resources by
the simulation process. In order to generate data in a
reasonable amount of time, we have been using the IN2P3
computing centre in Lyon.2 Twenty processors were allo-
cated for each bed of a whole-body simulation on Linux
scientific 32-bit running systems. Such a configuration
allowed us to generate a 14-min whole-body simulation
without respiratory motion in about 90 h.
2) Corrections and Reconstruction: Before the reconstruc-
tion of the images, the standard corrections were applied
to the simulated images: normalization [30], dead time,
radioactive decay, scattered [31], and random corrections
using a delayed coincidence window approach [18]. For
the attenuation correction, two different approaches were
used. In the first one, a transmission sinogram was em-
ployed. We simulated two acquisitions with a rotating 68Ge
source, one with the patient model in place (3 min) and
one in air [18]. The difference of the counts between the
two acquisitions gives the attenuation coefficients, which
can then be used for attenuation correction. An alternative
way could be using CT-based attenuation correction. The
simulation of CT images can be performed using the NCAT
patient-specific attenuation maps created here and a de-
dicated CT simulator. This has been previously shown
using standard NCAT maps and an analytical CT simulator
[32]. However, since the simulation of patient-specific CT
images was not the objective of the work described in this
paper, an alternative approach, similar to the use of CT
images for attenuation correction for the simulated emis-
sion images, was performed. The patient-specific NCAT
attenuation maps (see Section II) were first filtered
(Gaussian filter of 12 12 5 mm3) to match the reso-
lution of the PET emission images [33] and subsequently
projected forward [34] to derive the correction factors
used for the attenuation correction.
The images were reconstructed with the iterative
AW-OSEM algorithm, which is used clinically with the
ECAT HR+ scanner [35]. The number of subsets (16) and
iterations (four) used in the clinical setting was employed
for the reconstruction of the simulated images. The final
step was the use of a Gaussian isotropic filtering of 8 mm.
Images were reconstructed using two different voxel sizes
(5 5 2:425 mm3 and 2:5 2:5 2:425 mm3), since
this parameter represents an important factor influencing
overall emission image quality and spatial sampling of the
objects of interest (such as, for example, lesions in onco-
logy applications). As such, it is important to be able to test
the influence of voxel size on different image-processing
algorithms, which is an example of the use of a database of
simulated emission images introducing patient-specific
variability, such as explained in this paper.
The different steps of the simulation process were
detailed in this section. The following list of steps sum-
marizes the procedure for the creation of one simulated
image:
1) modelling of the patient-specific anatomy based
on the CT clinical images;
2) description of the activity distribution in the main
organs based on measurements carried out on the
corresponding patient PET clinical images;
3) modelling of tumors (if necessary) by:
a) segmenting the tumors and defining the
various uptake levels within each tumor;
b) transformation of the tumor mesh in a
NURBS surface using Rhinoceros;
c) incorporation of the tumor into the phantom;
4) definition of the scanner geometry within the
chosen simulation environment;
5) simulation of the emission raw datasets (sino-
grams or list mode data) within the chosen simu-
lation environment;
6) correction of the simulated raw datasets (sino-
grams or list mode data);
7) reconstruction of the PET simulated images.
III . RESULTS AND APPLICATIONS
A. The Whole-Body PET Simulated Database
To date we have generated ten different patients, eight
of them corresponding to respiratory motion average PET/
CT whole-body acquisitions and two of them correspond-
ing to 4-D PET/CT acquisitions synchronized with
respiratory motion. The respiratory motion average data
were simulated with variable statistical qualities by varying
the acquisition time as explained in Section II-D. A few
examples of the simulated static PET whole-body images
highlighting the wide range of patient variability in terms
of anatomical and functional details are given in Fig. 3.
Two examples of tumors are shown in Fig. 4, where it
can be seen that, in comparison with clinical data, the
tumor shapes are qualitatively respected. In the clinical
data, the voxel size is 4 4 4 mm3 whereas in the
simulated datasets two different voxel sizes were used
(5 5 2:425 mm3 and 2:5 2:5 2:425 mm3). The
difference in the contrast between the high uptake
zone and the low uptake zone is about 2% in the second
illustrated tumor; the first one was modelled with one
level of activity only.
1) Activity Distribution: The injected dose in the cases of
the clinical data on which we based the simulations of PET2http://cc.in2p3.fr.
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Fig. 3. Coronal slices from three patient whole-body simulated images: (a) the labelled NCAT phantom, (b) the simulated image,
and (c) the clinical image.
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acquisitions ranged from 2:78 105 to 5:10 105 kBq. In
the simulated data, the injected dose ranged from
3:10 105 to 4:68 105 kBq.
Fig. 5 contains the mean activity concentration dif-
ferences for each organ of interest, derived using the ROI
analysis, considering all eight static PET simulated images.
A good agreement can be seen for most of the organs, with
the highest mean activity differences in the kidneys, brain,
and bladder (14%, 15%, and 23%, respectively), whereas
for the other organs (liver, lungs, etc.), the mean differ-
ence is less than 9%.
Table 3 contains the standard deviation of mean
activities within ROIs drawn inside organs of interest in
order to illustrate the variability of the activity distribution
from patient to patient. The patient variability of the sim-
ulated and the clinical data are of the same order of mag-
nitude. The standard deviation in the heart wall is higher
(about 5.3) than that of the other organs (mean standard
deviation of about 1.3), which is consistent with the varia-
ble contrast seen in clinical PET images between the heart
wall and the heart chamber.
2) Images of Different Statistical Quality: For the third
patient in Fig. 3, simulated images considering different
acquisition times (see Section II-E) leading to different
statistical quality, and hence various levels of noise, are
illustrated. The mean activity concentration and standard
deviation computed within the two ROIs drawn in the liver
and the lungs were compared. The longer the acquisition
time, the lower the standard deviation, with 24% and 23%
decreases of the noise from 7 to 14 min for the liver and the
lungs, respectively. On the other hand, the mean activity
concentrations were largely unchanged (þ=1%).
3) Dynamic Data: Results on the gated acquisitions can
be found in Fig. 6, which illustrates the resulting images at
Fig. 5. Mean percentage differences in the mean activity of the
organs of interest between the simulated and the clinical images.
The error bars denote the standard deviation in these mean
differences for each organ.
Table 3 Comparison of the Mean and Standard Deviation of the
Activities (in kBq/mL) Considering All of the Simulated Images for
Organs of Interest in Both the Clinical and Simulated Datasets
Fig. 4. Illustration of two different simulated tumors: (a) clinical image, (b) simulated image, and (c) labelled image. The table contains the
differences in the corresponding activity concentrations and contrasts for the second tumor, which has been modeled using two activity levels.
The results of the segmentation process are contoured in red, and the corresponding ground truth is shown in yellow.
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two different times of the respiratory cycle for patient 5
(see Table 1). It corresponds to bins 1 and 6 of the
respiratory cycle. These images were simulated with a
spherical tumor with medium contrast (10) in the lung.
The motion of the liver and the tumor in the lung are
clearly visible in these two images. The top of the liver and
the tumor are about 16 and 10 mm lower, respectively, in
bin 6 with respect to bin 1. The estimated liver motion
correlates well with the amplitude of the motion trace used
in the simulation, which is expected considering the linear
liver motion implemented in the NCAT phantom.
B. Applications
In this section, we discuss two examples on the use of
such a simulated database for the validation of PET image-
processing methods. The first one is on the correction of
partial volume effects and the second is on the automatic
segmentation of tumor volumes.
1) Partial Volume Effect Correction and Denoising: Partial
volume effect (PVE) is the consequence of the limited
spatial resolution in PET. It affects both qualitative and
quantitative accuracy of images as a result of the blurring
and spill-in and spill-out effects. This is especially evident
in tumor imaging, since the effect is major for structures of
less than 1 cm in diameter, that is, twice the FWHM of the
point spread function of the imaging device [36]. A large
number of approaches have been proposed to correct for
PVE [37]–[40], with some emerging methodologies
concentrating on the production of improved image
quality rather than concentrating on ROI analysis, which
has been traditionally used for brain imaging applications
[41]. In this application example, the method proposed by
Boussion et al. [14] was applied to one of the illustrated
simulated images (the second patient shown in Fig. 3). The
simulated image contains two spherical tumors, one in
the lung and one in the mediastinum, of 13 and 20 mm
diameter, respectively. The PVE correction method is
based on the use of PET data only and consists of the
combination of a deconvolution and a denoising method in
order to compensate for the noise amplification usually
associated with iterative deconvolution methods. The Lucy
Richardson deconvolution process is applied and the resid-
ual is denoised within each iteration using a wavelet-based
denoising method. Such PVE correction leads to improved
qualitative and quantitative analysis for oncology applica-
tions such as diagnosis and/or therapy assessment.
The original and corrected images are illustrated in
Fig. 7, using a line profile demonstrating a 40% increase of
the activity within the tumor in the mediastinum and a 28%
increase for the tumor in the lung. A smaller increase relative
to the ground truth is seen for the smaller lesion relative to
the larger which agrees with the results reported on the
original paper evaluating this PVE correction approach [14].
Table 4 shows the mean activity and associated standard
deviation computed in the tumors and lungs in both sim-
ulated and corrected images. The tumor/lung contrast is
Fig. 7. Result of PVE correction. The figure illustrates one transaxial slice of the simulated image (top) without and (bottom) with
PVE correction. Two line profiles are plotted on the right.
Fig. 6. Coronal slices of the simulated whole-body scans for patient 5
at two instants (bin 1 and bin 6) of the respiratory cycle.
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clearly improved after correction, with an increase from 3.4
to 5.3 in the case of tumor 1 and a similar improvement (from
6.2 to 10.4) for the second tumor, In addition, the derived
mean values in the activity concentration of the lesions are
closer to the simulated ground truth after correction, as
shown in Table 4.
2) Tumor Segmentation: Another important clinical
application in PET is tumor volume delineation for
applications like patient follow-up and radiotherapy treat-
ment planning, especially considering the growing interest
of using hypoxia and proliferation tracers for improved
biological target volume or dose painting and dose escalation
applications [42]. The fuzzy locally adaptive Bayesian
segmentation proposed by Hatt et al. [17] was applied here
on the tumor illustrated in the tumor modelling process (see
Fig. 1) and on the second heterogeneous tumor illustrated in
Fig. 4 (quoted from here onwards as the second tumor).
The ground truth volume of the first and second tumor
is 33.4 and 62.4 cm3, respectively. The results of the
segmentation are illustrated in Fig. 4 for the two tumors,
showing one coronal slice for each of the two segmented
tumors and the corresponding slice of the ground truth.
The segmentation process results in an overall tumor
volume of 35.2 cm3 (5% error) and 61.8 cm3 (1% error) for
the first and second tumor, respectively.
IV. DISCUSSION
The use of simulated datasets to evaluate new image-
processing algorithms in PET is crucial. Indeed, it allows
the control of the ground truth, which is not easily avail-
able when dealing with clinical datasets. In addition,
Monte Carlo–based simulated images can be produced
considering an accurate modelling of the overall detection
process. In the field of emission tomography, a few simu-
lated PET databases already exist, but the major concern
remains the realism of these simulated images and the lack
of variability between the different cases due to the use of
nonflexible models. Within this context, the aim of the
work described in this paper was to incorporate patient
variability in a PET simulated database to improve the
correspondence of the simulated images to the clinical
cases. This variability concerns both the anatomy based on
the clinical CT images and the 18F-FDG distribution based
on the corresponding PET acquisition. The realism of our
simulated images is also based on realistic tumor model-
ling’s allowing variable tumor shapes and heterogeneity in
the FDG uptake. Lastly, the possibility of generating respi-
ratory motion in the simulated images was also included.
The patient-specific organ reshaping of the NCAT
phantom, which forms the basic anthropomorphic model
used in this paper, showed good results for the overall body
shape and the organs of the thorax (lungs, liver, thoracic
cage, etc.). A wide anatomical variability may be observed
among the various images already simulated. Some prob-
lems, however, still remain at the abdominal region, parti-
cularly for the intestines as a result of the large interpatient
variability at this level in combination with large differ-
ences between patient and model-based intestines.
Concerning the tumor modeling, the data simulated to
date show good qualitative and quantitative correlation
between the simulated and clinical data. In this paper, the
choice of the number of activity levels needed to simulate
heterogeneous tumors was made considering a combined
visual and ROI analysis approach. However, this process
could be improved using statistical measures of tumor
heterogeneity [43].
For the images already simulated to date and included
in the database, a good correlation between the simulated
images and the clinical images was found in terms of
activity distributions. The organs with the greatest differ-
ences between simulated and clinical FDG uptake are the
kidneys, brain, and bladder. The differences measured in
these specific organs can be largely attributed to the lack of
realism in their modelling considering the version of the
NCAT phantom used in this paper. The NCAT phantom, as
its name indicates, was first developed for the thorax, with
a main feature remaining the incorporation of respiratory
and cardiac motions. Therefore, the main organs of in-
terest are those located in the thorax. The brain, for in-
stance, is only made of one simple structure, so the activity
simulated in the brain is not as variable as the one existing
in clinical images. For more realistic brain modelling, the
Zubal phantom [20] is currently more precise. The kidneys
and the bladder in the NCAT are also modelled with only
one level of activity, whereas in reality, these are both
heterogeneous organs in terms of FDG uptake.
Table 4 Comparison With the Ground Truth of the Mean Activity (in kBq/mL) in the Lungs and the Tumors as Well as the
Tumor/Lung Contrast in Simulated and Corrected Images
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The number of labelled regions available in the NCAT
phantom may be a limiting factor for the definition of a
more detailed activity map. For instance, in the version
used in this paper, the muscles are not modelled. More
specifically, there is only one structure named Bbody[
around the different organs, and no distinction exists
between the muscles and the fat. However, a later version
of the NCAT phantom [44], developed for CT simulation,
includes muscles and also more precise brain modelling.
On the other hand, considering the availability of more
structures within the NCAT phantom, there is no partic-
ular difficulty envisaged for the inclusion of additional
labels in the workflow proposed in the work for the pro-
duction of the simulated images.
The standard deviations in the different ROIs inside the
organs could not be compared between the clinical and
simulated images because the simulated images were not
reconstructed with the same reconstruction algorithm
(RAMLA for the clinical datasets and OSEM for the sim-
ulated images). In addition, the scanner geometry employed
was not that corresponding to the system used in the
acquisition of the clinical studies. Lastly, differences in
terms of the correction algorithms used (attenuation, scat-
ter, and random corrections) could also account for potential
differences in the noise characteristics between the clinical
and the simulated images. However, the purpose of this
paper was to obtain realistic simulated FDG whole-body
images rather than reproducing the exact clinical image
quality of the Philips PET/CT system. Although this was not
the objective of this paper, the simulation of different
specific imaging devices can be more easily performed with
alternative MC simulation codes than the SORTEO used
here, which was specifically developed and validated for the
Siemens ECAT HR+ scanner. For example, one such code is
GATE (Geant4 Application for Tomographic Emission) [8],
which facilitates an easier simulation of variable system
architectures and associated readout and processing elec-
tronics [7]. The SORTEO MC simulation platform was
chosen here because of its faster execution times in com-
parison to GATE at the beginning of the study. In any case,
the approach described in this paper regarding the anthro-
pomorphic model and its patient-specific adaptation is uni-
versal and applicable to any simulation platform.
The simulations including the respiratory motion
effects as well as the use of a patient-specific respiratory
cycle were validated as a first step and produced qualita-
tively acceptable images. The use of a patient-specific res-
piratory cycle improves the realism of the respiration
modelling as it incorporates irregularities in the amplitude
and the period of the motion. However, one should also
note that the realism of the NCAT phantom (at least in the
version used in this paper) in terms of respiratory motion
at the diaphragm level is limited (models only a linear
motion of the liver, the heart and the spleen). Lastly, the
use of the actual version of the PET SORTEO simulation
tool is not ideal for the simulation of respiratory motion
since simulations including real-time physiological motion
cannot be performed [45], and hence separate simulations
have to be carried out for different instances in the respi-
ratory cycle. In addition, the only raw data format available
is sinograms, which can be limiting in comparison to list-
mode format, which incorporates temporal information
along the recorded coincidences for the investigation of
dynamic processes and the application of associated cor-
rection algorithms [46]. Ongoing work will investigate the
ability to generate list-mode data with the PET SORTEO
simulation tool.
The execution times realized within the study de-
scribed in this paper for the simulation of a whole-body
PET image are reasonable within a research environment
considering limited computing capabilities. Eventually,
our objective will be to make available in a public database
not only the simulated images but also the corresponding
raw data files, which will facilitate the evaluation of image-
reconstruction algorithms and associated corrections. In
this paper, we have finally demonstrated on a couple of
applications the usefulness of such simulated images in the
validation and evaluation of postreconstruction processing
algorithms, making clear use of the clinically realistic
images and the availability of the ground truth.
V. CONCLUSION
We have described a generic methodology for the de-
velopment of a realistic simulated whole-body PET images
database including patient-specific variability. The patient
model was based on the NCAT anthropomorphic phantom
adapted to patient-specific CT images. Ten simulated datasets
containing tumors of various shapes and activity distributions
were generated, with two of them including the simulation of
respiratory gated PET frames, using patient-specific respira-
tory signals. The PET SORTEO simulation tool was used for
the generation of the simulated datasets based on the derived
patient-specific NCAT models.
Future work will include continuing the building of a
comprehensive database of simulated static and 4-D FDG
whole-body PET images from corresponding oncology
patient acquisitions. The contents of the database will be
complemented in the future by the raw simulated datasets
as well as the use of alternative simulation platforms of-
fering a larger spectrum of imaging system models and
facilitating the simulation of 4-D processes. h
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Intratumor Heterogeneity Characterized by Textural Features
on Baseline 18F-FDG PET Images Predicts Response to
Concomitant Radiochemotherapy in Esophageal Cancer
Florent Tixier1, Catherine Cheze Le Rest1,2, Mathieu Hatt1, Nidal Albarghach1,3, Olivier Pradier1,3,
Jean-Philippe Metges3,4, Laurent Corcos4, and Dimitris Visvikis1
1INSERM, U650, LaTIM, CHU Morvan, Brest, France; 2Department of Nuclear Medicine, CHU Morvan, Brest, France; 3Institute of
Oncology, CHU Morvan, Brest, France; and 4INSERM, U613, Faculty of Medicine, Brest, France
18F-FDG PET is often used in clinical routine for diagnosis, stag-
ing, and response to therapy assessment or prediction. The
standardized uptake value (SUV) in the primary or regional area
is the most common quantitative measurement derived from
PET images used for those purposes. The aim of this study
was to propose and evaluate new parameters obtained by tex-
tural analysis of baseline PET scans for the prediction of therapy
response in esophageal cancer. Methods: Forty-one patients
with newly diagnosed esophageal cancer treated with com-
bined radiochemotherapy were included in this study. All
patients underwent pretreatment whole-body 18F-FDG PET.
Patients were treated with radiotherapy and alkylatinlike agents
(5-fluorouracil-cisplatin or 5-fluorouracil-carboplatin). Patients were
classified as nonresponders (progressive or stable disease),
partial responders, or complete responders according to the
Response Evaluation Criteria in Solid Tumors. Different image-
derived indices obtained from the pretreatment PET tumor
images were considered. These included usual indices such as
maximum SUV, peak SUV, and mean SUV and a total of 38
features (such as entropy, size, and magnitude of local and global
heterogeneous and homogeneous tumor regions) extracted from
the 5 different textures considered. The capacity of each param-
eter to classify patients with respect to response to therapy was
assessed using the Kruskal–Wallis test (P, 0.05). Specificity and
sensitivity (including 95% confidence intervals) for each of the
studied parameters were derived using receiver-operating-
characteristic curves. Results: Relationships between pairs of
voxels, characterizing local tumor metabolic nonuniformities,
were able to significantly differentiate all 3 patient groups (P ,
0.0006). Regional measures of tumor characteristics, such as
size of nonuniform metabolic regions and corresponding inten-
sity nonuniformities within these regions, were also significant
factors for prediction of response to therapy (P 5 0.0002).
Receiver-operating-characteristic curve analysis showed that
tumor textural analysis can provide nonresponder, partial-
responder, and complete-responder patient identification with
higher sensitivity (76%–92%) than any SUV measurement.
Conclusion: Textural features of tumor metabolic distribution
extracted from baseline 18F-FDG PET images allow for the best
stratification of esophageal carcinoma patients in the context of
therapy-response prediction.
Key Words: 18F-FDG PET; esophageal cancer; textural
analysis; predictive value; response to therapy
J Nucl Med 2011; 52:369–378
DOI: 10.2967/jnumed.110.082404
Esophageal cancer is associated with high mortality.
In patients with early-stage disease at presentation, esopha-
gectomy is the treatment of choice and is potentially cu-
rative. Unfortunately most patients at presentation have
already locally advanced esophageal cancer or distant
metastases. In locally advanced esophageal cancer, preop-
erative chemotherapy or radiochemotherapy will improve
survival in patients who respond to induction therapy (1,2).
On the other hand, patients who do not respond to neo-
adjuvant therapy may be affected unnecessarily by the tox-
icity of an inefficient therapy. Therefore, the development
of a diagnostic test capable of noninvasively predicting
response to therapy early in the course of treatment is of
great interest, potentially allowing personalization of pa-
tient management. In patients treated by exclusive conven-
tional combined radiochemotherapy, assessment of response
is equally of great interest, because it could allow an early
change in the management of nonresponding patients. Such
assessment becomes more critical when one considers the
availability of new targeted therapies that could be tested
with higher efficiency if applied early in diagnosis (3,4).
18F-FDG PET is already well established for the initial
staging of esophageal cancer, because it is associated with a
better sensitivity and specificity than combined use of CT
and echoendoscopy, especially regarding detection of dis-
tant metastasis (5).
18F-FDG PET has been also used to assess response to
therapy and patient outcome prognosis (4,6). Within this
context, few studies have explored the potential prognostic
value of pretreatment 18F-FDG PET, demonstrating that
the level of activity concentration on preoperative PET,
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although not statistically significant, tends to predict overall
survival (7–9).
On the other hand, several studies have evaluated the
role of PET in assessing treatment response based on 18F-
FDG uptake changes between a pre- and a posttreatment
PET scan obtained during or after the treatment comple-
tion. Studies considering a second PET scan after treat-
ment completion have shown that a complete metabolic
response is associated with better outcome (10–12). How-
ever, because that information is of limited interest in
patient management if acquired late, different attempts
have been made to determine whether 18F-FDG PET
could be used for assessing response to therapy earlier
(usually within a few weeks) in the course of treatment
(13–15), showing some promising results that need to be
confirmed in multicenter trials (4). One of the highlighted
issues is that early response prediction during combined
chemoradiotherapy, in contrast to chemotherapy alone,
may be compromised by increased 18F-FDG tumor
uptake resulting from radiotherapy-induced inflammatory
processes (4).
An alternative to monitoring changes during treatment
is the potential of predicting response to therapy from the
baseline 18F-FDG PET scan alone, which may allow the
best available therapy regime to be chosen for a given
patient. However, to date there is only limited evidence
that a measure of tumor activity concentration on a base-
line PET scan in esophageal cancer can differentiate
groups of patient response (8,9). Within the same context,
parameters derived from pretreatment 18F-FDG PET have
shown the potential to differentiate between responders
and nonresponders (NRs) in non-Hodgkin lymphoma
patients (16).
The PET image index predominantly used in such studies
for assessment of metabolic response is the normalized
mean tumor activity concentration known as the mean
standardized uptake value (SUVmean), within a region of
interest around the tumor, or the maximum standardized
uptake value corresponding to the highest-activity pixel
value (SUVmax). However,
18F-FDG tumor uptake has been
associated not only with increased metabolism but also with
several other physiologic parameters such as perfusion, cell
proliferation (17), tumor viability, aggressiveness, or hyp-
oxia (18,19), all of which may in turn be responsible for
tumor uptake heterogeneity. Therefore, the hypothesis can
be made that characterizing tumor 18F-FDG distribution,
through its relationship to underlying tumor biologic char-
acteristics, may be useful in predicting therapy response.
18F-FDG tumor activity distribution may be assessed in
a global, regional, or local fashion, allowing in turn the
assessment of corresponding global, regional, or local pat-
terns of biologic heterogeneity. Although the measurement
of such features have been previously explored in anatomic
imaging (20–22), they have not to date been widely used in
PET. Until now, only 1 study has considered the use of
some textural features to predict treatment outcome from
baseline 18F-FDG PET images, with encouraging results in
cervical and head and neck cancer (23), and the assessment
of spatial heterogeneity was also shown to be significantly
associated with survival in sarcoma patients (24). However,
the potential predictive value of tumor heterogeneity char-
acterization on a baseline 18F-FDG PET scan has never
been assessed.
The objective of this current study was, therefore, to
assess the predictive value of 18F-FDG uptake heterogene-
ity characterized by textural features extracted from pre-
therapy 18F-FDG PET images of patients with esophageal
carcinoma by assessing the ability of each parameter to
identify different categories of responders. The predictive
value of these parameters was compared with the use of
standard image activity concentration indices (SUVmax,
SUVmean). The potential prognostic value of such image-
derived parameters for assessing overall patient survival
was not assessed in this study.
MATERIALS AND METHODS
Patients
Forty-one patients with newly diagnosed esophageal cancer
treated with exclusive radiochemotherapy between 2003 and 2008
were included in this study. The characteristics of the patients are
summarized in Table 1. The mean age at the time of diagnosis was
66 6 10 y (median, 69 y; range, 45–84 y), and 85% of patients
were male. Most of the tumors were squamous cell carcinoma
(76%), and most of the patients had a well or moderately differ-
entiated tumor (56%). Most of the tumors originated from the
middle and lower esophagus (76%). Twenty-six patients had a
T3 or T4 primary lesion, 25 had N1 (61%) lymph node metastases,
and 17 had distant metastases (Table 1). All patients were treated
with external-beam radiotherapy and chemotherapy with alkylatin-
like agents (5-fluorouracil-cisplatin or 5-fluorouracil-carboplatin).
A median radiation dose of 60 Gy was delivered in 180-cGy daily
fractions (5 d/wk and 6–7 wk in total). One month after the com-
pletion of the treatment, patients were reassessed to determine
response to therapy using thoracoabdominal CT and endoscopy.
Patients were subsequently classified as complete responders
(CR), partial responders (PR), stable disease, or progressive dis-
ease. Response was assessed using pretreatment and posttreatment
CT scans by evaluating the increase (or decrease) in the sum of the
longest diameters for all target lesions and the appearance, persis-
tence, or disappearance of nontarget lesions, according to the
Response Evaluation Criteria in Solid Tumors (RECIST) (25).
Considering the small number of patients in the stable disease (7)
and progressive disease (4) groups, these patients were eventually
combined into an NR group.
All patients underwent pretreatment whole-body 18F-FDG PET
for staging purposes. Patients were instructed to fast for a minimum
of 6 h before the injection of 18F-FDG. The dose of administered
18F-FDG was 5 MBq/kg, and static emission images were
acquired from thigh to head, on average 54 min after injection,
on a Gemini PET/CT scanner (Philips). In addition to the emission
PET scan, a low-dose CT scan was acquired for attenuation-cor-
rection purposes. Images were reconstructed with the 3-dimen-
sional (3D) row-action maximum-likelihood algorithm using
standard clinical protocol parameters (2 iterations, relaxation
parameter of 0.05, and 3D gaussian postfiltering of 5 mm in
370 THE JOURNAL OF NUCLEAR MEDICINE • Vol. 52 • No. 3 • March 2011
full width at half maximum). The current data analysis was per-
formed after approval by the institutional review board.
Tumor Analysis
For each patient, primary tumors were identified on 18F-FDG
PET images by an experienced nuclear physician. Tumors were
then delineated automatically using the previously validated fuzzy
locally adaptive Bayesian algorithm (26). All parameters were
subsequently extracted from this delineated volume. Only the pri-
mary tumors were considered because textural analysis cannot be
reliably performed on small lesions (nodal or distant metastases)
because of the small number of voxels involved.
Standardized Uptake Value (SUV) Analysis
The following SUV parameters were extracted from each
patient’s baseline PET images: SUVmax; peak SUV (SUVpeak),
defined as the mean of the voxel of maximum value and its 26
neighbors (in 3 dimensions); and mean SUV within the delineated
tumor (SUVmean). The SUVpeak was considered in addition to
SUVmax to investigate the impact of reducing the potential bias
in the SUVmax measurements as a result of its sensitivity to noise.
Textural Analysis
We define texture as a spatial arrangement of a predefined
number of voxels allowing the extraction of complex image
properties, and we define a textural feature as a measurement
computed using a texture matrix. The method used was realized
in 2 steps. First, matrices describing textures on images were
extracted from tumors, and textural features were subsequently
computed using theses matrices. All these parameters characterize
in some way tumor heterogeneity at local and regional (using
texture matrices) or global scales (using image-voxel-intensity
histograms).
Several different textures (Table 2, left column) were com-
puted. Voxel values within the segmented tumors (Fig. 1A and
1B) were resampled to yield a finite range of values (Fig. 1C),














where 2S represents the number of discrete values (16–128), I is
the intensity of the original image, and V is the set of voxels in the
delineated volume. This resampling step on the delineated tumor
volume, necessary for the computation of the textural analysis, has
2 effects: it reduces the noise in the image by clustering voxels
with similar intensities and it normalizes the tumor voxel inten-
sities across patients, which in turn facilitates the comparison of
the textural features. Local and regional features were computed
with different resampling considering 16, 32, 64, and 128 dis-
crete values to investigate the potential impact of this resampling
parameter.
All considered textures were originally described for 2
dimensions (27–30) and were therefore adapted in this work for
3 dimensions. The cooccurrence matrix (M1, Fig. 1D(a)) describ-
ing pairwise arrangement of voxels, and the matrix describing the
alignment of voxels with the same intensity (M2, Fig. 1D(b)),
were computed considering 13 different angular directions.
Finally, 3D matrices describing differences between each voxel
and its neighbors (M3, Fig. 1D(c)) and characteristics of homoge-
neous zones (M4, Fig. 1D(d)) were computed considering for each
voxel the neighbors in the 2 adjacent planes, adapting the normal-
izing factors to 3 dimensions.
From each of the extracted texture matrices, different features
summarized in Table 2 (middle column) were computed. Depend-
ing on the way the matrix is analyzed, it is possible to extract
features of a local or regional nature. Six features highlighting
local variations of voxel intensities within the image were
extracted from the cooccurrence matrices M1 (Fig. 2C). For exam-
ple, using the matrix M1, the local entropy and homogeneity are
calculated using Equations 2 and 3, respectively:
Local entropy 52+
i; j
M1ði; jÞlogðMði; jÞÞ Eq. 2





where M1 is a cooccurrence matrix, i, j are the rows and columns
index, and M1(i,j) is an element of the matrix.
In addition, M3 matrices were used to extract busyness
(quantifying sharp-intensity variations) and contrast and coarse-
TABLE 1
Characteristics of Patients (n 5 41)





Upper esophagus 10 (24)
Middle esophagus 15 (37)
Lower esophagus 16 (39)
Tumor cell type
Squamous cell carcinoma 31 (76)
Adenocarcinoma 10 (24)
Histologic grade
Well differentiated 12 (29)
Moderately differentiated 11 (27)





















Stable disease (NR) 7 (17)
Progressive disease (NR) 4 (10)
Data in parentheses are percentages.
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ness (quantifying tumor granularity). These features allow extract-
ing measurements describing tumor local heterogeneity propor-
tional to variations of 18F-FDG uptake between individual voxels.
On the other hand, the M2 and M4 matrices were used to extract
regional tumor uptake characteristics, representing regional hetero-
geneity, such as variation of intensity between regions and in the
size and alignment of homogeneous areas. For example, the M4
matrix links the homogeneous tumor regions to their intensity (Fig.
2B). It was hence used to calculate the variability in the size and the
intensity of identified homogeneous tumor zones according to Equa-















Texture Type and Associated Features
Type Feature Scale



































Features based on neighborhood intensity-difference matrix (M3) Coarseness Local
Contrast
Busyness
FIGURE 1. Whole-body 18F-FDG PET
scan (A), tumor segmentation (B), and
voxel-intensity resampling (C) allowing
extraction of different features (D) by analy-
sis of consecutive voxels in a direction (for
cooccurrence matrices) (a), alignment of
voxels with same intensity (b), difference
between voxels and their neighbors (c),
and zones of voxels with same intensity (d).














where Q represents the number of homogeneous areas in the
resampled tumor, M the number of distinct intensity values within
the tumor, and N the size of the largest homogeneous area in the
matrix M4.
Finally, global features are computed on the original image
voxels’ intensity distribution by analyzing the characteristics of the
intensity value histogram within the segmented tumor (Fig. 2A).
Thirty-eight features were extracted from the 4 different texture
matrices and intensity histograms. Seven of the 38 features
characterize the uptake distribution within the entire tumor (using
the intensity histogram), 9 describe local voxel arrangements (using
matrices M1 and M3), and 22 are related to the organization of
voxels at a regional scale (using matrices M2 and M4).
Statistical Analysis
The capacity of each feature to classify patients with respect to
therapy response was investigated on the primary tumor using the
Kruskal–Wallis test (8). P values of less than 0.05 were considered
statistically significant. Specificity and sensitivity (including 95%
confidence intervals [CIs]) for each of the studied parameters were
derived using receiver operating characteristic (ROC) curves mea-
suring associated areas under the ROC curves (AUC). Texture results
were compared with those of SUVmax, SUVmean, and SUVpeak for
their ability to distinguish among responders (PR and CR) and
NRs, CRs and non-CRs (PR, NR), and all 3 groups separately.
RESULTS
Patients were evaluated 1 mo after the completion of
combined radiochemotherapy. Nine patients (22%) had no
evidence of disease after treatment and were considered
CRs. Radiochemotherapy led to partial response in 21
(51%) patients, whereas 11 (27%) were stable or progressed
under treatment according to RECIST (25).
Results of the Kruskal–Wallis test show that SUVmax
(Fig. 3) and SUVmean were capable of differentiating only
CRs from NRs and PRs. Within this context, all SUV mea-
surements were significant predictive factors of response
(P 5 0.034, 0.044, and 0.012 for the SUVmax, SUVmean,
and SUVpeak, respectively). However, only SUVpeak was a
significant predictive factor (P 5 0.045) when considering
the differentiation of 3 patient response groups (i.e., NR, PR,
and CR), whereas SUVmax and SUVmean were not (P. 0.05).
Figure 4 shows examples of different extracted features
and associated values for tumors of CRs, PRs, and NRs.
The Kruskal–Wallis tests revealed no statistically signifi-
cant differences in the textural parameters derived using
FIGURE 2. Examples of features extracted from tumor resampled on 4 values: 3 global features computed using intensity histogram,
2 regional features computed using M4 matrix, and 2 local features computed using M1 texture matrices.
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different resampling values (16, 32, 64, or 128 discrete
values). All subsequent reported results were obtained
using 64 discrete values in the resampling normalization
process. This value was chosen because it allows for 0.25
SUV increments, which were considered sufficient given
the range of SUVs encountered (from ;4–20).
None of the global features extracted from the intensity
histogram within the tumor was a significant predictive
factor of response to therapy. However, considering local
variation of 18F-FDG uptake, a high predictive value (P ,
0.0007) was found using the cooccurrence features, partic-
ularly considering the use of the average feature values
FIGURE 3. Box-plot representation of
parameters’ values in function of patient
response (0, NR; 1, PR; and 2, CR) for SUVmax
(P 5 0.106) (A), SUVpeak (P 5 0.045) (B), local
entropy (P 5 0.0006) (C), and regional inten-
sity variability (P 5 0.0002) (D).
FIGURE 4. Example of different extracted features and associated values for tumors of CRs, PRs, and NRs (results are normalized in [0–1]
interval using range of observed values for local and regional parameters).
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computed using M1 matrices (Table 3). All these features
offered statistically significant differentiation of NRs and
responders (considering both CR and PR).
Regarding local features, the busyness and contrast
computed on M3 matrices were not statistically significant
predictive factors of response, but the coarseness, reflecting
the local granularity of the tumor functional image, was
found to be significant (P 5 0.0002). Among the local
measures of functional tumor characteristics computed
using M1 matrices, the measure of local entropy was the
only measure allowing statistically significant differentia-
tion of all 3 patient groups (P 5 0.0006, Fig. 3).
Because the features computed on M2 and M4 matrices,
used to highlight regional variability in the 18F-FDG dis-
tribution, were strongly correlated (r . 0.9), only features
based on M4 were used in the subsequent analysis.
Regional measures of tumor characteristics extracted from
these M4 matrices, such as the variability in the size and the
intensity of identified homogeneous tumor zones, were sta-
tistically significant in predicting therapy response (P 5
0.0002), allowing the differentiation of all 3 patient re-
sponse groups (Fig. 3).
The ROC curve analysis for SUVmax, SUVpeak, local
homogeneity, local entropy, and regional tumor character-
istics such as the variability in size and intensity of identi-
fied homogeneous tumor areas is presented in Figure 5.
Table 3 summarizes the ROC curve analysis results, com-
paring the performance of the different studied parameters
in terms of sensitivity and specificity in, on the one hand,
identifying complete-response patients and, on the other
hand, differentiating responders (PR and CR).
First, based on the ROC curve analysis, textural param-
eters can identify CRs better than can the SUV-based
measurements, as demonstrated by the respective AUCs
(Fig. 5). For example, SUVmax, with an AUC of 0.7,
allowed the identification of CRs, with a maximum sensi-
tivity of 46% and specificity of 91%, using a threshold of 6.
On the other hand, the variability in the size of the uniform
tumor zones (AUC, 0.85) allowed for the extraction of CR
patients with the best accuracy (sensitivity, 92%; specific-
ity, 69%).
Second, as Figure 5 shows, textural features were most
efficient in identifying responders (CRs and PRs), whereas
for the same task the performance of SUV measurements
was limited. For the differentiation of the patient respond-
ers, the AUC was less than 0.6 for the different SUV
parameters, compared with an AUC of more than 0.82
for the use of the texture parameters. For example, the
AUC of the SUVmax was 0.59, allowing a sensitivity of
53% and specificity of 73% in the differentiation of res-
ponders using an optimal threshold of 9.1. On the other
hand, for the same task the local homogeneity had a spe-
cificity and sensitivity of 88% and 73%, respectively
(AUC, 0.89).
DISCUSSION
Assessment of tumor response to therapy plays a central
role in drug development and patient clinical management.
Currently, response is mainly assessed by measuring
anatomic tumor size and classifying tumor shrinkage
according to standard criteria. Because metabolic changes
often occur before morphologic changes, metabolic imag-
ing appears to be a valuable tool for monitoring various
treatments in different cancer types. Within this context,
18F-FDG PET has shown promising results in assessing
response to therapy and prognosis. In esophageal cancer,
quantitative changes in 18F-FDG uptake at 2 wk after the
start of therapy have been shown to correlate well with
TABLE 3
Sensitivity and Specificity (Along with Corresponding 95% Confidence Intervals) of 3 SUV-Based
Measurements, 2 Cooccurrence Features, and 2 Size-Zone Features
Comparison Parameters Sensitivity (%) 95% confidence interval (%) Specificity (%) 95% confidence interval (%)
NR vs. PR 1 CR SUVmax 53 35.1–70.2 73 39.0–94.0
SUVmean 71 52.5–84.9 45 16.7–76.6
SUVpeak 56 37.9–72.8 73 39.0–94.0
Local homogeneity 88 71.8–96.6 73 39.0–94.0
Local entropy 79 61.1–91.0 82 48.2–97.7
Size-zone 76 58.8–89.8 91 58.7–99.8
Intensity variability 76 58.7–89.3 91 58.7–99.8
NR 1 PR vs. CR SUVmax 46 19.2–74.9 91 75.0–98.0
SUVmean 62 31.6–86.1 81 63.6–92.8
SUVpeak 62 31.6–86.1 81 63.6–92.8
Local homogeneity 92 61.5–99.8 56 37.7–73.6
Local entropy 92 61.5–99.8 69 50.0–83.9
Size-zone 92 64.0–99.8 69 50.0–83.9
Intensity variability 85 54.6–98.1 75 56.6–88.5
Data in top part of table are evaluation of parameters to distinguish PR or CR; data on bottom part of table are evaluation of parameters
to differentiate CRs.
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subsequent tumor shrinkage and patient survival (4). This
approach still has limitations, especially if patients undergo
radiotherapy treatment. Hautzel et al. have shown that even
low irradiation may enhance tumor uptake, and inflamma-
tory changes may contribute early to this increase, yielding
inaccurate information about treatment response (31).
Within the same context, induced ulceration may also
impair response assessment using PET (32).
On the other hand, the prediction of response before
treatment initiation may be of great interest to the optimi-
zation of patient management. With such an endpoint, few
authors have studied the predictive value of initial 18F-FDG
uptake for therapy response. Rizk et al. reported an SUVmax
of more than 4.5 to be a reliable predictor of pathologic
response (9), whereas Javeri et al. (8) demonstrated in a
larger group of patients a trend of greater rate of response
obtained after combined chemoradiotherapy in patients who
had an initial SUVmax higher than 10. Similarly in our study,
initial SUVmean, SUVmax, and SUVpeak were also predictors
of complete response. However, in general these indices did
not allow differentiating NRs from PRs, a distinction that
could be useful for patient management. For instance, within
the patient population of our study the identification of PRs
before any treatment could allow the definition of a subpo-
pulation for which the use of conventional radiochemother-
apy should be directly replaced by another option, such as a
new targeted therapy.
A few studies have already focused on the link between
image analysis and tumor biologic parameters. Gillies et al.
(33) suggested that imaging can longitudinally characterize
spatial variations in the tumor phenotype and its microen-
vironment so that the system dynamics over time can be
quantitatively captured. Segal et al. (22) showed that con-
trast-enhanced CT image characteristics (such as texture
heterogeneity score or estimated percentage of necrosis)
correlate with most of the liver global gene expression pro-
files, revealing cell proliferation, liver synthetic function, and
patient prognosis. Within the same context, Diehn et al. (34)
mapped neuroimaging parameters with gene-expression pat-
terns in glioblastoma, whereas Strauss et al. (35) combined
dynamic PET kinetic parameters with gene-array techniques.
Finally, Eary et al. (24) previously demonstrated that a glob-
ally assessed 18F-FDG distribution heterogeneity in sarcoma
is a potential prognostic factor.
In our study, the value of textural feature analysis was
explored on the pretreatment 18F-FDG PET scans for pre-
dicting response to combined chemoradiotherapy. Global
tumor metabolic features based on the intensity histogram
were computed directly on the original image. As such,
they were therefore highly correlated with 18F-FDG uptake,
which could explain why these textures could only predict
CRs but could not distinguish NRs from PRs, similar to the
SUV measurements. The other features evaluated in this
study highlight tumor heterogeneity at a local and regional
level, characterized in several ways, depending on the type
of matrix used and the kind of feature computed on this
matrix. Consequently, whereas a single feature cannot be
directly linked to a specific biologic process, one could
assume that a combination of textural parameters may be
closely related to underlying physiologic processes, such as
vascularization, perfusion, tumor aggressiveness, or hyp-
oxia (18,19). Therefore textural features could be correlated
to physiologic processes related to response to combined
radiochemotherapy. For example, one could reasonably
expect that a tumor exhibiting a heterogeneous, compared
with a homogeneous, 18F-FDG distribution may respond
less favorably to a uniformly distributed radiotherapy dose.
We could also hypothesize that underlying neoangiogene-
sis contributes to tumor 18F-FDG uptake heterogeneity,
FIGURE 5. ROC curves for SUVmax, SUVmean, SUVpeak, local
homogeneity, uniform tumor areas, intensity variability, and size-
zone variability for identification of CRs (A) and PRs or CRs (B).
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although it is now widely accepted that neoangiogenesis is
associated with reduced effectiveness of conventional che-
motherapy. However, the exact relationship between the
proposed image-derived indices and underlying tumor biol-
ogy can be established only on carefully designed prospec-
tive studies.
In this work, the cooccurrence features analyzing inter-
relationships between pairs of voxels, corresponding to the
characterization of local nonuniformities, were able to sig-
nificantly differentiate NRs from other patient groups. The
measurement of local homogeneity and entropy gave the
best results for this class of textures. Although in most
cases responders (PR and CR) were associated with greater
local heterogeneity than NRs, these features were less
efficient in discriminating CRs from PRs.
The 2 features facilitating the best patient stratification
were both associated with regional tumor characterization.
Both the intensity and the size variability of uniform zones
identified within the tumor, representing a measure of
regional tumor heterogeneity, were significant predictors of
response to therapy. ROC curve analysis showed that the
performance of these features is similar to that of cooccur-
rence features in identifying NRs, but they can in addition
distinguish between PRs and CRs with higher sensitivity
and specificity than SUV measurements. These results
suggest that regional (in terms of intensity and size of
homogeneous areas) rather than local heterogeneity offers a
superior differentiation of esophageal carcinoma patient
groups in terms of response to combined chemoradiother-
apy treatment than does any other global tumor metabolic
activity measurement currently used in routine clinical
practice, such as SUVs.
A limitation of the present study is that it is retrospective,
considering a relatively small patient cohort. Therefore, the
potential of new image-derived indices characterizing
tumor 18F-FDG distribution for prediction of response to
therapy studies demonstrated in this work needs to be vali-
dated by a prospective study on a larger patient cohort.
CONCLUSION
We have demonstrated that textural analysis of the
intratumor tracer uptake heterogeneity on baseline 18F-
FDG PET scans can predict response to combined chemo-
radiation treatment in esophageal cancer. Textural features
derived from cooccurrence matrices strongly differentiated
NRs from PRs, providing useful information for personal-
izing patient management. These results suggest that
regional and local characterization of 18F-FDG PET tracer
heterogeneity in tumors, exploring processes underlying the
18F-FDG uptake and distribution within tumors, are more
powerful than global measurements currently used in clin-
ical practice, holding the potential to revolutionize the pre-
dictive role of PET in cancer treatment. Finally, although
only 18F-FDG images in esophageal cancer have been con-
sidered here, clearly the same indices applied in other PET
radiotracer studies in the same or different tumor types may
help create even stronger links between imaging and under-
lying tumor biology.
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Purpose: Partial volume effects (PVEs) are consequences of the limited spatial resolution in emis-
sion tomography leading to underestimation of uptake in tissues of size similar to the point spread
function (PSF) of the scanner as well as activity spillover between adjacent structures. Among PVE
correction methodologies, a voxel-wise mutual multiresolution analysis (MMA) was recently intro-
duced. MMA is based on the extraction and transformation of high resolution details from an ana-
tomical image (MR/CT) and their subsequent incorporation into a low-resolution PET image using
wavelet decompositions. Although this method allows creating PVE corrected images, it is based
on a 2D global correlation model, which may introduce artifacts in regions where no significant
correlation exists between anatomical and functional details.
Methods: A new model was designed to overcome these two issues (2D only and global correla-
tion) using a 3D wavelet decomposition process combined with a local analysis. The algorithm was
evaluated on synthetic, simulated and patient images, and its performance was compared to the
original approach as well as the geometric transfer matrix (GTM) method.
Results: Quantitative performance was similar to the 2D global model and GTM in correlated
cases. In cases where mismatches between anatomical and functional information were present, the
new model outperformed the 2D global approach, avoiding artifacts and significantly improving
quality of the corrected images and their quantitative accuracy.
Conclusions: A new 3D local model was proposed for a voxel-wise PVE correction based on the
original mutual multiresolution analysis approach. Its evaluation demonstrated an improved and
more robust qualitative and quantitative accuracy compared to the original MMA methodology, par-
ticularly in the absence of full correlation between anatomical and functional information. VC 2011
American Association of Physicists in Medicine. [DOI: 10.1118/1.3608907]
Key words: emission tomography, partial volume effects, resolution and intensity recovery, wavelet
transform, multimodality
I. INTRODUCTION
Partial volume effects (PVEs) refer to two distinct phenom-
ena leading in underestimation or overestimation of the tis-
sues uptake. The first results from the limited spatial
resolution of the imaging device, leading to a three-dimen-
sional (3D) blurring and a loss of signal in tissues of size
similar to the system’s point spread function (PSF) full
width at half-maximum (FWHM), as well as activity cross-
contamination (“spillover”) between structures with different
uptakes.1 The second phenomenon arises from the discrete rep-
resentation on a grid with voxel sizes from 1 to 5 mm for the
reconstruction of images. The voxel values at the edges are
consequently a mixture of different tissues, an effect
4920 Med. Phys. 38 (9), September 2011 0094-2405/2011/38(8)/4920/14/$30.00 VC 2011 Am. Assoc. Phys. Med. 4920
commonly known as “tissue-fraction effect.” This effect exists
on all image modalities, but its magnitude is lower on anatomi-
cal datasets such as magnetic resonance image (MRI) or com-
puted tomography (CT), and the introduction of higher
resolution details from anatomical images in the functional
images could reduce its impact. In this study, we considered
both the spatial resolution of the scanner and the voxel grid
sampling, which are specific to the low-resolution images
obtained with PET.
Most of the previously proposed approaches for PVE
correction consist in using a priori anatomical information
provided by either computed tomography or magnetic reso-
nance images. Although these methodologies usually aim at
the recovery of accurate uptakes in specific regions of inter-
est (ROIs)1–4 requiring either a coregistered atlas or a seg-
mentation step, such as the ROI based geometric transfer
matrix (GTM) by Rousset et al.,2 some voxel-based imple-
mentations have been recently proposed. They could be clas-
sified in two groups; namely deconvolution without the use
of anatomical information5–8 or voxel-wise correction based
on the use of anatomical and functional images available
from multimodality devices.9–11
Teo et al.5 considered the use of iterative deconvolution
restricted to a ROI to avoid noise increase in the overall
image, while a more recent study applied iterative deconvo-
lution to brain images.6 Boussion et al.7 proposed the use of
wavelet-based denoising at the iterative level of the decon-
volution process to avoid noise amplification. The efficacy
of this denoising greatly depends on the choice of the wave-
let filtering algorithm and associated threshold values. Kirov
et al.8 suggested the use of regularized iterative deconvolu-
tion with variance control based on local topology as an al-
ternative solution for noise reduction. This latter approach is
not fully automatic because the determination and optimiza-
tion of the regularization parameters are dependent on the
properties of the image.
One methodology based on the use of anatomical informa-
tion to correct functional data was proposed by Boussion
et al.9 and is referred to as mutual multiresolution analysis
(MMA). It uses discrete wavelet transforms10 of a low-reso-
lution PET image L and a corresponding coregistered high
resolution anatomical MRI (or CT) H. The method extracts
the spatial frequencies like details, edges, and textures from
wavelet decompositions at a level of resolution common to H
and L (a specific decomposition layer in which both wavelet
images have the same PSF FWHM). A global linear model is
then inferred to build the lacking details of L from these
found in H. The method demonstrated accurate quantitative
correction comparable with the methodologies considered as
the current state of the art2–4 but limited to ROI analyses.
This approach has the advantage of generating PVE corrected
images, allowing for an accurate activity recovery, without
any segmentation or other preprocessing steps.
Despite these advantages, the original MMA approach
suffers from two limitations. First, it is based on a global cor-
relation between anatomical and functional structures, as a
linear and global link is assumed in order to model the rela-
tion between the wavelet coefficients of both modality trans-
forms at the same level of resolution. Consequently, where
there is little to no correlation between these structures, arti-
facts may appear in the corrected emission image as a result
of the incorporation of anatomical structures with no func-
tional significance. An alternative approach based on MMA
has been recently published11 restricted to the brain domain
and making use of atlases for the provision of the anatomical
information in an attempt to reduce the impact of functional
and anatomical image mismatches. However, such approach
is dependent on the use of atlases and is, therefore, only ap-
plicable to brain imaging. The second limitation of the origi-
nal MMA algorithm is due to the use of a 2D modeling as
the correction is applied independently slice by slice,
whereas PVE is a 3D effect for which it is important to con-
sider interactions in all three spatial directions.
The goal of the present study was to design a new model
in order to overcome the shortcomings associated with the
original MMA algorithm as highlighted above. More specifi-
cally, a new 3D wavelet decomposition scheme was
designed, and the global linear relation model was replaced
with an improved local analysis, in order to process limited
image areas at a time and adapt this model to each image
part based on local information. This new approach was
evaluated on synthetic and simulated images and applied to
brain and whole body patient datasets, and its performance
was compared to the results obtained with both the original
2D global MMA algorithm described by Boussion et al.9 and
the GTM reference methodology.2
II. MATERIALS AND METHODS
II.A. Multiresolution analysis in the wavelet domain
Performing multiresolution image analysis using wavelet
transforms consists in analyzing details across different lev-
els of resolution or scale,12 in order to extract consecutive
layers of details from large structures to small edges, by
separating the spatial frequencies they contain. Among the
many algorithms developed to perform wavelet transform
of an image, the most common approach is the multiresolu-
tion pyramidal methodology13 consisting in iteratively
reducing the resolution of the image. Such subsampling
may cause a loss of linear continuity in spatial features
such as edges and the appearance of artifacts in those struc-
tures.14 Therefore, the undecimated algorithms are often
more appropriate, for instance, for the image fusion pur-
pose.15 The “a` trous” (“with holes”) algorithm was used
here and extended to 3D to perform the wavelet decomposi-
tion10 based on the initial work of Boussion et al.9 This
algorithm presents several advantages such as a straightfor-
ward implementation, a reconstruction without any loss of
information and an isotropic process (i.e., no specific direc-
tions selected). This algorithm is related to the standard dis-
crete wavelet transform decomposition scheme16 as it
performs the subsampling of the filtered image by upsam-
pling the low-pass filter, inserting zeros between each of
the filter’s coefficient at each level. The detail coefficients
images fwjg are then obtained as the difference fIjþ1 Ijg
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between the low-pass filtered images from two consecutive
levels. At each iteration j, the resolution of the image Ij is
reduced to obtain the smoothed image Ijþ1 (called residual)
using




ðxþm:2j; yþ n:2j; zþ o:2jÞ; (1)
where h is a 3D low-pass filter defined by
hðx; y; zÞ ¼ h1DðxÞ  h1DðyÞ  h1DðzÞ
h1Dð0Þ ¼ 3=8; h1Dð61Þ ¼ 1=4; h1Dð62Þ ¼ 1=16; and h1DðnÞ ¼ 0 if jnj > 2

; (2)
with  the convolution operator and h1D a binomial filter
17 of
order 4. The inverse transform can be computed by adding
the detail layers fwjg from all levels to the final low-resolu-
tion image IJ
I0ðx; y; zÞ ¼ IJðx; y; zÞ þ
Xj¼J
j¼1
wjðx; y; zÞ; (3)
where J is the number of iterations from the initial image I0
to the final approximation IJ.
Due to the discrete convolution shown in Eq. (1), the
spatial resolution (or PSF FWHM) of the residual image
Ijþ1 depends on both the spatial resolution of Ij and the
size of its voxels. This is because the image Ij is sampled
according to the iteration index j (i.e., the level of scale in
the wavelet transform) and the convolution leads to a non-
linear dependency (factor 2j) on the resulting PSF FWHM
of the residual Ij þ 1. The relationship between voxel sizes
and the residual FWHM at different scales was determined
by applying the a` trous algorithm to an initial point source
of different sizes (from 0.6 to 1.4 mm) using the MATHEMA-
TICA software. This relationship was found to be linear
(see Table I). In order to change the voxel size of the ini-
tial image I0 and to obtain a residual Ij with a specific
spatial resolution according to the MATHEMATICA software
analysis, trilinear interpolation and third order B-spline
resampling were used for anatomical and functional
images, respectively.
Using both Eq. (3) and this resampling, the spatial fre-
quencies fwjg of the anatomical and functional images are
extracted in 3D and the spatial resolution of the final re-
sidual IJ is accurately determined. We define the spatial re-
solution of the anatomical image H as q (initial image H
referred to as Hq) and that of the functional image L as
r¼ qþ p (initial image L referred to as Lr), with r> q and
p the number of decompositions that have to be performed
to reach a common level of resolution between the two
modalities. This number is deduced from the PSF FWHM
and the voxel sizes of both initial images. We can then
perform the extraction of the spatial frequencies at a level
of resolution common to H and L (qþ pþ 1), using the a`
trous algorithm
Lrðx; y; zÞ ¼ Lqþpðx; y; zÞ
¼ Lqþpþ1ðx; y; zÞ þ w
L
qþpþ1ðx; y; zÞ; (4)
Hqðx; y; zÞ ¼ Hqþpþ1ðx; y; zÞ þ
Xk¼pþ1
k¼1
wHqþkðx; y; zÞ; (5)
where wL (in terms of units) and wH are the wavelet coeffi-
cients from the wavelet decomposition of the functional and
anatomical images, respectively.
II.B. Local mutual multiresolution analysis
Similarly to previously developed methodologies using
wavelets for PVE correction,9,11 our method is based on the
exploitation of existing correlations in the wavelet domain.
Such correlation is defined by establishing a relationship
between the anatomical and functional wavelet coefficients
at a common level of resolution, independently of the origi-
nal images content (in terms of units). In our proposed
approach, we assume that the residual Lr can be estimated by
a space dependent scaling of Hr, for which the scaling factor
can be obtained from a local analysis to account for local dif-
ferences between H and L. The corrected emission image Lq
(same level of resolution as Hq) is, therefore, obtained using
Eq. (6) by adding the original uncorrected value of L
[Lqþpþ1ðx; y; zÞ þ w
L
qþpþ1ðx; y; zÞ, see Eq. (4)] with the sum
of the anatomical wavelet coefficients weighted by a local
factor a






wHqþkðx; y; zÞ; (6)
where a stands for the median of the ratio map (MRM).
Equation (6) provides the corrected value for each voxel (x,
y, z) by adding to the original functional image value (L) the
wavelet coefficient. Each voxel is processed individually,
however, the parameter a is computed for each voxel using a
TABLE I. FWHM values of the residual scales for an initial FWHM of 1 mm
and initial voxel sizes of 0.6, 1, and 1.4 mm. The equation formula provided
by the software is presented.
Voxel size of the initial image (mm) 0.60 1.00 1.40 x
FWHM residual scale 1 1.56 2.61 3.65 2.61 * x
FWHM residual scale 2 3.38 5.64 7.90 5.64 * x
FWHM residual scale 3 6.89 11.48 16.08 11.48 * x
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3D sliding cube, simultaneously applied within the L and H








where WIND is a window in 3D (i.e., a cube) centered on
(x,y,z) with a fixed size of 3 3 3 voxels (i¼ 1…3) and T
is a threshold operator. Equation (7), therefore, computes a
for each voxel of coordinates x, y, z, as the median (within a
cube centered on this voxel) of the ratios between the wave-
lets coefficients of each transforms. The cubic moving win-
dow was introduced instead of a simple voxel-by-voxel ratio
to account for local variations in the anatomical and func-
tional images, contrary to the global model9 and to reduce
the noise and misregistration sensitivity associated with a
voxel-by-voxel analysis. The choice of using the median
instead of the mean within the cubic sliding window, as well
as the actual size of the cube was made based on the results
obtained on simulations (see Sec. IV). Different sizes (3, 5,
and 7 voxels) were compared since this parameter might
have an impact on the sensitivity of the method to spatial
misregistration, noise and inappropriate choice of the respec-
tive PSF FWHM values. Also, results obtained using the
mean or the median of the ratios were compared. The mean
was expected to be more sensitive to artifacts and noise in
contrast to the median, which would tend to discard extreme
values. Also, the use of a sliding cube should also make the
approach more robust to spatial misregistration or inaccurate
PSF FWHM values used in the process. On the one hand, the
ratio map allows a large amount of uncorrelated details such
as anatomical structures without significant uptake in the
functional image to be discarded. On the other hand, if no
structural information is associated with a significant uptake
in the corresponding functional image, the low values of the
wavelet coefficients may lead to MRM evaluation errors
with denominator values wHqþ pþ 1 close to zero. In order to
avoid extreme values that may be generated by the MRM
and preserve the activity of the functional image in such con-
figurations, we introduced a fixed threshold T [Eq. (7)] on
the anatomical wavelet coefficients. Its value was empiri-
cally chosen as 0.1 as it gave satisfactory results in most con-
sidered cases, however future studies should investigate the
automatic estimation of an optimal value for each case.
Therefore, an investigation regarding the cube optimal size
was carried out in this study.
II.C. Validation and comparison study
II.C.1. Analysis
Mean and associated standard deviation were computed
on ROI placed on the organs or objects of interest in order to
quantify the partial volume effect correction and compared
to the ground-truth when available (synthetic images and
simulated datasets). In such cases (for example, the spheres),
the ROIs were defined on the ground-truth, covering the
entire structure voxel-by-boxel, and were reported to both
uncorrected and corrected images. For clinical datasets, as
ground-truth was not available, the improvement between
uncorrected and corrected image was reported for ROI
placed on both images.
II.C.2. Synthetic images
The proposed algorithm was first validated using syn-
thetic images. All the images considered in this section were
generated in 3D and analyzed either on a 2D basis using the
original MMA method, or in 3D using the proposed
approach. Finally, the GTM methodology was also applied,
assuming a perfect knowledge of the ground-truth for the
definition of the necessary ROIs in order to eliminate any
potential errors that can be associated with a segmentation
step. Two different synthetic images were employed, the first
one Href [Fig. 1-(1)] to generate the functional images L
[Fig. 1-(2)], and the second one Hanat [Fig. 1-(3)] used for
the correction of PVE via both the 2D global and 3D local
methodologies. A Gaussian noise [standard deviation (SD)
2% of the mean in the uniform part of the phantom] was
added in the Hanat images prior to their use for the correction.
These 128 128 128 (1 1 1 mm3 voxels) images con-
tain a cylindrical background region with a fixed intensity of
100 and spheres of different sizes and intensities. The first
[Fig. 1(a)-(1)] contains five 2 cm diameter spheres with
decreasing intensities (200, 120, 90, 70, and 50). The second
one [Fig. 1(b)-(1)] contains four spheres of decreasing diam-
eter (6, 4, 2, and 1 cm) with intensity of 200. The last two
images [Figs. 1(c)-(1) and 1(c)-(3)] display spheres common
to both modalities with, however, no absolute intensity cor-
relation, as well as two additional structures: one which is
present only in the anatomical data Hanat with no correspond-
ing uptake in the functional image and, respectively, a hot
spot in the functional data L without any corresponding ana-
tomical structure in Hanat.
The L images [Fig. 1-(2)] (same voxel size and dimen-
sions as for Hanat) were generated by convolving Href [Fig.
1-(1)] with a 6 mm FWHM 3D Gaussian PSF and adding
Gaussian noise (SD 10% of the mean intensity). In this first
dataset, both Hanat and L images had a voxel size of 1 mm
3.
The Gaussian noise approximation is realistic enough for the
reconstructed PET images when considering a specific
ROI.18 The noise intensity (SD value) used was determined
through different ROI analyses in the lung and liver from
various whole body clinical datasets.
Different combinations of the 3D synthetic images in Fig.
1 were considered to compare the performance of the differ-
ent approaches considered. First, functional and anatomical
images with complete structural and intensity correlation
[Figs. 1(a)-(2) and 1(a)-(3)] were used to specifically study
the accuracy of the correction for spillover effects due to the
various contrasts. A second combination was analyzed [Figs.
1(b)-(2) and 1(b)-(3)] in order to examine the value recovery
of small objects. These two configurations were designed to
validate the performance of the local approach for cases
where the global approach already leads to satisfactory
results, i.e., with a perfect match (structure and intensity)
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FIG. 1. Three synthetic datasets for which the background region has a fixed value of 100. (a) A correlated case with spheres of constant size and decreasing
intensities (from 200 to 50); (b) a correlated case with spheres of constant intensity (200) and decreasing sizes; and (c) an uncorrelated case. For each one of
the three synthetic datasets: (1) a high-resolution anatomical image Href used to generate the low-resolution functional image L (2), (3) the high-resolution ana-
tomical image Hanat used for the PVE correction, (4) the PVE corrected images using the 2D global approach, and (5) images after PVE correction using the
3D local approach. Percentage of intensity recovery (mean6 SD) for the three datasets corrected for PVE using the GTM (mean only), 2D global or 3D local
approach: (d) a correlated case with spheres of constant size and decreasing intensities, (e) a correlated case with spheres of constant intensity and decreasing
sizes, and (f) an uncorrelated case. Spheres are numbered on 1-(1).
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between both modalities. A third combination was used to
investigate partial correlation between the two modalities
[Figs. 1(c) (2), and (3)] for which the 2D global MMA is
expected to perform with reduced qualitative and quantita-
tive accuracy. In each case, the new local 3D MMA
approach was compared to the previous 2D global model
and to the GTM method.
Finally, tests similar to those already used for the 2D
MMA (Ref. 9) were carried out to evaluate the impact of
noise and possible misregistration errors, or an inappropriate
choice of FWHM parameters. For this purpose, variable
noise intensities (SD from 10% to 50%) were added to the
functional images of Fig. 1(c)-(2). The robustness of the
approach against misregistration errors was evaluated by
applying different rigid transformations [translation up to 4
voxels (about 4 mm), rotation up to 5] or inappropriate scal-
ing (610%) to the functional image of Fig. 1(c)-(2). The
impact of an inappropriate choice of FWHM parameters for
the resampling was investigated by generating different L
images from the Href [Fig. 1(c)-(1)] with FWHM PSF from 4
to 8 mm. These L images were then corrected for PVE con-
sidering a unique FWHM value of 6 mm.
II.C.3. Simulated images
In the second part of this study, simulated images gener-
ated using a segmented brain phantom based on measured
T1 MRIs (Ref. 19) were analyzed. The images are a T1-
weighted MRI and an associated 18F-FDG PET. The func-
tional image was generated using the following procedure.20
Clinically measured plasma time activity curves (TACs)
were first used to generate a set of TACs for each anatomical
region of the brain phantom according to 28 different clinical
dynamic frames (1 30 s, 1 15 s, 1 5 s, 4 10 s, 4 30
s, 4 60 s, 4 120 s, 9 300 s). Pathological parameters
were introduced in the parietal and the anterior frontal lobes.
The dynamic images were then forward-projected using the
maximum ring difference, mash and span as for the patient
study, forming projection data of the ECAT HRþ scanner
(spatial resolution of 4.8 and 5.6 mm FWHM transaxially
and axially, respectively). These projection data were attenu-
ated using the values of the different tissue types contained
in the Zubal phantom (muscle, bone, fat, and skin), and
uncorrected for normalization by applying the inverse nor-
malization factors. These factors and the scatter additive
term were both taken from the human study. The random
contribution was simulated based on the system’s detection
efficiency factors pattern scaled to the total random events of
each frame in the acquired human study. Finally, Poisson
noise was added to the sinograms, and the images were
finally reconstructed with filtered backprojection including
scatter, attenuation, and normalization corrections. The
image sizes for both PET and MRI were 128 128 64
(2.35 2.35 2.42 mm3 voxels). The final static PET image
was eventually obtained by summing the last six temporal
frames. The respective considered FWHM values were 4.8
mm in plane and 5.6 mm axially for the PET images and 1
mm in all three dimensions for the anatomical datasets. The
performance of the method was assessed by comparison
with the known ground-truth of the simulation. This dataset
was also used to determine the optimal sliding cube size
among 3 3 3, 5 5 5 or 7 7 7 voxels (see Sec. IV).
II.C.4. Clinical images
The approaches were also compared on two clinical
images. The first one consists of a clinical T1 MRI (GE
1.5T) and associated FDG brain PET (Philips GEMINI dual
slice PET/CT) scans. The MRIs were chosen instead of the
CT for the correction to benefit from the improved contrast
in the different brain structures. The MRI contains a hyperin-
tensity signal in the left occipital lobe and the posterior cing-
ulum due to the gadolinium injection. The PET
reconstructed images [using RAMLA 3D (two iterations,
relaxation parameter of 0.05 and a 5 mm FWHM 3D Gaus-
sian postfiltering] and CT based attenuation correction) are
128 128 64 (1.41 1.41 2 mm3 voxels), and the MRI
is 512 512 160 (0.47 0.47 1 mm3 voxels). The PET
image and MRI were spatially coregistered using mutual in-
formation maximization and affine transformations using
MIPAV software [Center for Information Technology (CIT)
National Institutes of Health (NIH)]. The FWHM considered
was 1 and 5 mm in all three dimensions for the MRI and
PET datasets, respectively (considering the spatial resolution
for the Philips GEMINI PET system of 5.2 and 5.4 mm
FWHM transaxially and axially, respectively, in combina-
tion with the 5 mm FWHM Gaussian postfiltering applied to
the reconstructed image). Qualitative evaluation was carried
out using profiles through the frontal and the tempo-occipital
regions. Quantitative accuracy was evaluated by white and
gray matter quantification (mean intensity and standard devi-
ation) before and after PVE correction using an automatic
delineation on the MRI via the voxel-based morphometry
segmentation tool of the SPM software.21 The same delinea-
tion results were used for the ROI based correction using
GTM for comparison. The impact of the 3D analysis was
observed on this dataset in which voxels are anisotropic.
The second dataset is a whole-body 18F-FDG-PET/CT
image of a lung cancer patient (GE Discovery STE 4-slice
PET/CT), acquired 55 min after injection of 355 MBq (CT:
80 mA, 140 kVp, PET: 3 min per axial field of view). PET
images were reconstructed (voxel size of 4.68 4.68 3.27
mm3 and a matrix size of 128 128 47 voxels) using
OSEM (two iterations, 28 subsets) and CT based attenuation
correction. The resolution of the original CT image was
0.97 0.97 0.97 mm3 voxels (matrix dimension 421
321 100). The FWHM of the PET image was considered
as 6.1 and 6.7 mm in plane and axially, respectively (match-
ing the spatial resolution of GE Discovery STE), and 1 mm
in all three directions for the CT images. Manually drawn
spherical regions were placed on the lesion (ROIlesion) and in
the lung (ROInormal). An additional ROI in the spinal region
(ROIbone) was used in order to evaluate the potential of intro-
ducing artifacts in the PVE corrected PET images as a result
of prominent anatomical structures (such as bones) in the CT
images, which are not present in the FDG PET images. Since
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no ground-truth is available in this case, anatomical images
were semiautomatically segmented to generate ROIs for the
tumor, the lungs, the soft tissues, and the bones in order to
be used in the GTM method.
III. RESULTS
III.A. Synthetic images
The quantitative results regarding the correction using the
three methods can be found in Figs. 1(d)–1(f) for the three
different synthetic datasets. Figure 1(d) contains results of
the spillover effects correction for the spheres of constant
size and varying intensities [Fig. 1(a)]. It displays the per-
centage of recovered intensity (a value of 100 is a perfect re-
covery of the true activity) in the spheres, demonstrating
similar levels of recovery for the three methods, within 2%
for all of the different intensities considered. Figure 1(e)
shows quantification results for the constant intensity and
variable size spheres [Fig. 1(b)]. The recovered intensities in
the spheres demonstrate that both approaches perform with
similar accuracy. As the functional image is resampled with
the voxel size of the anatomical image as a first step for both
methodologies, the impact of tissue-fraction effect is reduced
by introducing the higher resolution details of the anatomic
imaging when available and correlated, achieving accurate
intensity recovery even for the smallest spheres where PVE
have the most significant impact. Figures 1(c)-(4) and (5)
show the results for the uncorrelated case in which the
spheres are different in the functional and anatomical images
in terms of both intensity and structure, revealing differences
between the 2D global and new 3D local approaches as the
new approach does not incorporate uncorrelated anatomical
details in the functional image during the correction,
whereas the 2D global MMA creates local artifacts related to
existing mismatches. In addition, the local approach handles
more accurately the differences in absolute signal intensity
between the anatomical and functional images. A quantita-
tive comparison of recovered intensities in the spheres is
shown in Fig. 1(f) and demonstrates much higher accuracy
for the new approach: without correction, the mean error
was 11.4%6 5.2%, whereas the 2D global and 3D local
corrections resulted in a mean error of 15.1%6 6.1% and
2.8%6 2.4%, respectively. The GTM method resulted in a
mean error of 3.2%. The standard deviation of each measure-
ment associated with the use of the 2D global MAA
approach was much larger than when applying the new
model. This is explained by the artifacts that are introduced
due to mismatch in structural information between anatomi-
cal and functional datasets that the 2D global approach is not
able to address. Such a case highlights the limitation of the
2D global MMA and the way the new 3D approach success-
fully overcomes such issues, with similar accuracy to GTM
using the ground-truth ROIs. The measurements in sphere 7
illustrate the fact that no PVE correction can be performed
due to the lack of corresponding structure in the anatomical
image. It is important, however, to emphasize that in such a
case, the functional activity in the corrected image remains
unchanged and no additional artifact is introduced.
The local approach appeared more robust with respect
to the increase of noise in the functional image in Fig.
1(c)-(2): mean recovered intensity across all structures
(excluding sphere 7) and the different noise levels was
99.5%6 1.1% for the 3D local, whereas the 2D global
results exhibited much higher standard deviation with a
mean recovery intensity of 97.8%6 27.8% as illustrated in
Fig. 2(a).
The impact of an inappropriate choice of FWHM value
and of a spatial misalignment between the anatomical and
functional images was investigated for the 3D local MMA
only as such an analysis has already been performed by
Boussion et al.9 for the 2D global approach only. This analy-
sis demonstrated overall satisfactory robustness with, how-
ever, recovery errors reaching 25%–50% for certain spheres
although the spatial misalignments and rotations considered
were smaller (up to 3 mm and 3, respectively). For the pres-
ent study of the 3D local MMA robustness, a maximum
mean error of 1.9%6 23.1% was reached with the investi-
gated misalignment, rotations, and inadequate scaling pa-
rameters [Fig. 2(b)]. Regarding the inadequate choice of
FHWM parameters, the mean error was 9.4%6 5.5% and
2.8%6 3% for6 2 mm and6 1 mm around the actual exact
value [Fig. 2(c)].
III.B. Simulated images
Figures 3(b) and 3(c) illustrate the correction obtained
using the mean and the median of the ratios, respectively
(use to establish the factor a), on the simulated 18F-FDG
brain PET and associated T1-weighted MRIs of Fig. 3(a).
The impact of the cube size (3 3 3, 5 5 5 and
7 7 7 voxels in (1), (2), and (3), respectively) is also
illustrated. Irrespectively of the cube size, the mean of the
ratio led to major artifacts due to noise and the possible
approximations in the FWHM parameters. On the contrary,
the use of the median led to better visual result. Only small
visual differences (mostly a slight increasing blurring effect)
were observed with the three different cube sizes [Figs. 3(c)-
(1) to 3(c)-(3)]. This blurring effect can be explained by the
inclusion of additional voxels for the computation of the me-
dian value and a less efficient local modeling. The quantita-
tive analysis as shown in Fig. 3(d) demonstrated higher
activity recovery when using the smallest cubic window size
(3 3 3). All other results were, therefore, generated with
this setting.
Figure 4(a) shows the results obtained on the simulated
18F-FDG brain PET images. The global 2D MMA led to the
incorporation of all the MRI details into the corrected PET
images [Fig. 4(a)-(3)], creating artifacts such as uptake cor-
responding to the skull, whereas the image corrected with
the new approach [Fig. 4(a)-(4)] was free of such artifacts.
Further evaluation using a frontal region profile is presented
in Fig. 4(b), demonstrating higher contrast with the local
approach. Both gray and white matters are better delineated.
The spikes on both sides of the profile [see red arrows in
Figs. 4(a)-(3) and 4(b)], corresponding to the artifact uptake
from the bone incorporation using the global MMA
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approach, are absent from the corrected image using the new
model. Comparison of ROI values placed in different regions
of the brain against the true image [Fig. 4(c) (1–5)] demon-
strated higher accuracy of the correction with the new
approach. In some regions such as amygdala, cerebellum, or
thalamus, the 2D global MMA and the GTM approach accu-
rately corrected the intensities. However, in other regions
such as the frontal or the hippocampus region, for instance,
it led to an overestimation or underestimation of the uptake,
respectively. Mean error for all analyzed regions was
31.9%6 8.5%, 21.3%6 6.8%, 16.7%6 5.7%, and 8.9%6
2.7% for the noncorrected PET, 2D global MMA, GTM, and
3D local MMA, respectively.
III.C. Clinical images
As a last evaluation step, the new approach was applied
and compared to the global MMA and GTM on two clinical
cases: a brain and a whole-body acquisition (Figs. 5 and 6,
respectively). Despite, the good correlation between the T1
MRI [Fig. 5(a)-(1)] and FDG PET [Fig. 5(a)-(2)] images
regarding the gray and white matter, noncorrelated
FIG. 2. (a) Percentage of mean recovered intensity relative to true values (mean6 SD) across all structures of Fig. 1(c)-(1) (excluding sphere 7) and the differ-
ent noise levels (SD from 10% to 50%) in Fig. 1(c)-(2). Percentage error of recovered intensity relative to true values (mean6 SD) in the different spheres
[Fig. 1(c)-(1)] considering: (b) different spatial misalignment scenarios between Figs. 1(c)-(2) and 1(c)-(3) (translation up to 4 voxels, rotation up to 5) or
inappropriate scaling (6 10%) of Fig. 1(c)-(2); (c) different PSF sizes (4–8 mm) in the PVE correction process relative to the true value (6 mm).
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structures also exist, such as the skull (see red arrows) and
the gadolinium enhancement (see white circle) in the MRI.
These MRI features, which do not match any FDG uptake,
were introduced in the corrected image by the 2D global
process [Fig. 5(a)-(3)], whereas the 3D local approach [Fig.
5(a)-(4)] suppressed these uncorrelated details, leading to a
more reliable and visually satisfying PVE correction. In
addition, the new approach led to higher contrast between
regions as shown in the profiles of Fig. 5(b). Furthermore,
using the SPM software to segment the gray and white matter
from the MRIs, we obtained quantitative results for the com-
parison of the two voxel-wise correction methodologies as
well as corrected values using the GTM approach in these
ROIs. The 2D global MMA led to higher standard deviation
values due to the incorporation of additional uncorrelated
details, with an average mean intensity variation with
respect to the initial PET image in the gray and white matter
regions of 1.8%6 21.1% and 0.2%6 31.6%, respectively.
In contrast, higher mean intensity variations and lower
standard deviation were obtained with the new approach:
11.4%6 6.5% in the gray matter and 2.6%6 8.3% in the
white matter. The new approach, therefore, led to less noisy
and higher uptake enhancements than the 2D global MMA.
By comparison, the use of GTM led to þ10% and 19%
FIG. 3. Optimization and validation for the local modeling parameters on (a) a simulated FDG PET (a)-(2)/MRI (a)-(3) brain dataset [ground-truth on Fig. (a)-
(1)] using; (b) the mean; and (c) the median of the ratio maps methodologies for, respectively a (1) 3 3 3, (2) 5 5 5, and (3) 7 7 7 3D cube. (d) Per-
centage intensity recovery in the different brain structures considered in the simulation following the PVE correction.
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mean activity changes for the gray and white matter ROIs,
respectively.
The whole-body 18F-FDG PET/CT image [Figs. 6-(1) and
6-(2)] of a patient with lung cancer was analyzed in order to
assess the potential of our new approach regarding oncology
applications. Figure 6 contains the correction results using
both approaches, demonstrating the incorporation of artifacts
such as the spine with the global approach [Fig. 6-(3)],
whereas the new model allowed avoiding them [Fig. 6-(4)].
Quantitative measurements in this bone region demonstrated
an uptake increase of 28.8%6 25.4% with the 2D global,
whereas the 3D local led to a much lower variation
(1.9%6 11.3%). Table II contains the results of quantitative
analysis using ROIs placed in the tumor and the lung, reveal-
ing an increase in lesion-to-lung ratio of 33.5% with the
global approach, 45.8% with the GTM method and 54.1%
with the 3D local approach. Furthermore, a variation in the
whole lung activity concentration of 13.3% with the global
approach was measured, whereas the new model leads to a
smaller variation of only 6.7% thanks to the fact that it disre-
gards anatomical structures in the lungs without matching
FDG uptake. A similar variation of 5.4% of the lung uptake
was obtained with the GTM approach.
IV. DISCUSSION
Multimodality PET/CT imaging is rapidly becoming the
gold standard for diagnostic studies especially in oncology
with 18F-FDG PET/CT. PET/CT systems are now widely
used in clinical practice thanks to the automatic fusion of
functional and anatomical information they provide. Accu-
rate and efficient PVC in this context might demonstrate
FIG. 4. (a) PET images of the simulated brain 18F-FDG PET/T1-weighted MRI dataset: (1) T1-weighted MRI, (2) noncorrected PET, (3) 2D global, and (4)
3D local MMA based PVE corrected images; (b) profile results across the frontal cortex on the uncorrected and PVE corrected PET images; (c) ROI quantifi-
cation intensity (mean value6 SD) comparisons between measured (black solid lines) and true image values (magenta dotted lines): (1) for the simulated
image and recovered from the corrected images using the (2) 2D global, (3) 3D local MMA, and (4) GTM approach. The ROIs and the associated true activity
concentration values used in the simulation are shown in c-(5) based on the segmented T1-weighted MRI (showing highlighted a frontal region of interest).
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significant clinical impact, for instance, for the detection of
small lesions in whole-body PET acquisitions, or for the
assessment of therapy response during or after treatment.
In addition, new technology developments now allow the si-
multaneous acquisition of PET image and MRI for clinical
brain studies22 and it is expected this will be also extended
to whole-body imaging. These developments facilitate the
use of anatomical information either during the reconstruc-
tion (attenuation correction23,24 or incorporation of a priori
information25,26) or as a postprocessing step for the improve-
ment of qualitative and quantitative accuracy of functional
images (denoising27 or partial volume correction9,11).
The recently introduced MMA methodology for partial
volume correction9 is based on the mutual multiresolution
analysis of a functional image and the corresponding ana-
tomical one. In contrast to the standard PVE correction
approaches using anatomical information,2 the MMA is
voxel-wise and, hence, does not use ROIs obtained from a
segmentation of the anatomical images. The algorithm was
validated on synthetic and simulated datasets with accuracy
similar to the reference GTM approach with the advantage
of not requiring an atlas or a segmentation step as well as
leading to PVE corrected images which are subsequently
available for further analysis. There was, however, certain
limitations associated with its 2D implementation and the
use of a strictly linear and global model. This model results
in the incorporation of every anatomical detail into the func-
tional image and can therefore lead to artifacts in the cor-
rected images where no correlation exists between
anatomical and functional details. For example, the method-
ology has been shown to work well with a combination of
FDG PET and T1 MRI brain images,9,28 but its performance
FIG. 5. (a) A clinical brain T1-weighted MRI/18F-FDG PET with injection of gadolinium contrast: (1) T1-weighted MRI, (2) noncorrected 18F-FDG PET
image, (3) 2D global, and (3) 3D local MMA based PVE corrected images; (b) profile results across the frontal and occipital cortex regions on the uncorrected
and PVE corrected PET brain images corresponding to the datasets shown in (a).
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with respect to receptor brain PET imaging has not been
demonstrated.
In this study, we have developed and evaluated a new
model for MMA, based on a locally adaptive 3D analysis in
order to address the limitations of the 2D global MMA previ-
ous implementation. An accurate coregistration is considered
as a prerequisite to both MMA and our new proposed
approach, although we also demonstrated satisfactory robust-
ness of the method to misregistration errors. The implemen-
tation is based on the extension of the 2D analysis to the 3D
and the introduction of a local model. The impact of each of
the two modifications has not been evaluated individually.
On the one hand, the 3D analysis provides a better represen-
tation of the PSF convolution which is a 3D phenomenon,
allowing an accurate wavelet decomposition of the image
compared to the 2D approach. The local analysis applied to
this 3D decomposition allows computing a more accurate
model which is subsequently used for the correction, com-
pared to the simple global approach.
In addition, in order to discard uncorrelated details, the
initial linear model coefficient was replaced by a new one
based on the median value (rather than the mean) of the
voxel-by-voxel ratios in a local cube centered on each
voxel. Consequently, the 3D anatomical details in the
wavelet domain are discarded in the regions where there is
no matching functional uptake. The validation of the new
model was performed on synthetic and simulated datasets.
The results demonstrated similar quantitative performance
with the 2D global approach and the GTM in the case of
correlated datasets [Figs. 1(a) and 1(b)]. It is worth noting
that the GTM was applied using the available ground-truth
for the definition of the ROIs, leading this way to the best
possible results with this approach. In addition, the per-
formance was significantly improved for noncorrelated
structural and functional image combinations [Figs. 1(c)
and 4]. The new model was also evaluated using clinical
whole-body and brain datasets. For both these clinical data-
sets we obtained a significantly improved image quality
without artifacts, as well as higher contrast improvements,
compared to the 2D global MMA correction (Figs. 5–6).
However in the absence of ground-truth, the absolute accu-
racy of the recovered activity values and spatial spread of
the structures of interest (such as small tumors) could not
be directly assessed on these datasets.
Although this new approach allows improved qualitative
and quantitative voxel-wise partial volume correction using
anatomical information, without assuming homogeneous
uptake in regions of interest as the GTM approach, and is ap-
plicable to both brain and oncology imaging, one should
consider potential pitfalls associated with any postprocessing
PVE correction approach based on anatomical information.
As the correction is performed based on the anatomical
image details, if no or not enough information is available
for a specific structure, the PVE correction will be either not
possible or incomplete. The new proposed approach is cer-
tainly able to handle mismatches between anatomical and
functional information. However, in the case of tumor imag-
ing, if the lesion is necrotic in the functional image, but there
is no corresponding necrosis in the anatomical structure,
then the correction will be incomplete as only the external
outline of the lesion will be corrected. Absence of contrast in
the anatomical dataset corresponding to a specific structure
would lead to a lack of significant wavelet coefficients in the
wavelet decomposition of such a structure; therefore, no cor-
rection can be deduced and applied to the corresponding
functional uptake. However, when a relationship exists
between the anatomical signal and the functional one, such
an issue may be overcome by using alternative acquisition
protocols in order to generate such contrast. For instance, a
contrast enhanced anatomical imaging or different sequences
available in MRI imaging will be certainly interesting in
enhancing the potential of PVC approaches such as our own
for newly developed PET/MRI devices. Finally, one can
identify the areas of the image where no significant PVE cor-
rection was applied as a result of lack of anatomical details
by analyzing the MRM. This map indeed contains the cor-
rection that was applied to each voxel and very low or zero
values correspond to little or no correction. It is also impor-
tant to emphasize that the tissue-fraction effect can be cor-
rected only where the frontier between tissues can be
FIG. 6. A clinical whole body CT/18F-FDG PET study: (1) CT, (2) original
noncorrected PET, (3) PVE corrected images using the 2D global MMA
algorithm, and (4) PVE corrected images using the 3D local MMA
approach.
TABLE II. ROI quantification [mean6SD of the uptake value (kBq/ml) in
different ROIs] for the original whole body PET image and the corrected
one using the GTM, the 2D global and the 3D local MMA approaches. Note
that there is no SD in the case of the GTM approach since it is a ROI based
PVE correction approach.
Activity (kBq/ml) ROI lung ROI lesion ROI bone
Original PET 1.56 0.1 8.96 1.4 5.26 0.5
GTM 1.2 10.9 5.5
2D global 1.36 0.3 10.36 1.6 6.76 1.7
3D local 1.46 0.1 12.86 1.9 5.36 0.6
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extracted from anatomical images. This effect can in addi-
tion only be reduced, not entirely corrected, as it also exists
in the anatomical datasets, although with a lower magnitude
than in the functional images.
Another potential limitation of voxel-wise partial volume
correction approaches based on the use of anatomical
images may come from the dependency of the algorithm on
the noise level in both the anatomical and functional
images. However, our approach demonstrated high robust-
ness versus noise. In addition, the local aspect of the corre-
lation model greatly reduces the sensitivity of the correction
to potential artifacts/distortions present in the anatomical
images.
Misregistration is also a limiting factor for multimodality
PVE correction approaches such as the one reported in this
work. However, current techniques29–31 allow fully auto-
mated 3D elastic image registration and can accurately align
(with errors within 1–2 voxels) whole-body PET and CT
images acquired on standalone as well as on combined PET-
CT scanners. Furthermore, although both the 2D and 3D
approaches are sensitive to a spatial registration error between
the anatomical and functional images, the different tests car-
ried out on synthetic images with translation movements up
to 4 voxels and rotation movements up to 5, as well as inap-
propriate scaling of the anatomical image showed limited
impact with a maximum error of 1.9%6 23.1% thanks to the
use of the sliding cube and the median of the ratios. However,
misregistration should be limited to a minimum in order to
ensure the most accurate correction, since large translations
and rotations might lead to errors up to 25%.
Finally, as with any postprocessing PVE correction algo-
rithm the new model requires the exact knowledge of both
modalities’ spatial resolution (FHWM) and voxel sizes in
order to determine the parameters of the wavelet decomposi-
tion scheme. However, our new methodology also demon-
strated satisfactory robustness versus errors up to 2 mm in
the choice of the FWHM parameters. After images coregis-
tration, the process is automatic and takes from about a mi-
nute to several minutes (depending on the size of the
images) on a desktop computer.
We assumed a constant value of the PSF FWHM in the
entire image, which is a simplification considering the poten-
tial variation of the PSF FWHM throughout the field of view,
especially in the case of whole body imaging. This aspect
could be improved by modeling the exact PSF FWHM in
each direction according to the spatial position of the ana-
lyzed voxel. Finally, an automatic estimation of the threshold
T value regarding the wavelets coefficients might improve
the results on a case by case basis. Future studies will also
investigate the performance of postreconstruction processing
approaches such as the one developed in this study with the
incorporation of the PSF and other a priori information into
the reconstruction iterative algorithm. Within this context a
couple of existing studies have shown similar performance
between the postprocessing deconvolution and PSF incorpo-
rated reconstruction based PVE correction approaches,32,33
with the generic advantage of postreconstruction approaches
being reconstruction algorithm independent.
V. CONCLUSION
We developed an improved voxel-wise methodology to
correct for partial volume effects in emission tomography.
This new model overcomes limitations encountered in the
originally proposed MMA and allows for a more universal
approach that can potentially handle any combination of
coregistered anatomical and functional images. Our new
methodology extends the 2D MMA to a 3D local analysis,
in which local details are conditionally taken into account
in the correction process. PVE correction was successfully
applied to images with either high correlation, for which
the 2D MMA correction was already adequate, or more
challenging cases for which correlation between anatomical
and functional datasets was not complete and for which
global 2D MMA failed by introducing artifacts and led to
inaccurate quantification. The local 3D process was suc-
cessfully tested and validated on synthetic, simulated, and
clinical datasets, with similar performance to the reference
GTM method without requiring a segmentation step, pro-
ducing PVE corrected images, and avoiding artifacts gener-
ated by the 2D global approach. In addition, it proves to be
overall more robust with good accuracy and robustness
without particular requirements regarding the structural and
intensity correlations between the anatomical and func-
tional images.
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Abstract
In positron emission tomography (PET) imaging, an early therapeutic response
is usually characterized by variations of semi-quantitative parameters restricted
to maximum SUV measured in PET scans during the treatment. Such
measurements do not reflect overall tumor volume and radiotracer uptake
variations. The proposed approach is based on multi-observation image
analysis for merging several PET acquisitions to assess tumor metabolic
volume and uptake variations. The fusion algorithm is based on iterative
estimation using a stochastic expectation maximization (SEM) algorithm. The
proposed method was applied to simulated and clinical follow-up PET images.
We compared the multi-observation fusion performance to threshold-based
methods, proposed for the assessment of the therapeutic response based on
functional volumes. On simulated datasets the adaptive threshold applied
independently on both images led to higher errors than the ASEM fusion and
on clinical datasets it failed to provide coherent measurements for four patients
out of seven due to aberrant delineations. The ASEM method demonstrated
improved and more robust estimation of the evaluation leading to more pertinent
measurements. Future work will consist in extending the methodology and
applying it to clinical multi-tracer datasets in order to evaluate its potential
impact on the biological tumor volume definition for radiotherapy applications.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Positron emission tomography (PET) is now a widely used tool in the field of oncology,
especially in applications such as diagnosis, patient follow-up studies (Krak et al 2005)
3 Author to whom any correspondence should be addressed.
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or in radiotherapy planning (Jarritt et al 2006). In the context of patient follow-up, early
metabolic changes detected with 2′-deoxy-2′-[18F]-fluoro-D-glucose (FDG) PET imaging can
occur before anatomic changes observed with computed tomography (CT) imaging. By
assessing differences in several PET scans acquired before and at different times during
treatment, various qualitative and quantitative methods have been proposed to characterize the
therapeutic response (Weber 2007). In patient monitoring studies, qualitative methods such as
visual assessment are less accurate and reproducible than quantitative measurements (Lin et al
2007). Furthermore, different therapeutic parameters (indexes) have been defined either on
dynamic or static PET acquisitions with a similar reproducibility (Weber et al 1999). Being
less restrictive in clinical routine, only the parameters computed in the static PET scans have
been considered in our work. Most widely used in patient follow-up studies, the standardized
uptake value (SUV) measures the tracer uptake in the tumor. Derived from the SUV index,
two measurements, namely the maximum SUV (SUVmax) and the mean SUV (SUVmean), were
assessed in our study by computing, respectively, the maximum and the mean of SUV in voxels
included in a region of interest defining the tumor. The reproducibility and the robustness
of both SUV indexes have been previously assessed (Weber 2007, Nahmias and Wahl 2008)
and compared to the reproducibility of tumor volume measurements with various automated
methodologies (Hatt et al 2010). An early therapeutic response can be characterized by
measuring relative or absolute SUV variations between pre-treatment and mid-treatment PET
scans. Other quantitative parameters have been used such as the total lesion glycolysis (TLG)
defined as the product of the mean SUV and the tumor volume (Larson et al 1999, Hatt et al
2010).
The therapeutic response is usually estimated by measuring the tumor size on the CT scans,
and according to guidelines such as World Health Organization (1979) and RECIST (Therasse
et al 2000). More recent criteria have been proposed such as PERCIST (Wahl et al 2009),
adding the consideration of quantitative parameters extracted from PET images. However,
these criteria are still limited to simple SUV measurements and do not include volumetric
characterization of the tumors, and no guidelines have been established recommending the
best way to characterize the therapy response according to the variation of metabolically active
tumor volumes. In the current clinical practice, the therapeutic response is therefore usually
assessed by considering one single value as the SUVmax within the primary lesion, extracted
from each PET scan. Presently, the measure of SUVmax variation is considered as the gold
standard of the treatment response definition. This method however accounts neither for the
tumor volume variations nor the spatial uptake variation within the tumor volume.
Among the new methodologies developed in PET tumor delineation (Zaidi and El Naqa
2010), most of them have only considered the use of such delineation for static images
segmentation and for diagnosis/prognosis. A few authors have recently proposed different
methodologies dedicated to PET follow-up, like the one by Necib et al (2008), which is
aimed at assessing a response by comparing two follow-up PET images. After voxel-to-voxel
registration of the two scans, a biparametric map is generated representing the tracer uptake
variations within the tumor. In the context of cancer treatment prediction, El Naqa et al (2009)
have recently proposed a texture-based approach, considering texture properties of voxels
within tumors as prognosis factors for the assessment of therapy response.
Regarding the use of PET in radiotherapy, the gross tumor volume (GTV) definition
is usually carried out manually on fused FDG-PET/CT scans. However, imaging tumor’s
glucose consumption with the FDG alone may not be sufficient to determine the GTV
(Mankoff et al 2003). Considering the measure of other features of cancer metabolism
like proliferation, hypoxia and apoptosis using additional tracers may generate more complete
information regarding the target tumor volume (Bentzen 2005, Shields 2003, Vaupel and
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Mayer 2007). Accurate tumor volume delineation would therefore require a fusion of all
available measurements obtained with these different tracers. Such a fusion could be valuable
to thoroughly and potentially more accurately assess tumor volume definition as well as
evolution during therapy.
The main objective of this study was to develop a fusion method derived from multi-
observation approaches such as these developed in satellite and astronomical imaging (Masson
and Pieczynski 1993). Considering either patient follow-up and/or multi-tracer PET datasets,
the proposed method aims at assessing a treatment response and tumor volume definition
by automatically determining the different variations of tracer uptakes within the regions
of the analyzed fused images. Our approach is statistical and assumes that the data can
be modeled by a mixture distribution of multi-observation random fields. The parameters
defining the mixture distribution are estimated using a stochastic expectation maximization
(SEM) algorithm (Celeux and Diebolt 1986) combined with a locally adaptive spatial priors
estimation in order to account for voxels correlation.
Our method was applied to simulated and clinical pre- and post-treatment PET scans of
esophageal cancer within the context of radio-chemotherapy follow-up. It was compared to
current quantitative methods proposed for the assessment of the therapeutic response based on
tumor volume evolution, namely the definition of the tumor volumes independently on both
scans using adaptive thresholding.
2. Materials and methods
2.1. Multi-observation framework
The proposed method could potentially be applied for both patient follow-up applications and
multi-tracer analysis using PET scans. The proposed method is aimed at merging the available
PET images in order to derive a fusion of the information regarding the treatment response in
patient follow-up application or/and the multi-tracer tumor volume, as illustrated in figure 1.
While the analysis for both applications might require different fusion rules or interpretation,
the basics of the approach are the same and are based on the unsupervised Bayesian methods,
widely used in segmentation and classification of satellite, astronomical or medical imaging
(Masson and Pieczynski 1993, Pieczynski 2003, Hatt et al 2009).
2.1.1. Bayesian model. Let T be a finite set corresponding to the voxels of 3D registered
PET images. We consider two random processes Y = (yt)tT and X = (xt )tT . Y models
the observed multi-tracers or follow-up PET scans, acquired at different times during the









, containing the voxel values of each PET image, with B being the image
number observed in the fusion. Each yt is associated with a label xt. X models the fusion
map which is designated in our specific application as the therapeutic response classification.
X takes its values in a set {1 . . . K}, with K being the number of classes that is usually user-
dependent and defined depending on the fusion goal. The objective of the approach is therefore
to estimate the distribution of (X, Y). Considering the Bayesian framework, the relationship
between X and Y can be modeled using the joint probability:
p(X,Y) = p(Y|X)× p(X), (1)
where p(X) is the prior knowledge about X and p(Y|X) is the ‘noise model’: the likelihood of
the observation Y conditionally to the hidden ground-truth X. In this Bayesian framework, the
prior knowledge p(X) can be modeled globally, for instance by considering Markovian models
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Figure 1. Multi-observation framework of multi-tracer and patient follow-up data.
(Pieczynski 2003) such as chains or trees, or locally with blind, contextual or adaptive models
(Peng and Pieczynski 1995). Different noise distributions can be used for the observation
model p(Y|X) such as Gaussian or generalized Gaussian (Delignon et al 1997).
In our fusion method, we have used a locally adaptive prior model and the noise model
has been assumed Gaussian; however, other distributions could be considered in future
developments. The distribution of (X, Y) is hence defined by the priors k , the mean
vectors µk and covariance matrices Ŵk associated to each of the K classes in the mixture. The









The SEM algorithm was used here to estimate the parameters of the distribution of (X, Y). It
is a stochastic version of the classic EM algorithm, ensuring better and faster convergence as
well as higher independence on the initialization. From here onwards, our approach will be
denoted as ASEM.
2.2. Fusion process
2.2.1. Pre-processing: image deconvolution. PET images are characterized by their high
level of noise and the limited spatial resolution inducing partial volume effect (PVE) (Soret
et al 2007). The under estimation of the tissues uptakes and activity cross contamination
between structures with different uptakes are two consequences of the PVE effects in PET
images. When considering several co-registered PET images, the voxels most affected by PVE
may not be on the same coordinates for each scan, which implies intensities distributions that
might complexify both estimation and classification steps in the fusion process. In addition,
without PVE correction (PVC), SUV values extracted from each scan may be significantly
biased. This can lead to under or over estimation of the uptake variation between pre- and
post-treatment scans, especially if significant tumor volume variation occurs. Indeed, PVE
impact on the SUV measurement within the tumor strongly depends on the object’s size. In
order to reduce the impact of these effects on the subsequent steps, a PVE correction (PVC)
was applied to each image prior to their fusion. The chosen PVC method was developed by
Boussion et al (2008) and further improved by Le Pogam et al (2009) and consists of a 3D
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(a) (b)
Figure 2. (a) Illustration of VOI definition in the pre-treatment scan and (b) automatically reported
on the registered mid-treatment scan.
voxel-wise correction using an iterative deconvolution improved by wavelet-based optimal
denoizing of the residual. This preprocessing step offers two advantages: first, it reduces
the size of blurred frontiers between the different regions of the images, hence reducing their
impact on subsequent registration and fusion complexity. Second, it allows the extraction of
corrected uptake values from fusion maps for a quantitative characterization of evolution of
the activity within tumor volume and/or sub-volumes.
2.2.2. Local-based analysis. As our goal is to automatically determine the variation of tracer
activity and position/volume of a functional tumor, we assume that the overall tumor volume
has been previously automatically or manually isolated in a 3D box or volume of interest
(VOI) by a clinician on the co-registered PET images. Therefore, the box should be large
enough to encompass the entire tumor in each scan and avoid including too many neighboring
tissues with significant physiological uptake. Consequently, the definition of such a processing
box should allow any shape and size in 3D. The definition of this 3D VOI should therefore
be carried out on the scan in which the tumor appears to be the largest, and automatically
registered on the other volumes involved in the fusion as illustrated in figure 2.
2.2.3. Fuzzy k-means initialization and choice of the number of classes. In unsupervised
Bayesian segmentation framework, the initialization is an important step. In our method, we
used the fuzzy k-means (FKM) algorithm (Krishnapuram and Keller 1994) based on fuzzy
logic applied to the voxels values. In his PhD thesis, Provost (2001) described an improved
version of FKM, allowing the automatic estimation of the optimal number of classes in the
mixture, based on the use of an entropy criterion and a user selection of the upper limit of
the number of classes. This upper limit was defined as the product of the number of images
and the number of classes within each image considered in the fusion. In each iteration and
for all the voxels of the image, a membership coefficient associated to the K classes of the
mixture is estimated. At the end of FKM execution, the mixture parameters associated with
each class k (k,µk, Ŵk) are initialized for the Bayesian estimation. The cost function of the




















where E is the cost function to minimize, K is the number of classes in the mixture, T is
the number of voxels in the volume, ψkt is the membership matrix of each voxel t to the kth
class, ck is the centroid of the kth class. The second term of the equation (2) is the entropic
criterion where α is the parameter weighting the cost function. The minimization of the FKM
cost function is performed by constraining the entropic term. This latter is high in the first
iterations, leading to a reduction of the number of classes in the mixture, and it decreases
exponentially in order to allow the FKM classification process.
2.2.4. Parameters estimation. The parameters (k,µk, Ŵk) defining the Gaussian mixture
of the (X, Y) distribution are estimated by the SEM algorithm by sampling several realizations
of X according to its posterior distribution p(X|Y). In the adaptive framework, the global prior
k associated to the kth class of the mixture are re-estimated using a local neighboring 3D
cube and replaced by local priors π t,k defined for each voxel and each class. The mean vector
µk and the covariance matrix Ŵk are finally computed for each of the K classes in the mixture.
The details of parameters estimation with the SEM algorithm are given in the appendix section.
2.2.5. Decision step. In order to perform fusion on a voxel-by-voxel basis, we used a
classification criterion to assign a class to each voxel. For this purpose we chose the maximum
likelihood method. To compute a solution, this criterion requires the parameters defining the
a priori model (priors of each class and for each voxel) as well as the observation data model
(mean and covariance matrices of each class), previously estimated using the SEM algorithm
(see appendix).
2.3. Simulated datasets
In order to evaluate the behavior of the fusion approach within the context of tumor evolution
assessment, we considered realistic simulations of non-spherical tumors. These simulated
tumors were created using as models real head and neck and esophageal observed in clinical
datasets. The procedure for the simulations of such data has been previously described (Le
Maitre et al 2009). The simulated cases used in our study are composed of two simulated PET
scans, one before and one after the treatment. The clinical cases used as models corresponded
to patients classified as partial responders or progressive disease to the radiochemotherapy
according to RECIST criteria.
In order to evaluate the robustness of the methods, three levels of noise were considered
for every simulated acquisition by selecting 100, 80 and 60% of the simulated lines of
response for the iterative reconstruction, respectively. With 20 clinical follow-up cases and
considering three levels of noise and various tumor-to-background ratios for each case, 70
different simulated cases were generated. Most of the simulated datasets, representing 15 out
of the 20 cases, were generated from patients classified as partial responders. The others
cases were designed to simulate progressive disease. The mean tumor volume and tumor to
background ratio used in the first and second simulated follow-up cases are given in table 1.
Three examples of these simulated follow-up cases (showing only central axial slice) with
their associated ground-truth are illustrated in figure 3. Similar to the clinical datasets they
are based on, these tumors are characterized by either homogenous or heterogeneous tracer
uptake. Background activity was simulated as homogeneous. The voxels were assumed to
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Table 1. Mean tumor to background ratios and mean tumor volumes computed for all the simulated
follow-up cases.
Tumor volume (cm3) T/B ratio
PET 1 34.1 ± 27 (6–90) 5.7 ± 2 (2.7–9.3)
PET 2 17.4 ± 2.5 (1.9–101) 4.2 ± 1.4 (2.0–6.5)
belong either to the background (BD) or to the tumor (T). In these simulated images, no
registration was required.
2.4. Clinical datasets
2.4.1. Patient data. After preliminary studies on simulated follow-up PET scans, the fusion
method was tested on real clinical datasets. Seven patients with esophageal cancer undergoing
concomitant radiochemotherapy between 2005 and 2008 were considered, with one PET
scan before treatment, and another PET scan after treatment, both acquisitions carried out
according to the same protocol. All these patients were classified as partial responders one
month after the completion of treatment, according to RECIST. Consequently, the variation of
metabolically active tumor volume as well as the SUV within the tumor volume is expected
to be less than 100% since residual tumor uptake is seen for all these patients, and also above
20 to 30% which is their reproducibility limits as previously demonstrated (Hatt et al 2010).
No volume or uptake increase should be measured in these cases. Visual illustrations of three
clinical follow-up cases are given in figure 5. The physiological uptake of the mediastinum
around the tumor volume was much more significant in the clinical images than in simulated
cased (for which background was simulated as homogeneous) and was therefore taken into
account in the fusion process as an additional class. Thus, on each scan, the voxels were
assumed to belong to the background (BD) of the lungs, the physiological tissues (PHY) of
the mediastinum or the tumor volume (T).
2.4.2. PET/PET registration. In the context of patient follow-up, the PET/CT images are
acquired at several month intervals. As an important prerequisite of the proposed method,
which works on a voxel level, the scans must therefore be registered before the fusion method
can be applied. The PET/PET registration was carried out using a method previously proposed
(Ouksili et al 2007), in which the PET data are first registered with their associated CT scans,
acquired in the same bed position. Having more landmarks and a higher resolution, the CT
scans are registered using the MIPAV software. The CT/CT registration was carried out using
a rigid transformation, which optimizes the least-squares criterion of a large VOI. The CT/CT
transformation matrix was then applied to the PET scans for registration. A rigid registration
was considered to be sufficient since the procedure was carried out only on small 3D regions
of interest surrounding the lesions which were located in the mediastinum or head and neck
regions. In addition, a rigid transformation avoids the deformation of tumor volumes in the
PET images which would be certainly associated with the use of a deformable model. Finally,
the consideration of head and neck and mediastinum lesions reduces the potential influence of
respiratory motion on the registration process.
In the fusion process, the use of a sliding estimation cube as described in section 2.2 for
the computation of the spatial priors is expected to reduce the impact of small registration
errors of the PET datasets. The impact of the scans misregistration on the fusion process was
considered in this study by shifting the second scan in a subgroup of the simulated datasets
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Figure 3. (b) and (d) Simulated follow-up tumors, (a) and (c) associated ground-truths, (e) ASEM
fusion map, individual segmented map with the adaptive threshold (f) and (g), and the ASEM
method (h) and (i) for the three simulated cases.
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by one and two voxels (4 and 8 mm, respectively) in a random direction, and then quantifying
the impact on the resulting volume error for each scan after ASEM fusion. The one to two
voxel shifts used in this work corresponds to typical registration errors associated with the use
of fusion algorithms in CT imaging.
2.4.3. Quantitative measurement of clinical datasets. In patient monitoring studies, the SUV





where C is the tracer concentration, A the injected activity and W the patient weight. Among
the different SUV indexes available, the most often used in clinical practice are SUVmax and
SUVmean, computed, respectively, as the highest value and the mean of voxels values in a given
region of interest (ROI), usually defined manually. Contrary to the SUVmax, the computation
of the SUVmean depends on the volume of the ROI. Our fusion method allows identifying
the variations of concentration activities. Therefore, according to the ASEM fused map, an
estimation of each individual tumor volume can be carried out. Then, for each scan, a measure
of SUVmean can be extracted according to the metabolic volume of the tumor VASEM estimated
with the multi-observation method. Note that the SUV values extracted from the fusion maps
are values corrected for PVE due to the deconvolution pre-processing step.
2.5. Alternative approaches used for comparison
We compared the multi-observation fusion results with methods that have been proposed for
patient follow-up studies. Most clinical studies only consider SUVmax variation. In order
to take into account full metabolically active volumes evolution as a response criterion, it
has been suggested to determine them independently on both scans using threshold-based
methodologies. Many studies have demonstrated that a fixed threshold value not adequate for
this task and that adaptive thresholding taking into account the background uptake performs
better (Nestle et al 2005, Tylski et al 2010). Manual tumor delineation by experts was
not considered in the study, due to its high inter- and intra-observer variability (Hatt et al
2010). We compared our approach to independent delineation of tumors in each scan using
adaptive threshold, the value of which is determined from the estimated contrast between
the tumor activity and the background activity and is optimized for a given scanner using
phantom acquisitions of spheres (Erdi et al 1997). Such an optimization was performed for
our acquisition protocol and scanner model. An associated SUVmean value was also computed.
2.6. Evaluation metric for simulated datasets
True volumes of simulated tumors are known. Therefore, the assessment of the fusion process
was achieved by the estimation of volume errors (VE). For each simulated case, segmented
maps of the first and second follow-up scans are obtained with the two methods, as illustrated
in figure 3. The individual segmented maps of the multi-observation method can actually be
deduced from the ASEM fused map. Although volume errors may be larger than 100% in
specific cases for which delineation completely fails, errors were limited to 100%.
2.7. Quantitative variation for clinical datasets
No ground-truth was available for the clinical follow-up cases. Hence, to compare the methods,
the following quantitative indexes have been considered. The variation of metabolic tumor
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volume (V) and mean of SUV (SUVmean) between the pre-treatment and the follow-up
PET scans for the different methods were measured with the two methods. In addition, the
evolution of the original (without PVE correction) maximum SUV in the ROI was considered
for comparison as it is the one currently used in clinical practice in oncology and defined as
the gold standard. Contrary to the simulated datasets, the background level in clinical cases
is not homogenous due to the physiological uptake of the mediastinum. The intra-observer
variability of the adaptive thresholding method has been investigated for the same context
of esophageal lesions in a previous study and demonstrated significant variability (Hatt et al
2011). Therefore, the adaptive threshold segmentation was carried out here by two clinicians
with similar training and experience for each follow-up case, in order to evaluate the impact on
the measurement of quantitative variations. The two clinicians followed a specific protocol:
they were instructed to measure the mean background value by placing manually a ROI within
the mediastinum, at least a few cm away from the lesions. They were free to choose the exact
location and size of the ROI.
3. Results
3.1. Results on simulated datasets
For the selected simulated cases, the fusion maps obtained by our multi-observation method
are illustrated in figure 3(e). In order to facilitate the interpretation of the ASEM fused
maps, colors have been affected to the different uptake variations. Blue areas represent a
response (negative difference in tracer uptake between the two scans) whereas green color
is associated with a stable tumor (similar significant uptake in both scans at this location).
Red color was used to indicate tumor progression (higher uptake in second scan with respect
to first one). Note that ASEM never wrongly resulted in tumor progression or regression.
The intensity associated with each voxel in the fusion map is set as the SUV relative
variation (SUV) between the first and the second scan. The segmented maps of the
first and second chosen follow-up scan computed the different methods are presented in
figure 3(f–h).
Mean volume errors and associated standard deviation associated with the use of ASEM
fusion or independent adaptive threshold-based delineation, for all pre-treatment and post-
treatment simulated cases are presented in figure 4. The VE computed for the first follow-up
scan was significantly (Kruskal-Wallis tests p < 0.0001) lower for ASEM (−2.6 ± 8%) than
for the adaptive threshold (+28 ± 17%). For the second follow-up scan, however, the VE were
higher for both methods. Adaptive threshold led to higher overestimation of the tumor volumes
than for the pre-treatment image (+30 ± 15%), whereas ASEM led to underestimation of the
true post-treatment tumor volume (−9 ± 25%) with a larger variability. Adaptive threshold
gave large volume overevaluation in all cases, whereas ASEM led to better results in several
cases but higher errors in some other cases. In both pre- and post-treatment images, the
adaptive threshold method tended to overestimate the tumor volume, with larger absolute
errors than the ASEM method, that tended to underestimate the volume in the second scan.
Three selected cases among the simulated dataset are illustrated in the figure 3. For the
first case, no significant differences were observed between the use of the adaptive threshold
applied independently to each image and the ASEM method. For the second more complex
case, both methods showed different results. As illustrated in figure 3(f), the adaptive threshold
led to an underestimation of the tumors uptake, contrary to the ASEM method. As the fusion
map (figure 3(e)) shows, the disappearing lesion is correctly identified (in blue) whereas
the larger lesion is shown as stable (in green) with a small blue part, indicating that this
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Figure 4. Mean VE (%) with standard deviation as error bars of the first and second follow-up
scans for adaptive threshold and ASEM methods applied to the simulated cases.
tumor uptake has indeed smaller volume in the post-treatment scan. The third case illustrates
the evolution of a necrotic tumor, on which ASEM correctly identified the various parts of
evolution (blue, green, red).
Finally, the ASEM fusion proved robust to random misregistration of one voxel (4 mm)
with volume errors increasing from −2.6 ± 8% to −9 ± 16% and −9 ± 25% to −13.5 ± 30%
for first and second scan, respectively. A spatial shift of two voxels (8 mm) led to similar error
levels regarding the first scan (−9 ± 17% versus −9 ± 16%) but a higher increase regarding
the second scan (−21 ± 37% versus −13.5 ± 30%).
3.2. Results on clinical datasets
The fusion maps obtained by applying the ASEM method to three representative clinical
follow-up cases are illustrated in figure 5(c). Three colors were used to represent physiological
uptake (in yellow), tumor response (in blue) area and stable tumor (in green), underlying the
partial response status of these patients. The color intensity associated to the voxels classified
as responders or stable is determined by the SUV relative variation (SUV) between the
first and the second follow-up scans. The segmented maps of the pre-treatment and post-
treatment scans, computed with the adaptive threshold and the ASEM methods are illustrated
in figure 5(d–g).
The quantitative measurements estimated for each clinical case individually are shown in
table 2, and mean measurements, estimated for all the patients are shown in table 3. The clinical
cases were more challenging to analyze than the simulated cases, due to a combination of
noisier and more heterogeneous background and tumor uptake distributions. Since the patients
were classified as partial responder, the tumor uptakes were expected to exhibit a significant
decrease of the SUVmax (at least 30%) between the pre- and post-treatment scans. Similarly,
the tumor volumes and associated mean tracer uptakes should also decrease (at least by 20 to
30%) and this can be confirmed visually.
5782 S David et al
Table 2. Measurements of volume, SUVmean and SUVmax evolution, computed with the adaptive
threshold and the ASEM methods for each patient.
SUVmax SUVmax
Patient Method SUVmean (%) V (%) without PVC (%) with PVC (%)
1 Tb 1 −35.7 −79.8 −51.7 −35.8
Tb 2 −33.5 −83.2
ASEM −33.1 −80.4
2 Tb 1 −69.5 −86.3 −74.2 −76.9
Tb 2 −74.2 −64.9
ASEM −71.4 −65.2
3 Tb 1 −59.7 −81.4 −60.2 −66.9
Tb 2 −68.9 −40.0
ASEM −62.7 −59.5
4 Tb 1 −27.0 −66.1 −32.7 −25.7
Tb 2 −24.2 −71.7
ASEM −26.7 −59.2
5 Tb 1 −28.4 −41.1 −28.1 −42.2
Tb 2 −35.2 −12.9
ASEM −20.6 −52.5
6 Tb 1 −87.3 402.5 −56.1 −87.8
Tb 2 −85.7 74.1
ASEM −83.3 −81.9
7 Tb 1 −65.9 361.0 −58.8 −66.9
Tb 2 −60.7 −16.1
ASEM −47.9 −59.8
Table 3. Mean measurements of volume, SUVmean and SUVmax evolution, computed with the
adaptive threshold and the ASEM methods for all patients.
SUVmax SUVmax
Method SUVmean(%) V (%) without PVC (%) with PVC (%)
Tb 1 −53.3 ± 23.2 58.4 ± 221.7
Tb 2 −54.7 ± 23.6 −30.7 ± 53.5 −51.7 ± 16.2 −57.5 ± 23.0
ASEM −49.4 ± 23.9 −65.5 ± 11.3
With or without PVC, variations of SUVmax were higher than 30% (−52 ± 16% without
PVC and −58 ± 23% with PVC), as expected by their partial responder status. Regarding the
other quantitative measurements, there was no significant (p > 0.05) difference between the
mean variation of SUVmean obtained with each observer using the adaptive threshold (−53 ±
23 for Tb1, −55 ± 24% for Tb2). SUVmean variation deduced from the ASEM fusion maps
was slightly, although not significantly (p > 0.05) lower (−49 ± 24%).
By contrast, the variations of tumor volumes were significantly different for all approaches.
The variations measured by the two observers using the adaptive threshold were significantly
(p < 0.0001) different (58 ± 222% for Tb1 and −31 ± 54% for Tb2). The results obtained
with the ASEM method were also significantly different from both adaptive threshold results
(−66 ± 11%). They were also much more homogeneous across the entire group of patients
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(11% standard deviation only). These results can be explained by analyzing the quantitative
parameters of each patient individually. Among the seven clinical cases, the adaptive threshold
and ASEM performed differently. On the one hand, for patient 1, 2 and 4, the variation of
SUVmean and tumor volume estimated with the adaptive threshold and the ASEM method
were similar and pertinent with respect to the partial responder status of the patients. On the
other hand, for patient 3 and 5, the tumor volume variation estimated by the two clinicians
using adaptive thresholding were significantly different with a factor of 2 to 4 between the two
measured variations (−81 and −40% for patient 3, −41 and −13% for patient 5). Finally, the
use of adaptive threshold on patient 6 and 7 led to completely aberrant values (above +400
and +75%, and +360 and −16%) contrary to the ASEM method that produced much more
consistent volume variation results.
Different behavior of the adaptive threshold and ASEM method, three clinical follow-up
cases corresponding to patients 2, 5 and 7 are illustrated in figure 5. Regarding patient 2, both
adaptive thresholding applied independently to each PET scan and the proposed fusion method
resulted in similar measurements leading to similar segmented maps. The first follow-up scan
of patient 3 clearly exhibited a heterogeneous uptake within the tumor as shown in figure 5(a).
The two segmentation maps obtained with Tb clearly underestimated the overall tumor volume
as shown in figure 5(d) and (f) by excluding the central part of the functional uptake, whereas
ASEM included it. The poor reproducibility of the adaptive thresholding methodology is
also emphasized for patient 7, for which the volume variation of the first observer is clearly
overestimated (+360%) contrary to the second observer which tends to under estimate this
volume evolution (−16%) while the ASEM method estimated it at −60%.
4. Discussion
The use multiple PET scans for response to therapy assessment is rising in oncology, due to
the need to assess response to therapy earlier, in order to improve patient’s management in
radiotherapy and/or chemotherapy. On the other hand, the use of different radiotracers to
visualize processes such as cellular proliferation or hypoxia for instance is generating a large
amount of research especially in radiotherapy and early therapy assessment (Shields 2003,
Vaupel and Mayer 2007).
The aim of this study was to propose a fusion method based on the multi-observation
framework in order to specifically address the simultaneous analysis of multiple follow-up
PET scans in the context of response to therapy assessment. The use of a fusion method
taking into consideration both scans at the same time was expected to produce more reliable
results than independent delineations performed on both scans separately. The ASEM method
demonstrated the ability to merge patient follow-up PET scans through unsupervised Bayesian
estimation, with especially good results on the first scan (error −2.6 ± 8%) and mostly good
results on the second scan, with however a few cases that prove more difficult especially
considering the second scan, therefore leading to a higher mean error and standard deviation
of −9 ± 25%. On simulated datasets, the adaptive threshold applied independently on both
images led to higher errors than the ASEM fusion with a systematic overestimation for both
the first and second scan (+28 ± 17% and +30 ± 15%, respectively). In the real clinical
datasets however, a significantly higher variability in the quantitative parameters measured
with the adaptive threshold method was observed for four patients out of seven.
These results can be explained by the fact that simulated data were generated with low
and uniform physiological uptake and considering homogenous tumor uptake, as well as
only one user to manually determine the background region of interest. However, noisy and
heterogeneous uptake in nearby healthy tissues are very common in actual clinical datasets
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Figure 5. (a) and (b) Clinical follow-up tumors, (c) ASEM fusion maps, individual segmented
map of the two clinicians (d), (e) and (f), (g) with the adaptive threshold, (h) and (i), the ASEM
method, for three real clinical datasets.
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affecting the delineation process, for instance in esophageal cancer for which the tumor is
located in the mediastinum and close to lung tissues. ASEM seemed much more resilient with
respect to non-uniform background and reduced tumor-to-background contrasts thanks to the
use of spatial (the local adaptive priors) and inter-observation correlations (multi-observation
framework using covariance matrices in the observation model) within the ASEM fusion. It is
to be emphasized that the ASEM fusion requires accurate co-registration of PET datasets with
a target registration error of 1 voxel (4 mm) as demonstrated by the results obtained by shifting
the second scan in the simulated datasets by one and two voxels (4 and 8 mm) in random
directions. The fusion was rather robust to 1 voxel spatial shifting; however, volume errors
regarding the second scan became higher when shifting by 2 voxels was applied, which can be
explained by the fact that as second scan tumor volumes are usually smaller, a misregistration
can lead to a higher impact on the volume error of such small volumes.
Despite being more dependent on the noise and the images reconstruction, SUVmax is
nevertheless a parameter that is most commonly used in clinical routine to assess and quantify
tumor evolution and response to therapy (Weber 2007, Nahmias and Wahl 2008). However,
the variation of SUVmax only may be not sufficient to characterize the tumor response, without
taking into account the information of the metabolic tumor volume, especially for early therapy
assessment. The SUVmean is considered more reproducible than SUVmax, but may depend on
the definition of the tumor volume (Tylski et al 2010).
In this study, three quantitative indexes, namely SUVmax, SUVmean and volume were
computed with both methodologies. An analysis of volume and SUVmean variations give
additional features to characterize the tumor response. In our results, SUV measurements
variations between pre- and post-treatment scans were similarly independent on the delineation
used. Tumor volume variations measured by the clinicians using the adaptive method were
close for patients 1, 2 and 4, and were significantly different for patients 3 and 5, emphasizing
the user dependence of such method in the presence of heterogeneous physiological uptake,
which is often the case for esophageal tumors (Hatt et al 2011). They were in addition
aberrant for patients 6 and 7, demonstrating the accuracy limitation of such an approach. By
contrast, tumor volume variations measured by ASEM were much more homogeneous across
the group of patients (−66 ± 11%). The poor reproducibility of the adaptive method was first
mentioned by Nestle et al (2005) in the case of non-small cell lung cancer. The measurements
and segmented maps obtained with the ASEM method were more appropriate considering the
known partial responder status of these patients. The combination of pertinent quantitative
indexes such as the metabolic volume and activity concentration in the tumor, measured with
a robust method could be valuable to thoroughly assess tumor response, as illustrated with the
use of the ASEM method on the clinical datasets.
5. Conclusion
A fusion method based on the multi-observation Bayesian framework was proposed to assess
multi-PET scans in the context of therapy response. Using the Bayesian framework, the
proposed method can potentially be applied to patient follow-up and multi-tracer datasets in
order to assess accurate treatment response and tumor volume definition by automatically
delineating the different variations of activity within the tumor. In this study, the multi-
observation method has been applied to simulated and clinical follow-up PET images and
compared with current threshold-based methods used in clinical practice for assessment of
the therapeutic response. On simulated datasets, the adaptive threshold applied independently
on both images led to higher errors than the ASEM fusion. The adaptive threshold proves
unreliable for more than half the patients, whereas ASEM produced measurements in line with
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what could be expected with respect to the classification of the considered patients. Future
work will also consider more than two PET scans within the context of therapy response
assessment, as well as multi-tracer studies in order to adapt the proposed fusion approach for
the definition of multi-tracer PET target volumes in radiotherapy, especially for dose boosting
or dose painting scenarios in radiotherapy (Sovik et al 2009).
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Appendix
Let us consider two random processes Y = (yt)tT and X = (xt )tT , modeling the
observations and the fusion map, respectively. Considering a mixture of multi-dimensional
Gaussian density probability functions, the distribution of (X, Y) is hence defined by the priors
k , the mean vectors µk and covariance matrices Ŵk associated to each of the K classes in the
mixture.
(1) The parameters (0k,µ0k, Ŵ0k
)
defining the Gaussian mixture of the (X, Y) distribution and
the class number K are initialized with a FKM algorithm based on entropy criterion.
(2) The mixture parameters are then computed with the SEM algorithm by sampling several
realizations of X according to its posterior distribution p(X|Y) defined for all the voxels
t ∈ [1, T ] and each class k ∈ [1,K] as
p(Xt = k|Y t) =
πt,k × f (Y t,µk, Ŵk)∑K
q=1 πt,q × f (Y t,µq, Ŵq)
, (A.1)
where π t,k is the adaptive prior of the voxel t and the class k defined at the step 4, and
f (Y t,µk, Ŵk) is the multi-dimensional Gaussian defined for the kth class by the mean
vectors µk and covariance matrices Ŵk .
(3) For each voxel and associated observation vector Yt with t ∈ [1, T ], a posterior realization
called R = (r1 . . . rT ) is sampled and a partition Q = (Q1, . . . ,QK) is defined as
Qk = {rt |rt = k} , (A.2)
where Qk is the partition associated to the k class. Using these realizations, the parameters
of the Gaussian mixture are estimated.
(4) First, in the adaptive framework, priors are re-estimated using a local neighboring 3D
cube, hence priors for each voxel depend on its position in the image and the current state
of its neighbors in the posterior realization. Replacing global prior k, local priors π t,k






δ(rj , k) for k ∈ [1,K], (A.3)
where Ct is the estimation cube and δ is the Dirac function. For our application we chose
a cube of size (3 × 3 × 3) voxels.










, for k ∈ [1,K], for b ∈ [1, B]. (A.4)
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[Y t − µk]t [Y t − µk]
Card(Qk)
, for k ∈ [1,K]. (A.5)
(7) The decision step based on the maximum likelihood criteria computes the posterior
probability p(X|Y) and selects for each voxel the class that maximizes it
kmax = arg max
k∈[1,...,K]
p (Xt = k|Y t) , ∀t, (A.6)
where Kmax is the estimated maximized class.
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r é  s u  m é
La tomographie  par  émission  de  positons  (TEP)  est dorénavant  un  outil  de  référence en routine clinique en
oncologie,  notamment dans  le cadre du diagnostic.  Des  applications  plus récentes,  telles  la prise en charge
et le suivi thérapeutique,  ou la définition de  cibles  en radiothérapie  nécessitent une  détermination rapide,
précise  et  robuste des volumes  métaboliquement  actifs  sur  les  images  d’émission,  ce  qui  ne  peut  être
obtenu  par  contours  manuels.  Ce besoin  clinique  a motivé  de  nombreux  développements ces dernières
années pour  la  mise  au  point de  méthodes  automatiques.  Cette  revue  propose une  vue  d’ensemble  de
ces méthodologies,  et  discute  leur mise en  œuvre  et  leur validation  méthodologique  et/ou  cliniques. Des
perspectives  sur  les  travaux  encore  à  accomplir  sont  également  suggérées.









a b  s t r a  c t
PET  imaging is  now  considered a gold  standard tool in clinical oncology,  especially for  diagnosis  pur-
poses. More  recent applications  such as  therapy  follow-up or  tumor targeting  in radiotherapy  require
a fast,  accurate  and  robust metabolically  active tumor volumes  delineation on  emission  images,  which
cannot  be obtained  through  manual contouring.  This  clinical  need  has sprung  a large  number  of methodo-
logical  developments  regarding  automatic  methods  to define tumor volumes  on PET images. This  paper
reviews  most of the  methodologies  that  have  been  recently proposed  and  discusses  their  framework  and
methodological  and/or clinical  validation.  Perspectives  regarding  the future  work  to be  done are  also
suggested.
© 2011 Société française  de  radiothérapie  oncologique  (SFRO).  Published by  Elsevier  Masson SAS.  All
rights reserved.
1. Introduction
La tomographie par émission de positons (TEP) est dorénavant
un outil de référence en routine clinique en oncologie, notam-
ment pour le diagnostic [1].  Des applications plus récentes de
cette imagerie fonctionnelle concernent la  prise en  charge et le
∗ Auteur correspondant.
Adresse e-mail : hatt@univ-brest.fr (M.  Hatt).
suivi thérapeutique, ou l’identification et la définition des cibles
en radiothérapie [2,3]. Ces dernières applications sont encore au
stade du  développement. Elles nécessitent des efforts en  termes
de standardisation [4],  notamment multicentriques, ainsi que la
mise au point d’outils permettant une quantification robuste,
précise et reproductible. En particulier, la mise à  disposition de
méthodes permettant la définition automatique, rapide et fiable
des volumes métaboliquement actifs  (VMA) des tumeurs a  été
identifiée comme  un besoin important et urgent [2,5].  Les applica-
tions visées sont notamment la mise au point de nouveaux indices
1278-3218/$ – see  front matter © 2011  Société française de radiothérapie oncologique (SFRO). Publié par Elsevier Masson SAS. Tous droits réservés.
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pronostiques ou  prédictifs de la  réponse, le suivi thérapeutique
et l’évaluation de la réponse et la définition des contours des
volumes tumoraux macroscopiques (gross tumour volumes [GTV])
en radiothérapie [2,6–10].  Ce  besoin a  notamment émergé suite
aux efforts déployés depuis le début des années 2000 pour tenter
de mettre en œuvre le «  volume cible biologique », avec l’utilisation
de radiotraceurs différents et plus spécifiques que le (18F)-
fluorodésoxyglucose [(18F)-FDG], dont l’utilisation reste largement
majoritaire en oncologie. Les traceurs permettant de visualiser la
prolifération cellulaire [(18F)-fluorothymidine (FLT)] ou l’hypoxie
[(64Cu)-diacétyl-bis(N4-méthylthiosemicarbazone (ATSM)], (18F)-
fluoromisonidazole (FMiso)] suscitent un intérêt particulier en
radiothérapie car ils permettent d’identifier des régions plus
agressives ou radiorésistantes. Ils prennent une importance
accrue en combinaison avec les nouvelles techniques d’irradiation
ciblée comme  la radiothérapie conformationnelle avec modula-
tion d’intensité (RCMI) et les scénarii d’escalade de dose [11] et de
dose painting [12].  Toutefois, la méthode standard de définition des
volumes tumoraux macroscopiques reste le contour manuel coupe
par coupe par le radiothérapeute sur les volumes obtenues par
tomodensitométrie (TDM) de planification. Cette dernière bénéficie
d’une résolution spatiale élevée de l’ordre du  millimètre, supé-
rieure à celle offerte par la TEP (de l’ordre de 4 à 6 mm).  Plusieurs
travaux ont étudié l’impact de l’utilisation des images fusionnées
TEP/tomodensitométrie sur la reproductibilité des contours ainsi
que sur la taille et la  forme des volumes tumoraux macrosco-
piques. Par rapport à l’utilisation de l’image anatomique seule, les
contours réalisés sur la  fusion TEP/tomodensitométrie mènent à
des volumes tumoraux macroscopiques en général plus reproduc-
tibles et souvent significativement plus petits ou plus grands en
fonction des localisations et des cas [13–16].  Actuellement, la TEP
est utilisée en routine clinique au mieux comme  un guide visuel à  la
définition des volumes tumoraux macroscopiques. La planification
réellement fondée sur l’imagerie fonctionnelle (avec le traceur FDG,
seul ou combinant différents traceurs), bien qu’ayant été suggérée
[17], est loin d’être une réalité clinique. Une des limites majeures
à la réalisation d’une telle méthodologie est sa complexité :  si  la
variabilité inter- et intra-utilisateur de la  détermination manuelle
des volumes tumoraux macroscopiques sur l’imagerie anatomique
peut être significative [14],  celle constatée sur l’imagerie fonc-
tionnelle est plus importante et incompatible avec une pratique
clinique [18].
Nous proposons dans cette revue une évaluation critique des
solutions qui ont été proposées jusqu’à présent pour assister le cli-
nicien dans la démarche chronophage et complexe de définition
des contours du volume métaboliquement actif sur les images de
TEP. Nous discuterons des manques actuels qu’il faut combler pour
parvenir à des solutions pouvant être mises en  pratique en routine
clinique.
2. Évaluation critique
2.1. Problématique des méthodes fondées sur des seuillages
Les premiers travaux visant à  établir une définition des volumes
métaboliquement actifs en  TEP sont fondés majoritairement sur des
méthodes de seuillage déterministe (fixe ou adaptatif) des valeurs
des voxels de l’image. Une liste détaillée de ces travaux peut être
consultée dans la revue de Dewalle et al. [19].  Le cas de la  TEP
est particulier dans le  sens où les seuillages ont pris une grande
importance en termes de popularité auprès des cliniciens et en
conséquence un grand nombre de publications les utilisant. Le prin-
cipal attrait de ces approches est leur simplicité méthodologique
et leur facilité d’utilisation. Elles reposent toutefois sur des hypo-
thèses simplificatrices, en particulier concernant la  distribution
du  radiotraceur au sein du volume métaboliquement actif. Cela
explique la grande variabilité de valeurs de seuils indiquées dans
les publications (de 20 à 75 % du standard uptake value [SUV] maxi-
mum)  et leur manque de précision et de robustesse [18,20–24].  Afin
d’apporter une réponse au problème fondamental de l’utilisation
d’une valeur fixe de seuil, il a  été  proposé d’adapter cette valeur
aux caractéristiques du volume métaboliquement actif et de son
environnement immédiat. Ces «  seuils adaptatifs » se fondent sur
une estimation approximative du contraste entre le volume méta-
boliquement actif et le « fond » physiologique, en lien avec une
optimisation propre au système et au protocole d’acquisition. Les
résultats sont ainsi améliorés, mais ces approches souffrent encore
de nombreuses limites. L’estimation initiale du  contraste est le
plus souvent dépendante de l’utilisateur [18,22],  et l’optimisation
nécessaire rend la méthode spécifique au système et au protocole
du  centre clinique. Une variabilité significative peut en effet être
observée entre des centres cliniques différents utilisant pourtant
le même  modèle de scanner [25].  En l’absence de standardisation,
ces approches peuvent difficilement être utilisées dans le cadre
d’études multicentriques. Ces techniques sont en outre susceptibles
d’échouer dans des situations complexes, notamment de distribu-
tion hétérogène du radiotraceur [6,23,26], comme illustré en Fig. 1.
Il est dorénavant acquis que les seuillages fixes sont à  proscrire, et
qu’en absence d’alternative, une segmentation manuelle est préfé-
rable [20].  Les seuillages adaptatifs sont susceptibles d’apporter une
précision suffisante dans les cas simples, mais sont dépendants des
utilisateurs et du  système. Ils  font globalement trop d’hypothèses
simplificatrices pour pouvoir être considérés comme  une solution
d’avenir.
3. Méthodologies de segmentation d’images
Étant données les limites des méthodes à  base de seuillage, il
est pertinent de s’intéresser à des méthodologies fondées sur des
approches de segmentation d’image plus avancées. Ces dernières
ont en commun des outils d’analyse et de segmentation d’image
ayant été développés auparavant dans d’autres domaines. Elles se
distinguent par le type de méthodologie considérée, les éventuelles
modifications apportées, leur niveau d’automatisation, la  nécessité
de pré- et/ou post-traitement(s) et par leur niveau de validation.
Bien que les spécificités propres à chaque localisation et type
de tumeurs ou au radiotraceur considéré doivent être gardées à
l’esprit, la  définition automatique d’un volume métaboliquement
actif sur une image de TEP reste avant tout une problématique de
segmentation d’image. C’est dans cette optique que nous orientons
cette revue critique. Certaines méthodologies ont été dévelop-
pées pour résoudre la problématique de fac¸ on globale, tandis que
d’autres l’ont été pour une localisation particulière (sphère ORL,
poumon, rectum. . .)  ou une problématique plus spécifique encore
(imagerie dynamique, contours en radiothérapie. . .). Notons éga-
lement que  l’immense majorité des travaux ont étudié le problème
en considérant le (18F)-FDG.
3.1. Méthodologies considérées
Il existe littéralement des centaines de méthodes de segmenta-
tion d’images, et plusieurs des plus connues ont été considérées par
différents groupes pour étudier la problématique de la segmenta-
tion d’images de TEP afin de définir les volumes métaboliquement
actifs. Certaines cherchent à  identifier les contours dans l’image,
d’autres tentent d’identifier les régions ou regroupements de
voxels. Cela peut être fait suivant des critères variés comme  les
valeurs, les  formes ou les textures, par des approches déterministes,
statistiques et probabilistes, ou d’intelligence artificielle.
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Fig. 1. Erreurs de classification (%) obtenues par des seuillages sur  simulations Geant4 Application for Tomography Emission (GATE) [59].  A :  vérité terrain simulée et B :
binarisée  pour le calcul d’erreurs ; C–F  : simulations avec différents niveaux de contraste et  bruit. T42 et  T50 :  seuils fixes à  42  et 50 %  du  maximum. Tbckgd et TSBR : seuillages
adaptatifs de Nestle et Daisne [19].
Une approche classique en  segmentation d’images consiste en
la détection de contours par analyse du gradient de l’image, afin de
définir une région interne et une région externe au contour détecté.
L’application directe de ce  type de méthode en TEP est difficile
car les contours sont flous et les gradients difficiles à  identifier.
Plusieurs études ont étudié l’adaptation de ces  méthodes pour la
définition de volume métaboliquement actif en TEP. Par exemple,
la méthode du « partage des eaux » (watershed),  qui est fondée sur
l’analogie avec une surface topologique se remplissant d’eau [27].
Une autre approche est fondée sur la détection des pics de gradient
pour identifier les contours des objets d’intérêt [28–32].  Il a  éga-
lement été proposé d’améliorer le  résultat d’un seuillage adaptatif
par l’utilisation d’un contour actif [33].  Notons qu’il a été suggéré
également de faire évoluer de tels contours en prenant en compte
les images de TEP et de tomodensitométrie simultanément [34].
Les méthodologies fondées sur le regroupement (clustering)  flou
non supervisé de voxels (en anglais : Fuzzy C-Means [FCM]) ont été
utilisées par plusieurs groupes [21,35,36].  Notons que l’algorithme
original est relativement simpliste et ne prend pas en compte les
corrélations spatiales entre voxels, par exemple, et mène à  des
résultants décevants [21,36].  Il semble toutefois a  priori assez bien
adapté aux images de TEP, du  fait de sa modélisation floue. Le
groupe ayant proposé la méthode la plus aboutie fondée sur le
FCM, a utilisé une version modifiée incorporant des informations
supplémentaires comme  la détection automatique du  nombre de
classes (ou clusters), la  corrélation spatiale des voxels et l’analyse
de l’hétérogénéité du traceur [36].
Le  regroupement des voxels pour définir les régions tumorales
et  physiologiques peut aussi se  faire par la différentiation statis-
tique des valeurs dans l’image. Ce type de méthode est très utilisé
en traitement d’images et a  de nombreuses applications en  ima-
gerie satellite et astronomique notamment [37].  Le principe est de
distinguer les voxels appartenant aux tumeurs de ceux appartenant
aux tissus sains par leurs propriétés statistiques respectives. Elles
sont toutefois assez peu adaptées au traitement d’images de TEP
à  cause de la difficulté de prise en  compte du flou. Une approche
simple consiste à faire croître la région de l’image correspondant au
volume métaboliquement actif à  partir du voxel d’intensité maxi-
male, avec comme critère de croissance la moyenne et la variance
[38]. Une autre approche est appliquée aux projections maximum
intensity projection (MIP) pour bénéficier du contraste ainsi aug-
menté, et fait correspondre le volume métaboliquement actif défini
sur la TEP d’origine grâce aux ensembles flous associés à un opé-
rateur de fusion [35].  L’utilisation de mélanges de gaussiennes
pour opérer la classification des voxels a  été proposée également.
Cette méthode ne considère pas de modèle spatial et nécessite une
complexe estimation du nombre total de gaussiennes à  utiliser et
de celles qui sont à associer au volume métaboliquement actif [39].
Dans ce contexte, il est possible de modéliser l’information spatiale
dans l’image par des modèles de Markov [40]. Il est aussi possible
de modifier la  modélisation des données au sein de ces outils, pour
prendre en compte le flou et ainsi obtenir des résultats amélio-
rés [41]. L’approche fuzzy locally adaptive bayesian (FLAB) utilise ce
principe [18,21,22,26].
L’analyse de texture a  également fait l’objet d’adaptation pour
classifier les voxels d’images de TEP/tomodensitométrie [42,43].
Cette approche consiste à apprendre à l’algorithme, via une base
de données d’images pour lesquelles la  vérité est identifiée par
des médecins, en quoi les voxels de tumeurs forment des textures
différentes de celles des voxels physiologiques. Cet apprentissage
permet la construction de classifieurs (par exemple des arbres de
décision) servant à  classifier les voxels d’une nouvelle image pro-
posée en entrée de l’algorithme. Une méthode similaire dans son
approche (apprentissage sur base de données pour générer un clas-
sifieur), mais utilisant des réseaux de neurones, a récemment été
proposée [44].
D’autres approches peuvent être citées, notamment une étude
qui s’est spécifiquement intéressée à  la segmentation de tumeurs
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en détectant les fixations physiologiques situées à proximité pour
éviter de les incorporer au volume métaboliquement actif [45].
Il a aussi été proposé de classifier les voxels comme  tumoraux
ou physiologiques en les regroupant en fonction de la courbe
temps–activité (time–activity curve) les caractérisant [46].  Cette
méthode ne peut toutefois être  utilisée que sur des images para-
métriques issues d’acquisitions de TEP dynamiques.
3.2. Prise en compte de la  nature des images de  tomographie par
émission de positons
Des méthodes reconnues comme  peu robustes au bruit et fon-
dées sur des décisions de segmentation peu flexibles paraissent
a priori mal  adaptées à l’analyse d’images de TEP. C’est pourtant
le cas des seuillages. Certaines approches, au contraire, proposent
de modéliser explicitement les caractéristiques des images de TEP.
C’est notamment le cas de l’approche FLAB [21].  D’autres méthodes
ont modifié des algorithmes connus pour obtenir une précision
satisfaisante. C’est le cas de l’algorithme par partage des eaux,
pour lequel le contour d’origine a  été modifié [27]. De fac¸ on simi-
laire, l’algorithme FCM a  été  modifié pour incorporer l’information
de corrélation spatiale et celle de l’hétérogénéité du  traceur [36].
Les approches fondées sur des techniques issues de l’intelligence
artificielle [42–44] ne proposent pas de modélisation explicite des
caractéristiques des images de TEP, toutefois leur nature intrin-
sèque doit leur permettre d’apprendre ces  caractéristiques pour
s’y  adapter. Une alternative consiste à améliorer la qualité des
images de TEP préalablement à  la  segmentation. Ainsi, la métho-
dologie fondée sur la théorie des possibilités est appliquée aux
projections MIP  et non aux images d’origine, dans le but d’opérer
la segmentation sur un  contraste plus élevé [35].  Les approches
utilisant l’analyse du gradient sont souvent associées à une ou
plusieurs étapes de prétraitement visant à  permettre une détec-
tion moins complexe des contours [32,34]. Ces prétraitements
atténuent le bruit et réduisent le flou. La même  méthodologie pro-
posée par l’industrie MIMVista semble ne  pas faire appel à  de tels
prétraitements1 [28–31].  Cela pose la  question de la  dépendance à
cette étape, car ces corrections sont délicates à étendre à l’ensemble
des  images de TEP [47,48].  D’autres approches ont par ailleurs
démontré de bonnes performances sur les images d’origine sans
nécessiter de tels prétraitement(s) [21,36].
Le développement d’une approche de segmentation automa-
tique d’images de TEP nécessite, en  effet, la  prise en  compte de
plusieurs paramètres.
D’une part, ceux qui sont liés à la tumeur ou à l’organe à définir :
• hétérogénéité de la distribution du traceur au sein de la
tumeur/organe ;
• hétérogénéité de la distribution du traceur au sein du  fond phy-
siologique ;
• contraste(s) mis  en  jeu entre l’objet et le fond, et au sein même
de l’objet et du fond ;
• complexité de la  forme de l’objet.
D’autre part, ceux qui sont liés à  la nature de l’acquisition :
• niveau de bruit ;
• taille des voxels et échantillonnage spatial ;
• type et modèle du scanographe ;
• algorithme de reconstruction et ses paramètres.
1 Il est important de souligner que  les détails de la méthodologie ne sont pas
disponibles, seuls les résultats étant présentés dans  des papiers de conférences et
non  des articles en journaux à comité de lecture.
Les paramètres ayant le plus d’impact sur la précision et la robus-
tesse d’une segmentation sont l’hétérogénéité de la  distribution du
traceur et les contrastes mis  en jeu (Fig. 1). Les volumes métabo-
liquement actifs réels sont rarement sphériques et homogènes sur
un fond homogène comme  le supposent de nombreuses méthodes,
et comme  sont conc¸ ues les données de validation utilisées dans de
nombreuses publications.
Les autres paramètres peuvent également avoir un impact
important sur  la qualité globale de l’image. La taille des voxels,
par exemple, a  un impact significatif sur la  définition d’un contour.
Plus les voxels utilisés pour définir la  grille de reconstruction sont
petits, meilleur est l’échantillonnage spatial des structures, et plus
le contour peut être finement défini. Toutefois, la réduction de la
taille des voxels dans la  grille de reconstruction entraîne une baisse
significative des statistiques disponibles en chaque voxel, et une
augmentation significative du  bruit (Fig. 2). Une alternative pour
améliorer l’échantillonnage spatial consiste à suréchantillonner
l’image, ce qui est d’ailleurs réalisé dans les stations commer-
ciales pour la  visualisation. Cela a  toutefois un impact important
sur l’aspect visuel des images et peut varier en fonction de la
méthode utilisée (Fig. 3). Étant donnée la grande variabilité des
modèles et types de scanner en  activité, le manque de standardisa-
tion des protocoles d’acquisition, et le grand nombre d’algorithmes
de reconstruction existant (et la possibilité de varier leurs para-
mètres), les images de TEP peuvent présenter des aspects très
variés (Fig. 4). Se pose alors le problème de l’universalité et de
la robustesse des méthodes proposées qui n’ont été validées que
sur un nombre restreint de données. Enfin, les mouvements phy-
siologiques, en particulier la respiration, ont un impact important,
notamment pour les localisations thoraciques. Plusieurs études ont
récemment concerné cette problématique [49,50],  mais la grande
majorité des méthodes ne prennent pas  en compte ce  paramètre
dans leur validation. Soulignons toutefois qu’il n’est pas déraison-
nable de faire l’hypothèse que les effets de la respiration puissent
être corrigés en amont au cours ou après la reconstruction [51].
3.3. Validation
Afin de démontrer rigoureusement les performances d’une
méthodologie, il  faut évaluer :
• la précision absolue ;
• la robustesse ;
• la reproductibilité et la dépendance éventuelle à  l’utilisateur.
La précision désigne la  capacité de l’algorithme à  définir la
position, la forme et le volume du volume métaboliquement
actif et pour l’évaluer, il est nécessaire de disposer d’une vérité
terrain. Certains travaux ont suggéré l’utilisation des volumes
segmentés sur les images tomodensitométriques comme vérité
terrain, ce  qui est aberrant car rien ne garanti que les volumes
anatomiques et fonctionnels soient parfaitement superposés. La
définition manuelle par un expert ne permet pas non plus de
générer une vérité terrain satisfaisante du fait de la variabilité
inter- comme  intra-utilisateurs [14,18].  Une alternative est de
définir un consensus de nombreux utilisateurs. Cela reste tou-
tefois dépendant des utilisateurs, ainsi que de la fac¸ on dont
le consensus est défini [52].  Dans le cas des images cliniques,
c’est toutefois la seule alternative à l’analyse histopathologique
qui consiste à  extraire chirurgicalement l’objet et d’en réaliser
des mesures macroscopiques. Cette opération comporte de nom-
breuses sources d’erreurs et d’approximations, l’objet pouvant
subir des déformations, devant être coupé en  tranches (ce qui
peut provoquer des pertes de matériau), et les régions corres-
pondant aux zones tumorales étant définies manuellement sur
les coupes. Enfin, les données doivent être recalées spatialement,
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Fig. 2. Acquisition de tomographie par  émission de positons (TEP) corps entier au (18F)-FDG reconstruite avec des voxels de A : 2 × 2 ×  2 mm3 et B : 4 ×  4 ×  4 mm3 .
ce qui est complexe étant donnée la nature très différente des
images. Peu de jeux de données existent [14,53–57].  Ils sont de
taille réduite, de moins d’une dizaine à  une trentaine de patients.
Dans la majorité des cas, seul le diamètre maximal est mesuré, ce
qui constitue une mesure réductrice du volume métaboliquement
actif.
Une alternative à l’utilisation de données cliniques pour évaluer
la précision consiste à réaliser des acquisitions de modèles phy-
siques réels dont les dimensions sont connues, tels les fantômes
NEMA IEC contenant des sphères de taille variable. La seule mesure
pertinente qu’il est possible d’évaluer sur de telles données est la
robustesse par rapport à  des structures de tailles et de contrastes
variables. En effet, les objets en question sont des sphères dont
l’activité est homogène, placées sur un fond homogène, ce  qui est
simpliste par rapport aux volumes métaboliquement actifs réels.
Des fantômes physiques permettant de générer des activités hété-
rogènes et/ou des formes plus complexes ont été proposées [40],
mais restent loin  de la complexité des images cliniques réelles
et sont complexes à  produire et utiliser. Une étude rigoureuse et
complète de la robustesse devrait idéalement être réalisée sur des
Fig. 3. Image de tomographie par émission de positons (TEP) d’une tumeur pulmonaire. A : originale (5,31 ×5,31 ×  5 mm3) et  interpolée sur  des voxels de 1 mm3 par approche
B  : linéaire et C : B splines cubiques.
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Fig. 4. A–C : tumeurs pulmonaires sur  A :  Philips Gemini ; B : Siemens Biograph et C : GE Discovery LS  ; D :  tumeur œsophage et E : tumeur rectale sur Philips Gemini ; et F :
tumeur  du sein avec (18F)-fluorothymidine sur Siemens Biograph.
objets plus complexes en termes de formes et d’hétérogénéité, que
des acquisitions de fantômes contenant des sphères. Cela peut être
réalisé grâce aux simulations numériques.
Une troisième solution permettant d’évaluer les performances
d’une approche est l’utilisation de données simulées réalistes.
Générer de telles données nécessite l’utilisation de simulateurs de
particules comme  Simulation of Realistic Tridimensional Emitting
Objects (SORTEO) ou Geant4 Application for Tomography Emission
(GATE) associant des modèles de fantômes anthropomorphiques
numériques comme  Zubal ou XCAT (4D eXtended CArdiac Torso
phantom) avec des modèles de systèmes d’acquisition [58–63].  Il
est possible avec ces  outils de générer des structures complexes et
réalistes, y compris en  ce qui concerne la  modélisation des tumeurs
[64], avec l’avantage de connaître la vérité terrain et de contrô-
ler la plupart des paramètres. Toutefois, cette approche nécessite
des compétences spécifiques et des matériels dédiés, du  fait de
l’exigence en termes de puissance de calcul. Des simulations ana-
lytiques plus simples peuvent également être considérées, mais les
résultats doivent alors être considérés avec plus de précaution car
elles impliquent des simplifications.
La mesure de mérite utilisée afin d’évaluer la  précision par rap-
port à la vérité terrain a également son  importance. Les erreurs de
volume peuvent être  suffisantes pour les sphères homogènes, mais
ne sont pas rigoureuses pour évaluer la  précision sur des objets plus
complexes, car une segmentation erronée peut fournir le même
volume absolu. Des mesures de mérite comme  les erreurs de clas-
sification ou les coefficients de Dice sont plus pertinents [21,65].
La robustesse mesure la capacité d’une méthode à  fonction-
ner sur la grande variabilité des images de TEP, sans ajustement
préalable de paramètres. Il est donc nécessaire de considérer diffé-
rents modèles de scanographe et les algorithmes de reconstruction
associés, et pour chacun, différents paramètres d’acquisition
pour évaluer la robustesse au bruit, au contraste, ou encore à
l’échantillonnage spatial. Il  est envisageable de générer de telles
données avec les outils de simulations réalistes, mais cela implique
la modélisation de différents scanographes et peut donc être
laborieux. Une alternative consiste à  exploiter des acquisitions de
fantômes physiques réalisées dans différents centres, pour obtenir
une large gamme de situations. Ce type de données est toutefois
long à acquérir, et souffre des limites évoquées précédemment pour
l’évaluation de la précision.
Évaluer la reproductibilité (aussi dénommée «  répétabilité »)
peut se  faire par la  répétition de l’exécution de la segmentation sur
les mêmes  données. On peut ainsi la comparer avec la variabilité
observée avec la définition manuelle [18].  Ainsi, l’exécution répétée
d’un seuillage fixe sur une même  image donne systématiquement le
même  résultat avec une variabilité nulle. Au  contraire, l’utilisation
de méthodes avancées nécessitant par exemple un processus itéra-
tif peut mener à  différents résultats en fonction, par exemple, des
paramètres d’initialisation et du  critère de convergence.
L’évaluation des interactions avec l’utilisateur est plus délicate
à quantifier. Il est nécessaire de déterminer si  l’utilisateur doit
détecter et isoler le volume métaboliquement actif, définir des
régions d’intérêt (dans le volume métaboliquement actif et/ou le
fond), ou encore ajuster des paramètres au cas par cas. La plupart
des méthodes proposées font l’hypothèse préalable que le volume
métaboliquement actif a  été détecté et isolé par l’utilisateur.
Quelques méthodes se sont toutefois positionnées dans le cadre de
la segmentation de l’image entière (Tableau 1), l’interaction avec
l’utilisateur intervenant une fois la  segmentation effectuée, pour
analyser le résultat et associer au volume métaboliquement actif
certaines des régions obtenues par la  segmentation.
Par rapport à  ces exigences, les méthodologies évoquées dans la
section précédente fournissent des preuves de performances à des
niveaux différents. Le Tableau 1 résume pour chaque approche le
type de segmentation utilisée, l’interaction utilisateur, les pré- ou
post-traitement nécessaires, les données utilisées pour la valida-
tion de la  précision (et la vérité terrain associée), et si une évaluation
de la robustesse et de la  reproductibilité a été réalisée.
L’analyse de ce tableau révèle de grands écarts de qualité de vali-
dation entre les publications, ainsi qu’une grande variabilité dans















































































































Comparaison des méthodologies de segmentation d’images.









[27] Partage des eaux Standard +  placement de
plusieurs marqueurs
Ø Globale AF(1) - Vol. et images CT Non  Non Non
[28–31]  Gradient Standard +  initialisation Ø Globale AF(5) - Vol.
25 TSMC -  Vol. + TLG
18 TCH -  Diam.
Oui Oui Oui
[32]  Gradient Standard +  initialisation Débruitage et déconvolution Globale SF et AF - Vol. + Diam.
7 TCH - Complet
Oui Non Non
[33]  SA + contour actif Standard +  nécessité de fixer
plusieurs paramètres
Ø Globale AF(1) - Vol. 1 TC - Ø Non  Non Oui
[34]  Contours actifs
multimodaux (TEP/TDM)




Normalisation et  recalage des
données de TEP et  de
tomodensitométrie,
déconvolution des images de
TEP
GTV TEP/TDM AF - Vol.
2  TC -  CM(1), SF
Non Non Non
[35]  Théorie des possibilités sur
projections MIP
Standard Ø Globale AF(1) - Vol.
5  TSMC – Vox.
7  TCH - Complet
Oui Non Non
[36]  Fuzzy C-Means (FCM)
amélioré
Interprétation des classes de




Globale 3 TSA – Vox.
21 TCH -  Diam.
7 TCH - Complet
Oui Non Non
[39] Mélange de  gaussiennes Standard +  initialisation du
modèle, choix du nombre de
classes
Ø Tumeurs pulmonaires 7 TC -  Ø Non  Non Oui
[40] Champs de Markov
multi-résolution
Choix du nombre de
classes  +  interprétation des
classes  de la segmentation
effectuée sur  l’image entière
Transformations en  ondelettes Globale AF(1) - Vol.
3  TC -  Ø
Non Non Non
[41]  Chaînes de Markov floues
(FHMC)
Standard Ø Globale SF(1) et AF(2) -  Vox. Non  Non Non
[18,21,22,26] Fuzzy locally adaptive
bayesian (FLAB)
Standard Ø Globale SF (1) et AF (4) - Vox.
20 TSMC - Vox.
18 TCH -  Diam.
Oui Oui Oui
[38]  Croissance de  région sur
critères statistiques
Standard Optimisation sur chaque
système nécessaire
Tumeurs rectales 18 TC - CM(1) Non  Non Non




Interprétation de  la
segmentation finale réalisée
sur  l’image entière
Apprentissage et construction
des arbres de décision
GTV  ORL 10 TC - CM(3) Non  Non Non
[44]  Réseau de neurones Interprétation des classes de
la  segmentation effectuée sur
l’image entière
Apprentissage et construction
du réseau de neurones
Globale AF(1) - Vol.
3  TSA - Vox.
1 TCH - Diam.
Non Non Oui
[45]  Algorithme Spherical Mean
Shift
Standard Rééchantillonnage dans un
domaine de coordonnées
différent
Globale 280 TSA -  Vox. Non  Non Non
[46]  Classification des voxels à
partir des courbes
temps–activité
Standard +  initialisation et






AF - Vol. + Diam.
21 TC - CM(1)
Non Non Non
a Standard :  interaction « standard »  (détection et  placement du  VMA  dans une région d’intérêt).
b Globale : non restreint à une application.
c AF(x) : acquisitions de fantôme sur  x scanographes différents ; SF(x) : simulations de fantôme sur x scanographes différents ;  TSA : tumeurs simulées de fac¸ on analytique ; TSMC : tumeurs simulées par approche Monte Carlo ;
TC  :  tumeurs cliniques ;  TCH :  tumeurs cliniques avec histopathologie ; Vol. : volume uniquement ; Vox. :  voxel à  voxel ; Diam :  diamètre maximum uniquement ;  complet :  reconstruction histopathologique 3D ;  CM(x) : contours
manuels  (x expert(s)) ; SF :  seuillage fixe.
d Fortement hétérogènes, formes complexes, faibles contrastes, etc. avec vérité terrain rigoureuse.
e Requiert de  multiples acquisitions sur plusieurs systèmes et un grand nombre de paramètres.
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Fig. 5. Sur des tumeurs similaires et fortement hétérogènes, A :  d’après [31] méthode par gradient (rose) qui englobe toute la tumeur sans différencier le cœur du  pourtour
et  un seuil à 37 % (bleu) qui ne prend que le pourtour ;  B : Fuzzy locally adaptive bayesian (FLAB) avec trois classes [26]  qui définit le contour externe, le cœur nécrosé, et la
fixation de plus haute activité.
de publications ayant explicitement démontré la  capacité de la
méthode à segmenter avec précision des volumes métabolique-
ment actifs réalistes dont la  fixation de radiotraceur est fortement
hétérogène, c’est-à-dire dont les contrastes intra-tumoraux sont
suffisamment élevés pour rendre inadéquate une segmentation
comme  celle des seuillages [26,29,36].  Notons le cas particulier de
la méthode par gradient, qui semble capable de générer un contour
sur une tumeur hétérogène contenant un cœur nécrosé, mais n’est
pas capable de définir le  contour interne de la nécrose en question,
ou de définir des régions différentes au sein de la  tumeur (Fig. 5).
Pour une majorité des publications, la  précision a été évaluée sur
des jeux de données relativement simplistes et de taille limitée
et/ou des données cliniques sans vérité terrain rigoureuse. Plusieurs
approches ont été appliquées sur  des jeux de données disposant
de mesures histopathologiques en commun. La méthode par gra-
dient, le FCM, et celle de la  théorie des possibilités ont  été testées
sur sept patients atteints de cancer de la sphère ORL [53],  avec des
erreurs par rapport aux volumes de 19 ± 22 %, 9 ± 28 % et 18 ± 10 %
respectivement. Les méthodes FCM et FLAB ont été appliquées
sur 18 patients avec tumeurs pulmonaires [14],  avec ±  6 %  d’erreur
par rapport au diamètre maximum pour FLAB [26] et ± 15 % pour
FCM [36] (Fig. 6). Dans la majorité des publications, les méthodes
proposées ont été comparées avec des seuillages, et non avec une
méthode plus performante déjà publiée. Cela explique en  partie la
multiplication des méthodes proposées. Il est en effet plus facile de
démontrer des résultats améliorés par rapport aux seuillages, dont
la  précision et la robustesse sont très limitées.
La plupart des études n’ont pas  apporté d’informations perti-
nentes sur  les aspects de robustesse et de répétabilité, à l’exception
des méthodes par gradient de MIMvista et FLAB. Quelques résul-
tats concernant la répétabilité sont également disponibles dans le
cas du contour actif, des réseaux de neurones et du  mélange de
distributions gaussiennes [33,39,44].
En  conclusion, les méthodologies ayant bénéficié de la valida-
tion la plus complète (fantômes sur plusieurs scanographes pour la
robustesse, images simulées réalistes, images cliniques avec histo-
pathologie, répétabilité) sont les méthodes par gradient et FLAB.
3.4. Démonstration de l’impact clinique
Un enjeu important d’actualité est l’évaluation de l’impact cli-
nique d’une définition précise, fiable et reproductible des volumes
métaboliquement actifs pour les différentes applications de la TEP.
Cela est crucial afin de convaincre les cliniciens et les industriels
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Fig. 6. Sur une même  tumeur hétérogène, A : Fuzzy C-Means (FCM) amélioré [36] et B :  FLAB [26].  Les contours rouge, jaune et  vert correspondent respectivement au  FCM
simple,  au FCM-S (avec corrélation spatiale), et  au FCM-SW (rajoutant la  gestion des hétérogénéités), qui sous-évalue la  partie droite de  la  tumeur.
de mettre en œuvre ces approches en routine. À ce jour, seuls
quelques travaux sont disponibles, démontrant, par exemple, un
impact en dosimétrie pour la  planification de radiothérapie utili-
sant la méthode par gradient [66]. Des travaux récents démontrent
également l’intérêt d’une précision accrue dans la définition
des volumes métaboliquement actifs, permettant d’extraire des
images des paramètres tels que le volume métaboliquement actif
et le total lesion glycolysis (TLG) associé [67].  Il a été démontré
que ces derniers, contrairement aux mesures classiques de SUV,
peuvent avoir une valeur prédictive de la survie et de la réponse
thérapeutique dans le cadre des lymphomes, des mésothéliomes
et des cancers localement évolués de l’œsophage, et ce, sur l’image
prétraitement uniquement [6,9,68,69].  Ces paramètres nécessitent
toutefois, contrairement à la mesure de SUVmax,  une définition pré-
cise des volumes métaboliquement actifs. Notons également que
cela permet d’envisager la caractérisation de l’hétérogénéité
du traceur au sein du volume métaboliquement actif
[8,70,71].
La détermination d’intervalles de confiance permettant de
caractériser la reproductibilité des mesures de volume métabo-
liquement actif, afin de les utiliser pour caractériser la réponse
thérapeutique [2], peut se faire sur des acquisitions répétées à
quelques jours d’intervalle sans traitement. Utiliser une méthode
robuste permet d’atteindre le même  degré de reproductibilité que
le SUVmax (±30 %),  contrairement à  l’utilisation de seuillages qui
mènent à des niveaux de variabilité nettement plus élevés (± 35 à
±  94 %) [18,72].
La grande majorité des méthodologies de segmentation
d’images de TEP qui ont  été publiées ces dernières années n’ont
pour l’instant pas encore été  utilisées afin de démontrer l’intérêt
d’une définition fiable des volumes métaboliquement actifs dans
les différentes applications cliniques, ce qui conduit à retarder leur
adoption par l’industrie, et donc a fortiori par les cliniciens.
4. Perspectives
Comme nous l’avons exposé, la problématique de la défini-
tion automatique (ou du  moins semi-automatique) des volumes
métaboliquement actifs sur les images de TEP a  été en partie
résolue par les travaux de certains auteurs, y compris pour des
situations relativement complexes de formes et d’hétérogénéité,
de faibles contrastes ou rapports signal sur bruit. Les difficultés
résident essentiellement dans la validation, souvent délicate et
controversée, et dans l’étape de transfert à  l’utilisation clinique,
ce que peu de groupes ont jusqu’à présent réalisé en  utilisant leurs
méthodes respectives. Ajoutons à  cela la popularité des seuillages
fixes et adaptatifs dans les publications, qui parasitent fortement
la diffusion et l’acceptation au sein de la  communauté clinique de
méthodologies plus performantes.
Certaines difficultés pratiques restent pour l’instant non réso-
lues. Citons, en  particulier, outre la problématique de la spécificité
du  radiotraceur, la différentiation automatique des fixations patho-
logiques et physiologiques. En ce qui concerne l’identification du
volume métaboliquement actif à segmenter, il est probable que
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l’intervention de l’utilisateur restera nécessaire, en particulier pour
des cas complexes de tumeurs situées à  proximité de zones ou
d’organes associés à  une fixation physiologique élevée. La robus-
tesse des méthodes face au manque actuel de standardisation des
protocoles d’acquisitions est loin d’être démontrée, bien que cer-
taines investigations aient déjà été menées [22].  Les faibles niveaux
de contraste et les hauts niveaux de bruit (ou de fixations physio-
logiques) associés à  l’utilisation de traceurs différents du FDG sont
encore, même  pour les approches les plus performantes, des limites
complexes à dépasser. De plus, toutes les méthodes partagent des
limitations techniques en termes d’initialisation de paramètres
et de dépendance à l’utilisateur et peu d’entre elles ont  fait la
démonstration d’une automatisation suffisante pour permettre une
utilisation aisée et rapide par les cliniciens. Cela est toutefois un
obstacle surmontable car de nombreuses solutions d’interface utili-
sateur et d’estimation automatique existent, permettant de limiter
les interventions de l’utilisateur ou  de les rendre plus reproduc-
tibles. Il  s’agit toutefois d’un effort à  fournir essentiellement de
la part des industriels pour la mise en œuvre des méthodologies
développées par les équipes de recherche au sein de leurs produits
destinés aux cliniciens.
Pour ce faire, les industriels doivent pouvoir identifier les
méthodologies les plus prometteuses, ce qui est délicat, car la
comparaison des méthodes est sujette à controverse si elle est réali-
sée sur la base des publications disponibles, faute de données de test
communes. La mise à disposition de larges bases de données conte-
nant des données cliniques associées à une vérité terrain rigoureuse
comme  les données d’histopathologie, et des données simulées
réalistes couvrant une vaste gamme  de situations, permettrait de
mettre en place de telles études comparatives. Cet effort n’est pour
le moment consenti que  par quelques équipes regroupées au sein
de collaborations limitées, bien que certaines initiatives soient déjà
menées pour tenter de construire et mettre à disposition des bases
de données plus conséquentes [73].
Les développements actuels de l’imagerie multimodale au sens
large génèrent aussi de nouveaux défis que les méthodes déve-
loppées jusqu’à présent ne permettent pas de prendre en compte
explicitement. La tendance actuelle est en  effet à  l’augmentation
du nombre de modalités d’imagerie disponibles (IRM, TEP, tomo-
densitométrie, etc.) et des modes d’acquisitions (radiotraceurs en
TEP, séquences en IRM, etc.). Cela entraîne potentiellement la  mul-
tiplication d’examens pour un patient donné, et les cliniciens sont
confrontés à la prise en  compte de multiples images, éventuel-
lement associées, mais souvent acquises dans des configurations
spatiales et temporelles différentes. La prise en compte auto-
matique de ces données hétérogènes et multi-sources (plusieurs
modalités et/ou plusieurs modes d’acquisition ou  traceurs pour une
modalité donnée, ainsi que l’évolution temporelle à  différents ins-
tants d’un traitement par exemple) pour un même  patient, devra
donc faire l’objet de développements appropriés, pour lesquels des
outils de recalage et d’analyse d’image et de données existent mais
doivent être adaptés et validés.
5. Conclusion
Il n’existe pour l’instant pas de consensus dans la communauté
sur la méthodologie à adopter pour définir automatiquement les
volumes métaboliquement actifs sur les images TEP, que ce soit
pour des applications de suivi thérapeutique ou la définition de
nouveaux critères pronostiques et prédictifs en oncologie, ou bien
la définition des volumes tumoraux macroscopiques en  radiothé-
rapie. Malgré l’existence de méthodologies ayant démontré des
performances largement supérieures aux seuillages, qui  restent
le standard, le manque d’études approfondies et comparatives
sur des données établies comme  références en  est la principale
raison. Ce manque s’explique principalement par une ignorance des
méthodologies existantes de la part d’une majorité de cliniciens, et
d’une persistance de la communauté à n’utiliser et populariser les
seuillages. Il s’explique également par un manque de bases de don-
nées disponibles et ouvertes, sur lesquelles chaque groupe pourrait
tester les performances d’une méthode développée et la comparer
à  celles proposées précédemment. Tant que de telles données et
études ne  sont pas disponibles, il sera difficile d’obtenir des indus-
triels une implémentation de méthodologies performantes au sein
des outils destinés au cliniciens pour leur pratique routinière.
La plupart des méthodologies existantes souffrent de défauts
plus au moins fondamentaux et importants, et des travaux sont
encore nécessaires, notamment en termes d’automatisation et de
fiabilité. Par ailleurs, de nouveaux défis voient le jour avec le déve-
loppement de l’imagerie TEP multi-traceurs et les imageries multi
modalité (TEP/tomodensitométrie, TEMP/tomodensitométrie,
TEP/IRM, etc.), notamment pour le traitement d’informations
multidimensionnelles et multi-résolution, nécessitant le déve-
loppement d’approches d’analyse d’images appropriées et
innovantes.
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L e t t e r s t o t h e E d i t o r
Autocontouring Versus Manual Contouring
TO THE EDITOR: We read with interest the study of Wu et al.
(1) regarding autocontouring methodologies for target delineation
in PET/CT for non–small cell lung cancer (NSCLC). Seventeen
NSCLC tumors were delineated with both automated and manual
approaches, using either combined PET/CT or CT and PET inde-
pendently. As expected, manual contouring of PET uptake corre-
lated better with the maximum diameter of the primary tumor than
did autocontouring using a fixed threshold at 50% of maximum
tumor uptake. We believe that this result is largely associated with
the various shortcomings of fixed-threshold approaches, a point
that needs to be clearly emphasized.
The authors have previously demonstrated that the best
correlation between histopathology-derived maximum tumor
diameters and image-derived ones was obtained using a 50%
fixed threshold (2). This conclusion was reached by comparison
with results obtained using other fixed-threshold values (from 20%
to 55%), with a modest correlation of 0.77 and nonstatistically
significant differences from the other fixed-threshold values tested.
Most significantly, the use of a 50% fixed threshold led to differ-
ences larger than 1 cm in half the tumors considered. Such differ-
ences in maximum tumor diameter will most certainly lead to
larger differences in the overall 3-dimensional volume. Consider-
ing similar comparisons based on 3-dimensional NSCLC tumor
volumes determined by histopathology, other authors have dem-
onstrated that an “optimal” threshold cannot be determined; con-
siderable variability is seen (20%–42% [31% 6 11%] of the
maximum), whereas CT-based volumes significantly overesti-
mated the pathologic volume (3).
It is therefore important to emphasize that a fixed threshold
(irrespective of its absolute value) is not an adequate methodology
to delineate elevated uptake signal in PET, because of its binary,
deterministic nature and lack of robustness versus varying contrast
and noise conditions (4,5). To account for these widely docu-
mented literature findings concerning tumor target delineation
incorporating PET uptake information, fixed thresholding should
be avoided, and at the very least, methodologies considering
target-to-background ratios such as adaptive thresholding (5,6)
should be favored. Eventually, the wider availability of automatic
segmentation approaches (7–10), some of which can account for
the presence of heterogeneous tumor uptake (7), may improve the
accuracy and reproducibility of adaptive thresholding (11) for
determination of functional tumor volume.
Considering all these facts, we do agree with the authors that
manual contouring should be preferred to autocontouring at a 50%
threshold for functional tumor volume delineation. On the other
hand, one should consider that manual delineation of PET uptake is
not the ideal approach either, for multiple reasons. Most importantly,
it represents a long process, particularly when it has to be performed
in 3 dimensions, and it is inherently of low reproducibility (11).
We therefore recommend that future studies investigating this
issue include the use of advanced image segmentation approaches
(4–10), which have demonstrated improved performance in com-
parison to a fixed threshold and may therefore lead to alternative
or complementary conclusions regarding the role of manual
contouring. Irrespective of the performance of a segmentation
algorithm, operator intervention will always be necessary to
appropriately identify the functional uptake of interest and avoid
the inclusion of non–tumor-specific uptake.
REFERENCES
1. Wu K, Ung YC, Hwang D, et al. Autocontouring and manual contouring: which
is the better method for target delineation using 18F-FDG PET/CT in non–small
cell lung cancer? J Nucl Med. 2010;51:1517–1523.
2. Wu K, Ung YC, Hornby J, et al. PET CT thresholds for radiotherapy target
definition in non-small-cell lung cancer: how close are we to the pathologic
findings? Int J Radiat Oncol Biol Phys. 2010;77:699–706.
3. Yu J, Li X, Xing L, et al. Comparison of tumor volumes as determined by
pathologic examination and FDG-PET/CT images of non–small-cell lung
cancer: a pilot study. Int J Radiat Oncol Biol Phys. 2009;75:1468–1474.
4. Hatt M, Turzo A, Roux C, et al. A fuzzy Bayesian locally adaptive
segmentation approach for volume determination in PET. IEEE Trans Med
Imaging. 2009;28:881–893.
5. Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods
for delineation of 18F-FDG PET-positive tissue for target volume definition in
radiotherapy of patients with non-small cell lung cancer. J Nucl Med. 2005;46:
1342–1348.
6. Daisne JF, Sibomana M, Bol A, et al. Tri-dimensional automatic segmentation
of PET volumes based on measured source-to-background ratios: influence of
reconstruction algorithms. Radiother Oncol. 2003;69:247–250.
7. Hatt M, Cheze le Rest C, Descourt P, et al. Accurate automatic delineation of
heterogeneous functional volumes in positron emission tomography for
oncology applications. Int J Radiat Oncol Biol Phys. 2010;77:301–308.
8. Geets X, Lee JA, Bol A, et al. A gradient-based method for segmenting FDG-
PET images: methodology and validation. Eur J Nucl Med Mol Imaging.
2007;34:1427–1438.
9. Montgomery DWG, Amira A, Zaidi H. Fully automated segmentation of
oncological PET volumes using a combined multiscale and statistical model.
Med Phys. 2007;34:722–736.
10. Yu H, Caldwell C, Mah K, et al. Automated radiation targeting in head-and-
neck cancer using region-based texture analysis of PET and CT images? Int J
Radiat Oncol Biol Phys. 2009;75:618–625.
11. Hatt M, Cheze Le Rest C, Aboagye EO, et al. Reproducibility of 18F-FDG and
18F-FLT PET tumor volume measurements. J Nucl Med. 2010;51:1368–1376.
Mathieu Hatt*
Dimitris Visvikis
Catherine Cheze Le Rest
*INSERM U650 LaTIM
Batıˆment 2bis (I3S), CHU Morvan,
5 Avenue Foch, Brest 29609, France
E-mail: hatt@univ-brest.fr
DOI: 10.2967/jnumed.110.084897
REPLY: We thank Dr. Hatt and colleagues for their interest in
and comments about our study of autocontouring and manual con-
touring for target delineation using 18F-FDG PET/CT in non–
small cell lung cancer (NSCLC) (1). These authors are extremely
accomplished in the use of PET/CT in NSCLC. We think their
statement that a fixed threshold is not an adequate methodology
because of its considerable variability is reasonable.COPYRIGHT ª 2011 by the Society of Nuclear Medicine, Inc.
658 THE JOURNAL OF NUCLEAR MEDICINE • Vol. 52 • No. 4 • April 2011
There are limited data on contouring the gross tumor volume
(GTV) using PET/CT thresholds correlated with tumor size on
histopathologic examination. Our study demonstrated that using the
50% fixed threshold for contouring GTV produced the best cor-
relation between maximum tumor diameters and histopathologic
findings (2). However, the 50% fixed threshold led to a larger differ-
ence in the diameter of GTVon PET, and CT-based volume signifi-
cantly overestimated the pathologic volume. In fact, the window and
level of CT also led to more differences in determining the CT-based
volume (2). Much uncertainty exists regarding the most appropriate
threshold to define a PET target volume in NSCLC radiation treat-
ment planning. The use of a standardized uptake value (SUV) fixed-
threshold intensity to define a tumor on PET may be inadequate for
target volume definition and tends to underestimate target volumes
(3). Nestle et al. (4) demonstrated that a GTVapplying a threshold of
40% of the maximum SUV does not appear to be suitable for target
volume delineation, although they used CT volume compared with
PET volume because there was no available pathology correlation.
For laryngeal tumors, the segmented volumes by the gradient-based
method agreed with those delineated on the macroscopic specimens,
whereas the threshold-based method overestimated the true volume
by 68% (5).Yu et al. (6) have shown that the absolute SUV had no
significant correlation with the GTVof pathology or tumor diameter.
The simplest method, which is widely used, is a visual inter-
pretation of the PET scan and definition of contours as judged
visually in cooperation with an experienced nuclear medicine
physician (7–9). Another method using SUV is absolute SUV and
regression function or source-to-background ratio. Hatt et al. (10)
established the repeatability and reproducibility limits of several
volume-related PET image–derived indices—namely tumor volume,
mean SUV, total glycolytic volume, and total proliferative volume.
Fixed and adaptive thresholding, fuzzy C-means, and fuzzy locally
adaptive Bayesian (FLAB) methodology were considered for tumor
volume delineation. The reproducibility of different quantitative
parameters associated with functional volumes depends significantly
on the delineation approach. State-of-the-art algorithms for functional
volume segmentation use adaptive thresholding. The new 3-FLAB
algorithm is able to extract the overall tumor from the background
tissues and delineate variable-uptake regions within the tumors, with
improved accuracy and robustness compared with adaptive threshold
(tumor and background intensities) and fuzzy C-means. The gradient-
based segmentation method applied to denoised and deblurred
images proved to be more accurate than the source-to-background
ratio method (5).
The different techniques to define tumor contour by 18F-FDG
PET in radiotherapy planning resulted in substantially different
volumes, especially in patients with inhomogeneous tumors (4).
In our study, manual contouring was preferred to autocontouring
at a 50% threshold for PET tumor volume delineation (1). How-
ever, manual delineation of functional volumes using PET images
leads to high inter- and intraobserver variability (11). Furthermore,
manual contouring is a long process when it has to be performed
in 3 dimensions (12). As for the conclusion in our paper, when
using autocontouring of the target in NSCLC, one should consider
manual contouring of 18F-FDG PET to check for any missed dis-
ease that might be incompletely covered (1).
We agree with the recommendation of Hatt and colleagues that
future studies investigating this issue should include a more
accurate methodology, such as a segmentation algorithm. We also
need to attain more data on functional volume compared with
pathologic volume. Much more work must be done to resolve
these issues concerning the delineation target of NSCLC using
PET/CT, and we still must correlate with the gold standard—
pathologic findings—whenever possible.
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DEFINING RADIOTHERAPY TARGET VOLUMES USING
18F-FLUORO-DEOXY-GLUCOSE POSITRON EMISSION
TOMOGRAPHY/COMPUTED TOMOGRAPHY: STILL
A PANDORA’S BOX?: IN REGARD TO DEVIC ET AL. (INT J
RADIAT ONCOL BIOL PHYS 2010)
To the Editor:We read with interest the article by Devic et al. (1) investi-
gating the use of fixed thresholds to define non–small-cell lung carcinoma tu-
mor positron emission tomography (PET) volumes exhibiting heterogeneous
uptake. They found no correlation between the computed tomography–based
and the PET-based volumes, and they associated the observed variations with
intrinsic properties of PET acquisition rather than the segmentation choice.
They also concluded that PET-based volumes should not be used for radio-
therapy dose painting/boosting. Several studies recently dealt with similar is-
sues considering fixed threshold to determine tumor metabolic volumes,
showing large variability in the threshold values (2, 3). Other recent studies
also showed the limitations of fixed thresholding and proposed more
accurate and robust methods, from adaptive thresholding (4, 5) to advanced
algorithms (6–8) capable in some cases of handling heterogeneous uptake
frequently characterizing tumors treated with radiotherapy.
Fixed thresholds cannot reliably define functional volumes because of
their deterministic and binary nature, whereas tumor uptake is variable, spa-
tially heterogeneous, and dependent on a large number of data acquisition
and image reconstruction parameters. We agree that additional studies are
needed to better characterize the correlation between tracer uptake and un-
derlying metabolism. However, irrespective of such correlation, differentia-
tion of a PET volume from its background is an image segmentation issue
that cannot be rigorously addressed using fixed threshold–based methodolo-
gies, which lead to inconsistent tumor volumes in most clinical cases (1–5),
especially heterogeneous ones (1, 5, 8). In these cases and in the absence of
appropriate segmentation tools, it may be more accurate (though less
reproducible) to rely on manual delineation rather than a fixed threshold.
The use of inappropriate segmentation tools may lead to misleading con-
clusions regarding the potential of 18F-fluorodeoxyglucose–PET in guiding
radiotherapy treatment planning or as a prognostic and predictive factor for
therapy response (9). As new algorithms become available and clinical re-
search applications show their potential, the medical equipment and soft-
ware industry should implement them. Minimum standards and guidelines
regarding functional volumes segmentation need to be developed by the dif-
ferent societies involved, first in clinical research and eventually in clinical
practice. This is a slow process, and misleading conclusions as a result of the
use of inappropriate approaches will only reduce further the process of
making available new technology. We therefore suggest a more radical
stance avoiding the use of any fixed threshold-based definition of PET
metabolic tumor volumes in the future, especially if they are to be used
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RANDOMIZED COMPARISON OF WHOLE BRAIN
RADIOTHERAPY, 20GY INFOURDAILYFRACTIONSVERSUS 40
GY IN 20 TWICE-DAILY FRACTIONS, FORBRAINMETASTASES.
IN REGARD TO GRAHAM ET AL. (INT J RADIAT ONCOL BIOL
PHYS 2010;77(3):648-54.)
Dr. Graham and colleagues are to be congratulated in persevering and
completing their randomized study of accelerated whole-brain irradiation
for brain metastases (1). The accelerated prescription of 40 Gy in 20 frac-
tions given twice daily gained attention after Vecht et al. (2) reported that
this prescription provided a median survival in non-operated patients of 26
weeks. This outcome was far superior to the results previously described
in a number of randomized trials of palliative whole-brain irradiation,
which typically used daily hypofractionated prescriptions. Our own at-
tempt (3) to reproduce the experience of Vecht et al. failed. However,
we are reassured to see the findings of our own randomized study with re-
spect to survival (the same as conventionally hypofractionated radiation)
and local control (improved by a factor of 2) duplicated in the report
by Dr. Graham et al.
Nevertheless, how can a treatment that improves local control by a factor
of 2 fail to have a positive impact on survival? Dr. Graham et al. (1) attri-
bute this to the competing risk of death from uncontrolled extracranial dis-
ease. Although important, it is of interest that a quality-of-life study (4) that
opened at our institution and competed with ours for prognostically favor-
able patients (age of\60 and Karnofsky performance scale of $70) pro-
vided those patients with a median survival of 18 weeks. By contrast,
similar patients entering the accelerated trial at our institution achieved
a median survival of 27 weeks (95% confidence interval, 19-35 weeks).
We suspect that, in prognostically favorable patients, the provision of sal-
vage treatments for intracranial relapse (as was done in our study at our in-
stitution) can improve overall survival in patients with controlled
extracranial disease.
Where does this leave accelerated whole-brain irradiation? At the present
time, we have been offering the accelerated regimen described by Vecht
et al. (2) to patients whom I expect to be long- term survivors, in the hope
of reducing the risks of long-term morbidity. The accelerated regimen pro-
vides a slightly lower equivalent dose in 2-Gy fractions (EQD2) than a com-
monly prescribed daily regimen of 37.5 Gy in 15 fractions over 3 weeks
(EQD2 = 42.2 Gy for an alpha:beta ratio of 2 Gy) and published data (5)
do suggest an increasing risk of measurable cognitive loss above an EQD2
of 40 Gy. Of course, no one really knows what the dose per fraction sensi-
tivity is for neurocognitive injury, whether or not the dose response is inde-
pendent of clinical factors such as age, or whether alternative strategies such
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